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Abstract
We have demonstrated that the stereocontrolled conjugate addition of organoduprates to
y-alkoxy-u.f3-unsaturated esters proceeds with high diastereoselectivity in a two
directional strategy. This protocol affords acyclic chains that contain three contiguous
substituents of the anti, anti propionate triad type and its phenylacetate equivalent. a
Aikylations and aldol type reactions on the cuprate adduct also proceed in a
stereoselective manner.
Enolate hydroxylation with a chiral oxaziridine and cuprate additions can be done in an
iterative manner to generate seven carbon acyclic motifs harboring five contiguous
stereocenters consisting of alternating hydroxyl and phenyl substituents with complete
stereocontrol. A series of 1,2-asymmetric inductions starting with a resident y-aIkoxy
group propagate with excellent stereoselectivity through two successive conjugate
additions and two enolate hydroxylations.
We have also dernonstrated that the high degree of 1,2-induction in the Œ-alkylation and
a-hydroxylation reactions can 5e also extended to solid phase. Polypropionate synthesis
can be achieved on solid phase with excellent 1,2 induction through two cuprate additions
and two enolate hydroxylation cycles. The stereoselectivities of these reactions on solid
phase are as good as in solution chemistry and the stereofacial selectivities are the same
for solid—phase and solution chemistry.
xix
The enantiopure indanes and tetrahydronaphthalenes were synthesized from the y-alkoxy
cL,13-unsaturated ester with very high stereoselectivities and good yields using the
stereocontrolled cuprate additions and Friedel-Crafts reactions as the key steps.
The natural macrolide Bafilomycin A1 was successfully synthesized originally from D
mannitol and D-valine using stereocontrolled cuprate conjugate additions and c
hydroxylation to efficientiy instail ail the chiral centers. The Stifle coupÏing reaction was
used to join the two fully assembled segments and macrolactonization was accomplished
with a Keck reaction.
Keywords: 1,2 induction, cuprate addition, solid phase, total synthesis, Bafilomycin A1
xx
Résumé
Nous avons démontré que Ï’addition conjuguée d’organocuprates sur des y-alkoxy esters
a,3-insaturés est réalisée avec une haute diastéréosélectivité, dans une stratégie
bidirectionnelle. Cette méthodologie permet d’obtenir des chaînes acycliques contenant
trois substituants contigus, du type de la triade anti, anti propionate et de son équivalent
phénylacétate. Les réactions de type Œ-alkylation et aldol sur 1’ adduit cuprate procèdent
aussi de façon stéréosélective.
L’hydroxylation d’énolates au moyen d’une oxaziridine chirale et l’addition de cuprates
peuvent être réalisées de façon itérative, de manière à générer des motifs de sept carbones
acycliques contenant cinq stéréocentres chiraux contigus consistant en l’alternance de
substituants hydroxyles et phényles, ce avec un complet stéréocontrôle. Ceci est réalisé
au moyen de deux additions conjuguées et deux hydroxylations d’énolates successives,
qui se propagent avec une excellente stéréosélectivité grâce à une série d’inductions
asymétriques 1,2 débutant avec un groupe y-alkoxy.
Nous avons aussi démontré que le haut degré d’induction 1,2 dans les réactions d’a
aikylations et Œ-hydroxylations peut être étendu à la phase solide. Ainsi la synthèse de
polypropionates peut être réalisée sur support solide avec une excellente induction 1,2 par
itération de deux additions de cuprates et deux hydroxylations d’énolates. Les
stéréosélectivités et sélectivités stéréofaciales obtenues en phase solide sont identiques à
celles obtenues pour la chimie en solution.
xxi
Des indanes et des tétrahydronaplitalènes énantiopurs ont été synthétisés avec une très
haute stéréosélectivité et de bons rendements à partir de y-alkoxy esters Œ,13-insaturés, en
utilisant des additions de cuprates stéréocontrôlées et des réactions de Friedel-Crafts
comme étapes clés.
Le macrolide naturel Bafilomycine A1 a été synthétisé avec succès à partir du D-rnannitol
et de la D-valine; des réactions d’additions conjuguées de cuprates et d’Œ-hydroxylations
ont permis d’installer efficacement tous les centres chiraux. Un couplage de Stille a été
employé pour connecter les deux longs segments entièrement assemblés. La
macrolactonisation a quant à elle été réalisée par une réaction de Keck.
Mots clés: induction-1,2, addition de cuprate, phase solide, synthèse totale, bafilomycin
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THEORETICAL PART
Chapter one Asymmetric synthesis
+ 1-1 The (R)- and (S)- worlds
Organic compounds play an important foie in life, not least in the area of pharmaceuticals
and agrochemicals. The synthesis of an increasing number of compounds possessing
specific structures is required to meet particular needs in the pharmaceutical industry.
Today, a large number of organic compounds have to be synthesized and screened for
biological activity in order to discover potential drug candidates.
The vastly different biological activities of enantiomers and enantiopure diastereomers in
biological systems are welI documented.1 Examples (Figure 1) of the different physical
properties of enantiomers and enantiopure diastereomers include the different odors of
(R)-carvone (speannint and (S)-carvone (caraway), the different tastes of L-(S)-amino
acids such as leucine, phenylalanine, tyrosine and tryptophan (bitter) and the
corresponding D-(R)-enantiomers (sweet), (S,S)-aspartame (sweet) and its (S,R)
diastereomer (bitter). Further relevant examples to modem medicine include the different
bioactivities of D-propoxyphene (analgesic) and L-propoxyphene (antitussive, no
analgesic effect), (R)-thalidomide (sedative and hypnotic) and (5)-thalidomide
(teratogenic, the cuiprit of the welÏ-known tragedy of birth defects), and the profen-drugs
(2-arylpropionic acids, non-steroidal anti-inflammatory drugs).
Ï
Figure 1 The (R)- and (S)- worlds
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Often biological activity arises through the interaction of an organic compound with a
biomolecule such as an enzyme or a receptor. When dealing with curai non-racemic
molecules, especially with single enantiomers, specificity becomes an important issue, if
(R)-(-)-carvone
spearmint
(5)-thalidomide
teratogenic
(R)-thalidomide
sedative and hypnotic
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an organic compound itself is chiral, then its two enantiomers are Iikely to interact
differently with a given curai biomolecule resulting in different biological responses.
The levels of such biological activity for two enantiomers may be so different that the
two enantiomers should be viewed as two distinct compounds. So using the racemate of a
particuar biologicaily active compound is equivaent to using a mixture of two different
compounds 2
For several reasons, a racemic mixture of a dmg is seldom used in the phannaceutical
industry.2 Firstly, one enantiomer of the two may be more active than the other.
Secondly, both enantiomers may have some side-effects. Thus it is better to use the most
active and least toxic enantiomer in therapeutic practice. Therefore, enantiopure drngs are
imperative.
There are two general methods for preparing enantiopure or diastereopure cornpounds,
resolution of the racemate, and asymmetric synthesis.3 Resolution, aithougli apparently
straightforward, may often be expensive because a stoichiometric amount of a suitable
agrent is required and because the unwanted enantiomer lias to be disposed of.3
Therefore, asymmetric synthesis is invariaNy considered in the initial plans.
+ 1-2 Asymmetric synthesis
Asymmetric synthesis is a process in which a chiral moiecule in a mixture of molecules is
converted into enantiopure or enantio-enriched units. For asymmetric synthesis, we
divide substrates into two categories, cyclic systems and acycÏic systems. In cyclic
3
systems, especially in six-membered ring systems, where the conformations are rigid and
predictable,4’5 diastereoseÏective synthesis with stereocontrolled introduction of
substituents may 5e carried out by reying on conformatïonal bias.6
In acyclic systems, the substrate can adopt numerous conformations depending on many
electronic, steric, solvent, additive, and temperature effects.7 It is therefore more difficuit
to achieve diastereoselectïve synthesis in these systems. High stereoselectivities were not
achieved before 1970 though many studies had been carried out.7 However in the last
two decades, great progress lias been made in acyclic stereocontroL Many complex
natural compounds such as Palytoxin,8 Swinholide A,9 Rapamycin’° with over ten
stereogenic centers have been synthesized. Virtually complete stereocontrol is quite a
common feature of asymmetric synthesis today and obtaining enantiopure compounds
with a few stereogenic centers is now an easy task.
lii order to achieve high Ïevel of induction in asymmetric synthesis, at least one
component of the reaction must 5e chiral.1’ if there is no asymmetric component in the
reaction, then the transition state wiIl be enantiomeric and equal in energy, resulting in
the formation of a racemate. In principle, the use of a chiral, non-racemic substrate,
reagent, sovent or catalyst should lead to asymmetric synthesis.
+ 1-2-1 Chiral solvent control
In an organic reaction, using a chiral and non-racemic solvent may lead to asymmetric
induction if the solvent is involved in the transition state.’2 Because the solvent is chiral
4
and non-racemic, the transition state of the organic reaction should be enantiomeric or
diastereomeric and an asymmetric synthesis should become possible. Unfortunately, this
approach has been of littie use because the level of induction is often low and
unpredictable.13 In addition to their high costs, there are very few enantiomerically pure
solvents which are available in sufficient quantity and which possess the properties
required to be useful.
Involving a chiral and non-racemic substrate, auxiliary, reagent, or cata]yst to obtain
good stereoselectivity are more promising approaches.
+ 1-2-2 Chiral non-racemic substrate control (chiron approach’4)
This approach is a basic strategy for asymmetric synthesis and uses curai non-racemic
molecules, where the chirality usually cornes from a resident stereogenic carbon present
in a natural compound. Because the chiral center is usually close to the site of reaction,
the resulting transition state is chirai and then asymmetric induction is achieved. The
advantage of this approach is that there is no need to take extra steps to attach and then
remove a chiral auxiliary, nor are curai reagents needed to control stereoselectivity.
Nature provides many chiral compounds such as carbohydrates, amino acids, terpenes,
steroids and alkaloids’5 for use in this approach. 1,2-Asymmetric induction gives the
greatest control and is the most important and extensively studied case. 1,3-Asymmetric
induction is often found in the biosynthesis of natural systems, such as l,3-polyol
compounds’6, and several highly stereocontrolled methodologies have been developed.’7
High stereocontrol of 1,4-asymmetric induction lias been difficuit to achieve and only a
5
few examples are documented.’8 So the limitatïon of this approach is that it is flot
possible to control the stereochemistry of the newly formed center(s) the further it is from
the resident (usually over three carbon bonds) center(s). In this approach, the Feikin
Ahn’9 model and Cram’s rule2° are very important models for prediction of the
stereochemical outcome of 1,2- and 1,3 —induction on reactions involving nucleophilic
attack.
• 1-2-3 Chiral auxiliary control
In this approach the pro-curai substrate is attached to a chiral, non-racemic group, known
as a chiral auxiliary, prior to the reaction, and these chiral auxiliaries then control
stereoselectivities of the asymmetric reaction. The chiral auxiliaries must be cheap and
easy to obtain in quantity with high enantiomeric purity to insure high disoselectivity.
Chiral auxiliaries must be easiiy attached to the pro-chiral substrates and the control of
stereoselectivity must be high and predictable. The major diastereoisomers should be
easily purified after the reaction. Chiral auxiliaries shouid be easily removed from the
reaction products without jeopardizing the diastereoisomeric or enantiomeric purity of the
products.
Finally, chiral auxiliaries should be easily separated and recovered after cleavage.
Evans2’ and Oppolzer’s22 curai auxiliaries are two excellent examples (Scheme 1) of
what can be achieved using chiral auxiliaries.
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Scheme 1 Evans’ and Oppoizers chiral auxiliaries in asyinmetric synthesis
a: Evans’ auxiliary
ONH
Ph’ Me
A1
BuLi
RCH2COCI
OÀN
‘Me
A2
1. LDA ONfR
2. EtI L.___/ Et
Ph Me
A3
LiOH, H20/MeOH /
or LiOH, H202, H2OtrHF
HO
R
LiAIH4
or NaBH4
R
b: Oppolzer’s auxiliary
NaH, then
RCH2COCI 1. R2BOTf, (Pr’)2NEt
2. R2CHO
Me Me
NR2
R1
A5
L1OH, H2O2//
HOR2
4
R2
A10
The chiral auxiliaries A1 and A6 are easily attached to the pro-chiral substrates to form A2
and A7 respectively, which undergo the asymmetric reactions to give enantiopure
products A3 and A8. In these two reactions, the stereoselectivities and stereochemistry are
totally controlled by the two curai auxiliaries A1 and A6 through rigid coordinated metal
intermediate enolates. Finally, A1 and A6 can be cleaved from A3 and A8 by using
A6 A7
7
reduction or hydrolysis to give the A4 and A9 or A5 and A10 for further modifications. A1
and A6 can be separated and recovered from the reaction mixture for further usage.
Figure 2 Chiral auxiliaries
OMe
SMP 23a
OMeNH2
SAMP 23b
ONH
Oxazolidone 23c
Me
Me
trans-1 2-diaminocyclo
-hexane-based 23U
OH
Menthol-based 23g
Ph
RN
OMe
Oxazoline 23e Bicyclolactam 23f
o
tBu111KH
SRS-based 23i
Extensive studies conceming this approach have been carried out and many chiral
auxiliaries have been developed and tested (Figure 223). At present, there are relatively
few chiral auxiliaries which meet ail the requirements.
The advantage of this approach is that it can allow the generation of a curai center (or
centers) which is far from a chiral center. The reactions are often highly predictable and
Camphor-based 23h
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reliable. The auxiliaries can be recycled. The limitation is that stoichiometric quantities of
the curai auxiliaries are required to be attached to the substrates before the reactions and
to be cleaved after the reactions.
4 1-2-4 Chiral catalyst control
A chiral, non-racemic catalyst can be used ta control the stereoselectivity in asymmetric
synthesis. The principle of this approach is depicted in figure 3. In this approach, the
stoichiometric reagent is achiral but does flot react with prochirai substrate in the absence
of the catalyst. The catalyst associates with the prochiral substrate first to form the
complex A which then reacts with the reagent to give the new complex B in which a new
chiral center shouid be fonned. Then the catalyst is disassociated from the rnodified
substrate B and goes back into the catalytic cycle.
,..._— prochiral
substrate
association
catalyst
compiex
B
asymmetric achiral reagent
reaction
Because the chiral catalyst is involved in the transition state, asymmetric induction is
expected. This approach is most promising for asymmetric synthesis because it can be
Figure 3 Protocol of chiral catalyst control
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economic. A small amount of the chiral, non-racemic catalyst leads to stoichiometric
amounts of the desired enantiomerically enriched product. This approach is most
generally studied in asymmetric chemical synthesis, and synthetic catalysts24 are used to
achieve asymmetric synthesis in academic laboratories and in industry. Que of the earlier
representatives of this approach is the Sharpless epoxidation25 which is shown in Scheme
2. Unfortunately, relatively few catalysts, which give a high enantiomeric excess within a
class of substrates, are universally applicable.
Scheme 2 Chiral catalyst controlled-Sharpless epoxidation reaction
Ti(OPr, ButOOH
R2R3
Ti(OPr’)4, ButOOH
R2R3
R1 (+)-dialkyl tartrate (cat.) (-)-dialkyl tartrate (cat.) R1’’
A11 A12 A13
+ 1-2-5 Chiral and non-racemic reagent control
In this approach, a stoichiometric amount, or more, of the chiral reagent is used to
achieve stereochemical control. The stereogenic center(s) in the chiral non-racemic
reagent(s) controls the stereochemistry of newly formed chiral center(s) in the product.
Roush’s allyl boranes26 (Scheme 327) and Brown’s crotylborane reagents28 (Scheme 329)
are among the most successful examples of this approach. The stereoselectivities are high
and stereochemistry predictable. Unfortunately, only a few of these reagents have been
developed and most of them are usually expensive.
‘o
Scheme 3 Chiral and non-racemic reagent control
a: Rousli’s chiral allyl dialkoxy borane
CO Pr’
+
Me
Me
+ 1-2-6 Kinetic resolution
In this approach, a resolution of a racemic substrate is achieved at the same time as an
asymmetric reaction is carried out. This approach relies on the difference in the rate of
reaction of the individua enantiomers of the racemate with an enantiomerically pure
R
A14 R=n-C8H17
R
Me
A15 A16
CO2Pr’
OH
o o
R +
IflhIICOPri R
H
Me
A17 R=n-C8H17 Me A13 A19
b: Brown’s chiral crotylboranes
MeH
+
A20
Me
Me
A22
MeH
+
A23
Me2
A25
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reactant, reagent, or catalyst. In an ideal case this rate difference is so large that one
enantiomer of the racemate does flot react, whule the other reacts rapidly. Routine
separation of the product and the unreacted enantiomer wouÏd then provide both in an
enantiomerically pure form. There are numerous examples of the use of Sharpless
asymmetric epoxidation3° for kinetic resolution in the asymmetric synthesis of various
types of targets. An example of those is shown in Scheme 4•3a
Scheme 4 Kinetic resolution-Sharpless epoxidation
HOj ÷ Ti(OPr4, ButOOH +
E D-(÷)-diethyl tartrate E
Me Me
A26 A28
Racemic mixture
Under the above reaction conditions, the enantïomer A26 of the racemate reacts very fast
with the reagents to form enantiomerically pure epoxide product A28, whule the
enantiomer A27 of the racemate reacts very slowly. At the end of the reaction, only the
epoxide A28 and enantiomer A27 are left. These two different compounds may be
separated easily by column chromatography or crystallization.
The above approaches are basic strategies actually used for asymmetric synthesis. In
many cases, two or even three approaches are used at different stages of the total
synthesis of natural and unnatural products.
Me
A27
Me
A29
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Chapter two Cuprate reagents
+ 2-1 Introduction
The conjugate addition of organometaïlic reagents (R-M) to a.f3-unsaturated carbonyl
compounds is one of the most important carbon-carbon bond formation reactions for
organic synthesis. Aithough organometallic compounds such as M=Li,3’ B,32, AI,33, AÏ-
Ni34, Si-Ni35, Zr-Ni36, or Zn37 have provided convenient methods for conjugate addition,
organocopper derivatives are definiteiy the most widely used reagents. Colirnan and
Hegedus38 summed up the situation some years ago in their text on organometallic
chemistry by stating, ‘0f ail the transition-metal-organometallic reagents developed for
application to organic synthesis, organocopper complexes are by far the most heavily
used and enthusiastically accepted in synthetic chemistry “ Numerous publications
and reviews have documented specific organocopper chemistry.39
+ 2-2 Cuprate reagents
Numerous cuprate reagents have been developed and they are basically prepared by
reacting either organolithium reagents (Jithium-based) or Grignard reagents (magnesium
based) with different copper saits such as CuX (X=I, Br, Cl) or CuCN at certain
stoichiometric ratios. The reactivities of these reagents can be dramatically changed by
adding ligands and additives. A large number of diverse new cuprate reagents have been
developed and they can be classified into three categories (R, aikyl group; M, metal ion,
Li or Mg; X, halide from copper saits and Grignard reagents; L, iigand; A, additive as
activators):
(I) RM + CuXLA (CuX, catalytic amount)
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Using Grignard reagents alone as organometallic components in dispiacement reactions
or conjugate addition reactions usually does flot afford coupling products in syntheticaÏly
useful yields or the reactions arc very siow.39e The reaction can be significantly improved
when these reactions are run in the presence of catalytic amount of copper(l) sait (such as
Li2CuCi2 or Cul). Aithough the effectiveness and reproducibiiity may need to be
improved, these catalytic processes are a very promising ways to reduce the amount of
copper used in the reaction (which is a big problem on an industrial scale)4° and to
deveiop asymmetric version of this reaction.4’
(II) RCuMXLA
Because the solubility of these kinds of cuprate reagents in organic solvents is iow, RCu
type reagents are not usuaily reactive enough for synthetic use.39C The soiubility can be
increased, however, by using certain iigands (CN, R3P, (RO)3P, R2S)39e and additives
(BF3, etc.).39e
(II) R1R2CuMXLA
These cuprates are the most frequently used reagents in organic synthesis because they
are soluble in THF and ether, their reactivity is greatly enhanced. In the reaction, oniy
one R group (R1 or R2) of R1R2CuMXLA is transferred, therefore, selectively
transferring only one group R (uniess R1 and R2 are same) for a specific reaction has been
the ‘holy grau” for this ldnd of cuprate. The two basic approaches to this problem have
been the use of a non-transferable group R (or “dummy’) bonded to Cu at an sp or sp2
carbon (e.g., alkynyl42 or 2-thienyl,43) or attached to Cu via a heteroatoms (S,44 N, or
P46).
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R2CuLi (Gilman reagents, a low order cuprate, made from CuX and 2 equv. of RLi) are
the original forms of this type of organocopper reagents. Many modifications of Gilman
reagents have been made to increase the reactivity further or to meet the needs for some
specific uses.
R2Cu(CN)Li2 (Lipshutz reagent, higher order cyanocuprate, made from CuCN and 2
equv. of RLi) is another frequently used cuprate whose reactivity is as good as that of the
Gilman reagent.
+ 2-3 Mechanism of cuprate addition
The popularity of organocopper complexes as reagents in organic synthesis, especially in
conjugate addition reactions, has spawned numerous mechanistic investigations, as weII
as useful tools for carbon-carbon Œ-bond formation. However, the structure of
organocopper reagents and detailed mechanisms of the reactions remain unclear. The
aggregate structure and mechanism show a strong dependence on the substrates and the
reaction conditions (solvents, temperature, additives). For ah cuprate reagents, the basic
structure R2CuM remains.47 The “higlier order cuprate” (Lipshutz reagent)48 seems to be
R2CuLiLiCN and the Ashby reagent (R3CuLi2)49 seems to be R2CuLiRLi. Organocopper
reagents (Gilman and Lipshutz reagents) are mostly used in the conjugate addition of
carbonyl compounds.
Studies show that conjugate additions of cuprate to Œ,13-unsaturated carbonyls, or related
compounds (cuprate addition) are greatly accelerated by additives such as BF3 etherate,5°
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and TMSX (X=C1, I, CN, OTf).51 Its mildness and compatibility with many functional
groups make TMSC1 the most frequently used additive in cuprate additions.
It is generally agreed that the cuprate reagent and substrate initially react rapidly with
each other to form a d-7t* comp1ex,5r followed by formation of a copper (ffl)-bond.
Reductive elimination from this copper (III) species affords the enolate or enoates.
Although the accelerating effect of TMS-C1 on cuprate additions remains unclear, some
scientists do propose mechanisms for this reaction.
+ 2-3-1 Corey’s proposai5
Corey proposed that TMS-C1 trapped an initial cuprate-substrate (d-7t) complex B2
(figure 4) thus shifting the equilibrium towards the resultant silyl enol ether B3.
Reductive elimination then gave the 1,4 addition product B4.
Figure 4 Corey’s proposai for the Me3SiCI-accelerated cuprate 1,4-conjugate addition
reaction
TMS
CuR2RQ
+ 2-3-2 Kuwajima’s proposai52
A second scenario suggested by Kuwajima (Figure 5) invokes a TMSC1-substrate
interaction in a Lewis acid-Lewis base sense. TMSCJ acts as a Lewis acid and binds the
B2
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ooxygen of enone B5 giving B6 in which the 13-carbon becomes more electrophulic and
reacts with nucleophilic cuprates. In this way, the cuprate conjugate addition reactions are
accelerated.
Figure 5 Kuwajima’s proposai for the Me3SiC1-accelerated cuprate I ,4-conjugate
addition reaction
clE.
-S1Me3 tl.
-SiMe3
TMSCI R2CuLi
1 UR2
B5 B6 B7
+ 2-3-3 Lipshutz proposaISb
Lipshutz proposed (Figure 6) that an interaction between TMS-Cl and R2CuLi might
exist where TMS-Cl acts as a Lewis acid towards the cuprate. Interaction between the
lithium cation and chlorine increase the Lewis acidity of the trimethylsilyl group itself.
The Me3Si residue is well-positioned within the cuprate cluster on an enhanced “pusli and
pull” effect, which is generaily regarded as essential for the activity of the cuprate as a
Michael donor.
R2
B8 B9
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Figure 6 Lipshutz’s proposai for Me3SiC1-accelerated cuprate 1,4-conjugate addition
reaction
Si. / Q SiMe3
cl o cl /
enone 1 ,4 addition Li
e%
R—Li—R R—Li—R R—Li—R R
B10 B11 B12 B13
ê 2-3-4 Bertz’s proposai53
Bertz proposed a new mechanism (Figure 7) after he performed careful experiments on a
cuprate-TMSCI-enone system and carried out a density functional theory (DFT)
calculation. His proposai is consistent with both the experimental evidence and the
theoreticai resuits.
Bertz chose to react Bu2CuLiLiI wïth 2-cyclohexenone using TMSCI as an additive. The
study shows that a short reaction time favors compound B18, while longer reaction times
tends to favor compound B19. That means that TMSC1 reacts very siowiy with the enone
and even the enolate. This evidence mies out the three mechanisms suggested before
because they ail suggested TMSC1 reacts rapidly with enones to form TMS enol ethers.
Bertz proposed that TMSCI enhances the rate of cuprate addition by promoting
conversion of the initially formed drt* complex B15 to a reactive copper species B16
capable of rapid reductive elimination to product B17. The presence of a bridging Cl
18
places the Si atom in the [3-position relative to Cu (1H), in analogy with [3-silylcarbenium
ion, thus stabilizing the transition state for reductive elimination.
Figure 7 Bertz’s proposai for Me3SiCi-accelerated cuprate l,4-conjugate addition
reaction
Bertz did experiments to test his proposai.54 He prepared three cuprates,
BuCu(CH2SiMe3)Li, RCu[N(SiMe3)2JLi and BuCu(SSiMe3)Li, ail of which have silicon
in the F3 position relative to copper and compared their reactivities towards 2-
cyclohexenone with those for BuCu(Th)LiLiCN and Bu2CuLi LïCN. The resuit shows
that the BuCu[(CH2Si(CH3)3] LiLil is significantly more reactive towards 2-
cyclohexenone than the corresponding 2-thienylcuprate and cyano Gilman reagents in
both diethyl ether and THF. In fact, the yields of 3-butylcyclohexanone are quantitative
-78°C
R2CuU
B14
Reductive
Eh mination
o
R2CuL1
B15
Ç[MSCI
Slow.
LiC
TMSCI
CI—SiMe3
B16
B18
B17
B19
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or nearly so (99-100%) from BuCu{(CH2Si(CH3)3J LiLil and BuCu[(CH2$i(CH3)3]
LiLiCN in both ether and THE even at the shortest time (4 seconds).
The resuit also shows that the yieids appear to be independent of the nature of the lithium
sait such as LiCN and Lii, but dependent on the atom to which silicon is bonded to (eg.
N, S or C), carbon being the best. His other experÏments on the thermal stability of the
silicon containing cuprates show that cuprates are much more thermally stable than the
corresponding 2-thienylcuprates and the cyano Gilman reagents.
+ 2-4 Role of counter-cation, M
Although the exact nature of the counter-cation, M of cuprate is stili an open question,55
it is very important for their reactivity. The reactivity of the cuprate can be adjusted,
depending on the nature of M, and its removal results in loss of reactivity. Certain
structural features such as the nature of M, the state of aggregation are vitally important
to the reactivity.
+ 2-5 Role of solvents
The choice of solvent also plays an important role in cuprate addition reaction, depending
on differences in their solubility and coordinating effects.54 Tetrahydrofuran and ether are
the commonly used solvents for synthetic purposes.54 The coordination of a solvent can
facilitate cuprate formation and stabilize the Cu (1H) intermediate species.
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Chapter three Stereocontrolled cuprate additions to conjugated systems
+ 34 Introduction
As already discussed, cuprate conjugate addition reactions are very versatile in organic
synthetic chemistry. Stereocontrolled cuprate additions make this carbon-carbon bond
forming reaction much more powerful. Numerous publications have documented these
studies56 and several approaches have been developed to reach this goal.
(a) Using cuprates with non-transferable chiral ligands to control enantioselective
1,4-additions, and in some cases, remarkable e.e (90%) have been achieved.57
Because a stoichiometric amount of chiral ligand has to be used, this approach is
expensive and not practical in industrial synthesis.
(b) Catalytic amount of chiral copper complex or external curai ligands is used to
control enantioselective Ï ,4-conjugate additions. Sometirnes, as high as 95% e.e
can be obtained.57 This approach can only be used for Grignard or organozinc
reagents and cannot be applied to Gilman reagents.
(c) Chiral auxiliary control. This approach is mostly used in enantioselective 1,4-
conjugate addition of cuprate reagents to a,f3-unsaturated esters or amides. The
chiral auxiliaries are attached to the esters or amides to control the 1 ,4-conjugate
addition, The most successful exampie of this approach so far is to use Oppoizers
camphorsultam58 as the auxiliary, where the resulting e.e is high and different
enantiomers of the camphorsultam auxiliary give different enantiomers of the
product after hydrolysis. The limitation of this approach is the chiral auxiliaries
have to be attached to the substrate and then removed after reaction.
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(d) Conformational control is mostly used in cyclic systems.59 Because of the
relatively weIl-defined conformation of the cyclic systems, cuprate reagents
approach the conjugate system from one favored face achieving stereoselectivity.
This approach is of limited applicability in acyclic systems.
(e) Substrate control (especially 1,2 induction) is the most versatile methodology to
achieve diastereoselective cuprate conjugate addition on carbonyl compounds.6°
The conjugate addition of organocopper reagents to enones is a classical reaction in
today’s repertoire of stereocontrolled C-C bond forming reactions60. In contrast,
stereocontrolled conjugate addition of organocopper reagents to acyclic Œ,f3-unsaturated
esters had remained less exploited until Yamamoto and co-workers6’ demonstrated that
MeCuBF3 addition to 7-substituted cL,J3-unsaturated esters gives quite good
stereoselectivity.62 More studies of cuprate addition to y-alkoxy-a,J3-unsaturated esters
were pubÏished with pronounced stereoselectivity being observed.63 Yamamoto and co
workers64 have further shown that the y,-dia1koxy, a,j3-unsaturated esters and related
compounds react with organocopper-Lewis acidic reagents with 1 ,3-chirality transfer,
resulting in double bond transposition and Œ-aÏkylation with excellent stereoselectivity.
Organocuprate additions to Œ,J3-unsaturated esters in the presence of trimethylsilyl
chloride were also studied and faster reactions and higher yields were observed.65 There
are conflicting reports on the dependence or non-dependence of the double-bond
geometry on the stereochemical outcome of conjugate additions to y-alkoxy a,3-
unsaturated esters.61’ 63
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+ 3-2 Conjugate addition of cuprate to y-alkoxy a,13-unsaturated esters
Conjugate additions of cuprate to 7-alkoxy Œ,13-unsaturated ester (Table 1)66 with lithium
dimethylcuprate in TFTF in the presence of TMSC1 has also been studied in our
laboratory. Conjugate addition took place in excellent yields to give a high
preponderance of the anti (3S)-methyl products in each series. The highest
stereoselectivity was observed for the BOM ether with an anti/svn ratio of 14: 1.
Table 1 Stereocontrolled addition to y-alkoxy a,f3-unsaturated ester (1, 2-induction)66
OR
OR Me-,CuLi/TMSCWTHF
TBDPSO
7$C to 20 °C, 2h TBDPSO
2 e 7$-92% E
Me
cl t’
‘—n
Substrate R Product Ratio
BOM antjjs’un 14:11
2 MOM anti/syn 11:1
antt/s’n 9.$:13 MTM
4 Me antt/syn 9.9:1
A modifïed Felkin-Ahn transition state model (Figure 8) for the ‘y-alkoxy series was
proposed to interpret the observed stereoselectivity. The proposed anti-adduct model
(OP-inside), which agrees with both the Morokuma67 and Yamamoto proposals,61c bas a
number of positive features in its favor. It allows a favorable interaction of the alkoxy
group with the It-system through a two-electron (p) and a four-electron (It) interaction68
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in the ground state. In addition, the high-lying aR’-C orbital can interact wïth the low
lying r* orbital thus stabilizing the Œ,13-unsaturated fragment, and rendering the carbonyl
of the ester a better chelation site. Furthermore, the anti-orientation of R group in the
proposed model may also stabilize the incipient c*CCu orbital in the d,ft* complex-f3-
cuprio (III) adduct, through sigma bond donation (Cieplak effect).69 The proposed model
is also free of 1, 2-allylic strain.
Figure 8 Transition state model for cuprate addition
HCO2Me PCO2Me
anti, major isomer syn, minor isomer
+ 3-3 Further studies of conjugate addition of cuprates to y-alkoxy a4-unsaturated
esters, and 1, 2 induction
Later, our group further explored the generality of this anti-conjugate addition of
dimethyl cuprates to y-alkoxy cLj3-unsaturated esters and extended it to other
organoalkyl7° groups (shown in Table 2). Good to excellent anti-stereoselectivity was
obtained for various cuprate reagents in the conjugate additions when the reactions were
carried out at —7$ °C. Thus, the generality of this methodology to prepare f3-alkyl
—y
alkoxy esters was proved.
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Table 2 Asymmetric cuprate additions to acyclic systems (Ï, 2-induction)70
060M R CuM TMSCI
060M
TBDPS0COMe THF,-78 C C0Me
R M YeId AntilSyn
Methyl Li 93% >50: 1
Ethyl M9Br
>50: 1
Butyl u 90%
>502
Vinyl MgBt 70% >12: 1
2-Propenyl Li 60% > 8: 1
Having demonstrated the generality of 1,2 -induction in the y-substituted Œ,13-unsaturated
ester motif, we then explored the prospects of electrophilic additions of the corresponding
enolates. Treatment of the adduct C2 obtained from lithium dimethylcuprate addition to
the cL,f3 unsaturated ester Ci, with KHMDS and quenching with methyl iodide and benzyl
bromide respectively (Figure 9) gave excellent yields of the 2S, 3S-dimethyl, and 2S-
benzyÏ-38-methyl substituted analogs essentially as single products as evidenced by
‘HNMR spectroscopy. No reaction occurred when LïHMD$ or NaHMDS were used as
base in this reaction. This method provides an expedient route to enantiomerically pure
acyclic compounds that contain vicinal syn-related aikyl substituents. Treatment of the
potassium enolate with the Davis oxaziridine reagent71 provided enantiomerïcally pure cx
hydroxy ester after chromatography. In each instance, and regardless of the nature or size
of the y-substituents on the chain, hydroxylation took place to give syn-selectivity. This is
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another way to generate propionate biosynthetic triads. The syit-selectivities of
these a
hydroxylation reactions were explained by the proposed mode! C3 (in figure 9)
Figure 9 Stereocontrolled a-hydroxylation7°
R
OBOM OBOME
TBDPSOJ
1.KHMDS TBDPSO
c
E syn/ anti >20 1
2 C3 E=OH, Me, Bn.
+ 3-4 Polypropionate syntheses and application to the synthesis of the
acyclic
segment of Rifamycin S72
This methodology was further explored in our group to synthesize polypropio
nates,72 a
ubiquitous motif produced by biosynthesis in important classes of antibiotics s
uch as
macrolides and ionophores.73
This methodo!ogy was expÏoited in the synthesis of the C19-C28 polypropionate subunit of
rifamycin S (figure 10). Starting from 7-a1koxy-a,3-unsaturated ester C1 and installing
vicinal methyl/hydroxyl groups to give C4, the chain was then extended via Wit
tig
reaction74 to generate a new y-alkoxy-a,f3-unsaturated ester motif C5. A conjugate
addition-hydroxylation protocol on C5 completed the second propionate-type stereotriad
to generate C6 which was subjected to chain-extension and reiteration of the conjugate
addition and hydroxylation process, provided an overail anti/syn/anti/polypropi
onate.
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Figure 10 Strategy for the synthesis of polypropionates72
“0k”OR OH OR OR
‘CO2Me
extension
CO2Me
L )
C4 C5 Cuprate
OR OR OH OR OR OH
extension
1LCOM
inversion
!‘1CO2Me
Me Me Me Me
C6 C7
Me Me
C8
Cuprate
OR OR OR OH
-- [1CO2Me
inversion
Me Me Me
cg continue
Four consecutive cuprate additions and four hydroxylations were performed to generate
eight vicinal stereocenters (four propionate units) in a highly stereocontrolled manner on
an acyclic system! The C19-C28 segment of rifamycin S with 9 stereogenic centers was
built from a single chiron in 23 linear steps (Scheme 5)•72
Scheme 5 Stereocontrolled synthesis of C19-C28 subunit of Rifamycin S72
OBOM
TBDPSOVCO2Me
Me Me Me Me
23 UNEAR STEPS
OMe OMOM 080M 080M 0H
ENANTIOPURE C10
Rifamycin S
uo+
CO2Me
Cuate 1
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The iteration could also be processed with an option to grow polypropionate stereotriads
having diastereomeric relationships by inverting the configuration of the a-hydroxylation
products via a Mitsunobu reaction. This simple protocol can give rise to combinations of
stereotriads shown as types A, B, C (Figure 11). The syn/svn motif in D cannot be
prepared by the above protocol because of the inherent stereochemical outcome of the
conjugate addition and subsequent hydroxylation. This particular stereotriad, however,
can be obtained indirectly by an oxidation-reduction sequence from a motif related to D,
with functionally different ends.
Figure 11 Propionate $tereotriads
OH ÏH
Me Me Me Me Me Me Me Me
- A B C o
ail the combinations
This powerful methodology may be used to synthesize many natural compounds, such as
macrolides and ionophores. Some examples are shown in Figure 12, where the red area
may be installed by the above methodology.
The above methodologies provide access to enantiopure propionate triads in acyclic
systems in a one-directional chain extension. We then decided to explore the option of
constructing triads in a two-directional way.
2$
Figure 12 Macrolides and ionophores
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Chapter four Stereocontrolled cuprate addition in a two directional manner
+ 4-1 Introduction
In organic synthesis, there are four main strategies to synthesize an acyclic chain (figure
13), namely:
Figure 13 Strategies for the synthesis of acyclic chain
1. Linear Synthesis (One directional)
AB ABC ABCD ABCDE
ABCDEF
2. Convergent Synthesis (One Directional)
AB ABC \ Coupling
-. )
______
/D E
3. Two-Directional Synthesis by Sequential Homologation
AB
CD CDE CDEF
ABCDEF
4. Two-Directional Synthesis by Simultaneous Homologation
CD BCDE
(B=E) (A=F)
(1) One-directionat tinear synthesis: this strategy consists of building target acyclic chain
from one end to the other and it can be used in any synthesis. This strategy may avoid the
difficuit coupling of two segments as in convergent synthesis; however, it possesses the
limitation that as the chain grows, one may require carrying multiple protecting groups.
Consequently, the synthetic sequence may be long with low overali yieïds.
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(2) One-directionat convergent synthesis: this strategy involves synthesizing the target
acyclic chain by coupling two nearly equal-length segments together. The synthetic
sequence may be shorter and the overail yieid higher than in a linear synthesis. Whenever
possible, this strategy is used in almost ail muiti-step syntheses. The major limitation of
this approach is the need for the coupling of the two large segments which may be
difficuit, especially if they are densely functionalised.
The one-directional linear and convergent syntheses are the two most commonly used
strategies in the literature.
(3) Two-directionaÏ synthesis by sequential homologation: This strategy is similar to the
one-directional linear synthesis. As matter of fact, target chains are synthesized from the
middle, finishing one haif of the chain from one end, then building up the other haif from
the other end. Although the synthetic sequence is stiil longer than by one-directional
convergent synthesis, it is comparable in efficiency to one-directional linear synthesis.
(4) Two-directional snthesis by sinzuttaneous homologation: This strategy involves
homologating both ends of the cliain at the same time. The operational requirement
necessitates that the two ends of the chain be symmetric, since desymmetrizing the ends
is required in the end of a synthesis. This strategy lias received considerable attention
over the Ïast few years, largely through the pioneering efforts of Schreiber75. This
strategy offers a highly efficient route to synthesize the target in relatively few steps,
compared with the above three strategies.76 The limitation is that this strategy can onÏy
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apply to molecules which have a significant element of symmetry and desymmetrizing is
difficuit in many situations.
+ 4-2 Stereocontrolled cuprate addition in a two directional manner
Having demonstrated the efficiency of asymmetric cuprate addition in one directional
linear synthesis by previous members in this group,72 we turned our attention to try two
directïonal asymmetric cuprate addition to uj3-unsaturated esters. In order to avoid the
difficult desymmetrization of the two ends when using two-directional simuÏtaneous
homologation strategy, we considered two-directional synthesis by a sequentiaÏ
homologation strategy as shown in Scheme 6.
Scheme 6 Two-directional cuprate additions by sequential homologation
- 000M Cuprate 000M Functional group
TBDPS0_ L. addition manipulations
Di R1=alkyl, vinyl, Ph etc
000M 000M
Cuprate addition MeO2CR
D2 R1 R2 i
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OBOM
OBOM 2 ORE Cuprate addition MeO2C N
EMeO2C 2 R3 R1
Ri D5 R3=alkyl, vinyl, Ph etcD4
Starting with a,f3-unsaturated ester C1, the first cuprate addition gave the product D1 with
very good trans-stereoselectivity and yield.64’ 68 After several functional group
manipulations, the chain of the first cuprate adduct was extended in the other direction to
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fomi the second Œ,f3-unsaturated ester D2. Analogously, cuprate addition on D2 afforded
the desired products with high trans-selectivity in good yield. Several kinds of
stereotriads may 5e synthesized by this method. The stereochemistry of the alkoxy group
of u,13-unsaturated ester D2 may be inverted such that cuprate additions on the resulting
ester D4 may give other stereotriads. Five kinds of triads may be synthesized by this
protocol (Scheme 7) including anti, anti propionate, phenylacetate, and mixed propionate
phenylacetate triads.
Scheme 7 Stereotriads
anti, syn
phenylacetate
triad
0f ail the propionate triads, the anti, anti orientation appears to be the most difficuit
accessible77. b the best of our knowledge, the analogous phenyi-hydroxy-phenyl triads
are flot known and they could constitute interesting phenylacetate counterparts of the
ubiquitous propionate assembly protocol.
Me Me
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OH
çç
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OH
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mixed propionate
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+ 4-2-1 Synthesis of anti, anti propionate triads and anti, anti mixed propionate
phenylacetate triads
Our synthesis of the above triads (Scheme 8) began with ester 1 which was synthesized
from D-mannitol in 100-mmol scale.78 In order to differentiate the end groups in the
intended seven-carbon acyclic motifs, the ester was reduced to the corresponding alcohol,
which was then protected as trityl ether to provide 2 in 82% overall yield. Deprotection of
the TBDPS with TBAF gave the primary alcohol 3, which was then transformed to the
Œ,j3-unsaturated ester 4 using a Swern oxidation and a Wittig reaction. Dimethyl cuprate
addition to 4 at — 78 oc with TMSCÏ as an additive provided the anti, anti triad 5 in 92%
yield with over 20:1 stereoselectivity.
Reaction of diphenyl cuprate with the a,J3-unsaturated ester 4 was found to be siower
than corresponding dimethyl cuprate addition reaction possibly due to steric interactions.
Thus, excess reagent and longer reaction times were needed to complete the reaction
leading to 7 in 86% with over 10:1 stereoselectivity.
The stereochemistry of 5 and 7 was assigned according to the cosy and nOe studies of
the corresponding lactones 6 and 8 which were obtained by hydrogenation of 5 and 7
respectively. The nOe spectra of 6 and 8 shows that one of H, and H2 has no nOe effect
with H4, but another one has strong nOe effect with H4. The first one must be H, and the
second one must be H2. The stronger nOe effects between H, and H3, than that between
H2 and I13, between H2 and H’ than that between H1 and H’ in the nOe spectra of 6 and 8
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indicate that the cuprate addition had proceeded with anti-stereoselectivity. The strong
nOe effect between H3 and H5 futher proved the above conclusion.
Scheme 8 Synthesis of anti, anti propionate triads and anti, anti mixed propionate
phenylacetate triads
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Thus, by this method, anti, anti propionate and mixed propionate phenylacetate triads,
which are usually very difficult to obtain, were synthesized from D-manito1 with good
yields and hïgh stereoselectivities. In these two cases, the cuprate additions proceded
generally with good anti-selectivity.
+ 4-2-2 Synthesis of anti, anti phenylacetate triad
Our attention was focused on the synthesis of the anti, anti phenylacetate triad, which, to
the best cf our knowledge, was not synthesized before by any other protocols (Scheme
9). Thus, addition of diphenyl cuprate to the Œ,13-unsaturated ester Ci according to the
procedure developed in our group7° afforded the product 9 in 86% yield with over 15:1
anti-stereoselectivity. This compound was further reduced to alcohol 10 with Dibal-H in
toluene, and 10 was then protected as the trityl ether to give 11. Deprotection of the
TBDPS group with TBAF, followed by Swem oxidation and Wittig reaction, afforded y
alkoxy-Œ,f3-unsaturated ester 13 in good yield.
The stage was now set for the second cuprate addition. The reaction turned out to be very
slow. Twenty equivalents of reagents and over 10 h were needed to ensure the
completion of the reaction. The desired product 14 was obtained in 86% with over 10:1
stereoselectivity. The stereochemistry of 14 was assigned according to the COSY and
nOe experiment of the correspondïng lactone 15 which was derived from 14 by
hydrogenation. The nOe spectra of 15 shows that one of H1 and H2 lias no nOe effect
with H4, but another one lias strong nOe effect with H4. The first one must be H1 and the
second one must be H2. The stronger nOe effect between H1 and FI3 than that between FI2
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and H3, between H2 and H1 than that between H1 and H1 in the nOe spectra of 15 indicate
that the cuprate addition reaction also liad anti-stereoselectivity. The strong nOe effect
between H3 and H5 provides futher evidence.
Scheme 9 Synthesis of anti, anti phenylacetate triad
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+ 4-2-3 Syntheses of anti, syn phenylacetate triad and anti, syn mixed propionate
phenylacetate triads
The anti, syn phenylacetate triad and anti, syn mixed propionate phenylacetate triads can
flot be synthesized directly by two-directionaï cuprate additions as shown in Schemes $
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and 9. These syntheses may be realized by inverting the configuration of the alkoxy
group in compound 13, followed by cuprate addition (Scheme 10).
Scheme 10 Syntheses of anti, sn phenylacetate and ctnti, syn mixed propionate
phenylacetate triads
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We started out with the compound 13 in which the labile trityl group was changed to the
bulky TBDPS group to give 16 in order to carry out functïonaÏ group manipulations in
the next several steps. The BOM group of 16 was removed with TM$Br79 to generate the
alcohol 17. The configuration of the hydroxyl group was inverted using a Mitsunobu
reaction to give 18.80
080M
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Protection of the y-hydroxyl group of 1$ as the BOM ether generated the new ‘y-alkoxy
u,3-unsaturated ester 19, which underwent conjugale addition with the mixed diphenyl
cuprate magnesium reagent to give the end-group differentiated C2-symmetrical (3R,
5R)-diphenyl-(4R)-ol motif 20 in excellent yield and with over 10:1 distereoseÏectivity.
Longer reaction time (12 h) and excess reagents (20 equiv.) were needed to complete the
reaction. Lithium dimethyl cuprate addition to 19 afforded the adduct 21 in 92% yield
and with over 20:1 diastereoselectivity. The anti-stereoselectivities were assigned based
on previous experience in this series.
+ 4-2-4 Stereocontrolled syntheses of phenylacetate triads
Previous work70’ 72 in the synthesis of propionate triads in an iterative manner from our
group had shown that ct-hydroxylation of the potassium enolate of the cuprate adduct
with the Davis oxaziridine reagent71 afforded a single isomer with an anti, syn 7-hydroxy-
methyl-hydroxy unit on the chain. It was of interest to explore the stereoselectivity of the
hydroxylation of the 3-phenyl analog.
Surprisingly, treatment of the potassium enoate of ester 9 generated with KHIvIDS with
the achiral Davis oxaziridine afforded a 1: 1 mixture of distereoisomers (Scheme 11).
High stereoselectivity (over 20:1) was found with the matched (1S)-(+)-(10-
camphorsulfonyl)oxazirïdine71 to afford the (2S)-liydroxy ester derivative 22 in 83%
yield. Selectivity with the (1R)-(-)-(10-camphorsulfonyl)oxaziridine7’ was over 12:1.
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Scheme 11 Stereocontrolled syntheses of phenylacetate triads
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In order to prove the stereochemistry of the adducts, the 1:1 mixture of 22 was
transformed into the corresponding lactones 23a and 23b by catalytic hydrogenation. The
stronger nOe effect between H1 and H2 of 23a than that between H and H2 of 23b, and
between H1 and H3 of 23a than that between H1 and 113 of 23b prove that hydroxy group
of 23b bas a syn-relationship with the phenyl ring. The lactones derived from the Œ
hydroxylation product 22, which were obtained from the reaction between the potassium
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enolate of ester 9 with (IS)-(+)-(1O-campliorsulfonyl)oxaziridine and (1R)-(-)-(1O-
camphorsulfonyl)oxaziridine, were identical in ail aspects with 23a. In this way, the syn
stereoselectivity of the u-hydroxylation reaction was secured. ‘9F NMR of the
corresponding Mosher ester of 23a further proved the stereoseÏectivity of this reaction by
comparing the intergration areas of the two isomers. By adopting our protocol, the
synthesis of anti, syn phenylacetate triad was realized.
4 4-2-5 Synthesis of R, S, S, S phenylacetate triads
After the stereocontroiled synthesïs of phenylacetate triad was successfully carried out
(Scheme 11), we wanted to synthesize phenylacetate triads by iterative cuprate addition
and hydroxylation in acydlic motifs as previously demonstrated for the propionate triads
77in our group. —
Scheme 12 Synthesis of R, L S, S phenylacetate triads
080M 80MO 0H
1. KHMDS, THF
-78°C
Q 2. (1 S)-(+)-(1O-camphor-suIfonyI)oxaziridne [,jj83%
9 22a
80MO OMOM
TBDPSO.L.0H
1. MOMCi
2. Dibal-H
Overafl 74%
Ph2CuMgBr
TMSCJ, THF
-78 °C, 86%
OMOM80MO
1. Swern
2. Wîttig E
84%
2524
80MO OMOM 1. KHMDS, THF
-78°C
2. (1 S)-(+)-(1Q-camphor
-suIfony)oxaziridine
82%
26
80MO OMOM 0H
TBOPSO
E R CO2Me
27
R, S, S, S isomer
41
This work was successfully carried out as shown in Scheme 12. Protection of the
hydroxy group of 22a as the MOM ether and reduction of the ester with Dibal-H gave 24
in 74% overali yield. Swern oxidation, followed by Wittig reaction, provided the ‘y
alkoxy-Œ,f3-unsaturated ester 25, which underwent mixed diphenyl magnesium cuprate
addition to afford the adduct 26 in 86% yield and with excellent stereoselectivity. Œ
Hydroxylation of the potassium enolate of ester 26 with (1S)-(-t-)-(10-
camphorsulfonyl)oxaziridine generated 27 in 82 % yield (based on recovered starting
material) with over 10:1 stereoseÏectivity by NMR spectroscopy. This reaction was found
to be very slow. Although three equivalents of the reagents were used, 50% of the
starting material was recovered after 7 h reaction. The stereoselectivity was also secured
by the ‘H and ‘9F proton spectroscopy of the corresponding Mosher ester of compound
26. Thus, phenylacetate triads with the 2R, 3$, 4$, 5$ configuration were synthesized by
this protocol.
+ 4-2-6 Synthesis of S, R, R, S phenylacetate triads
In order to extend the stereochemical versatility of the above protocol, the Œ-hydroxy
function in 22a was inverted via a Mitsunobu reaction.80 After alcohol protection with a
MOM group (Scheme 13), the ester 2$ was reduced to the corresponding alcohol whïch
was subjected to a Swem oxidation and a Wittig reaction to afford the new y-a1koxy-u,3-
unsaturated ester 29. Conjugate addition to 29 with mixed diphenyl magnesium cuprate
gave the corresponding anti, anti phenylacetate triad 30 as a single isomer in 86% yield.
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Scheme 13 Synthesis of S, R, R, S phenylacetate triads
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Œ-Hydroxylation of 30 was also found to be slow because of steric reasons. After 7 h, the
reaction was quenched and the product 31 was obtained in 84% yield (based on 50%
recovered material) and with over 12:1 stereoselectivity. Cornpared to the product
synthesized in Scheme 12, which has 2R, 35, 48, 58 configurations, 31 bas 28, 3R, 4R, 55
configurations. The sequences shown in Scheme 12 and 13 demonstrated that anti, syn,
anti phenylacetate triads and anti, anti, anti phenylacetate triads can be synthesized with
high yields and stereoselectivities. The drawback is that Œ-hydroxylation becomes more
and more difficuit with increasing chain length because of the increasing steric hinlirance.
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In summary, we have demonstrated that the stereocontrolled conjugate addition of
organocuprates to y-alkoxy-cL,j3-unsaturated esters proceeds with high diastereoselectivity
in a two-directional strategy. This protocol afforded acyclic chains that contain three
contiguous substituents of the anti, anti, propionate triad type and their phenylacetate
equivalents. Enolate hydroxylation and cuprate additions were performed in an iterative
manner in these series to generate seven-carbon acyclic motifs harboring five contiguous
stereocenters consisting of altemating hydroxyl and phenyl substituents with
stereocontrol. A series of 1,2-asymmetric inductions were achieved starting with a
resident ‘y-alkoxy group with excellent stereoselectivity through two successive conjugate
additions and two enolate hydroxylations.
+ 4-3 Polypropionates via the aldol reactions
The aldol reaction is another one of the most important and extensively studied carbon
carbon bond formation reactions in asymmetric synthesis81. It can generate two
stereogenic centers in one step. The stereoselectivity of aldol reactions is usually
controlled by using chiral auxiliaries or chiral reagents. In some cases, aldol reactions by
1,2-induction can give good to excellent stereoselectivity. This reaction82 was also tried
on compound 1 with benzaldehyde and selectivity was controlled by 1,2 asymmetric
induction (Scheme 14). Treatment of the potassium enolate generated from the ester 1
with benzaldehyde at -78 °C gave a 6:1 ratio of diastereomers which were separable by
column chromatography.82
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Scheme 14 The aldol reaction
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The stereochemistry of the major product was confirmed by detailed NMR studies of the
corresponding lactone 33, and the non-chelation controlled transition state 32A was
proposed for the outcome.78 We then treated the potassium enolate of 1 with aromatic
aldehydes with different substituents and moderate seiectïvity and yieÏds were observed
as shown in Scheme 14. Ail the diastereoisomers of 35, 36, 37, 38 are separable by
column chromatography. These reactions resuit from internai 1, 2- and 1,3 -asymmetric
inductions from the resident group to a stereogenic carbon, although the selectivity was
flot high.18’19
+ 4-4 Œ-Alkylations
u-Alkylation of ester enolates with reactive electrophiles such as allylic halides is another
kind of carbon-carbon bond formation reaction in which a new chirai center is formed. It
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is usually very difficuit to realize high stereoselectivity in such aikylations, especiaily in
acyclic systems.
Scheme 15 Œ-Alkylations
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The most popular methods to achieve practical levels of stereocontrol in enolate
aikylations normally rely on the use of curai auxiliaries.23 The alternative protocol is to
use internai asymmetric induction (especially 1,2-induction). With the knowledge of Œ
hydroxylation and aldol reactions of the enolate of 1 giving high svn-stereoselectivity, we
turned our attention to Œ-alkylation. To our deiight, treatment of the potassium enolate of
1 with different kinds of aiiyiïc bromides gave only the corresponding syn
diastereoisomers with good to excellent yields (Scheme 15). Confirmation of the
proposed syn-stereochemistry was secured by formation of the lactone 40. The strong
nOe effect between H1 and H3, and between H1 and H4 in lactone 40 proves that the
benzyl group lias syn-relationship with the methyl in compound 39. This stereochemical
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outcome can be rationalized based on a Feikin-type transition state 39B. This protocol is
important because manipulations of the aikene can generate other functional groups. This
extends the versatility of the protocols developed during the course of our work.
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Cliapter five Stereocontrolled synthesis in acyclic systems on solid phase
+ 5-1 Introduction
The techniques for solid-phase synthesis are based mainly on the pioneering work of
Merrifield83 which was followed by timely contribution in other areas of organic
synthesis by Leznoff,84 Camps,85 and Frechet86 during 1970-1985. It was Camps who, as
early as 1974, published a synthesis of benzodiazepines tising solid-phase chemistry. But
this remained as a specialised and untapped area of research activity until the advent of
combinatorial techniques for drug discovery and lead optimisation.87 One of the reasons
might be that medicinal chemists have recently been challenged by developments in
biology and automation that allow the screening of large numbers of compounds.
The great advantage of combinatorial chemistry is that it has the potential to generate
compounds faster than classical organic synthesis. Solid-phase chemistry is well suited
for combinatorial chemistry because it can: ta) simplify work-up procedures, (b) provide
high yields by employment excess reagent and be amenable to robotisation.
+ 5-2 Comments on solid phase chemistry
The most-commonly-used polymer backbone is polystyrene, crosslinked with 1 or 2%
divinylbenzene. This resin is frequently employed in reactions at higher temperatures as
well as reactions with organometallic reagents. The following are some comments for
solid phase chemistry:
4$
À Solvent: resins are compatible with many polar and apolar solvents in which they
can swell so that reactions can take place. Such solvents include DMF, NMP, alcohol,
TNF, acetonitrïle, dichioromethane.
À Stirring: mixing is achieved by vortexing (by employing orbital shakers),
ultrasonic or magnetic stirrers, or by bubbling gas through the suspension. Prolonged use
of mechanical stirring can cause mechanical damage to the resin (pulverization).
À Temperature: the tempefature for reactions fanges roughly from —7$ °C to 155 °C,
although room temperature is by far the most common.
À Reagents: a broad range of reagents is compatible with the conventional resins
employed, including acids (e.g. TFA, POC13), bases (e.g. DBU, RLi), Lewis acids (e.g.
BF3OEt), reducing agents (e.g. LiAIH4, Dibal-H, NaCNBH3), homogenous transition
metal complexes (e.g. Pd(OAc)2, Pd2dba3.CHCI3) and soluble saits (e.g. KOTBu).
Immobilized reagents are not usually used because of the inefficiency of solid-solid
interactions. Sometimes a limiting factor in the choice of reagents is the nature of the
linker attaching the molecule to the polymer.
À Work-up: after reactions are completed, resins are fihered and washed extensively
with solvents (usually from polar solvents to apolar solvents) to remove excess reagents
and high boiling solvents from their interior spaces.
À Linkers: Most of the linkers used in the beginning of solid-phase chemistry were
originally developed for oligomer chemistry and afforded carboxylic acids and amides
after cleavage which lias severe limitations. Several attempts to circumvent this problem
have lcd to alternative methods using the existing linkers to yield, after cleavage,
alcohols88 or amines89 instead of carboxylic acids or amides. Also, strategies have been
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developed in which the small molecules are released from the linker by a cyclization
reaction.9° Recently, linkers that are cleaved to other functionalities9’ have been reported.
À Reaction monitoring: solid phase reactions are generally more difficuit to
monitor, principally because the technique of “following a reaction by TLC” is flot
appropriate. Currently, the methods used for monitoring non-peptide solid-phase
reactions include (a) analysing small amounts whilst the substrate and pioduct are stili
bound to the resin, e.g. by FT-W83, ‘3C gel NMR92, MAS NMR,93 color detection
reagents for reactive functionalities94 (i.e, NH2, SH, COOH) (b) removing a srnall portion
of the resin, cleaving small molecule fragments, followed by analysis.
• 5-3 Asymmetric syntheses on solid phase
A current trend in solid-phase chemistry is to expand the repertoire of known organic
reactions on solid-phase to achieve as much functional diversity as possible in the
released substrate. Up to now, many known organic reactions can be used in solid-phase
chemistry.95 Furthermore, some asymmetric syntheses have been carried out on solid
phase.
+ 5-3-1 Evans-type aldol reactions and a-alkylations using a solid supported
auxiliary
Asymmetric syntheses controlled by a chiral auxiliary were first tried on solid phase and
some examples are given in Scheme 16. In equation (a)96 and (b)97, enantioselective
Evans-type aldol reaction and Œ-alkylation reaction with a solid supported auxiliary were
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used for the synthesis of an a-substituted acid or ester. Solid phase synthesis proceeded
with a high degree of enantioselectivity, as is observed in solution chemistry.
E3
1. Bu2BOTf, Hunig base,
CH2CI2
2. Isovaleraldehyde
3. H202-DMF
+ 5-3-2 Panek’s polypropionate synthesis by iterative crotylation on solid phase
Panek’s group has successfully applied the (E)-crotysilane reagent-based asymmetric
crotylation reaction on a solid support and provided functionalized curai homoallylic
ether E6 with high yield and diastereoseiectivity (10:1 to 30:1, Scheme 17).98 This
methodology was further extended to the synthesis of polypropionate-like subunit
through an iterative crotylation sequence. A polypropionate-lïke subunit E11, which
contains three propionate units and six contiguous stereogenic centers, was synthesized
from a solid-phase bounded achiral aldehyde E7 through iterative crotylation reactions.
An overali yield of 37% for 10 steps and a ds of around 90% was reported. Their study
Evans-type aldol reaction and Œ-alkylation using solid
supported auxiÏiary96’ ‘
Scheme 16
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also shows that stereoselectivities for crotylation reactions on solid phase are similar or
higher compared those in the solution reaction. This is a new and useful procedure for the
preparation of stereochemically well-defined polypropionate-like subunits on solid-phase.
Scheme 17 Asymmetric crotylation reactions on a solid support98
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+ 5-3-3 Paterson’s polypropionate synthesis by iterative aldol reaction and ketone
reduction on solid phase
Paterson’s group has also synthesized polyketide-type sequences by iterative asymmetric
boron-mediated aldol reactions and ketone reduction (Scheme 18). The segment E16
with eight contiguous stereocenters, which was isolated in 37% overall yield and with
87% ds after cleavage, was synthesized from the achirai aldehyde E12 on solid phase in
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eight steps. Notably, better yields and comparable diasteroselectivities can usually be
achieved on solid-phase in comparison with the conventional solution-phase reactions.
The methodology enables much greater structural and stereochemical diversification
through the variation of both chain extension reagents and the stereochemistry of the
aldol and reduction steps.
Scheme 1$ Asymmetric boron-mediated aldol reactions on solid phase99
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+ 5-4 Total synthesis of epothilone A on solid phase
A most remarkable achievement in solid-phase chemistry bas been the total synthesis of
epothilone A on solid-phase by the Nicolaou group (Scheme 19).b00 The total synthesis of
epothilone A started out with immobilized compound E17. After several steps of chain
extensions, functional group manipulations and coupling reactions, the solid bound
intermediate E18 was generated with good yield. A single olefin metathesis reaction
simultaneously cyclized and liberated the product E19 from the solid support. A simple
desilylation and an epoxidation reaction completed the total synthesis of epothilone A.
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+ 5-5 Cuprate reagents in asymmetric synthesïs on solid-phase
Cuprate reagents have also been used in asymmetric synthesis on solid phase as shown in
Scheme 20. In example (a)’°’, SN2’ reaction of organocopper reagents on solid support
was successfully carried out and the yield and stereoselectivity were both very high. In
example (b)’°2, 1,4-cuprate additions to a,13-unsaturated ketone E22 followed by Œ
aikylation provided adduct E23. The two examples show that cuprates can be used on
solid-phase even at low temperature such as —78 oc.
This was one of the first examples of solid-phase chemistry used in the total synthesis of
a complex natural molecule. This study further proved the great potential of solid-phase
chemistry.
Scheme 19 Total synthesis of epothulone A on solid phase10°
steps
Qci
E17
epothilone A
then TFA
QSoHd support
E19
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Scheme 20 Cuprate reagents used on solid phase chemistry’°” 102
(a) SN2’ reaction by cuprate reagents
Me Me
E20 Ns E21
(b) Cuprate conjugate addition
1. R1CuLi
2. R2X
SoIid support
+ 5-6 Cuprate additions to Œ, -unsaturated esters on solid phase
In order to further explore the application of stereocontrolled cuprate conjugate addItions
developed by our group,70’ 72 we extended the protocol to solid phase and the initial
resuits are shown in Scheme 21. The alcohol 45 was loaded on to Wang resin (4-
Benzyloxybenzyl alcohol, polymer-bound, polystyrene cross-linked) through the
thiocarbonate linkage’°3 with 90% yield as monitored the reaction by infraed
spectroscopy (1726 cm). With the a,f3-unsaturated ester 46 in hand, we then tried
cuprate addition on solid phase. After treatment of 46 with dimethyl cuprate in the
presence of TMSC1 at —78 oc for six hours, we found that only a trace of the product was
formed. The reaction was monitored by cleaving some of the compound from the solid
phase and NMR analysis. Realizing that this reaction is very slow at —78 °C, we decided
to raise the reaction temperature. The reaction was thus carried out at —78 °c for 2h, -40
°c for 2h and —20 °c for 2h. It was found that about only half of the starting material had
E22 E23
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reacted. In order to ensure completion of the reaction, the resin was subjected to the same
cuprate addition conditions again and ail the starting material reacted this time as we
expected. The product was cleaved from the solid phase and NMR characterization
showed that the cyclized cuprate adduct 49 was formed and stereoselectivity was over
10:1. The stereochemistry was assigned by comparing the chemical and physical
properties of the same compounds 51 and 52 made from known compounds 1 and 10 in
solution. It was found that 49 and 51, as welÏ as 50 and 52, were identical in every
respect. Vinyl cuprate conjugate addition on solid-phase failed under these conditions
because the cuprate reagent decomposed at —30 0C.
Scheme 21 Cuprate additions to Œ, f3-unsaturated esters on solid phase
80MO
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Me2CuLi or 80MO o o
PCuMg
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2. TsOHR BOMO
1 R=Me P 51 R=Me 85%
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+ 5-7 Œ-Alkylation reactions on solid phase
With the stereocontrolled cuprate conjugate additions on solid phase being successfully
carried out, we then decided to try Œ-alkylation reactions on solid phase. Treatment of the
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ester 47 with KRMDS in THF, as done in solution, followed by addition of the allylic
halides or benzyl bromide, led to the corresponding Œ-substituted products 53, 54, and
55, respectively, which were isolated as the corresponding -1actones 56, 57 and 58 in
good yields and with over 10:1 stereoselectivity by ‘H NMR spectra after cleavage and
column chromatography. The results show that solid phase reactions gave similar levels
of diastereoselectivity compared to the solution phase reactions. The difference between
the solid phase reactions and the corresponding solution phase reactions is that more
reagents and longer reaction times were needed in order to complete the reactions in the
solid phase.
Scheme 22 Œ-Alkylation reaction on solid phase
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1. TBAF-AcOH
60 R= C02Me
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41 Rz
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The stereochemical assignments were made by comparing chemical and physical
properties of the compounds 56, 57 and 5$ made from solid-phase to those of compounds
57
59, 60 and 61 made from known compounds 40, 41 and 42 in solution. They were
identical in every respect, proving that the stereofacial selectivity for this ldnd of reaction
either in solution or on solid phase is same.
+ 5-8 Stereocontrolled polypropionate synthesis on solid phase
After realizing the stereocontrolled cuprate conjugate addition and Œ-alkylation on solid
phase, we studied cL-hydroxylation (Scheme 23) as in solution chemistry.70’ 72 Indeed,
treatment of the potassium enolate generated from 47 witli Davis oxaziridine reagent7’
afforded the Œ-hydroxy ester 62 which, upon cleavage, gave an enantiopure lactone 63.
The strong nOe effect between H2 and H3, very weak nOe effect between Ht and H3
indicate that the hydroxyl group and methyl group in lactone 63 have anti-relationship.
Next, we decided to explore the possibility to synthesize polypropionate on solid phase as
we did in solution chemistry. Protection of the hydroxy group of 62 with MOM group
followed by the reduction of the ester with Dibal-H afforded the alcohol 64, which was
cleaved from solid phase to give 65. Swern oxidation of the alcohol 64 to the
corresponding aldehyde proved to be slow and to occur with moderate yield. The
Doering-Parikh reagent’°4 was found to be more efficient for this oxidation probably
because the resin could swell better at room temperature than at lower temperature.
Treatment of the aldehyde with Ph3P=CHCO2Me (10 eq.) in CH2C12 for two days
provided the a,13-unsaturated ester 66 which underwent lithium dimethyl cuprate addition
to give the adduct 6$ (Scheme 23).
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Scheme 23 Stereocontrolled polypropionate synthesis on solid phase
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As we mentioned previously, this cuprate addition was also very slow at low temperature,
so it was carried out at -78 oc for 2h, at —40 °C for 2 h and —20 oc for 2 h before it was
quenched. In order to ensure the completion of this reaction, the same cuprate addition
procedure was repeated and 69 was obtained after acidic cleavage. NMR showed that
the stereoselectivity was over 10:1.
Finally, a second a-hydroxylation of 69 with Davis oxaziridine afforded the a-hydroxy
ester 70, which upon cleavage gave ester 71, ‘H NMR shows that ds is over 10:1.
Conversion of 71 to the TBDPS ether afforded 72, which was identical in ail the chemical
and physical aspects to the known reference compound’°5.
+ 5-9 Summary
In conclusion, the high degree of 1,2-induction in the Œ-alkylation and Œ-hydroxylation
reactions can be aiso extended to solid phase. Polypropionate synthesis can be achieved
on solid phase with excellent 1,2 induction through two cuprate additions and two enolate
hydroxylation cycles. The stereoselectivities of these reactions on solid-phase are as good
as in solution chemistry and the stereofacial selectivities are same for solid—phase and
solution chemistry. This methodology has several disadvantages. First, more reagents and
longer reaction time are needed to ensure the completion of the reactions on solid phase
than in solution reactions, and sometime, the reactions have to be repeated. Second, it is
flot easy to monitor the solid-phase reaction because compounds had to 5e cleaved from
the solid phase in order to check the progress of the reaction. Finally, it is difficuit to
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measure the exact yield because several by-products can be formed when the products are
cleaved from the solid support.
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Chapter six Syntheses of enantiopure indanes and tetrahydronaphthalenes
Part one Synthesis of enantiopure indanes
+ 6-1 Introduction
Among the compounds containing a chiral indane subunit, none are more important than
the orally active HW protease inhibitor indinavir (L-735.524) and its analogs (Figure
14).b06
Figure 14 HW protease inhibitor indinavir and its analogs
OH
t-BuNHO
O
Indinavir
R10(Nhl
?
Ph 8
L-685.434 (-) R1=t-Bu, R2=R3=H, ArPh
L-697.807 (-) R13-THF, R2=R3=H, Ar=Ph
L-687.965 (-) R1zt-Bu, R2=Me, R3=H, Ar=Ph
L-689.428 (-) R1=t-Bu, R2=R3=-(CH2)2-, Ar=Ph
(-) R1=t-Bu, R2=R3=H, Ar=C6H4-p-OH
figure 15 Trans-fused indane lactones as inhibitors of thrombin
Trans-fused indane lactones (Figure 15) were found to be active inhibitors of the pro-
coagulant serine protease thrombin.’°7 Enantiopure indane derivatives were also used as
chiral auxiliaries in asymmetric synthesis.’°8 Some methodologies for the syntheses of
chiral indanes are shown in Scheme 24.
F1 F2 F3
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Scheme 24 Syntheses of indanes
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O=C< 1. Zn, CH3CO2H
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F7 F8 F9
Yield, % ee, %
Rh2L” H, Rh2(4S-MPPIM)4 75 92
(c) O CHN2
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F10 F11
In equation ta), the racemic indane F6 was synthesized from aikene F4 by a [2+2]
cycloaddition with dichioroketene, followed by reductive dechiorination and Baeyer
Villiger oxidation.’°9 In equation (b), indane F9 was obtained by Baker’s yeast reduction
of the corresponding f3-ketoester F7 with high enantio- and diastereoselectivity but with
low yield (34%) In equation (e), carbon-hydrogen insertion reaction of diazoacetate
F10 with Rh2(4S-MPPfl’vl)4 provided the indane f11 in good yield and stereoselectivity,
but the catalyst is very expensive.”
We therefore opted to synthesize the enantiopure indanes by a new protocol that uses
substrate control to instali the chiral centers as illustrated in the retrosynthetic plan in
Scheme 25.
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Scheme 25 Retrosynthetic plan for the synthesis of enantiopure indanes
çç.__•__OH 0=J. R3 FriedeI-Crafts>
Q QQF12 F13 F14
OR1
FogrouP R2O_J_-. Cuprate addition
F15
The enantiopure indanes F12 would be synthesized from the ketone F13 which could be
derived from the acid chloride F14 using a Friedel-Crafts reaction.lt2 F14 can be
synthesized from F15 by several functional group manipulations and F15 would arise from
C1 by stereocontrolled cuprate additions.
+ 6-1-1 Stereocontrolled aryl cuprate additions to Œ,-unsaturated esters
We started with studies of cuprate additions to a,f3-unsaturated ester C1 with different aryl
cuprate reagents and the resuits are summarized in Tab]e 3. The resuits in entries 1 and 2
indicate that stereoselectivity is not greatly influenced by whether the methoxy group is
in the para or meta position of the benzene ring. The stereochemistry was anti as
previously shown for other cuprate additions,70’ 72 and confirmed by single crystal X-ray
analysis later in this work.
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Table 3 Stereocontrolled aryl cuprate additions to a,f3-unsaturated ester C1
080M
TBDPSO._L
Me
Ar2CuMgBr
R—OMe
2 TMSCI, THF,-78 °C
- 75 R=p-F
c, 76 R=m-OMe
Entry R Yield anti/syn
H 85% 16:1
2 p-Me 86% 14:1
3 p-OMe 84% 13:1
4 p-F 87% 14:1
5 m-OMe 84% 15:1
+ 6-1-2 Synthesis of enantiopure indanes
We chose the cuprate addition adducts 10 and 76 for the synthesis of enantiopure indanes
(Scheme 26). We worred that the BOM group cannot survive the Friedel-Crafts reaction
conditions and may interfere with this reaction, it was removed by hydrogenation and
replaced with the bulky pivaloyl group to give 81 and 82, respectively. The TBDPS
group was removed from 81 and $2 with TBAF in good respective yields and the
resulting alcohols were oxidized to their aldehyde counterparts with the Doering-Parikh
reagent.’°4 friedel-Crafts reaction of the resulting aMehydes proved to be low in yïelds
and the stereoselectivitïes were poor. Altematively, oxidation of the aldehydes using
NaC1O23 gave the corresponding acids 83 and 84 in 71% and 73% overall yield for
three steps. Treatment of the acids 83 and 84 with oxalyl chloride and a catalytic amount
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of DMF”4 afforded the corresponding acid chlorides which were directly treated with
A1C13 in CH2C12 at O °C to afford the Friedel-Crafts products $5 and 86 in 82% and 84%
respectively. We were also pleased to find that no epimerization had occurred in this step.
However, removal of the pïvaloyl group of 85 and $6 at this stage with sodium
methoxide did resuÏt in epimerization of the a-position of the ketones. Reduction of the
carbonyl groups of 85 and $6 by hydrogenation in acetic acid, and removal of the
pivaloyl groups with Dibal-H afforded the indanes 87 and 8$ in excellent yield.
Scheme 26 Synthesis of enantiopure indanes
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—0H =
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R 88 R=OMe
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86 R= OMe, 84% 88 R= 0Mo, 76%
The meta-methoxy indane 8$ afforded X-ray quality crystals after column
chromatography and recrystallization from hexane-CH2CÏ2 (Scheme 26).
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+ 6-l-3 Summary
The indanes 87 and 8$ were synthesized from the Œ,3-unsaturated ester C1 with very high
stereoselectivitïes and good yields using stereocontrolled cuprate additions and Friedel
Crafts reactions as the key steps. Because $7 and 8$ contain two hydroxy groups, they
cari be further manipulated for other purposes. This work also proved that the pivaoyl
group is a very compatible protecting group in Friedel-Crafts reactions.
Part two Synthesis of enantiopure tetrahydronaphthalenes
+ 6-2-1 The retrosynthetic plan
We wanted to synthesize enantiopure tetrahydronaphthalenes applying the same
methodology as we used in the syntheses of enantiopure indanes. As shown in the
retrosynthetic plan in Scheme 27, the enantiopure tetrahydronaphthalene F16 would be
generated from the acid chloride F17 via a Friedel-Crafts reaction. The latter can be
obtained by functional group manipulations of F18. The stereocontrolled introduction of a
vinyl group in F18 would be accomplished using a cuprate addition to the a,j3-unsaturated
ester F19, which would originate from 77.
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Scheme 27 The retrosynthetic plan for the synthesis of enantiopure
tetrahydronaphthalenes
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FdedeCrafts Faup
MeO2CN°
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S Il d 080M Functional rou 080M
cuprate addition manipulations
Ô
F19 77
+ 6-2-2 Synthesis of a cis-fused tetrahydronaplithalene
The alcohol 77 was protected with a pivaloyl group, and then the TBDPS group was
removed with TBAF (Scheme 28). The resulting alcohol 90 vas oxidized to the
corresponding aldehyde which was treated with the Wittig reagent (Ph3P=CHCO2Me) to
give the Œj3-unsaturated ester 91 in good yield. Conjugate addition of the divinyl
magnesium cuprate to the u,t3-unsaturated ester 91 at —78 °C afforded the adduct 92 in
85% yield with a ratio over 8:1. The stereochemical outcome was expected to be trans
selectivity as in analogous cases70’ 72 which was confirmed later by X-ray analysis on
compound 99. As before, the BOM group was removed. Treatment of 92 with TMSBr79
in CH2C12 afforded lactone 93. The double bond of 93 was then cleaved and oxidized to
the corresponding acid 94 in 86% yield using Na104 and RuCI3.nH2O as catalyst.”5
Treatment of 94 with oxalyl chloride and catalytic DMF, followed by Frïedel-Crafts
reaction with A1C13, afforded the cyclized products in good yield. TLC showed two
products were formed and attempts to separate the two products by column
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chromatography failed because the less polar product was changed to the more polar
product on silica gel. We observed that the longer the column chromatography took, the
more less-polar product was transformed to the more polar product. After we had run the
column chromatography twice, almost ail the Iess-polar product was changed to the
more-polar product and nOe spectra revealed that this more polar compound was cis
lactone 96, which was confirmed later by x-ray analysis on compound 99.
Scheme 2$ Synthesis of enantiopure tetrahydronaphathalene
DBOM 080M 080M
TsDPS00H PivCl, Pyr. TBDPS00Piv TBAF H00Piv 1. Swern
=
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t0Piv I. tCOCI)2 0Piv Chromotography
2. AICI3, CH2CI2 - - +
on silica gelHOOC
82% from 94Q
94 95
116 dicates that the cis-lactone 96 as the free alcohol isMNDO-AM1-PM3 calculation in
mucli more stable than corresponding trans-lactone 95 (Scheme 29).
96 96
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Scheme 29 MNDO-AM1-PM3 calculated relative energy for trans and cis lactones
o o
II!ï
I Ii I O I II I
HO H = -6.8 to -9.6 kcal.mo11 H
(MNDO-AM1 -PM3)
trans-Iactone c/s-Iactone
+ 6-2-3 Reduction and deprotection
Attempt to remove the pivaloyl group of 96 using NaOMe in MeOH led to die
aromatized product 97 (Scheme 30). In order to avoid aromatization and epimerization,
the benzylic carbonyl group was reduced to a methylene group. Hydrogenation in acetic
acid with palladium on activated carbon as catalyst proved to be a very efficient for this
purpose and the reduced product 9$ was obtained in 82% yield.
The pivaloyl group was then removed with NaOMe in MeOH and some of hydrolyzed
product was formed at the same time. The mixture was treated with TsOH in THF and
the solid product 99 was obtained in 80% yield after column chromatography.
Recrystallization in a mixture of hexane-CH2C12 gave X-ray quality crystals of 99 whose
X-ray structure unambiguously proved the stereochemistry of the original cis-lactone 96.
Functional group manipulations were exemplified by transformation of the alcohol to the
corresponding azide by treatment of the alcohol with DEAD, PPh3, DPPA8° to afford 100
in 81% yield.
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Scheme 30 Synthesis of cis-tetrahydronaphthalene 100
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+ 6-2-4 Synthesïs of a trans-fused tetrahydronaphthalene
Because the trans-lactone 95 epimerized to cis-lactone 96 on silica gel, we subjected the
crude FriedeICrafts products to hydrogenation dïrectly in acetic acid wïth palladium on
charcoal. This led to 14% of cis-lactone 98 and 65% of the trans-lactone 101 (Scheme
31).
Scheme 31 Synthesis of trans-tetrahydronaphthalene
ooP
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AcOH
96
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Removal of the pivaloyl group with NaOMe in MeOH and treatment of the crude
products with TsOH in THF, as we did before, afforded the trans-lactone 102 in 74%
yield.
+ 6-2-5 Summary
The cis- and trans-lactones 100 and 102 were synthesized from the CL,f3-unsaturated ester
C1 using stereocontrolled cuprate addition and Friedel-Crafts reactions as the key steps.
The trans-lactone 94 was easily isomerized to cis-lactone 95 on silica gel. Column
chromatography of the cnide Friedel-Crafts products gave predominantly the cis-lactone
95 and hydrogenation of the crude Friedel-Crafts products provided predominantly trans
lactone 101.
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Chapter seven Total synthesis of Bafilomycin A1
Part one Introduction
+ 7-1-1 Background
The macrolide bafilomycin A1 (Figure 16) was first isolated from the fermentation broth
of Streptomyces griseus in 1983.117 It exhibited activity against Grampositive bacteria,
and was also found to be a specific inhibitor of various membrane ATPases’18 with
potential applications in the treatment of osteoporosÏs. Recently, studies showed that
Bafilomycin A1 potently reduced the production of Af3, a peptide related to Alzheimer’s
disease. 119
Figure 16 Bafilomycin A1
The Bafilomycins, Concanamycins12° and Hygrolides’21 are closely related families of
polyketide macrolide antibiotics characterized by a 6-membered or 1 $-membered
tetraenic macrolactone ring and a six-membered hemiketal ring. Bafilomycin A1 is a
typical member of the Bafilomycins and its structure and absolute configuration were
established by X-ray crystallographic analysis’22 which confirmed the earlier assignments
made by Corey and Ponder based on NMR data and molecular modeling)23 Inspection of
OMe Me Me
OMe
Bafilomycin A1
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the fine functional feaflires of the crystal structure of Bafïlomycin A1 reveals a unique H
bonding network involving the lactone carbonyl, the hemiacetal hydroxyl group, and the
C17 hydroxyl group. This bonding may play an important role in its biological behavior.
Indeed, a single crystal X-ray analysis of a ring-opened product’24, in which the
macrolactone remained intact and the pseudosugar unit was transformed into an ester,
maintained an H-bonding network similar to that of Bafilomycin A1 between the C17
hydroxyl group and the lactone carbonyl. This product also retained substantial H
APTase inhibitory activity.’25 On the other hand, a ring expanded 18-mernbered lactone
analog,’26 iso-Bafilomycin A1, that possessed the hemiacetal-lactone carbonyl H-bond
was inactive, no doubt due to the altered nature of the macrocycle.
Following the first report of total syntheses of Bafilomycin A1 by Evans and Calter,127
Toshima’28 and Roush’29 disclosed their total syntheses of Bafilomycin A1. The syntheses
of segments of Bafilomycin A1 have also been reported by Paterson13° and Marshall.’31
Total syntheses of Concanamycin F have been disclosed by Paterson’32 and Toshima133
respectively. Yonemitsu’34 has also described the total synthesis of Hygrolidin.
+ 7-1-2 General strategies for the total synthesis of Bafilomycin A1
In ail the studies towards the total synthesis of Bafilomycin A1, the polypropionate
subunits were constructed with different versions of the aldol approach. In general, these
strategies formed the 16-membered lactone G3 first, and then used an aldol reaction
between G2 and G3 to give G1. The 6-membered hemiketal ring was formed as the last
step after ail the protecting groups were removed. This general approach is outlined in
Scheme 32.
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Scheme 32 General strategies for the total synthesis of Bafilomycin A1
hemiketal formation
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+ 7-1-3 Retrosynthetic analysis of Bafilomycin A1
Our approach to the synthesis of Bafilomycin A1 relies on the generation of d-te
polypropionate subunits with stereocontrolled cuprate additions and Œ-hydroxylation
reactions developed in our group,70’72 instead of using aldol reactions. We also planned to
build the whole chain first, and then to form the 6-membered hemiketal ring and perform
the macrolactonization at a later stage. Our retrosynthetic analysis of Bafilomycin A1 is
depicted in Scheme 33. Bafilomycin A1 would be obtained by macrolactonization135 of
the acyclic precursor G5 which may be cut roughly into two equal pieces G6 and G7 (path
a), or G8 and G9 (path b), or G10 and G11 (path e).
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Scheme 33 Retrosynthetic analysis
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G6 and G7 could be coupled together by Ju1ia136 or Wittig olefination or other variants,
G8 and G9 could be joined together by Heck’37, Stille’38, Suzuki’39 or sorne other
palladium catalyzed coupling reactions, and G10 and G11 can be coupled together by
Nozaki-Kishi reaction140 or by nucleophilic attack on aldehyde G10 wïth dienic lithium or
other metallic reagents derived from G11. Further disconnection of G6 and G8 would
provide G10, which could be obtained from the acydlic ketone precursor G12. Ketone G12
could arise from the dithiane precursor G13 by the selective removal of protecting groups.
Disconnection of G13 could lead to the C21-C25 iodide segment G14, and the C14-C19
G10
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dithiane segment G16. Ail the stereocenters of G14 could be introduced from G15 by
stereocontrolled cuprate addition and Œ-hydroxylation reactions and G15 cari find its
origin from D-valine. G,6 would be obtained from a common chiron72 by several
functionai group manipulations.
ê 7-1-4 Syntheses of subunits G14 and G16
Subunits G14 and G16 have been previously synthesized in our group14’ and joined to give
G13 as shown in Schemes 34 and 35 respectiveiy.
Scheme 34 Synthesis of subunit G14
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Intermediate G15 was obtained from D-valine by a sequence of functional group
manipulations with very good overal] yield. Anti-cuprate addition to G15 followed by svn
Œ-hydroxylation successfully introduced the f3-methyl and a-hydroxy groups of 106 with
the correct stereochemistry. Further functional group manipulations of 106 provided G14
(Scheme 34).
Scheme 35 Synthesis of subunit G16 and coupling reaction
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Scheme 35 shows how several functional group manipulations of the common chiron’42
provided the subunit G16 which was successfully joined with G14 to give the important
subunit G13 in 76% yield.
+ 7-1-5 Deprotection problems
Others143 in this group planned to join two segments G6 and 67 using a Julia protocol and
tried to synthesize G6 first. Compound G17 was successfully synthesized from G13 in 6
steps (Scheme 36). Unfortunately, the next step to remove the acetonide protecting group
proved to be a problem.
Scheme 36 Deprotection problems
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The acetonide protecting group was too stable to be removed without affecting other
functionalities and ah attempts under acidic and neutral conditions led to either no
reaction or spiroketal G18. The latter was very stable and could not be converted to any
useful compound. The mechanism for forming the spiroketal is shown Scheme 36.
+ 7-1-6 Revised retrosynthetic analysis
Because efforts to replace the acetonide with other protecting groups were not fruitful, we
decided that our strategy to form the six-membered hemiketal before macrolactonization
was not practical.
To modify our strategy, we planned to do the macrolactonization before six-membered
hemiketal ring formation as shown in Scherne 37. Bafilomycin A1 would be obtained
from G22 by a deprotection process with spontaneous hemiketal formation. Precusor G22
would arise from G23 after macrolactonization and dithiane deprotection. As in Scheme
33, G23 may be divided roughly into two equal segments for the coupling of which, the
Julia coupling protocol of fragments G24 and G25, was first explored.
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Scheme 37 Retrosynthetic analysis-2
0Mo Me Me 0Mo Me Mehemiketal
____
LÇ1
Me
2-g
1
0H formation
HO 2
1Mo Me
HO
Me 0Mo Me
022Bafilomycin A1
II
Macrolactonization
a
Julia or Wittig Olefination
P0 P0 0H 0H J OTBS
G23
ss I
e ÔMe 1 1 Me Me Me Me OMe
b
_ ___
Nozaki-Kishi
-- Heck Stille Suzuki coupling
coupling
OTES
0P2 O
Path a Me Me Me 0Mo
025G24
P0 P0 0P2 0P2
OTES
Path b +
Me Me Me Me 0Mo
026 G27
P0 P0 P2
OTES
Path C +
Me Me Me Me OMe
G29
$2
Part two Julia coupling method
+ 7-2-1 Retrosynthetic analysis of G25
For this strategy, two segments, G24 and G25 had to be synthesized. We decided to
synthesize segment G25 first as shown in Scheme 38. G25 should be obtained from G30 by
Horner-Wadworth-Emmons reaction.’44 Functional group manipulations of G32 should
produce the aldehyde G31 which would undergo Wittig reaction to give G30. Central to
this synthetic plan was the introduction of the trans-propionate component in G32, which
would be accomplished from C1 by the two-directional cuprate addition protocol
developed in our group.’4
Scheme 38 Retrosynthetic analysis of G25
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+ 7-2-2 Synthesis of aidehyde 123
The synthesis of the sulfone G15 started with the alcohol 1 which was transformed into
the iodide 115 in 87% yield (Scheme 39). Treatment of the iodide 115 wïth NaSO2Ph in
DMF at O °C successfully provided the sulfone 116, which was treated with KHMDS at —
78 °C, followed with iodomethane, to give the isomeric mixture 117. Because the two
isomers of 117 would give the same product after Julia coupling reaction, they were
carried on without separation.
Scheme 39 Synthesis of aldehyde 123
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The TBDPS protecting group of 117 was removed with TBAF to generate the alcohol
118 which underwent Swern oxidation’46 and Wittig reaction to give the u,f3-unsaturated
ester 119 in excellent yield. At this point, we had to introduce the methyl group with the
correct stereochemistry using our stereocontrolled cuprate addition.
Treatment of the Œ,f3-unsaturated ester 119 with lithium dimethyl cuprate at —78 oc with
TMSC1 as the additive afforded the adduct 120 in 90% and with a ratio of 20:1 by ‘H
NMR spectroscopy. The stereochemistry should be trans as ail the cuprate addition
reactions which we tried before. Enolate formation of 120 with KHMDS followed by
quenching with Davis oxaziridine reagent provided the Œ-hydroxy ester mixture 121,
which was further reduced to diol 122 with LiBH4 in MeOH. The BOM protecting group
of 122 was removed by hydrogenation to give the triol in 95% yield and the vicinal diol
of the resulting triol was cleaved with Na104 to provide the corresponding aldehyde 123
in excellent yield.
+ 7-2-3 Synthesis of aldehyde 127
With the aldehyde 123 in hand, we wanted to extend the chain with a Wittig or Horner
Wadsworth-Emmons reaction. In order to safely carry out this reaction, the hydroxyl
group of the aldehyde 123 was protected with TESOTf (Scheme 40). Unfortunately,
Horner-Wadsworth-Emmons reaction of the aldehyde 123 provided a 2:1 mixture of
inseparable transicis isomers 124. (the trans- and cis-isomers were assigned Jater by
comparing the ‘H NMR of compound 125 and its corresponding TES ether).
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We then turned to the Wittig reaction to solve this problem. Treatment of the aldehyde
123 with the required Wittïg reagent’47 in refluxing benzene for 48 h afforded exclusively
the trans-isomer 125 in 90% yield. Protection of the hydroxy group of 125 with TESOTf
foïlowed by reduction with Dibal-H generated the allylic alcohol 126 which was then
quantitatively oxidized to the corresponding aÎlylic aldehyde 127 with Mn02 in CH2Cb.
Scheme 40 Synthesis of aldehyde 127
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+ 7-2-4 Problems with the Horner-Wadsworth-Emmons reaction
The chain extension of this allylic aldehyde with a Horner-Wadsworth-Emmons reaction
proved flot to be efficient (Scheme 41). Various conditions were tried for this reaction,
but only 1:1 inseparable transicis isomers were isolated.
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Scheme 41 Studies of Horner-Wadsworth-Emmons Reactions
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+ 7-2-5 Synthesfs of sulfone G25
We decided to use another protocol to solve this problem (Scheme 42). Condensation of
the allylic aldehyde 127 with the lithium enolate of methyl methoxyacetate gave the
alcohol 128, which was activated by forming mesylate 129 to effect elimination. After
the mesylation reaction was complete, DBU was added to the reaction mixture and only
the trans-product was formed in 84% yield.
The stereochemistry of the newly formed double bond was further confirmed by
comparing ‘H NMR spectra of G25 with that of a segment obtained from degradation of
Bafilomycin A,. Thus, segment G25 was successfully synthesized for compound 1 and it
is equivalent to the C,-C,0 segment of Bafilomycin A,.
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Scheme 42 Synthesis of sulfone G25
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4 7-2-6 Coupling problems
Unfortunately, attempts to joïn the sulfone G25 and the aldehyde G6, which was obtained
from degradation of Bafilomycin A1, were unsuccessful (Scheme 43) using various
conditions. We then decided to explore the Nozaki-Kishi coupling protocol14° as a
coupling method.
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Scheme 43 Attempted Julia coupling
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+ 7-3-1 Synthesis of the model compound
For this approach, the aldehyde G26 and dienic iodide G27 had to be synthesized (Scheme
44). This time. we decided to do some model studies using compound 131.
Scheme 44 Nozaki-Kishi method
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The attempted synthesis of the model compound 131 is shown in Scheme 45. Oxidation
of alcoho1 1 with PDC provided the corresponding aldehyde which was treated with
MeLi to generate the secondary alcohol 132 in excellent yield. The alcohol 132 was
oxidized to the ketone 133 which underwent a Homer-Wadsworth-Emmons reaction in
refluxing THE, providing the a,3-unsaturated ester 134 with a ratio of trans/cis greater
than 9:1. Reduction of the ester 134 with Dibal-H in toluene followed by oxidation with
Mn07 afforded Œ,f3-unsaturated aldehyde 135 which was subjected to a Corey-Fuchs
reaction148 to give the enyne 136 in good yield.
Scheme 45 Synthesis towards model 131
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At this point, we tried to convert the enyne into dienic stannane 137. First, we tried a
radical hydrostannylation reaction with Bu3SnH in refluxing benzene and unfortunately,
the reaction turned out to be low yielding. Hydroboration’49 of 136 with catecholborane
and 9-BBN was tried, but either no reaction occurred or complex products resulted.
Hydrozirconation’5° of enyne 136 generated a mixture in which the BOM protecting
group had been removed.
+ 7-3-2 Synthesis studies towards the dienic iodide using cuprate reagents
We then decided to try a tributyltin cuprate addition reaction151 to convert the enyne 136
to the dienic stannane 137A. The methyl tributyltin cuprate was tested first and the resuits
were summarized in Scheme 46. 1n the temperature range —7$ °C to —20 °C, only the
internai addition product 137B was obtained in very good yield.
Scheme 46 Methyl tributyitin cuprate addition to enyne 137
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In the hope that increasing the size of the “R” group in the tributyltin cuprate wouÏd
produce more 137A instead of 137B, we tried t-butyl tributyltin cuprate. Only the internai
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addition product 137B was produced in good yield when the reaction was carried out at
—
7$ °C. As the reaction temperature was increased from —78 °C, more and more of the
desired extemal addition product 137A was obtained.
Scheme 47 t-Butyl tributyltin duprate addition to enyne 136
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The ratio of 137A to 137B could be increased to 4:1 when the reaction was carried out at
room temperature. Unfortunately, 137A and 137B were inseparable by column
chromatography and they were also unstable on silica gel even when 1% of Et3N was
used as stabilizer in the eluting solvent. Treatment of the cnide mixture of 137A and
1373 with iodine generated the corresponding mixture of the dienic iodides 131A and
131B, but the two isomers were inseparable by column chromatography and were also
unstable on silica gel (Scheme 48). It became clear that it is flot easy to synthesize the
diennic iodide G27. Our next and final choice was to try a Stille coupling.
OBOM
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Scheme 4$ Transformation of the dienic stannanes to dienic iodides
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Part four The Stille coupling method
+ 7-4-1 Mechanism of the Stille coupling
The late Professor J. K. Stille pioneered the development of a very effective and versatile
palladium-mediated C-C bond forming method: the palladium-catalyzed cross-coupling
of organic electrophiles with organostannanes.’52 This process continues to enjoy mucli
success in organic synthesis because it proceeds in high yields under mild reaction
conditions and because it tolerates a variety of functional groups (e. g. CO2R, CN, OH
and even CHO) on either coupling partner. An additional virtue of this palladium
catalyzed coupling process is that a wide variety of organic electrophiles and organotin
reagents can be utilized. The catalytic cycle is shown in Figure 17.
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Figure 17 Catalytic cycle of the Stille coupling reactionl52a
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It is presumed that a coordinatively unsaturated 14-electron palladium (O) complex such
as bis(triphenylphosphine)palladium (O) serves as the catalytically active species.l52a An
oxidative addition of the organic electrophile, RX, to the palladium catalyst generates a
16-electron palladium (II) complex A, which then participates in a transmetalation with
the organotin reagent (see A—*B). After facial trans—*cis isomerization (see B—>C), a
reductive elimination releases the primary organic product D and regenerates the
catalytically active palladium (O) complex. if the coupling reaction is conducted in the
presence of carbon monoxide, the two coupling partners become linked through a
carbonyl bridge, giving rise to a ketone. The catalytic cycle presented in figure 1$ serves
as a working model for this variant. 152a
L
R—Pu—L
C
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Figure 18 Catalytic cycle of the Stille reaction in the presence of carbon monoxidel52a
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ê 7-4-2 Lïgands and effects of copper in the Stille coupling
Later it was found that using AsPh3 as ligand in place of PPh3 greatly accelerated the
Stille reaction because the weak clielation of AsPh3 to palladium accelerates the rate
determining step, (transmetalation A—*B in Figure ;7)153 Another modification that
accelerates the StiÏle coupling is to add a copper sait like CuC1. The proposed
mechanism154 by Professor Corey is shown in Figure 19.
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Figure 19 The effects of copper in the Stille coupling reaction’54
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the rate-determining step (transmetallation) is greatly accelerated and the reaction
proceeds faster. The Pd(PPh3)4ICuC1ILiC1 system discovered by Professor Corey and bis
group is very efficient and many Stiile coupiing reactions which otherwise fail can be
carried out efficiently.
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reaction has been its reliance on stoichiometric quantities of toxic, costly and
R—X +
R—R1
E
reductive elimination
Pd(O) R—R1
+ X—Sn(R2)3CuCI, LICI
R—X
L2Pd°
L
R_dR1
L
÷CuX C
+ LICI
Oxidative addition
L
R—P d—X
L A
R1 CuLiCI
I (R)3SnCI
R1Sn(R2)3+ CuCI + UCI
96
occasionally unstable organostannanes.’5 Therefore, a Stille reaction using catalytic
amounts of tin would be of considerable benefit. Promising resuits have been reported by
Professor Maleczka and his group.156
+ 7-4-3 Retrosynthetic analysis of BafilomycinAi using the Stille coupling method
We decided to use the Stille coupling protocol for the total synthesis which would require
the two segments G28 and G29 (in Scheme 37). In order to avoid spiroketaÏ formation as
described in Scheme 36, we decided to generate the pyran hemiketal in the last stage of
the synthesis. This new strategy is depicted in Scheme 49. Bafilomycin A1 would be
obtained by deprotection of the ketone G22 and spontaneous formation of the hemiketal
pyran ring. Ketone G22 couÏd be generated by deprotection of the dithiane of G35 which
would arise from the seco-acid G23 by macrolactonization followed by the protection of
the two hydroxy groups at the C17 and C- positions. This strategy avoids the
oxymercuration reaction that was observed during the chernical modification of
Bafilomycin A1.157
The seco-acid G23 was envisaged to arise from vinylstannane G28 and vinyl iodide G29
via a Stille coupling followed by deprotection and then hydrolysis. The vinylstannane G28
would be generated by palladium-catalyzed hydrostannylation of the acetylene G36,
which would be obtained by nucleophilic addition of ethynylmagnesium bromide on the
aldehyde G37 followed by protecting group adjustment. The aldehyde G37 would be
generated by a condensation of the iodide G38 and the dithian G16 followed by
deprotection and oxidation reactions.
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Scheme 49 Retrosynthetic analysis-the Stille coupling method
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Iodide G38 could be obtained from 108 by manipulations of the protecting groups. This
time, we decided to replace the BOM protecting group with TBS because our early
studies proved that removal of the BOM group at a later stage was difficult.’58 The ester
G29 would be obtained from G39 by an aldol type condensation and a,J3-elimination.
Aldehyde G39 would be generated from the acetylene G40 by a Negishi reaction followed
by deprotection and oxidatïon reactions. The acetylene G40 could arise from the aldehyde
G41 by a Corey —Fuchs reactiont48 and G41 could be obtained by functional group
manipulations of G42 which could be generated from D-mannitol.
+ 7-4-4 Synthesis of iodide G38
Scheme 50 summarizes the synthesis of the iodide compound G38 originally from D
valine.
Scheme 50 Synthesis of iodide compound G38
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Protection of the hydroxy group in 108 as the pivaloyl ester led to 138 from which the
BOM group was removed with hydrogenation to generate the alcohol 139. Without
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purification, the crude alcohol 139 was reacted with TBSOTf to give 140, and then the
pivaloyl group in 140 was removed with Dibal-H to afford the primary alcohol 141,
which was treated with iodine, PPh3 and imidazole to generate G38 in good yield.
+ 7-4-5 Synthesis of vinyl iodide G29
The construction of the vinyl iodide subunit G29 is shown in Scheme 51. This synthesis
started out with alcohol 1 in which the hydroxy group was protected as a MOM ether to
give 142. Removal of the TBDPS group of 142 with TBAF followed by Swern oxidation
and Wittig reagent provided the y-aikoxy-Œ43-unsaturated ester 144. We were now in a
position to try the pivotai two-directional cuprate additions for this synthesis.
Conjugate addition of lithium dimethyl cuprate to 144 with TMSC1 as an additive at —
78°C afforded 145 in 90% and with a ratio over 20:1. Treatment of the potassium enolate
of 145 with Davis reagent Ïed to the Œ-hydroxy ester 146 which was further reduced to
the diol 147 with LiBH4. The BOM protecting group of 147 was rernoved at this stage to
avoid functionality incompatibility.
Oxidative cleavage of the two vicinal hydroxy groups of the triol 148 with Na104
afforded the corresponding aldehyde which, when treated with ethyl 2-
(triphenylphosphoranylidene)propionate in benzene at refux,147 ied after TES protection
to the trans-olefin 150. Reduction of the ester 150 with Dibal-H followed by protection
with pivaloyl group generated 151 in high yield.
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In order to introduce the vinyl iodide functionality, the MOM protecting group of 151
had to be removed and B-bromocatecheborane was chosen for this purpose,’59 affording
the desired alcohol 153 in 30% yield, accompanied by a major quantity of diol 152. The
diol 152 was efficiently converted to 153 in a two-step procedure: protection of the diol
with TES groups and selective removal of the primary TES group with PPTS. Choosing
the proper solvent is very important for the second step because no reaction was observed
when only CH2C12 was used and both of the TES groups were removed in MeOH. After
numerous experiments, it was found that a CH2CÏ2-MeOH (3:1) system gave the best
selectivity. Oxidation of alcohol 153 under Dess-Martin conditions generated aldehyde
154 which was further converted to the acetylenic intermediate 155 in high yield.
Particularly the diazophosphonate method’6° (97%) proved much more efficient than the
venerable Corey-Fuchs procedure148 (72%).
Iodination utilizing the modified Negishi protocol16’ provided vinyl iodide 156 in 72%
and was followed by deesterification with Dibal-H to give the alcohol 157. Oxidation of
the allylic alcohol 157 with Mn02 afforded the Œ,-unsaturated aldehyde 15$ which
underwent a simple aldol condensation with lithium 2-methoxyacetate, followed by
mesylation of the resulting alcohol and f3-elimination with DBU to introduce the c
methoxy ester group maintaining a trans-dienic geometry. Much to our satisfaction the
resulting subunit G29 was stereochemically pure by ‘H NMR spectroscopy.
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Scheme 51 Synthesis of vinyl iodide G29
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+ 7-4-6 Synthesis of vinylstannane G28
The elaboration of the entire vinylstannane subunit G28 is shown in Scheme 52. Thus,
generation of the dithiane anion of G16 with t-butyllithium in a mixture of THF and
HIvIPA, and condensation with the iodide G38 provided 159 in 84% yieÏd. In order to
introduce the vinylstannane group and an acetylenic alcohol having an S-configuration at
C14, the TBDPS ether of 159 was selectively cleaved with TBAF-AcOH complex and the
resulting alcohol 160 was oxidized to the aldehyde 161 using the Doering-Parikh
reagent.’°4 Other oxidative methods such as Swern were also tried but the reactions either
did flot occur or the desired product vas formed in ]ow yield.
Treatment of the aldehyde 161 with ethynylmagnesium bromide in THF at —10 oc
generated the separable acetylenic alcohols 162. The undesired R-isomer of 162 was
easily converted to the desired S-isomer of 162 by two step-sequence, oxidatïon of the
alcohol to ketone and then reduction the ketone to desired S-isomer of 162. For the
oxidation, the Dess-Martin reagent proved more efficient because Swern and Doering
Parikh oxidations did not work. Although oxidation with Mn02 resulted in an 80% yield
of the corresponding ketone, the reaction was slow.
Reduction of the ketone to the desired S-isomer of 162 was successfully carried out with
Super hydride. As reported in the original reference,162 CH2C12 was found to be the best
solvent because it does flot interfere with the coordination between the ketone and the
reagent. The oxidation-reduction sequence led to the desired isomer of 162, which would
be ascertained later through completion of the synthesis of Bafilomycin A1. Methylation
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of the hydroxy group of 162 with t-BuOK as base proved to be efficient, but using NaH
as base gave a low yield.
Scheme 52 Synthesis of vinylstannane G28
T6SO TBSO OOSO3Py f V I MgBr
DMSO. Et3N Tr h— CHO THF, -1091% Me Me Me 89%
161
According to our previous work, it was necessary to remove the C-C17 isopropylidene
acetal at this juncture and to use protective groups that would be removed easily without
affecting the final target structure or intermediates leading to it. With this in mmd, the
acetonide group of 163 was carefully removed with CSA in MeOH. The reaction was
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carefully monitored with TLC and the reaction was quenched when the by-product was
formed. Treatment of the diol 164 with TESC1 and imidazole in THF-DMF for 18 h
provided the mono-TES ether 165 in very good yield. Finally, treatment of 165 with
tributyltin hydride in the presence of a catalytic quantity of bistriphenylphosphine
palladium (II) chloride led to the desired vinylstannane subunit G28 in a highly
stereocontrolled manner. The coupling constant between H1 and FI2 of the aikene was
found to be 19.08 Hz, which confirmed the trans-alkene stereochemistiy.
ê 7-4-7 The Stille coupling ami macrolactonization
With chirons G28 and G29 in hand, we were in a position to try the Stille coupling
reaction. Although the previous syntheses’27’ 12$ also used a Stille coupling protocol to
join segments in the total synthesis of Bafilomycin A,, their precursors for the coupling
were flot as fully functionalized as our segments G28 and G29. Furthermore, G28 contained
the dithiane group in a Stille coupling, which has few precedents. The initial results using
PdCI2(MeCN)2, PdC12(PPh3)2 or Pd(dppf)C12 as the catalysts for this Stille coupling were
discouraging and no coupling was observed. Curiously, Pd(dppC12 in DMF was the
cataÏyst used by Toshima’28 in the Stille coupling of two short segment in their work of
total synthesis of Bafilomycin A1. However, using a Pd(dppf)C12, Hunig base’63 and
triphenylarsine system for the Stille coupling was successful, providing the seco-ester
166 in 60% yield (Scheme 53). This reaction indicates that the dithiane group does not
interfere with the Stille coupling reaction if present in the vinylstannane segment. Our
resuits agree with Smith’s work in their total synthesis of Rapamycin.’64 In their work,
when the dithiane group was on the vinyl iodide segment, the Stille coupling reaction was
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retarded. This is presumably because strong chelation between sulfur and palladium
occurred after the oxidative addition (figure 17), which hindered the transmetalation
step. After they interchanged the vinylstannane and the vinyl-iodide groups, and the
dithiane group was on the vinylstannane segment, the Stille coupling occurred without
problem.
With the pivotai Stille coupling successfully carried out, we focused our attention on
macrolactonization. To do this, we had to deprotect the C15 hydroxy group and to
hydrolyze the ester. In this event, we fourni that a mixture of TBAF and acetic acid was
highly effective in the selective cleavage of the C7 and C,5 TES ethers to afford 167 in
the presence of the C21 and C23 TBS ethers. Hydroiysis of the ester was found to be easier
when potassium hydroxide was used in aqueous dioxane at 80°C and afforded the desired
seco-acid 168 in excellent overail yield. With the seco-acid in hand, we were now poised
to try the macrolactonization reaction. The previous syntheses of the short subunit of
Bafilomycin A1 have succeeded in the macrolactonization reactions adopting the
Yamaguchi protocol’65 to give the 16-membered lactone. We used the traditional EDC,
DMAP coupiing protocoi’66 which afforded a 65% yield of the lactone 169.
Up to this point, the only remaining problem was to remove ail the protecting groups. We
were aware that the previous work in the manipulation of Bafilomycin A, in the presence
of mercuric chioride indicated that the oxymercuration reaction led to tetrahydrofuran
ring involving the C7 hydroxy group and the C,0-C11 double bond.’57
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Scheme 53 The Stille coupling and macrolactonization
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We decided to protect the hydroxy groups in the C7 and C17 positions with TMS groups
before we did the dethioacetalization reaction with mercuric chloride to generate the
ketone 170. The only task remaining for the total synthesis was to remove ail the silyl
protecting groups. Unfortunately, various fluoride reagents such as TBAF, TBAF-AcOH,
TAS-F’67 and HFPy did not lead the desired natural product.
+ 7-4-8 Total synthesïs of Bafilomycin A1
We figured that the cL,f3 eliminatïon reaction of the ketone was a fast reaction under these
conditions and we decided that the ketone should be released in the last stage of the total
synthesis (Scheme 54). Accordingly, the two TBS groups were removed with p
toluenesulfonic acid in methanol to give 171 in 86% yieid. Finaliy, treatment of 171 with
mercuric chloride and calcium carbonate in aqueous acetonitrile effected smooth
dethioacetalization to afford crystalline Bafilomycin A1, identical in ail respects with an
authentic sample.
+ 7-4-9 Summary
In summary, the natural macrolide BafilomycinAi was successfully synthesized
originally from D-mannitol and D-valine using stereocontroiled cuprate conjugate
additions and Œ-hydroxylation to efficiently instail ail the chiral centers. The Stille
coupling reaction was used to joïn the two long fully assembled segments and
macrolactonization was accomplished with a Keck reaction. This work further proves the
power of stereocontrolled cuprate conjugate additions and Œ-hydroxylation developed in
our group and used in the total synthesis of a natural compound.
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Scheme 54 Total synthesis of Bafilomycin A1
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EXPERIMENTAL PART
Materials and Methods. Ail commercially available reagents were used without further
purification unless otherwise noted. Ail solvents were reagent grade and distilled under
positive pressure of dry nitrogen before use. Diethyi ether and tetrahydrofuran (THF)
were freshly distilled from sodiumi’benzophenone under argon. Dichloromethane,
benzene and diisopropylamine were distilled from calcium hydride. Triethylamine and
diisopropylethylamine was freshly distilied from calcium hydride and stored over
potassium hydroxide. Hexamethylphosphoramide was freshly distilied from calcium
hydride and stored on 4Â molecule sieves. Ail reactions were performed under nitrogen
atmosphere in oven or flame-dried giassware. Except as indicated otherwise, reactions
were magnetically stirred and monitored by thin layer chromatography with 0.25-mm E.
Merck pre-coated silica gel plates. Flash column chromatography was performed on E.
Merck silica gel 60 (40-60 pm) using ethyl acetate/hexane (E/H) in different ratios.
Yields refer to chromatographicaily and spectroscopicaily pure compounds, unless
otherwise stated. NMR (‘H, ‘3C) spectra were recorded on a Bruker AM-300 MHz or a
Bruker AM-400 MHz spectrometer either in CDC13 with CHC13 (H, = 7.26 ppm: C, =
77.0 ppm) or in C6D6 with C6H6 (H, = 7.26 ppm: C, = 12$ ppm) as internai reference.
X-Ray analysis was performed using graphite monochromatized Mo KŒ radiation, and
the structure was solved using direct methods (MULTAN$0) and difference Fourier
caiculations (SHELX76). Low resolution mass spectra (MS) and high resolution mass
spectra (HRMS) were measured at the University of Montreal Mass Spectrometry
Service Centre with desorption chemicai ïonization (Cl) or fast atom bombardment
(FAB). Infrared spectra (IR) were recorded either in a chloroform solution or neat with
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sodium chloride ceil with a Perkin-Elmer Model 2$3B spectromer. Optical rotations were
measured at the sodium une with a Perkin-Elmer model 241 polarimeter at amblent
temperature. Melting points are uncorrected.
[(2S, 3S)-2-Benzyloxymethoxy-3-methyl-5-trityloxypentyloxyl-ter t
butyldiphenylsilane (2):
060M 1. Dibal-H 060M
Toluene, -78°C, 86%
TBDPSO TBDPSO OTr
- CO2Me 2. TrCI DMAP -
r’5e CH2CI2, reflux, 76% 2
To a solution of ester 1 (2.00 g, 3.84 mmol) in toluene (50 mL) at —78 °C was added
Dibal-H (0.50 M, 23.1$ mL, 11.53 mmol). The reaction mixture was stirred at —7$ °C for
1 h before a solution of HC1 (1 M, 60 mL) was added. The resulting mixture was warmed
to room temperature and then extracted with hexane-ethyl acetate (1:1, 40 mL x 2). The
combined organic layers were washed with NaHCO3 solution, dried over Na7SO4 and
concentrated in vacuo. The residue was purified by column chromatography (E/H=1:4) to
give the product (1.64 g, 86%).
To a solution of the above alcohol (1.20 g, 2.43 mmol) in CH2CI7 (30 mL) was added
DMAP (0.7 1 g, 5.83 mmol) and trityl chloride (1.35 g, 4.86 mmol). The reaction mixture
was heated at reflux for 24 h before a solution of saturated NH4CÏ solution (20 mL) was
added. The mixture was extracted with hexane (30 mL x 2) and the combined organic
layers wcre dried over anhydrous Na2SO4 and concentrated in vacuo. The residue was
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purified by column chromatography on silica gel (E/H=1:20) to give product 2 (1.35 g,
76%) as a colorless oïl;
[XlD-l5.49 ° (c 1.2, CHC13);
‘H NMR (300 MHz, CDC13) 0.8$ (d, J=6.87 Hz, 1H), 1.12 (s, 9H), 1.40-1.54 (m, 1H),
1.90-2.02 (m, 1H), 2.06-2.17 (m, 1H), 3.06-3.14 (m, 1H), 3.20-3.28 (m, 1H), 3.66-3.70
(m, 1H), 3.74-3.90 (m, 2H), 4.60 (d, 1=11.79 Hz, 1H), 4.73 (d, J=11.79 Hz, 1H), 4.87 (d,
J=6.90 Hz, 1H), 4.97 (d, 1=6.90 Hz, 1H), 7.20-7.50 (m, 26H), 7.73-7.77 (m, 4H);
13C NMR (100 MHz, CDC13) 15.77, 19.17, 26.84, 31.76, 32.17, 61.92, 64.39, 69.59,
82.47, $6.38, 94.74, 126.79, 127.51, 127.69, 127.79, 128.34, 128.67, 129.66, 133.47,
135.59, 135.63, 138.03, 144.47;
IR (thin film) vmax 2963, 2932, 2859, 1474, 1456, 1433, 1113, 846, 820, 743, 700 cm’;
mIe: 732.1, 702.4, 689.2, 589.2, 484.1, 429.2, 386.4, 256.3.
(2S, 3S)-2-Benzyloxymethoxy-3-methyl-5-trityloxypentan-1-ol (3):
OBOM OBOM
THF88%
HO%.J_OTt
2 Me Me
3
To a solution of ether 2 (1.50 g, 2.04 mmol) in THF (20 mL) at room temperature was
added TBAF solution (1:1 complexed with acetic acid, 0.93 M, 6.00 mL, 5.58 mmol).
The mixture was stirred at r.t for 6 h before a saturated solution of NaHCO3 (30 mL) was
added. The mixture was extracted with hexane-ethyl acetate (1:1, 50 mL x 2). The
combined organic layers were washed with saturated NaHCO3 solution, brine, dried over
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Na2SO4 and concentrated in vacuo. The residue was purified by column chromatography
(E/H=1 :6) to afford product 3 (0.87 g, 88%) as a colorless ou;
[ŒJD+l6.77 ° (c 1.21, CHC13);
‘H NMR (300 MHz, CDC13) 0.83 (d, J=6.81 Hz, 3H), 1.40-1.50 (m, 1H), 1.82-2.04 (m,
2H), 3.04-3.14 (m, 1H), 3.18-3.24 (m, 1H), 3.42—3.50 (m, 1H), 3.60-3.82 (m, 2H), 4.60
(cl, J=11.73 Hz, 1H), 4.73 (cl, J=11.73 Hz, 1H), 4.74 (cl, J=6.96 Hz, 1H), 4.90 (cl, J=6.90
Hz, 1H), 7.24-7.52 (m, 20H);
‘3C NMR (100 MHz, CDCI3) 15.63, 32.28, 32.48, 61.56, 63.33. 69.98, 86.34, 86.80,
95.51, 126.73, 127.59, 127.81, 128.39, 128.49, 137.65, 144.20;
IR (thin film) vmax 3340, 2935, 2863, 1471, 1429, 1113, 1028, 778, 701 cm1;
mIe: 519.1, 487.1,471.2,429.1,323.1,243.1,217.1, 197.1, 109.1, 91.1, 73.0.
(4S, 5S)-4-Benzyloxymethoxy-5-methyl-7-trityloxyhept-2-enoic acid methyl ester (4):
OBOM 1. Swern OBOM
2. Ph3PCO2Me
.
1e
CH2CI2, 87% Me
3 4
To a solution of oxalyl chloride (0.17 mL, 1.93 mmol) in CH2CI2 (5 mL) at —78 oc was
added DMSO (0.21 mL, 2.89 mmol). The reaction mixture was stirred for 15 min before
alcohol 3 (0.47 g, 0.96 mmol) in CH2C12 (3 mL) was added. The mixture was stirred and
slowly warmed to —30 °c in about 30 min before triethylamine (0.54 mL. 3.85 mmol)
was added. A white precipitate was formed and the mixture was stirred at this
temperature for 15 min before being quenched by NH4C1 solution (10 mL). The organic
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layer was separated, drïed and concentrated in vacuo. The cmde aldehyde was dissolved
in dry CH2C12 (15 mL) and Ph3P=CHCO2CH3 (0.66 g, 1.93 mmol) was added to the
solution. The mixture was stirred at r.t. for 6 h. The solvent was removed and the residue
was purified by column chromatography (E/H=l:10) to give product 4 (0.46 g, 87%) as a
colorless oil;
[Œ]D 349 O (c 0.96, CHCI3);
‘H NMR (300 MHz, CDC13) 0.83 (d, 1=6.81 Hz, 3H), 1.38-1.50 (m, 1H), 1.79-1.91 (m,
1H), 1.92-2.09 (m, 1H), 3.02-3.13 (m, 1H), 3.13-3.23 (m, 1H), 3.76 (s, 3H), 4.10-4.16
(m, 1H), 4.54 (d, J=1l.72 Hz, 1H), 4.65 (d, J=1l.72 Hz, 1H), 4.71 (d, J=7.05 Hz, 1H),
4.74 (d, J=7.05 Hz, 1H), 5.95 (dd, J=1.23, 15.78 Hz, 1H), 6.84 (dd, J=6.60, 15.78 Hz,
1H), 7.20-7.38 (m, 14H), 7.42-7.50 (m, 6H);
‘3C NMR (100 MHz, CDCÏ3) 15.22, 32.68, 34.56, 51.51, 61.51, 69.81, 79.48, 86.53,
92.90, 122.80, 126.88, 127.68, 127.74, 127.83, 128.39, 128.65, 137.72, 144.35, 146.26,
166.37;
IR (thin film) vmax 3033, 2950, 2865, 1724, 1494, 1452, 1278, 1027, 744, 700 cm’;
mIe: 551.3 (M+1), 503.1, 485.2, 429.0, 243.1, 165.1, 119.1, 77.0.
(3R, 4S, 5S)-4-Benzyloxymethoxy-3,5-dïmetliyl-7-trityloxyheptanoic acid methyl
ester (5)
OOM OBOM
MeO2C” TMSC,THF-78
1e 92% ro te
4 5
To a sluny of Cul (0.38 g, 1.99 mmol) in THF (8 mL) at —30 oc was added MeLiLiBr
(1.50 M, 2.65 mL, 3.98 mmol) and the reaction mixture was allowed to warm up to O °C
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over 30 min. before it was cooled to —78 °C. To the resulting mixture were added
Me3SiC1 (0.6 mL, 4.73 mmol) and ester 4 (0.22 g, 0.39 mmol) in THF (3 mL). The
reaction mixture was stirred at —78 oc for 3 h before being quenched with saturated
NH4C1 solution (10 mL). The reaction mixture was diluted with hexane (30 mL), washed
with NH4c1-NH4OH (1:1, 30 mL), brine (20 mL) and dried over Na2SO4. The solvent
was removed in vacuo and the residue was subjected to column chromatography
(E/H=1 :30) to afford product 5 (0.2 1 g, 92%) as a colorless ou;
[Œ]D -16.7 O (c 0.42, cHcl3);
‘H NMR (400 MHz, D13) 0.84 (d, J=6.88 Hz, 1H), 1.02 (d, J=6.76 Hz, 1H), 1.37-
1.45 (m, 1H), 1.94-2.05 (m, 2H), 2.16 (dd, J=9.52, 15.12 Hz, 1H), 2.23-2.38 (m, 1H),
2.64 (dd, J=3.80, 15.16 Hz, 1H), 3.01-3.09 (m, 1H), 3.15-3.22 (m, 2H), 3.68 (s, 3H), 4.64
(s, 2H), 4.77 (s, 2H), 7.22-7.47 (m, 15H), 7.49-7.52 (m, 5H);
‘3C NMR (100 MHz, cDcl3) 16.87, 17.79, 31.55, 32.25, 32.69, 37.42, 51.30, 61.65,
70.02, 86.33, 88.51, 96.48, 126.73, 127.52, 127.66, 128.29, 128.56, 137.75, 144.33,
173.89;
IR (thin film) vmax 2951, 2877, 1737, 1491, 1449, 1381, 1277, 1161, 1073, 1037, 746,
706, 698 cm’;
HRMS: c37H43O5(M+1), caic.: 567.3 1104, found: 567.3 1280.
(4R, 5S)-[(1$)-3-Hydroxy-1-methylpropylJ-4-methyldihydrofuran-2-one (6):
H2, Pd(OH)2/C
MeOH, 87% -Me Me
=
5 Me Me 6
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A mixture of ester 5 (0.20 g, 0.35 mmol) and Pd(OH)2/C (20% Pd, Degussa type, 30 mg)
in MeOH (10 mL) was stirred under hydrogen at atmospheric pressure for 24 h. The
resulting mixture was filtered through a pad of Celite to remove the catalyst. The solvent
was removed in vacuo. The product was purified by column chromatography (E/H= 1:1)
to give product 6 (0.074 g, 87%) as a colorless ou;
[Œ]D —35.1 0 (c 0.50, CHCI3);
‘U NMR (300 MHz, CDC13) 1.02 (d, J=6.84 Hz, 3H), 1.17 (d, J=6.72 Hz, 3H) 1.40-
1.52 (m, 1H), 1.59-1.70 (broad, 1H), 1.76-1.86 (m, 1H), 1.88-2.02 (in, 1H), 2.119 (dd,
J=7.83, 11.52 Hz, 1H), 2.32-2.48 (m, 1H), 2.69 (dd, J=$.76, 17.55 Hz, 1H), 3.63-3.82 (m,
2H), 3.95 (t, .1=6.30 Hz, 1H);
‘3C NMR (100 MHz, CDC13) 15.51, 19.24, 32.24, 33.37, 34.57, 36.97, 60.26, 91.2$,
172.50;
IR (thin film) vmax 3420, 2926, 1771, 1460, 1421, 1384, 1271, 1171, 1056, 978 cm’;
URMS: C9H1703 (M+1), caic.: 172.10993, found: 172.10934.
(3R, 4S, SS)-4-Benzyloxymethoxy-5-methyl-3-phenyl-7-trityloxheptanoic acid
methyl ester (7):
OBOM
;B0M
OTr
Ph2CuMgBr
MeO2CÇ
MeO2C
%%_ TMSCI, THF E E
- Me
le 78 °C, 86% I4 7
To a slurry of Cul (0.33 g, 1.73 mmol) in THF (20 mL) at —78 oc was added PhMgBr
solution (1M, 3.46 mL, 3.46 mmol). The reaction mixture was stined at this temperature
for 1 h before Me3SiC1 (0.60 mL, 4.73 mmol) and ester 4 (0.22 g, 0.39 mmol) in THF (3
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mL) were added. The mixture was stirred at —78 °C for 6 h before NH4CI solution (15
mL) was slowly added. The resulting mixture was warmed to room temperature and then
extracted with hexane (30 mL x 2). The combined organic layers were washed with
NH4C1-NH4OH solution (1:1, 30 mL x 2), brine (30 mL), dried over anhydrous Na2SO4
and concentrated in vacuo. The residue was purified by column chromatography on silica
gel (E/H=1:20) to give product 7 (0. 21 g, 85%) as a colorless ou;
[OElo +7.8 ° (c 0.39, CHC13);
‘H NMR (300 MHz, CDC13) 0.80 (d, J=6.87 Hz, 3H), 1.28-1.40 (m, 1H), 1.70-f .83 (m.
1H), 1.90-2.04 (m, 1H), 2.64 (dU, J=9.69, 15.45 Hz, 1H), 2.85-2.95 (m, 1H), 3.02 (dd,
J=5.10, 15.54 Hz, 1H), 3.08-3.15 (m, 1H), 3.45-3.54 (m, 1H), 3.54 (s, 3H), 3.62 (dU,
J=2.61, 8.85 Hz, 1H), 4.62 (U, J=l1.91 Hz, 1H), 4.67 (d, J=11.91 Hz, 1H), 4.69 (d,
J=6.93Hz, 1H), 4.80 (U, J=6.93 Hz, 1H), 7.20-7 .44 (m, 20H);
‘3C NMR (100 MHz, CDC13) 16.94, 30.68, 3 1.89, 38.04, 44.8 1, 5 1.26, 6 1.37, 70.20,
26.21, 87.95, 96.49, 126.66, 126.28, 127.56, 127.64, 127.67, 128.11, 128.32, 128.50,
128.55, 137.70, 144.36, 172.97;
IR (thin film) vmax 2933, 2849, 1737, 1455, 1429, 1272, 1164, 1110, 1053, 1028, 700
cm1;
mIe: 537.5,473.2,269.1,243.1,183.1,147.1,135.1.
(4S, 5S)-5-[(1S)-3-Hydroxy-1-methylpropyl)-4-phenyldihydrofuran-2-one (8):
MeO2C 01t H2, Pd(OH)2/C OH
MeOH, 85%
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A mixture of ester 7 (0.23 g, 0.36 mmol) and Pd(OH)2/C (20% Pd, Degussa type, 40 mg)
in MeOH (10 mL) was stirred under hydrogen at atmospheric pressure for 24 h. The
resulting mixture was filtered through a pad of Celïte to remove the catalyst. The solvent
was removed in vacuo. The product was purified by column chromatography (E/H=1:5)
to give product $ (0.086 mg, 85%) as a colorless ou;
[ŒID —14.54 ° (c 0.35, CHC13);
1H NMR (400 MHz, CDC13) 6 0.95 (d, J=6.88 Hz, 3H), 1.43-1.52 (m, 1H), 1.77-1.87 (m,
1H), 2.01-2.10 (m, 1H), 2.67 (dcl, J=9.04, 17.96 Hz, 1H), 2.99 (dd, J9.36, 18.04 Hz,
1H), 3.47 (dd, J=8.88, 9.13 Hz, 1H), 3.60-3.70 (m, 1H), 3.70-3.80 (m, 1H), 4.45 (dd,
J=5.96, 7.44 Hz, 1H), 7.26-7.40 (m, 5H);
13C NMR (100 MHz, CDCI3) 6 15.54, 33.65, 34.51, 38.14, 44.11, 60.17, 90.61, 127.01,
127.42, 129.05, 140.62, 175.58;
W (thïn film) vmax 3401, 2932, 1773, 1497, 1457, 1417, 1208, 1171, 1056, 1002, 761,
700 cm’;
HRMS: C14H1903 (M+1), caic.: 235.12558, found: 235.12508.
(3R, 4S)-4-Benzyloxymethoxy-5-(tert-butyldiphenylsilanyloxy)-3-phenylpentanoic
acid methyl ester (9):
OBOM
BOM Ph2CuMgBr
TMSCI, THF, -78 C
Cl
86%
To a slurry of Cul (1.05 g, 5.51 mmol) in THE (30 mL) at —78 °C was added PhMgBr (1
M in THF, 11.03 mL, 11.03 mmol). The reaction mixture was stirred at —78 °C for 1 h
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before TMSC1 (3.00 mL, 2.57 g, 23.63 mmol) and ester Ci (0.56 g, 1.10 mmol) in THF
(8 mL) were added. The reaction mixture was stirred at —78 oc for 5 h before NH4c1
solution (50 mL) was added. The resulting mixture was allowed to warmed to room
temperature before being extracted with hexane (70 mL x 2). The combined extracts were
washed with NH4C1-NH4OH (1:1, 60 mL x 3) and NaHCO3 solution (40 mL), dried over
Na2SO4 and concentrated in vacuo. The residue was subjected to column
chromatograaphy (E/H=20: 1) to give product 9 (0.55 g, 8 6%).
(3R, 4S)-4-Benzyloxymethoxy-5-(tert-butyldiphenylsilanyloxy)-3-plienyl-pentan-1-o]
(10):
080M 080M
Diba-H, Toluene TBDPS0L___OH
-78 °C, 86%
9 10
To a solution of ester 9 (0.70 g, 1.19 mmol) in toluene (20 mL) at —78 oc was added
Dibal-H (0.50 M, 7.17 mL, 3.58 mmol). The reaction mixture was stirred at —78 oc for 1
h before HCI solution (1.00 M, 40 mL) was added. The resulting mixture was warmed to
room temperature and then extracted with hexane-ethyl acetate (1:1, 40 mL x 2). The
combined organic layers were washed with NaHcO3 solution, dried over Na2SO4 and
concentrated in vacuo. The residue was purified by column chromatography (E/H=1 :5) to
give the alcohol 10 (0.57 g, 86%);
[Œ] —21.41 O (c 2.1, cHcl3);
‘H NMR (400 MHz, cDcl3) 6 1.04 (s, 9H), 1.42-1.47 (broad, 1H), 1.89-1.95 (m, 1H),
2.23-2.28 (m, 1H), 3.13-3.19 (m, 1H), 3.42-3.36 (m, 4H), 3.86-3.90 (m, 1H), 4.49 (d,
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J=11.84 Hz, 1H), 4.62 (d, Jz11.82 Hz, 1H), 4.73 (cl, J=7.0 Hz, 1H), 4.86 (d, J=7.0 Hz,
1H), 7.19-7.66 (m, 20H) ppm;
‘3C NMR (400 MHz, CDCI3) 6 19.67, 26.84, 34.19, 43.76, 61.22, 64.05, 69.91, 81.75,
94.57, 126.58, 127.60, 127.67, 127.69, 127.73, 128.13, 128.28, 128.35, 128.43, 128.46,
129.21, 129.55, 129.62, 129.75, 133.22, 133.34, 135.48, 135.53, 135.54, 135.59, 137.85,
142.0 1 ppm;
IR (thin film) vmax 3376, 2930, 2858, 1472, 1428, 1115, 1028, 778, 700 cm1;
mIe: 555.3 (M+1), 485.2,439.1, 243.1, 214.0, 165.1, 119.1, 77.0.
[(25’, 3R)-2-Benzyloxymethoxy-3-phenyl-5-trityloxypentyloxyj-tert-
butyldiphenylsîlane (11):
080M
080M
TBDPS00H Tl, DMAP, CH2CI2
TBDPS00Tr
E reflux, 80% Q
To a solution of alcohol 10 (0.70 g, 1.25 mmol) in CH7CI2 (35 mL) was added DMAP
(0.6 1 g, 5.02 mmol) and TrCI (1.05 g, 3.75 mmol). The mixture was heated at reflux for
two days before being quenched with a solution of NH4CI (30 mL). The resulting mixture
was extiacted with hexane (30 mL x 2). The combined extracts were dried over Na,804
and concentrated in vacuo. The residue was purified by column chromatography
(E[H=1:25) to afford product 11(0.80 g, 80%) as acolorless ou;
[Œ]D -30.86 O (c 1.16, CHCI3);
‘H NMR (400 MHz, CDCI3) 6 1.05 (s, 9H), 1.84-1.94 (m, 1H), 2.38-2.49 (m, 1H), 2.85
(dt, J=5.52, 8.98 Hz, 1H), 3.03-3.09 (m, 1H), 3.33-3.40 (m, 1H), 3.51 (dcl, J=4.76, 11.0
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Hz, 1H), 3.61 (dd, J=4.04, 10.96 Hz, 1H), 3.81-3.88 (m, 1H), 4.45 (d, J=11.76 Hz, 1H),
4.58 (d, J=11.76 Hz, 1H), 4.69 (d, J=6.96 Hz, 1H), 4.82 (d, .1=6.96 Hz, 1H), 7.18-7.70
(m, 30H);
13C NMR (100 MHz, CDC13) 19.12, 26.79, 31.12, 43.51, 61.31, 63.98, 69.77, 82.60,
86.21, 94.51, 126.58, 127.49, 127.52, 127.56, 127.75, 127.85, 128.07, 128.28, 128.56,
133.27, 133.37, 137.88, 141.79, 144.3$;
IR (thin film) vmax 295$, 2932, 2859, 1472, 1430, 1114, 8430, $20, 741, 700 cm’;
(2S, 3R)-2-Benyloxymethoxy-3-phenyl-5-trityloxypentan-1-ol (12):
080M 080M
TBDPS0I—0Tr
TBAF
H0L_.0Tr
THF, 86%
11
- 12
To a solution of ether 11 (1.80 g, 2.26 mmol) in THE (30 mL) at room temperature was
added TBAF solution (1:1 complexed with acetic acid, 0.94 M, 14.42 mL, 13.56 mmol).
The reaction mixture was stirred at room temperature for 6 h before a saturated solution
of NaHCO3 (40 mL) was added. The resulting mixture was extracted with hexane-ethyl
acetate (1:1, 50 mL x 2). The combined organic layers were washed with saturated
NaHCO3 solution (30 mL), brine (20 mL), dried over Na2SO4 and concentrated in vacuo.
The residue was purified by column chromatography (E/H=1:7) to afford product 12
(1.08 g, 86%) as a colorless ou;
[ŒJD +1.69 O (c 1.24, CHCI3);
‘11 NMR (300 MHz, CDCI3) 1.80-1.92 (m, 1H), 2.28-2.39 (m, 1H), 2.80-2.97 (m, 2H),
2.99-3.08 (m, 2H), 3.35-3.45 (m, 1H), 3.45-3.58 (m, 1H), 3.68-3.74 (m, 1H), 4.64 (cl,
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J=11.73 Hz, 1H), 4.74 (d, J=6.96 Hz, 1H), 4.76 (d, J=11.73 Hz, 1H), 4.97 (d, J=6.96 Hz,
1H), 7.08-7.12 (m, 2H), 7.18-7.24 (m, 23H);
13C NMR (100 MHz, CDCI3) 3 1.93, 44.55, 61.23, 63.92, 70.18, 78.09, 86.31, 86.49,
95.68, 126.47, 126.64, 127.51, 127.56, 127.61, 127.86, 127.88, 128.21, 128.32, 128.46,
128.50, 129.54, 134.70, 137.06, 141.17, 144.22;
IR (thin film) vmax 3460, 3059, 2930, 287$, 1597, 1492, 1449, 1383, 1218, 1163, 1027,
746, 699 cm’;
HRMS: C38H39O4(M+1), cale.: 559.27697, found: 559.27657.
(4$, 5R)-4-Benzyloxymethoxy-5-phenyl-7-trityloxyhept-2-enoic acid methyl ester
(13):
OSOM OBOM
H0L.0Tr
2. PhaPCO2Me
CH2CI2, 87%
12 73
To a solution of oxaly chloride (0.17 mL, 0.24 g, 1.93 mmol) in CH2CI2 (10 mL) at —78
°C was added DMSO (0.19 mL, 0.21 g, 2.41 mmol). The reaction mixture was stirred for
15 min at —78 oc before alcohol 12 (0.36 g, 0.96 mmol) in CH2C12 (3 mL) was slowly
added at —78 °c. The resulting mixture was stined and slowly warmed to —30 °c in about
30 min before Et3N (403 tL, 2.89 mmol) was added. The white precipitate was formed
and the mixture was stirred at this temperature for 15 min before being quenched by
NH4C1 solution (10 mL). The organic layer was separated, dried and concentrated in
vacuo. The crude aldehyde was dissolved in dry CH2C12 (15 mL) and Ph3P=CHcO2cH3
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(970 mg, 2.89 mmol) was added. The mixture was stirred at r.t. for 6 h. The solvent was
removed and the residue was purified by column chromatography (E/H=1:10) to give
product 13 (1.02 g, 87%) as a colorless ou;
[Œ]D -34.92 ° (c 0.96, CHCI3);
‘H NMR (400 MHz, CDCI3) 1.92-2.26 (m, 1H), 2.22-2.37 (m, 1H), 2.86-2.97 (m, 1H),
3.05-3.18 (m, 2H), 3.72 (s, 3H), 4.41 (t, J=6.40 Hz, 1H), 4.46 (d, J=11.68 Hz, 1H), 4.52
(d, 1=11.68 Hz, 1H), 5.8$ (d, J=15.76 Hz, 1H), 6.79 (dd, J=6.56, 15.76 Hz, 1H), 7.10-
7.39(m, 20H);
‘3c NMR (100MHz, CDCI3) 30.59, 47.04, 51.45, 60.97, 69.81, 79.29, 86.26, 92.79,
122.44, 126.62, 127.49, 127.61, 127.69, 127.83, 128.11, 128.27, 128.44, 128.75, 134.73,
135.41, 137.43, 140.21, 144.18, 146.54, 166.22;
IR (thin film) vmax 3031, 2950, 1726, 1492, 1450, 1275, 1167, 1027, 746, 699 cm’;
m/e: 635.2 (M+Na), 625.2, 611.2, 484.2,429.0,411.0,243.1,214.0, 165.1, 132.9.
(3S, 4S, 5R)-4-Benzyloxymethoxy-3,5-diphenyl-7-trityloxyheptanoic acid methyl
ester (14):
080M 0
MeO2C0Tt
M O
0Tr
Ph2CuMgBr e 2
TMSCI, THF, -78 oc (2O (“kO
86% I
— —
13 14
To a slurry of Cul (2.00 g, 10.5 mmol) in THF (50 mL) at —7$ °C was added PhMgBr
solution (1 M, 21.00 mL, 21.00 mmol) and the mixure was stirred at this temperature for
1 h before TMSC1 (4.00 mL, 3 1.50 mmol) and ester 13 (0.33 g, 0.52 mmol) in THF (5
mL) were added. The reactïon mixture was stirred at —78 °C for 12 h before a saturated
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solution of NH4CI (10 mL) was slowly added. The mixture was extracted with hexane
(30 mL x 2). The combined organic layers were washed with NH4C1-NH4OH solution
(1:1, 30 mL x 2), dried over anhydrous Na2$04 and concentrated in vacuo. The residue
was purified by column chromatography on silica gel (E/H=:1:30) to give product 14
(0.3 1 g, 86%) as acolorless ou;
[ŒJD —23.4 O (c 1.35, CHCÏ3);
‘H NMR (400 MHz, CDCI3) 1.94-2.07 (m, 1H), 2.30-2.40 (m, 1H), 2.70-2.80 (m, 1H),
2.97-3.08 (m, 3H), 3.38-3.48 (m, 1H), 3.51 (s, 3H), 3.89 (dd, J4.72, 7.02 Hz, 1H), 4.26
(d, Jt=6.92 Hz, 1H), 4.41 (U, J=6.92 Hz, 1H), 4.57 (U, J=11.89 Hz, 1H), 4.62 (d, J=11.84
Hz, 1H), 6.83 (dd, J=0.96, 8.64 Hz, 1H), 6.90-7.04 (m, 2H), 7.13-7.40 (m, 27 H);
‘3C NMR (100 MHz, CDC13) 28.59, 36.43, 44.16, 44.73, 51.36, 60.79, 70.51, $6.04,
88.31, 96.95, 126.53, 127.44, 127.70, 128.02, 128.28, 128.34, 128.46, 128.59, 129.55,
141.80, 144.23, 173.15;
IR (thin film) vmax 2950, 1737, 1492, 1453, 1428, 1275, 1167, 1027, 736, 703 cm’
(4$, 5S)-[(1R)-3-Hydroxy4-phenylpropyl)-4-phenyldfhydrofuran-2-one (15):
MeO2C0Tt
H2, Pd(OH)2 /C OH
QQ MeOH, 88% cic:5
A mixture of ester 14 (0.20 g, 0.29 mmol) and Pd(OH)2/C (20% Pd, Degussa type, 0.040
mg) in MeOH (12 mL) was stirred under hydrogen at atmospheric pressure for 24 h. The
resulting mixture was filtered through a pad of Celite to remove the catalyst. The solvent
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was removed in vacuo. The product was purified by column chromatography (EIH= 1:7)
to give product 15 (0.068 g, 88%) as a colorless ou;
[Œ]D -26.85 O (c 0.35, CHCJ3);
‘H NMR (400 MHz, CDC13) 1.85-1.95 (m, 1H), 2.20-2.29 (m, 1H), 2.61 (dd, J=7.60,
18.12 Hz, 1H), 2.87 (dd, J=9.52, 18.16 Hz, 1H), 3.05-3.10 (m, 1H), 3.32-3.42 (m, 1H),
3.42-3.48 (m, 1H), 4.70 (dd, J=6.12, 7.52 Hz, 1H), 6.88-6.92 (m, 2H), 7.10-7.28 (m, 8H);
‘3C N1’IR (100 MHz, CDCI3) 34.51, 37.01, 44.37, 46.88, 60.13, 89.99, 126.64, 127.03,
127.34, 128.49, 128.63, 128.79, 138.94, 140.87, 143.76, 144.07, 175.71;
W (thin film) vmax 2917, 2849, 1777, 1496, 1455, 1173, 760, 700 cm’;
HRMS: C19H71O3(M+1), caic.: 296.14125, found: 296.12176.
(4R, 5R)-4-Benzyloxymethoxy-7-(tert-butyJdiphenylsilanyloxy)-5-phenylhept-2-enoic
acid methyl ester (16):
OBOM OBOM
MoO
L_OTr 1. TsOH, THF, 84%
E 2. TBDPSCI, imidazole E
TRF, 89%
13 16
b a solution of ester 13 (2.40 g, 3.98 mmol) in THf (30 mL) at room temperature was
added p-TsOHH20 (0.28 g, 1.45 mmol). The reaction mixture was stïred for 30 min
before a saturated solution of NaHCO3 (30 mL) was added. The resulting mixture was
extracted with ethyl acetate (30 mL x 2). The combined extracts were dried over Na2SO4
and concentrated in vacuo. The residue was subjected to column chromatography
(E/H=1:3) to give the alcohol (1.00 g, 84%) which was used directly in the next step.
127
To a solution of the above alcohol (1.00 g, 2.70 mmol) in CH2CI2 (20 mL) at O °C was
added imidazole (0.36 g, 5.4 mmol) and TBDPSC1 (0.83 g, 0.83 mL, 3.00 mmol). The
mixture was then stirred for 2 h at room temperature before being quenched by NH4C1
solution (20 mL). The mixture was extracted with hexane (30 mL x 2). The combined
organic layers were dried over Na2SO4 and concentrated in vacuo. The residue was
subjected to column chromatography (E/H=1 :15) to afford product 16 (1.50 g, 89%) as a
colorless ou;
[Œ]D —28.7 ° (c 0.69, CHC13);
‘H NMR (300 MHz, CDCI3) 6 1.02 (s, 9H), 1.82-1.98 (m, 1H), 2.19-2.31 (m, 1H), 3.10-
3.19 (m, 1H), 3.42-3.54 (rn, 1H), 3.56-3.63 (m, 1H), 3.72 (s, 3H), 4.42 (dt, 1=1.21, 6.30
Hz, 1H), 4.43 (d, J=11.5$ Hz, 3H), 4.50 (d, J=11.5$ Hz, 1H), 4.68 (d, J=7.0$ Hz, 1H),
4.70 (d, 1=7.08 Hz, 1H), 5.85 (dd, 1=1.21, 15.78 Hz, 1H), 6.79 (dd, 1=6.30, 15.78 Hz,
1H), 7.10-7.68 (m, 20 H);
‘3C NMR (100 MHz, CDC13) 6 19.04, 26.71, 32.88, 46.51, 51.47, 61 31, 69.79, 79.33,
92.78, 122.41, 126.72, 127.43, 127.49, 127.64, 127.84, 128.22, 128.30, 128.77, 129.33,
129.42, 133.62, 133.69, 135.37, 135.44, 137.46, 140.17, 146.67, 166.25;
IR (thin film) vmax 2931, 2858, 1727, 1472, 1428, 1269, 1166, 1112, 1026, 701 cm1;
mIe: 631.3 (M+Na), 589.2, 567.2, 442.2, 409.1, 243.1, 136.0, 77.0.
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(4R, 5R)-7-(tert-Butyldiphenylsilanyloxy)-4-hydroxy-5-phenylhept-2-enoic acfd
methyl ester (17):
080M 0H
E TMSBr, CH2CI2 E
O oc, 74% [j1
16 17
To a solution of ester 16 (0.60 g, 1.0 mmol) in CH2CL (20 mL) at —7$ °C was added
TMSBr (0.37 g, 0.32 mL, 2.46 mmol). The reaction mixture was slowly warmed from —
78 oc to —30 oc in 2 h and a saturated NaHCO3 solution (30 mL) was then added. The
mixture was extracted with ethyl acetate (30 mL x 2). The combined organic extracts
were dried over anhydrous Na2SO4 and concentrated in vacuo. The oily residue was
purified by column chromatography on silica gel (E/H=1:$) to give product 17 (0.35 g,
74%); -
[Œ]D +3.2 ° (c 0.75, CHCJ3);
1H NMR (300 MHz, CDC13) 6 1.04 (s, 9H), 1.90-2.05 (m, 1H), 2.07-2.20 (m, 1H), 2.53
(d, J5.67 Hz, 1H), 3.06-3.13 (m, 1H), 3.60-3.68 (m, 1H), 3.73 (s, 3H), 4.47-4.53 (m,
1H), 6.03 (dd, J1.83, 15.63 Hz, 1H), 6.90 (dd, J=4.44, 15.63 Hz, 1H), 7.12-7.67 (m,
15H);
13 NMR (100 MHz, cDcl3) 6 19.00, 26.69, 33.41, 48.52, 51.45, 61.65, 74.52, 1 20.70,
126.93, 127.53, 127.58, 128.43, 128.56, 128.71, 129.51, 129.59, 133.19, 133.24, 135.39,
135.49, 140.42, 148.69, 166.71;
IR (thin film) vmax 3449, 2933, 2859, 1726, 1429, 1276, 1169, 1119,825,703 cm1.
HRMS; C30H3704$i (M+1), calcd: 489.23826, found: 489.23856.
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(4$, 5R)-7-(tert-Butyldfphenylsilanyloxy)-4-hydroxy-5-phenylhept-2-enoic acid
methyl ester (1$):
MeO2COTBS co2 MeOCOTPS
Toluene, 80%
2. MeONa, MeOH -
85%
17 18
To a solution of alcohol 17 (0.33 g, 0.72 mmol) in toluene (4 mL) at O °C was added
PPh3 (0.37 g, 1.44 mmol), DEAD (0.24 g, 1.44 mmol), chloroacetic acid (0.14 g, 1.44
mmol). The reaction mixture was stilTed at O °C for 1 h, and at room temperature for 16 h
before saturated NaHCO3 solution (20 mL) was added. The resultïng mixture was
extracted with ethyl acetate (20 mL x 2). The combined organic layers were washed with
brine (15 mL), dried over anhydrous Na2SO4, and concentrated in vacuo. The residue was
purified by column chromatography (E[H=1:4) to give the ester (0.30 g, 80%) which was
used directly in the next step.
To a solution of the above ester (0.30 g, 0.60 mmol) in MeOH (6 mL) was added NaOMe
solution (1 M, 0.10 mL, 0.10 mmol). The reaction mixture was stirred at room
temperature for 20 min before a saturated solution of NH4CI (20 mL) was added. The
mixture was extracted with ethyl acetate (20 mL x 2). The combined organic layers were
washed with brine, dried over anhydrous Na2SO4 and concentrated in vacuo. The residue
was purified by column chromatography (EIH=1 :6) to provid product 18 (0.25 g, 85%);
[ŒJn—l6.76 ° (c 1.01, CHC13);
‘H NMR (400 MHz, CDC13) 1.04 (s, 9H), 1.90-2.01 (m, 1H), 2.06-2.18 (m, 1H), 2.44-
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2.60 (broad 1H), 3.03-3.13 (m, 1H), 3.49-3.55 (m, 1H), 3.59-3.68 (m, 1H), 3.72 (s, 3H),
4.46-4.50 (m, 1H), 6.02 (dd, J=1.52, 15.64 Hz, 1H), 6.90 (dd, J=4.44, 15.64 Hz, 1H),
7.10-7.68 (m, 15H);
l3 NMR (100 MHz, CDCI3) 18.98, 26.67, 33.39, 48.49, 51.45, 61.61, 74.49, 120.66,
126.91, 127.51, 127.57, 128.41, 128.54, 129.49, 129.57, 133.14, 135.37, 135.46, 140.39,
148.69, 166.71;
IR(thinfilm)vmax344$,2931,2857, 1725, 1428,1277,1168,1117,823,701 cm’;
HRMS; C30H37O4Si (M+1), calcd: 489.23826, found: 489.23856.
(4S, 5R)-4..Benzyloxymethoxy-7-(tert-butyldiphenylsilanyloxy)-5-phenylhept-2-enoic
acid methyl ester (19):
0H 050M
BOMCI, DJPEA
I CH2CI2, 82%
18 19
To a solution of ester 18 (0.18 g, 0.38 mmol) in CH2CI2 (6 mL) at O °C was added
D1PEA (0.39 mL, 0.29 g, 2.27 mmol) and BOMC1 (65%, 0.45 mL, 030 g, 1.89 mmol)
with stirring. The reaction mixture was then warmed to room temperature and then stirred
for 2 days. The reaction mixture was diluted with hexane (20 mL), washed wth NH4C1
(15 mL), brine (10 mL), dried over Na2SO4 and concentrated in vacuo. The residue was
subjected to column chromatography (E/H=1 :20) to afford product 19 (189 mg, 82%) as
a colorless ou;
[Œ]D -24.8 ° (c 0.79, CHCI3);
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‘H NMR (300 MHz, CDCI3) 6 1.01 (s, 9H), 1.83-1.97 (m, 1H), 2.19-2.30 (m, 1H), 3.0$-
3.18 (m, 1H), 3.42-3.50 (m, 1H), 3.52-3.60 (m, 1H), 3.71 (s, 3H), 4.38-4.48 (m, 1H), 4.42
(d, J=10.50 Hz, 1H), 4.49 (d, J=10.50 Hz, 1H), 4.6$ (d, J=6.$7 Hz, 1H), 4.71 (d, J=6.$7
Hz, 1H), 5.87 (dd, J1.23, 15.7$ Hz, 1H), 6.77 (dd, J=6.4$, 15.78 Hz, 1H), 7.10-7.67 (m,
20H);
‘3C NMR (400 MHz, CDC13) 6 19.00, 26.67, 32.81, 46.45, 61.25, 69.75, 79.26, 92.72,
122.37, 126.69, 127.39, 127.46, 127.61, 127.81, 128.19, 128.27, 128.73, 129.30, 129.39,
133.57, 133.64, 135.33, 135.41, 137.41, 140.12, 146.64. 166.23;
IR (thin film) vmax 2933, 2859, 1729, 1472, 1458, 1428, 1267, 1166, 1111, 1028, 700
cm;
mIe: 63 1.3 (M÷Na), 589.2, 567.2, 442.2, 409.1, 243.1, 136.0, 77.0.
(3R, 4R, 5R)-4-Benzyloxymethoxy-7-(tert-butyldiphenylsilanyloxy)-3,5-diphenyl-
heptanoic acid methyl ester (20):
OBOM
MeO2COTBDPS
Ph2CuMgBr, TMSCI
THF,84%
19
To a sluny of Cul (1.00 g, 5.25 mmol) in THF (20 mL) at —78 oc was added PhMgBr
solution (1.00 M, 10.50 mL, 10.50 mmol) and the mixure was stirred at this temperature
for 1 h. Then, to the mixture were added TMSCI (2.00 mL, 15.75 mmol) and ester 19
(0.20 g, 0.33 mmol) in THf (3 mL). The resulting mixture was stirred at —78 oc for 12 h
before a saturated solution of NH4C1 (10 mL) was slowly added. The mixture was
extracted with hexane (30 mL). The organic layer was washed with NH4C1-NH4OH
OBOM
20
132
solution (1:1, 30 mL x 2), dried over anhydrous Na2804 and concentrated in vacuo. The
residue was purified by column chromatography on silica gel (EIH=1:30) to give product
20 (0.18 g, 84%) as a co1oress ou;
[Œ] -12.38 O (c 0.42, CHC13);
‘H NMR (300 MHz, CDC13) 0.89 (s, 9H),1.82-1.95 (m, 1H), 1.94-2.06 (m, 1H), 2.01
(dd, 1=12.00, 15.00 Hz, 1H), 2.91-2.99 (m, 2H), 3.11-3.19 (m, 1H), 3.19-3.27 (m, 1H),
3.42 (s, 3H), 3.42-3.50 (m, 1H), 4.11 (dd, J=2.80, 7.90 Hz, 1H), 4.56 (s, 2H), 4.73 (d,
J=$.60 Hz, 1H), 4.81 (d, J=$.60 Hz, 1H), 7.18-7.55 (m, 30H);
13 NMR (100 MHz, CDC13) 18.30, 26.61, 36.95, 37.87, 43.69, 45.60, 5 1.14, 60.86,
70.39, 87.04, 98.60, 126.29, 126.73, 127.34, 127.42, 127.59, 127.72, 128.29, 128.3$,
129.34, 129.91, 133.65, 135.33, 137.62, 140.95, 143.20, 172.68;
IR(thinfilm)vmax 2931, 2848, 1734, 1472, 1465, 1428, 1260, 1112, 1022, 701 cm’;
(3$, 4$, 5R)-4-Benzyloxymethoxy-7-(tert-butyldiphenylsflanyloxy)-3-metliyl-5-
phenylheptanoic acid methyl ester (21)
OOM OBOM
Me2CuLi, TMSCI
MeO2C[S
r
THF, 92% Me
19 21
To a slurry of Cul (0.20 g, 1.05 mmol) in THF (8 mL) at —30 °C was added MeLiLiBr
(1.50 M, 1.40 mL, 2.10 mmol) and the reaction mixture was allowed to warm up to O °C
over 30 min before it was cooled to —78 °C. To the resulting mixture were added Me3SiC1
(0.40 mL, 3.15 mmol) and ester 19 (0.20 g, 0.33 mmol) in THF (3 mL). The reaction was
stirred at —78 °C for 3 h before being quenched with saturated NH4C1 solution (10 mL).
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The mixture was diluted with hexane (30 mL) and the organic layer was separated. The
organic layer was washed with NH4CÏ-NH4OH (1:1, 30 mL), dried over Na,S04 and
concentrated in vacuo. The residue was subjected to column chromatography (E[H= 1:30)
to afford product 21 (0.2 1g, 92%) as a colorless ou;
[ŒJD —17.9 ° (C 0.69, CHC13);
‘H NMR (300 MHz, CDC13) 1.01 (s, 9H), 1.02 (d, J=7.26 Hz, 3H), 1.81-1.92 (m, 1H),
2.02-2.18 (m, 2H), 2.20-2.32 (m, 1H), 2.53 (dd, J=2.10, 13.95 Hz, 1H), 3.09-3.18 (m,
1H), 3.32-3.46 (m, 1H), 3.51-3.58 (m, 1H), 3.63 (s, 3H), 4.47 (d, J=6.96 Hz,ÏH), 4.56 (d,
J=11.85 Hz, 1H), 4.68 (d, J=1l.85 Hz, 1H), 4.70 (d, J=6.96 Hz, 1H), 7.08-7.8 (m, 20H);
‘3C NMR (100 MHz, CDCI3) 17.46, 19.07, 26.73, 32.86, 32.94, 36.94, 44.19, 51.29,
61.41, 70.24, 87.91, 96.59, 126.44, 127.41, 127.49, 127.71, 128.33, 128.41, 128.48,
129.3 1, 129.40, 135.40, 135.45, 141.84, 173.80;
W (thin film) vmax 2931, 2849, 1736, 1454, 1428, 1270, 1163, 1111, 1053, 1028, 701
cm’;
(2$, 3R, 4S)-4-Benzyloxymethoxy-5-(tert-butyldiphenylsilanyloxy)-2-liydroxy-3-
phenylpentanoic acid methyl ester (22a):
OOM BOMO OH
TBDPSO 1. KHMDS, THF DPSO
- CO2Me - 78 C . CO2Me
E E
2. (1S)-(+)-(1O-camphor
-I -suIfony)oxaziridine
83%
9 22a
To a solution of ester 10 (3.06 g, 5.23 mmol) in THF (100 mL) at —78 °C was added
KHMD$ (0.50 M, 12 mL, 6.0 mmol). The reaction mixture was stirred at this
temperature for 1 h before a solution of (1$)-(+)-10-camphorsulfonyloxaziridine (1.37 g,
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6.00 mmol) in THF (30 mL) was added. The resulting mixture was stirred at —78 °C for
another 2 h before being quenched with aquouos NH4C1 solution (70 mL). The product
was extracted with diethyl ether (100 mL x 3). The combined organic extracts were dried
over Na2SO4, and concentrated in vactto. Column chromatography (E/H=1:7) of the
residue on silica gel provided product 22a (2.61 g, 83%);
[ŒID -34.7$ (c 0.92, CHCI3);
1H NMR (400 MHz, CDCI3) 1.01 (s, 9H), 3.08 (d, 1=5.72 Hz, 1H), 3.45 (dd, J=3.84,
11.52 Hz, 1H), 3.57 (dd, J2.84, 10.80 Hz, 1H), 3.06 (s, 3H), 4.28-4.32 (m, 1H), 4.53 (d,
J=11.80 Hz, 1H), 4.72 (d, 1=11.80 Hz, 1H), 4.93 (d. J=6.76 Hz, 1H), 4.95 (d, J=6.76 Hz,
1H), 4.99 (dd, J=2.64, 5.2$ Hz, 1H), 7.19-7.40 (m, 1$ H), 7.58-7.62 (m, 2H);
‘3C NMR (100 MHz, CDCI3) 19.06, 26.65, 49.84, 52.12, 60.28, 69.85, 70.25, 77.12,
94.25, 12732, 127.41, 127.49, 127.60, 127.89, 128.05, 128.21, 128.30, 129.28, 129.35,
129.51, 133.00, 133.09, 135.30, 135.30, 136.20, 137.39, 174.59;
IR (thin film) vmax 3617, 3031, 2931, 2857, 1739, 1589, 1495, 1455, 1428, 1269, 1224,
1113, 1026, 702 cmt;
HRMS: C36H42O6Si (M+1), caic.: 599.28290, found: 599.28 170.
(3$, 4$, 5S)-5-(tert-Butyldiplienylsilanyloxymetliyl)-3-hydroxy-4-
phenyldihydrofuran-2-one (23a):
HOMO OH
TBDPSOCO2Me H2, Pd(oH)2/c TBDPSO
MeOH, 88%
22a 23a
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A mixture of ester 22a (0.15 g, 0.25 mmol) ami Pd(OH)2/C (0.040 g, 20% Pd, Degussa
type) in MeOH (8 mL) was stined under hydrogen at atmospheric pressure for 36 h. The
resulting mixture was filtered through a pad of Celite to remove the catalyst. The solvent
was removed in vacuo. The product was purified by column chromatography (E/H= 1:4)
to give product 23a (0.096 g, 86%) as colorless oïl;
[Œ]D —50.67 O (c 1.14, CHCh);
‘H NMR (400 MHz, CDC13) 1.06 (s, 9H), 2.82-2.86 (broad, 1H), 3.69-3.78 (m, 2H),
3.97 (dd, 1=2.36, 12.12 Hz, 1H), 4.50-4.58 (m, 2H), 4.66 (dd, 1=2.88, 10.92 Hz, 1H),
6.76-7.48 (m, 11H), 7.58-7.67 (m, 4H);
‘3C NMR (100 MHz, CDC13) 19.09, 26.69, 49.90, 52.10, 63.59, 69.89, 70.29, 77.12,
94.33, 127.34, 127.43, 127.51, 127.61, 127.90, 128.06, 128.22, 128.31, 129.32, 129.37,
129.52, 133.07, 133.16, 135.34, 135.53, 136.2$, 137.66, 174.59;
IR (thin film) vrnax 3420, 2917, 2850, 1779, 1496, 1457, 1165, 760, 700 cm’;
HRMS: C27H3oO4SiNa(M+Na), calc.: 469.1$ 112, found: 469.18240.
(2$, 3$, 4$) -4-Benzyloxymethoxy-5-(tert-butyldiphenylsilanyloxy)-2-
methoxymethoxy-3-phenylpentan-1-ol (24):
HOMO OH
HOMO OMOM
TBDPSo 1. MOMCI TBDPsooH
2 2. Dibal-H
I Overall 74%
22a 24
To a solution of Œ-hydroxyl-ester 22a (2.20 g, 3.66 mmol) in CH2C12 (50 mL) at room
temperature was added i-Pr2NEt (1.27 mL, 7.32 mmol) and MOMC1 (0.55 mL, 7.32
mmol). The reaction mixture was stirred at room temperature for 16 h before being
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quenched with NH4CÏ (50 mL x 2). The product was extracted with hexane (100 mL x 2).
The combined organic extracts were dried over NaSO4, and concentrated in vacuo. The
residue was purified by column chromatography (E/H=1:20) to give the MOM ether
(2.06 g, 88%);
[ŒID —13.6° (c 0.8$, CHC1);
‘ii NMR (400 MHz, CDCI3) 6 1.07 (s, 9H), 3.37 (s, 3H), 3.54 (dU, J=3.52, 11.40 Hz,
1H), 3.64 (s, 3H), 3.73 (dd, J=4.16, 10.24 Hz, 1H), 3.7$ (dd, J=2.20, 11.44 Hz, 1H),
4.18-4.24 (m, 1H), 4.52 (U, J=12.24 Hz, 1H), 4.63 (U, J=12.24 Hz, 1H), 4.70 (d, J=6.4$
Hz, 1H), 4.76 (U, J=6.4$ Hz, 1 H), 4.83 (U, J=4.16 Hz, 1H), 4.92 (d, J=6.60 Hz, 1H), 4.95
(U, J=6.60 Hz, 1H), 7.25-7.43 (m, 18H), 7.63-7.66 (m, 2H);
‘3C NMR (100 MHz, CDC13) 6 19.12, 26.74, 31.84, 49.91, 51.48, 56.73, 63.83, 69. 81,
76.54, 78.56, 94.81, 97.01, 127.13, 127.42, 127.46, 127.50, 127.61, 128.04, 128.25,
129.36, 129.52, 129.74, 133.14, 135.41, 135.63, 136.81, 137.81, 172.21;
IR (thin film) vmax 3069, 2931, 2893, 2857, 1748, 1496, 1472, 1428, 1389, 1361, 1210,
1152, 1114, 1072, 1039, 1026,921,823,7$7,740,710cm’.
To a solution of the above MOM ether (1.90 g, 2.96 mmol) in toluene (25 mL) at —78 oc
was added Dibal-H (0.50 M, 17.76 mL, 8.8$ mmol). The reaction mixture was stirred at —
78 °C for 1.5 h before being quenched with NH4CI solution (30 mL). The mixture was
extracted with diethyl ether (100 mL x 2). The combined extracts were dried over
Na2SO4 and concentrated in vacuo. The residue was purified by column chromatography
(E[H=1:5) to give product 24 (1.50 g, 84%);
[c]D +9.68 ° (c 0.96, CHCI3);
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1H NMR (400 MHz, CDCI3) 6 1.08 (s, 9H), 3.21-3.28 (m, 2H), 3.35 (s, 3H), 3.47 (dd,
J=3.68, 11.44 Hz, 1H), 3.54 (dd, J=1.84, 11.36 Hz, 1H), 3.70 (dd, J=2.08, 11.36 Hz, 1H),
4.20-4.24 (m, 1H), 4.24-4.31 (m, 1H), 4.52 (d, J=12.0$ Hz, 1H), 4.65 (d, J=12.08 Hz,
1H), 4.76 (d, J=6.84 Hz, 1H), 4.79 (d, J=6.84 Hz, 1H), 4.90 (d, J=6.60 Hz, 1H), 4.93 (cl,
J=6.60 Hz, 1H), 7.28-7.48 (m, 18H), 7.65-7.67 (m, 2H);
‘3C NMR (100 MHz, CDC13) 6 19.13, 26.76, 31.85, 49.56, 55.39, 63.86, 66.27, 69.85,
78.82, 82.76, 94.69, 97.81, 126.78, 127.44, 127.51, 127.56, 127.62, 127.94, 128.31,
129.39, 129.52, 129.88, 133.17, 133.23, 133.41, 135.60, 137.71, 137.82;
IR (thin film) vmax 3462, 3069, 3030, 2857, 1589, 1496, 1471, 1454, 1428, 1362 cm1;
HRMS: C37H47O6Sï (M+1), caic.: 615.3 1421, found: 615.3 1600.
(4R, 5S, 6S)-6-Benzyloxymethoxy-7-(tert-butyldiphenylsilanyloxy)-2-hydroxy-4-
methoxymethoxy-5-phenylliept-2-enoic acid methyl ester (25):
80MO OMOM 80MO OMOM
TBDPSO.I2%...OH
1 Swern
— 2. Wittig Z
84%
24 25
To a solution of oxalyl chloride (0.15 g, 0.10 mL, 1.15 mmol) in CH2CI2 (5 mL) at —78
°C was added DMSO (0.18 g, 0.20 mL, 2.30 mmol). The reaction mixture was stirred for
15 min before alcohol 24 (0.18 g, 0.29 mmol) in CH2CJ2 (3 mL) was added. The reaction
mixture was stirred and slowly warmed to —30 oc in about 30 min before triethylamine
(0.29 g, 0.40 mL, 28.8 mmol) was added. The white precipitate was formed and the
mixture was stirred at this temperature for 15 min before being quenched by a solution of
NH4CI (10 mL). The organic layer was separated, dried and concentrated in vacuo. The
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crude aldehyde was dissolved in dry CH2C12 (15 mL) and Ph3P=CHCO2CH3 (0.20 g, 0.57
mmol) was added. The mixture was stirred at r.t. for 12 h. The solvent was removed and
the residuc was purified by column chromatography (EIH=10: 1) to give product 25 (0.16
g, 84%) as a colorless ou;
Rff 0.4 (E/H=1:8);
[ŒJD -33.60 O (c 0.86, CHCI3);
1H NMR (400 MHz, CDCI3) 1.06 (s, 9H), 3.26-3.30 (m, 1H), 3.2$ (s, 3H), 3.54 (dd,
J=3.64, 11.32 Hz, 1H), 3.71 (s, 3H), 3.76 (dd, J=2.68, 11.32 Hz, 1H), 4.23-4.28 (m, 1H),
4.52 (d, J=12.16 Hz, 1H), 4.61 (d, J=12.16 Hz, 1H), 4,62 (d, J=6.6 Hz, 1H), 4.46 (d,
J=6.60 Hz, 1H), 4.87-4.89 (m, 1H), 4.93 (d, J=6.64 Hz, 1H), 4.96 (d, J=6.64 Hz, 1H),
5.93 (dd, J=0.88, 15.76 Hz, 1H), 6.76 (dd, J=7.00, 15.76 Hz, 1H), 7.24-7.42 (m, 1$ H),
7.62-7.69 (m, 2H);
‘3c NMR (100 MHz, CDCI3) 19.08, 26.76, 51.40, 52.29, 55.96, 63.89, 69.79, 75.95,
78.61, 94.88, 95.67, 121.65, 126.84, 127.43, 127.49, 127.53, 127.5$, 127.84, 128.26,
129.37, 129.54, 130.3 1, 133.08, 133.12, 135.39, 135.60, 137.03, 137.78, 148.24, 166.34;
IR (thin film) 3030, 2931, 2891, 2859, 1726, 1472, 1485, 1362, 1274, 1168, 1112, 1042,
719 cm’;
HR1VIS: C40H49O7Si (M÷1), caic.: 669.32477, found: 669.32260.
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(3S, 4R, 5S, 6S)-6-Benzyloxymethoxy-7-(tert-butyl-diphenylsi]anyloxy)-4-
methoxymethoxy-3,5-diphenylheptanoic acid methyl ester (26):
80MO OMOM
TBDPSO Ph2CuMgBr
DPS0
CO2Me
o TscI
26
To a slurry of Cul (0.34 g, 1.7$ mmol) in THF (10 mL) at -7$ °C was added phenyl
magnesium bromide solution (1.00 M, 3.56 mL, 3.56 mmol). The reaction mixture was
stirred for 1 h at -78 oc before TMSC1 (0.67 mL, 0.5$ g, 5.34 mmol ) and a,f3-
unsaturated ester 25 (0.12 g, 0.1$ mmol) in THF (4 mL) were added. The reaction
mixture was stirred at —78 °C for 7 h before being quenched with a solution of NH4CI-
NH4OH (1:1, 10 mL). The resulting mixture was extracted with hexane (20 mL x 3). The
combined extracts were washed with NH4CI-NH4OH solution (10 mL x 2), dried over
NaSO4, and concentrated in vacuo. Column chromatography of the residue (E/H=1 :20)
to give product 26 (0.11 g, 86%);
[Œ] +20.81 ° (c 0.86, CHCT3);
‘H NMR (400 MHz, CDCI3) 6 0.87 (s, 9H), 2.52 (dd, J=10.12, 14.92 Hz, 1H), 2.92 (dd,
J=4.56, 15.00 Hz, 1H), 2.98-3.42 (m, 2H), 3.24 (dd, J=3.$8, 11.56 Hz, 1H), 3.41 (s, 3H),
3.49 (s, 3H), 3.54 (dd, J1.40, 11.68 Hz, 1H), 4.04-4.07 (m, 1H), 4.49 (d, J=12.28 Hz,
1H), 4.57 (d, J=10.40 Hz, 1H), 4.66 (d, J=12.28 Hz, 1H), 4.85 (d, J=6.12 Hz, 1H), 4.87
(d, J=6.36 Hz, 1H), 4.8$ (d, J=6.12 Hz, 1H), 4.98 (d, J=6.36 Hz, 1H), 7.14-7.41 (m, 23
H), 7.46-7.57 (m, 2H);
‘3C NMR (100 MHz, CDC13) 6 18 97, 26.60, 39.37, 45.98, 48.24, 51.01, 50.39, 63.72,
69.97, 79.38, 82.01, 94.57, 99.54, 126.63, 126.74, 127.28, 127.35, 127.43, 127.55,
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127.61, 128.24, 128.40, 128.57, 129.23, 129.35, 130.87, 133.14, 133.31, 135.32, 135.65,
137.26, 138.01, 141.21, 172.74;
IR (thin film) vmax 3030, 2931, 2857, 173$, 1496, 1454, 1428, 1362, 1260, 1155, 1113,
1104, 700 cm’;
HRMS: C46H54O7SiNa (M+Na), caic.: 769.35364, found: 769.35190.
(2R, 3S, 4$, 5$, 6S)-6-Benzyloxymethoxy-7-(tert-butyldiphenylsilanyloxy)-2-
hydroxy-4-methoxymethoxy-3,5-diphenylheptanoic acid methyl ester (27):
OMOM
1 KHMDS THF BOMO OMOM OH
-
- 78 oh TBDPSO k :
R CO2Me
2.(iSH+)-(iOcamphor
27
To a solution of ester 26 (0.10 g, 0.13 mmol) in THF (3 mL) at —7$ 0C was added
KHMDS (0.50 M, 0.54 mL, 0.28 mmol). The reaction mixture was stined at this
temperature for 1 h before a solution of (1S)-(+)-10-camphorsulfonyloxaziridine (0.064 g,
0.27 mmol) in THF (2 mL) was added. The resulting mixture vas stirred at —78 oc for
another 6 h before being quenched with NH4CI solution (70 mL). The product was
extracted with diethyl ether (100 mL x 3). The combined organic extracts were dried over
Na2SO4, and concentrated in vacuo. Column chromatography of the residue provided
starting marterial (42 mg, with E/H=1:15 as eluents) and product 27(0.049 g, 82% based
on recorvered starting marterial, with E/H=1:8 as eluents);
[Œ]D -12.56 O (c 0.78, CHCÏ3);
‘H NMR (400 MHz, CDC13) 60.82 (s, 9 H), 2.84 (dd, J2.64, 11.20 Hz, 1H), 2.94 (d,
J=10.04 Hz, 1H), 3.28-3.35 (m, broad, 1H), 3.4$ (s, 3H), 3.49 (s, 3H), 3.40-3.53 (m, 1H),
26
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4.08-4.12 (m, 1H), 4.49 (d, J=12.16 Hz, 1H), 4.69 (d, J=12.06 Hz, 1H), 4.68-4.74 (m,
1H), 4.90-4.99 (ru, 3H), 5.01 (cl, J=6.28 Hz, 1H), 5.09 (cl, J=6.28 Hz, 1H), 7.02-7.48 (m,
25 H);
‘3C NMR (100 MHz, CDCI3) 18.92, 26.52, 31.79, 47.94, 51.77, 52.43, 56.36, 63.75,
70.01, 70.65, 78.34, 79.3 1, 94.67, 99.56, 126.61, 127.23, 127.32, 127.42, 127.59, 127.66,
128.23, 129.16, 129.32, 129.55, 130.78, 133.30, 135.27, 135.54, 136.35, 137.17, 137.91,
171.19;
IR (thin film) 3511, 2930, 2849, 1778, 1495, 1492, 1453, 1407, 1261, 1225, 1113, 1041,
701 cm1;
(2R, 3R, 4S)-4-Benzyloxymethoxy-5-(tert-butyldiplienylsilanyloxy)-2-
methoxymethoxy-3-pheuylpentanoic acid methyl ester (27):
BOMO OH BOMO OMOM
TBDPSO
- 1 Mitsunobu TBDPSO
- COMe
- CO2Me
E 2.MOMCI E
overall 80%
22a 28
b a solution of Œ-hydroxyl ester 22a (1.50 g, 2.50 mmol) in toluene (20 mL) at O °C
were added Ph3P (3.28 g, 12.5 mmol), CH2CICO2H (1.18 g, 12.5 mmol) andDEAD (2.17
g, 12.5 mmol). The reaction mixture was stirred at O °C for 0.5 h and at room temperature
for 24 h before being quenched with NRCI solution (20 mL). The resulting mixture was
extracted with diethyl ether (30 mL x 2). The combined organic extracts were dried over
Na2SO4 and concentrated in vacuo. Column chromatography of the residue provided the
starting material (0.43 g, 29%, with E/H=1:6 as eluents) and the desired Œ-chloro-actoxyl
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ester product (1.00 g, with EIH=1:10 as eluents, 85% based on recovered starting
material).
To a solution of the a-chloro acetate product (1.00 g, 1.50 mmol) obtained from the
above reaction in methanol (10 mL) was added sodium methoxide solution (0.50 M, 30
FIL, 0.0 15 mmol). The reaction mixture was stirred ar room temperature for 1 h before
being quenched with NH4C1 solution (10 mL). The product was extracted with diethyl
ether (20 mL x 2). The combined organic extracts were dried over Na2SO4 and
concentrated in vacuo. The residue was purified by column chromatography (silica gel,
E/H=1:6) to give the alcohol (0.80 g, 90%);
[Œ] —35.9 ° (c 1.1, CHCÏ3);
‘H NMR (400 MHz, CDC13) 6 1.09 (s, 9H), 3.49 (dd, J=3.04, 11.48 Hz, 1H), 3.57-3.65
(broad, 1H), 3.67 (dd, J=1.$4, 11.52 Hz, 1H), 3.84 (s, 3H), 3.98 (dd, J=Ï.68, 10.76 Hz,
1H), 4.22-4.28 (m, 1H), 4.38-4.44 (m, 1H), 4.46 (d, J=12.04 Hz, 1H), 4.61 (d, J=12.04
Hz, 1H), 4.74 (d, J=7.66 Hz, 1H), 4.78 (d, J=6.6 Hz, 1H), 7.26-7.48 (m, 18H), 7.64-7.66
(m, 2H);
‘3C NMR (100 MHz, CDCI3) 6 19.23, 26.69, 49.13, 52.20, 63.29, 69.98, 73.03, 94.56,
127.13, 127.46, 127.54, 127.62, 128.30, 128.42, 128.98, 129.44, 129. 54, 133.18, 133.30,
135.39, 135.62, 137.65, 139.73, 174.88;
IR (thin film) 3498, 2931, 2857, 1735, 1495, 1472, 1454, 1428, 1258, 1234, 113, 1026,
701 cm’;
HRMS: C36H42O6Si (M÷1), calc.: 599.28290, found: 599.28 170.
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To a solution of the above alcohol (0.80 g, 1.33 mmol) in CH2CI, (15 mL) at room
temperature was added i-Pr2NEt (0.46 mL, 2.66 mmol) and MOMC1 (0.20 mL, 2.66
mmol). The mixture was stirred at room temperature for 16 h before being quenched with
NH4C1 solution (20 mL). The product was extracted with hexane (30 mL x 2). The
combined organic extracts were dried over Na2SO4 and concentrated in vacuo. The
residue was purified by column chromatography (silica gel, E/H=1:20) to give 28 (0.79 g,
92%);
[al0 -2.33 ° (c 0.85, CHC13);
‘H NMR (400 MHz, CDC13) 1.08 (s, 9H), 3.16 (s, 3H), 3.55 (dd, J=2.80, Ï 1.28 Hz,
1H). 3.74 (s, 3H), 3.80 (dd, J=2.12, 11.32 Hz, 1H), 4.09 (dd, J=2.64, 10.24 Hz,1H), 4.36
(dt, J=2.60, 10.48 Hz, 1H), 4.39 (d, J=2.64 Hz, 1H), 4.43 (d, J=12.04, 1H), 4.56 (d,
J=2.00 Hz, 1H), 4.59 (d, J=7.04 Hz, 1H), 4.73 (d, J=7.08 Hz, 1H), 4.80 (d, .1=6.84 Hz,
1H), 4.90 (d, J=7.04 Hz, 1H), 7.21-7.43 (m, 18H), 7.67-7.69 (m, 2H);
13C NMR (100 MHz, CDCI3) 19.22, 26.67, 48.85, 51.44, 56.17, 63.58, 76.64,
94.63, 96.37, 127.06, 127.31, 127.39, 127.40, 127.64, 128.17, 128.25, 129.26, 129.33,
129.52, 133.32, 134.71, 135.37, 135.46, 135.56, 135.67, 138.07, 139.32, 171.96;
IR (thin film) vmax 3071, 2933, 2893, 1746, 1499, 1474, 1378, 1364, 1155, 1072, 1032,
923, 789, 710 cm1.
(4$, 5S, 6S)-6-Benzyloxymethoxy-7-(tert-butyldiplienylsilanyloxy)-2-hydroxy-4-
methoxymethoxy-5-phenylhept-2-enoic acid methyl ester (29):
BOMO OMOM BOMO OMOM1.Dibal-H, THF
TBDPSO
- CO2Ma 2. Swern
TBDPSO
COM
E 3. Wittg E
28 29
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To a solution of ester 28 (0.70 g, 1.09 mmol) in toluene (15 mL) at —78 °C was added
Dibal-H (0.50 M, 6.54 mL, 3.27 mmol). The reaction mixture was stirred at —7$ °C for
1.5 h before being quenched with NH4C1 solution (15 mL). The resulting mixture vas
extracted with diethyl ether (30 mL x 2). The combined organic layers were dried over
Na2SO4 and concentrated in vacuo. The residue was purified by column chromatography
(silica gel, E/H=1:5) to give the corresponding alcohol (0.58 g, 87%);
[Œ]D —35.19 ° (c 0.85, CHC13);
1H NMR (400 MHz, CDCJ3) 6 1.06 (s, 9H), 3.37 (t, J=6.60 Hz, 1H), 3.41 (s, 3H), 3.50
(dd, J=7.12, 10.08 Hz, 1H), 3.60-3.70 (m, 2H), 3.78 (dd, J=3.92, 10.08 Hz, 1H), 4.11-
4.18 (m, 1H), 4.28-4.30 (m, 1H), 4.55 (U, J=11.84 Hz, 1H), 4.69 (s, 2H), 4.70 (U, J=1 1.76
Hz, 1H), 4.90 (d, J=6.80 Hz, 1H), 4.96 (d, J=6.80 Hz, 1H), 7.20-7.48 (m, 6H), 7.50-7.53
(m, 2H), 7.68-7.70 (m, 2H);
13C NMR (100 MHz, CDCI3) 6 19.08, 26.74, 48.99, 55.69, 64.55, 64.64, 69.95, 78.98,
$3.51, 94.68, 97.51, 126.81, 127.52, 127.57, 127.69, 128.12, 128.30, 128.89, 129.48,
129.59, 129.76, 133.16, 133.18, 135.39, 135.55, 137.69, 139.51;
IR (thin film) vmax 3462, 2931, 2889, 2857, 1496, 1472, 1454, 1428, 1389, 1361, 1149,
1112, 1040, 823, 740, 702 cm’.
HRMS: C37H47O5Si (M+1), calc.: 615.31421, found: 615.31600.
To a solution of oxalyl chloride (0.21 g, 0.15 mL, 1.73 mmol) in CH2C12 (15 mL) at —78
was added DMSO (0.27 g, 0.30 mL, 3.46 mmol). The reaction mixture was stirred for
15 min before the above alcohol (0.53 g, 0.86 mmol) in CH2C12 (10 mL) was added. The
reaction mixture was stirred and slowly warmed to —30 °C over 30 min before
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triethylamine (0.87 g, 1.20 mL, 11.89 mmol) was added. The white precipitate was
formed and the mixture was stined at this temperature for 15 min before being quenched
by NH4C1 solution (20 mL). The organic layer was separated, dried and concentrated in
vacuo. The crude aldehyde was dissolved in dry CH2C12 (25 mL) and Ph3P=CHCO2CH3
(0.60 g, 1.72 mmol) was added. The mixture was stined at r.t. for 12 h. The solvent was
removed and the residue was purified by column chromatography (EIH= 1:10) to give the
product 29 (0.16 g, 84%) as a colorless ou;
Rff 0.4 (E/H=1:8);
[Œ]D -15.17 ° (c 0.85, CHC13);
1H NMR (400 MHz, CDC13) 1.03 (s, 9H), 3.37 (s, 3H), 3.51 (dd, J=5.20, 9.28 Hz, 1H),
3.55 (dd, J=4.48, 11.16 Hz, 1H), 3.69 (s, 3H), 3.74 (dd, J=2.88, 11.08 Hz, 1H), 4.13 (m,
1H), 4.53 (d, J=1 1.96 Hz, 1H), 4.62 (d, J6.80 Hz, 1H), 4.64 (d, J=6.80 Hz, 1H), 4.68 (d,
J=11.96 Hz, 1H), 4.86 (d, J=6.88 Hz, 1H), 4.90-4.93 (m, 1H), 4.95 (d, J=6.88 Hz, 1H),
7.11-7. 14 (m, 2H), 7.23-7.43 (m, 16H), 7.60-7.63 (m, 2H);
‘3c NMR (100 MHz, CDC13) 19.05, 26.66, 5 1.38, 55.78, 64.00, 70.06, 75.55, 78.66,
94.49, 94.79, 122.10, 126.89, 127.45, 127.51, 127.65, 127.97, 128.26, 129.40, 129.52,
133.06, 135.51, 137.64, 137.68, 146.41, 166.42;
IR (thin film)vmax 3030, 2931, 2891, 2859, 1726, 1472, 1485, 1362, 1274, 1168, 1112,
1042, 719 cm’;
HRMS: C40H49O7Si (M+l), cale.: 669.32477, found: 669.32260.
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(3R, 4$, 5$, 6S)-6-Benzyloxymethoxy-7-(tert-butyldiphenylsilanyloxy)-4-
methoxymethoxy-3,5-diphenylheptanoic acid methyl ester (30):
80MO OMOM 80MO OMOM
Ph2CuMgr
TMSCI,THF E E
I -78C,86% — -
29 30
To a slurry of Cul (0.20 mg, 1.05 mmol) in THF (8 mL) at -78 °C was added PhMgBr
(1.00 M, 2.10 mL, 2.10 mmol). The mixture was stirred for Ï h at -78 oc before TMSC1
(0.56 mL, 0.4$ g, 4.43 mmol) and Œ,f3-unsaturated ester 29 (0.080 g, 0.12 mrnol) in THF
(2 mL) were added. The mixture was stirred at -78 °C for 7 h before being quenched with
NH4CI-NH4OH solution (1:1, 10 mL). The product was extracted with hexane (50 mL).
The extract was washed with NH4CI-NH4OH solution (10 mL x 2), dried over Na7SO4,
and concentrated in vacuo. Column chromatography of the residue (silica gel, E/H=1:20)
gave product 30 (0.076 g, 86%);
[ŒID -20.87 ° (c 0.9 1, CHC13);
‘H NMR (400 MHz, CDC13) 6 0.93 (s, 9H), 2.62 (dd, J=10.64, 12.8$ Hz, 1H), 2.83 (dd,
1=4.64, 12.88 Hz, 1H), 3.37 (s, 3H), 3.40 (dd, J=3.76, 8.24 Hz, 1H), 3.47 (s, 3H), 3.50
(dd, J=3.72, 11.08 Hz, 1H), 3.74 (dd, J=2.84, 10.96 Hz, 1H), 3.76-3.82 (m, 1H), 4.01 (dd,
J=3.80, 8.24 Hz, 1H), 4.32-4.37 (m, 1H), 4.51 (d, J=7.82 Hz, 1H), 4.53 (d, J=7.82 Hz,
1H), 4.54 (d, 1=12.04 Hz, 1H), 4.63 (d, J=12.04 Hz, 1H), 4.91 (d, J=$.40 Hz, 1H), 4.93
(d, J=8.40 Hz, 1H), 6.90-93 (m, 2H), 7.16-7.42 (m, 21H), 7.62-7.68 (m, 2H);
‘3C NMR (100 MHz, CDC13) 6 18.98, 26.58, 36.79, 45.66, 48.03, 51.21, 56.44, 63.91,
69.51, 78.03, 86.97, 94.26, 99.23, 115.15, 120.50, 126.58, 127.29, 127.35, 127.45,
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127.64, 128.20, 128.28, 128.26, 128.40, 128.59, 128.72, 129.1$, 129.44, 129.51, 133.09,
133.21, 135.29, 135.59, 138.04, 140.98, 142.16, 173.10;
IR (thin film) vmax 3029, 2930, 2856, 1737, 1495, 1454, 1428, 1255, 1154, 1112, 1026,
701 cnï’;
HRMS: C46H54O7SiNa (M+Na), caic.: 769.35364, found: 769.35 190.
(2$, 3R, 4R, 5$, 6S)-6-Benzyloxymethoxy-7-(tert-butyldiphenylsilanyloxy)-2-
hydroxy-4-methoxymethoxy-3,5-diphenylheptanoic acid methyl ester (31):
OMOM
1. KHMDS, THF BOM0 OMOM OH
TBDPSO._L___L__ - 78CC
2. (1 S)-(+)-(1 O-camphor E
-sutfonyoxaziridine 00
To a solution of ester 30 (0.050 g, 0.06$ mmol) in THF (3 mL) at —7$ °C was added
KHMDS (0.50 M, 0.27 mL, 0.13 mmol). The reaction mixture was stilTed at this
temperature for 1 h before a solution of (1S)-(+)-10-camphorsulfonyloxaziridine (0.031 g.
0.13 mmol) in THF (1.5 mL) was added. The resulting mixture was stirred at —78 oc for
another 6 h before being quenched with NH4C1 solution (7 mL). The product was
extracted with diethyl ether (15 mL x 3). The combined organic extracts were dried over
Na2SO4, and concentrated in vacuo. Column chromatography of the residue provided
starting marterial (0.024 g, with E/H=1:15 as eluents) and product 31 (0.022 g, 82 %
based on recorved starting marterial, with E/H=1:7 as eluents);
[ŒJD -45.00 O (c 0.35, CHC13);
‘H NMR (400 MHz, CDC13) 0.82 (s, 9H), 3.31-3.35 (m, 2H), 3.41 (s, 3H), 3.52-3.55
(m, 1H), 3.57 (s, 3H), 3.65 (d, J=11.48 Hz, 1H), 4.03-4.08 (m, 1H), 4.25 (d, J=11.12 Hz,
148
1H), 4.39 (d, J=10.60 Hz, 1H), 4.59 (d, J:=12.08 Hz, 1H), 4.64 (d, J=6.32 Hz, 1H), 4.75
(cl, J=12.08 Hz, 1H), 4.77 (d, J=6.32 Hz, 1H), 4.88-4.92 (m, 1H), 4.90 (d, J=6.76 Hz,
1H), 4.9$ (d, J=6.76 Hz, 1H), 6.91-6.93 (m, 2H), 7.07-7.17 (m, 3H), 7.20-7.40 (m, 18H),
7.52-7.55 (m, 2H);
‘3c NMR (100 MHz, CDC13) 18.93, 26.45, 46.30, 5 1.69, 53.24, 56.54, 63.13, 69.66.,
70.53, 93.55, 100.11, 126.43, 127.19, 127.36, 127.61, 128.21, 128.31, 128.36, 129.07,
129.38. 129.99, 135.57, 135.79, 174.90;
IR (thin film) 3515, 2932, 2851, 1776, 1495, 1494, 1455, 1401, 1257, 1113, 1046, 703
cm1;
(2$, 3$, 4S)-4-Benzyloxymethoxy-5-(tert-butyldiphenylsilanyloxy)-2-[(R)-(4-chloro-
phenyl)-liydroxymethylJ-3-methylpentanoic acid methyl ester (35):
BOMO 1. KHMDS BOMO CO2Me
2. CI__O__CHD
78%, RIS 5:1 OH
1
To a solution of ester 1 in THF (0.22 g, 0.42 rnmol) at —7$ °C was added KHMDS
solution (0.50 M, 1.26 mL, 0.63 mmol). The mixture was stirred at —78 oc for 1 h before
a solution of 4-chlorobenzaldehyde (0.19 g, 1.27 mmol) in THF (3 mL) was added. The
mixture was stirred at —78 oc for 2.5 h before a solution of NHEfl (15 mL) was added.
The resulting mixture was extracted with hexane-ethyl acetate (1: 1, 50 mL x 2). The
combined organic layers were dried over Na2SO4 and concentrated in vacuo. The residue
was purified by column chromatography (E/H=1:8) to afford 35-R-isomer (0.23 g, 78%)
and 35-S-isomer (0.046 g, 15.6%);
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35-R -isomer
° (c 0.99, CHC13);
‘H NMR (300 MHz, CDC13) 1.07 (s, 9H), 1.15 (d, J=7.0 Hz, 3H), 1.15 (d, 1=7.0 Hz,
1H), 2.50-2.60 (m, 1H), 2.8$ (dd, J=3.96, 8.68 Hz, 1H), 3.45 (s, 3H), 3.61-3.65 (m. 1H),
3.76-3.86 (m, 2H), 4.56 (d, J=11.96 Hz, 1H), 4.63 (d, J=11.96 Hz, 1H), 4.7$ (d, 1=6.76
Hz, 1H), 4.86 (d, J=6.76 Hz, 1H), 5.04 (dd, J=3.76, 9.0$ Hz, 1H), 7.20-7.48 (m, 15H),
7.67-7.70 (m, 4H);
‘3C NMR (100 MHz, CDCI3) 13.52, 19.11, 26.71, 35.62, 5 1.38, 54.15, 64.16, 69.65,
71.12, $0.09, 94.40, 126.92, 127.50, 127.62, 128.25, 128.27, 129.67, 132.88, 133.13,
133.17, 135.5 1, 135.56, 137.75. 141.16, 175.27;
IR (neat) vmax 3479, 2956, 2863, 1734, 1592, 1518, 1456, 1432, 1181, 1111, 1041, 703
cm’;
m/e: 683 (M+Na), 673, 643, 603, 553, 445,413, 385, 267, 235, 197, 135, 91, 77.
35-S-isomer
[Œ]D +4.50 O (c 0.8 6, CHC13);
‘H NMR (400 MHz, CDC13) 1.0$ (s, 9H), 1.20 (d, J=7.20 Hz, 1H), 2.48-2.57 (m, 1H),
3.13 (dd, 1=2.16, 9.64 Hz, 1H), 3.42 (s, 3H), 3.81 (dd, 1=5.12, 11.16 Hz, 1H), 3.89 (dd,
1=4.29, 11.04 Hz, 1H), 3.95-4.00 (m, 1H), 4.28 (d, J=4.04 Hz, 1H), 4.56 (d, 1=11.84 Hz,
1H), 4.66 (d, 1=11.84 Hz, 1H), 4.81 (d, 1=6.52 Hz, 1H), 4.93 (d, 1=6.52 Hz, 1H), 7.26-
7.50 (m, 15H), 7.68-7.73 (m, 4H);
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‘3C NMR (100 MHz, CDCI3) 6 13.80, 19.12, 26.72, 34.94, 5 1.20, 53.93, 63.92, 70.17,
71.37, 81.50, 95.18, 127.66, 127.69, 127.72, 127.76, 128.16, 128.22, 128.39, 129.73,
133.06, 133.12, 135.5 1, 135.58, 137.09, 141.37, 173.36;
IR (neat) vmax 3481, 2963, 2863, 1733, 1589, 1517, 1455, 1433, 1184, 1112, 1044, 702
cm’;
mIe: 683 (M+Na), 643, 603, 553, 445, 413, 385, 267, 235, 197, 135, 91, 77.
(2$, 3$, 4S)-4-Benzyloxymethoxy-5-(tert-butyldiphenylsilanyloxy)-2-[(R)-hydroxy
(4-methoxyphenyl)-methyl]-3-methylpentanoic acid methyl ester (36):
BOMO 1. KHMDS BOMO CO2Me —
2. MeOD—CHO
E Me OH
Me 72%, R/S = 6 1 36
To a solution of ester 1 (0.20 g, 0.3$ mmol) in THF (6 mL) at —78 °C was added
KHMDS solution (0.50 M in toluene, 1.15 mL, 0.58 mmol). The reaction mixture was
stirred at —78 oc for 1 h beforep-anisaldehyde (0.16 g, 0.14 mL, 1.14 mmol) was added.
The reaction mixture was stirred at —78 °C for 2.5 h before a solution of saturated NH4CI
solution (10 mL) was added. The resulting mixture was extracted with hexane-ethyl
acetate (1:1, 100 mL x 2). The combined organic layers were dried over Na2SO4 and
concentrated in vacuo. The residue was purified by column chromatography (E/H=1 :7) to
afford 36-R-isomer (0.19 g, 72%) and 36-S-isomer (0.03 1 g, 12%);
36-R-isomer
[c]n -23.17 0 (c 1.10, CHC13);
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‘H NMR (400 MHz, CDCI3) 6 0.95 (s, 9H), 2.05-2.11 (m 1H), 2.80-2.86 (broad, 1H),
3.23 (dd, J=3.92, 8.64 Hz, 1H), 3.57-3.60 (m, 1H), 3.63 (s, 3H), 3.71 (dd, J=4.40, 11.16
Hz, 1H), 3.77 (s, 3H), 3.77-3.86 (m, 2H), 4.49 (d, J12.00 Hz, 1H), 4.57 (d, J=12.00 Hz,
1H), 4.73 (d, J=6.80 Hz, 1H), 4.77 (d, J=6.$0 Hz, 1H), 4.96 (d, J8.52 Hz, 1H), 6.85 (d,
J=8.68 Hz, 2H), 7.23-7.45 (m, 13H). 7.56-7.63 (m, 4H);
‘3C NMR (400 MHz, CDC13) 6 12.46, 19.04, 26.64, 34.20, 51.29, 51.99, 55.06, 63.34,
69.54, 73.65, $0.44, 94.65, 113.91, 127.39, 127.51, 127.55, 127.81, 128.21, 129.56,
133.24, 133.29, 133.45, 135.48, 135.56, 137.87, 159.23, 174.65;
IR (neat) vrnax 3478, 2933, 2858, 1732, 1612, 1588, 1513, 1428, 1250, 1173, 1112,
103$, 703 cm’;
m/e: 679 (M+Na), 657, 609, 547, 517, 461, 441, 381, 323, 247, 217, 135, 91, 73.
36-S-isomer
(c 1.32, CHC13);
‘H NMR (400 MHz, CDC13) 6 1.06 (s, 9H), 1.19 (d, J=7.24 Hz, 1H), 2.49-2.54 (m, 1H),
3.16 (dd, J=2.44, 9.76 Hz, 1H), 3.39 (s, 3H), 3.79 (s, 3H), 3.78-3.84 (m, 1H), 3.8$ (dd,
J=4.36, 11.08 Hz, 1H), 3.96 (d, J=6.36 Hz, 1H), 3.99 (d, J=6.36 Hz, 1H), 4.56 (d,
J=11.88 Hz, 1H), 4.67 (d, J=11.88 Hz, 1H), 4.87 (d, J=6.60 Hz, 1H), 4.94 (d, J=6.60 Hz,
1H), 4.96 (dd, .1=3.92, 9.72 Hz, 1H), 6.80 (d, J=8.68 Hz, 2H), 7.20-7.48 (m, 13H), 7.6$-
7.73 (m, 4H);
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‘3C NMR (100 MHz, CDC13) 13.65, 1 9.11, 26.71, 35.06, 51.09, 53.93, 55.09, 64.07,
70.10, 71.64, 81.57, 95.17, 113.65, 127.62, 127.65, 127.71, 127.87, 128.34, 129.66,
133.13, 134.95, 135.51, 135.57, 137.26, 158.88, 173.59;
W (neat) vmax 3479, 2954, 2856, 1733, 1591, 1514, 1432, 1240, 1176, 1111, 1039,
703cm’;
mIe: 679 (M÷Na), 657, 609, 547, 517, 461, 441, 381, 323, 247, 217, 135, 91, 73.
(2$, 3S, 4S)-4-Benzyloxymethoxy-5-(tert-butyldiphenylsilanyloxy)-2-[(R)-hydroxy-
(2-methoxyphenyl)-methylJ-3-methylpentanoic acid methyl ester (37):
MeC
BOMO 1. KHMDS BOMD CO2Me
2.
Me OMe
68%,R/S 5:J
To a solution of ester 1 (0.20 g, 0.38 mmol) in TEF (6 mL) at —78 °C was added
KHMDS solution (0.50 M in toluene, 1.15 mL, 0.5$ mmol). The reaction mixture was
stirred at —78 oc for 1 h before a solution of o-anisaldehyde (0.16 g, 1.14 mmol) in THF
(2.5 mL) was added. The reaction mixture was stirred at —78 °C for 2.5 h before a
solution of NH4CÏ (10 mL) was added. The resulting mixture was extracted with hexane
ethyl acetate (1:1, 100 mL x 2). The combined organic layers were dried over Na2SO4
and concentrated in vacuo. The residue was purified by column chromatography
(E/H=1:7) to afford the 37-R isomer (0.18 g, 68%) and 37-S isomer (0.036 g, 13.5%);
37-R -isomer
[a]—12.6 ° (c 0.98, CHC13);
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‘H NMR (400 MHz, CDC13) 0.96 (s, 9H), 0.9$ (d, J=7.22 Hz, 1H), 2.09-2,17 (m, 1H),
3.32 (dd, J=3.62, 8.6$ Hz, 1H), 3.58 (s, 3H), 3.49-3.69 (m, 2H), 3.69 (s, 3H), 4.50 (d,
J=11.86 Hz, 1H), 4.61 (d, J=11.96 Hz, 1H), 4.77 (d, J=6.68 Hz, 1H), 4.82 (d, J=6.72 Hz,
1H), 5.22 (t, J=$.08 Hz, 1H), 6.83 (d, J=8.2$ Hz, 1H), 6.95 (t, J=7.48 Hz, 1H), 7.20-7.48
(m, 12H), 7.59-7.65 (m, 4H);
‘3C NMR (100 MHz, CDC13) 12.76, 19.06, 26.67, 34.77, 51.09, 51.15, 55.04, 63.67,
69.46, 70.22, 80.37, 94.75, 110.51, 120.73, 127.37, 127.50, 127.55, 127.62, 127.73,
128.21, 128.76, 129.35, 129.53, 129.66, 133.36, 135.50, 135.56, 137.96, 156.46, 174.62;
IR (neat) vmax 3498, 2933, 2858, 1735, 1602, 1589, 1492, 1463, 1428, 1242, 1167,
1112, 1027, 741,702, 610cm;
mIe: 550, 517, 461, 441, 381, 309, 267, 247, 197, 135, 91.
37-S-isomer
(c 1.24, CHC13);
‘H NMR (400 MHz, CDC13) 1.05 (s, 9H), 1.19 (d, 1=6.96 Hz, 3H), 2.49-2.69 (m, 1H),
2.96 (dd, 1=3.36, 10.36 Hz, 1H), 3.36 (s, 3H), 3.60-3.68 (m, 1H), 3.72 (s, 3H), 3.76-3.8 1
(m, 2H), 4.56 (d, J=11.92 Hz, 1H), 4.63 (d, J=11.92 Hz, 1H), 4.79 (d, 1=6.76 Hz, 1H),
4.87 (U, J=6.76 Hz, 1H), 5.32 (dU, J=3.32, 10.08 Hz, 1H), 6.82 (d, 1=8.16 Hz, 1H), 6.95
(t, 1=7.44 Hz, 1H), 7.20-7.49 (m, 13 H), 7.62-7.72 (m, 4H);
‘3c NMR (100 MHz, CDC13) 6 12.90, 19.07, 26.65, 35.55, 51.05, 52.10, 55.10, 64.45,
67.24, 69.59, 80.83, 94.29, 109.89, 120.32, 125.94, 127.42, 127.55, 127.57, 127.64,
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127.71, 128.13, 128.23, 129.53, 129.55, 130.51, 133.28, 133.34, 135.51, 135.55, 137.91,
155.54, 175.57;
IR (neat) vmax 3499, 2945, 2858, 1734, 1601, 1588, 1496, 1465, 1421, 1248, 1112,
1026, 744, 701 cm’;
mIe: 550, 517, 461, 441, 381, 309, 267, 247, 197, 135, 91.
(2S, 3$, 4S)-4-Benzyloxymethoxy-5-(tert-butyldiphenylsilanyloxy)-2-[(R)-hydroxy-
(3-trffluromethylphenyl)-methylJ-3-methylpentanoic acid methyl ester (3$):
BOMO 1. KHMDS BOMO CO2Me
CF3
TBDPSO(CO2Me
2.
Me F3C Me OH
68%,R/S=6:1 38
To a solution of ester 1 (0.16 g, 0.3 mmol) in THF (4 mL) at —78 oc was added KHMDS
solution (0.50 M in toluene, 0.45 mmol). The reaction mixture was stirred at —78 °c for 1
h before a solution of a,Œ,u-trifluoro-rn-tolualdehyde (0.10 g, 80 j.iL, 0.60 mmol) was
added. The reaction mixture was stined at —78 °C for 2.5 h before a solution of NH4C1
(10 mL) was added. The resulting mixture was extracted with hexane-ethyl acetate (1:1,
50 mL x 2). The combined organic layers were dried over Na2SO4 and concentrated in
vacuo. The residue was purified by column chromatography (EIH=1 :8) to afford 3$-R-
isomer (0.14 g, 68%) and 38-$-isomer (0.024 g, 11.33%);
38-R -isomer
[Œ]—1.29 ° (c 0.92, cHcl3);
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‘H NMR (400 MHz, CDC13) 1.06 (s, 9H), 1.18 (d, J7.00 Hz, 3H), 2.53-2.65 (m, 1H),
2.93 (dd, J=3.60, 9.8$ Hz, 1H), 3.42 (s, 3H), 3.64 (dd, J=5.12, 10.28 Hz, 1H), 3.72-3.84
(m, 2H), 3.87 (d, J=9.44 Hz, 1H), 4.55 (d, J=11.96 Hz, 1H), 4.61 (d, J=11.96 Hz, 1H),
4.7$ (d, J=6.72 Hz, 1H), 4.85 (d, J=6.76 Hz, 1H), 5.10-5.16 (m, 1H), 7.22-7.74 (m, 19H);
‘3C NMR (100 MHz, CDC13) 13.37, 19.05, 26.65, 35.65, 51.33, 54.05, 64.11, 69.67,
71.15, 79.96, 94.32, 122.21, 122.25, 124.01, 124.05, 127.50, 127.62, 128.26, 128.55,
128.96, 129.66, 129.68, 130.36, 130.68, 133.08, 133.10, 135.49, 135.54, 137.71, 143.82,
175.11;
IR (neat) vmax 3461, 2932, 2857, 1732, 1612, 1587, 1513, 1462, 1428, 1248, 1037, 830,
740, 702 cm1;
38-S-ïsorner
{ŒJD—l8.2 ° (c 1.40, CHC13);
‘H NMR (400 MHz, CDCI3) 1.07 (s, 9H), 1.22 (d, J=7.24 Hz, 3H), 2.56-2.65 (m, 1H),
3.14 (dd, J=2.32, 9.68 Hz, 1H), 3.40 (s, 3H), 3.20 (dd, Jtz5.0$, 11.04 Hz, 1H), 3.89 (dd,
1=4.92, 11.08 Hz, 1H), 3.98 (q, J=6.32 Hz, 1H), 4.51 (d, J=3.92 Hz, 1H), 4.57 (d,
J=Ï1.84 Hz, 1H), 4.66 (d, 1=11.84 Hz, 1H), 4.87 (d, J=6.56 Hz, 1H), 4.92 (d, J=6.56 Hz,
1H), 5.08 (dd, J=3.80, 9.68 Hz, 1H), 7.27-7.77 (m, 19H);
l3 NMR (100 MHz, CDC13) 13.94, 19.10, 26.69, 34.87, 51.17, 54.23, 63.79, 70.21,
71.49, 81.35, 95.07, 123.56, 123.60, 124.29, 124.33, 127.66, 127.69, 127.76, 128.38,
128.53, 129.75, 130.18, 130.53, 133.01, 135.50, 135.56, 137.03, 143.89, 173.22;
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IR (neat) vmax 3461, 2932, 2857, 1732, 1612, 1587, 1513, 1462, 1428, 1248, 1037, 830,
740, 702 cm’;
(3$, 4$, 5S)-3-Benzyl-5-benzyloxymethoxy-4-methyltetrahydropyran-2-one (40):
OBOM 1. KHMDS, THF
-78°C
TBDPSO
- CO2Me
2. Benzyl bromide
3. TBAF, AcOH
Me
To a solution of ester 1 (0.30 g, 0.5$ mmol) in THF (8 mL) at —78 oc was added
KHMDS solution (0.50 M in toluene, 1.50 mL, 0.75 mmol). The reaction mixture was
stirred at —78 °c for 1 h before a solution of benzyl bromide (0.35 mL, 0.51 g, 3.00
mmol) was added. The reaction mixture was stirred at —78 °c for 2.5 h and then a
solution of saturated NH4C1 solution was added. The resulting mixture was extracted with
hexane-ethyl acetate (1:1, 20 mL x 2). The combined organic layers were dried over
Na2SO4 and conDentrated in vacuo. The residue was purified by column chromatography
(E/H=1:15) to afford the Œ-benzyl ester (0.30 g, 86%).
b a solution of the above Œ-benzyl ester (0.30 g, 0.49 mmol) in THF (9 mL) at room
temperature was added TBAF-AcOH (1:1, 0.94 M, 2.2$ mL, 2.15 mmol). The reaction
mixture was stirred and monitored by TLC. After 2 h, the reaction was complete and the
reaction mixture was acidified with acetic acid to pH 1. The mixture was then stirred for
1 h before being diluted with ethyl acetate (15 mL). The resulting mixture was washed
with NaHcO3 solution, NH4C1 solution, brine and dried over Na$O4. The solvent was
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removed in vacuo. The residue was purified by column chromatography (E/H=1 :3) to
give lactone 40 (0.14 g, 82%);
[Œ]D—3l.57 ° (c 0.89, CHC13);
1H NMR (300 MHz, CDC13) 6 1.14 (d, 1=6.69 Hz. 1H), 1.87-1.98 (m, 1H), 2.82-2.92 (m,
1H), 2.92 (dd, J=5.25, 18.93 Hz, 1H), 3.50 (dd, J=4.26, 18.36 Hz, 1H), 3.73-3.80 (m,
1H), 3.8$ (dd, 1=1.53, 12.09 Hz, 1H), 4.44 (dd, 1=2.58, 12.15 Hz, 1H), 4.61 (d, J=1Ï.55
Hz, 1H), 4.67 (d, J=1l.55 Hz, 1H), 4.79 (d, J=7.32 Hz, 1H), 4.91 (d, J=7.32 Hz, 1H),
7.20-7.45 (m, 10H);
‘3C NMR (100 MHz, CDC13) 6 15.99, 33.04, 34.79, 45.50, 69.84, 69.90, 72.67, 93.59,
126.63, 127.82, 127.85, 128.29, 128.42, 128.47, 129.3$, 137.18, 138.13, 172.61;
IR (thin film) vmax 2937, 2896, 1729, 1603, 1496, 1454, 1399, 1252, 1209, 1164, 1103,
1044cm’;
HRMS; C21H7504 (M+l), calcd: 341.16746, found: 341.167 12.
(2R)-2-[(1S, 2S)-2-Benzyloxymethoxy-3-(tert-butyldipheny]silanyloxy)-1-methyl-
propylJ-4-methylenepentanedioic acid dimethyl ester (42):
OBOM
BOMO CO2Me CO2Me
IBDPSO_L_ï___CO2Me
1 KHMDS,THF
1 Me 42
To a solution of ester 1 (0.15 g, 0.29 mmol) in THE (5 mL) at —78 °C was added
KHMDS solution (0.50 M, 0.75 mL, 0.37 mmol). The reaction mixture was stirred at —7$
°C for 1 h before methyl (2-bromomethyl)acrylate (0.26 g, 0.17 mL, 1.44 mmol) was
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added. The reaction mixture was stirred at —78 oc for 2.5 h before a solution of NH4CÏ
(10 mL) was added. The resulting mixture was extracted with hexane-ethyl acetate (1:1,
20 mL x 2). The combined organic layers were dried over Na2SO4 and concentrated in
vacuo. The residue was purified by columu chromatography (EIH=1:6) to afford product
42 (0.15 g, 82%);
[afr -3.7 1 ° (c 1.10, cHCl3);
‘H NMR (400 MHz, cDcl3) 1.00 (d, J=7.08 Hz, 1H), 1.09 (s, 9H), 2.37-2.46 (m, 1H),
2.55 (dd, 1=11.72, 13.68 Hz, 1H), 2.67 (dd, J=1.96, 14.20 Hz, 1H), 2.98-3.05 (m, 1H),
3.63 (s, 3H), 3.72 (s, 3H), 3.71-3.78 (m, 1H), 3.80 (dd, 1=5.36, 11.01 Hz, 1H), 4.55 (d,
J=12.00 Hz, 1H), 4.62 (d, J=12.00 Hz, 1H), 4.81 (d, 1=6.84 Hz, 1H), 4.88 (d, J=6.$4 Hz,
1H), 5.57 (s, 1H), 6.13 (s, 1H), 7.27-7.46 (m, 11H), 7.68-7.73 (m, 4H);
13C NMR (100 MHz, CDcI3) 12.27, 19.13, 26.73, 30.29, 37.12, 45.53, 51.16, 51.72,
64.19, 69.58, 80.50, 94.70, 110.51, 126.06, 127.40, 127.59, 127.62, 128.22, 129.61,
133.29, 135.55, 135.61, 137.89, 138.55, 167.09, 175.25;
IR (thin film) vmax 2951, 2888, 2858, 1732, 1631, 1590, 1472, 1439, 1428, 1389, 1362,
1306, 1196, 1149, 1112, 1039, 823, 740, 702 cm’;
mIe: 619.3 (M+1), 589.2, 561.2, 511.3, 481.3, 309.2, 239.1, 197.1, 135.1.
(2R, 3S, 4S)-5-Benzyloxymethoxy-4-methyl-3-(2-methylallyl)-tetrahydropyran-2-one
(43):
OBOM 1.KHMDS,THF BOMO CO2Me CH3
TBDPSO..J.._ oc
2. L1 84%
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To a solution of ester 1 (0.15 g, 0.29 mmol) in THF (5 mL) at —78 oc was added
KHMDS solution (0.50 M in toluene, 0.75 mL, 0.37 mmol). The mixture was stined at —
78 °C for 1 h before a solution of 3-bromo-2-methyl propene (0.15 mL, 0.14 g, 1.44
mmol) was added. The mixture was stirred at —78 °C for 2.5 h before a solution of
saturated NH4CI solution was added. The resulting mixture was extracted with hexane
ethyl acetate (1:1, 20 mL X 2). The combined organic layers were dried over Na2SO4 and
concentrated in vacuo. The residue was purified by column chromatography (EIH= 1:15)
to afford product 43 (0.14 g, 84%);
[Œ] +1.18 O (c 1.43, CHCÏ3);
‘H NMR (300 MHz, CDCI3) 0.94 (U, J=7.1 1 Hz, 3H), 1.07 (s, 9H), 1.70 (s, 3H), 2.1 5-
2.23 (m, 1H), 2.29-2.40 (m, 2H), 2.91-3.00 (m, 1H), 3.60-3.64 (m, 1H), 3.64 (s, 3H), 3.76
(dd, J=5.28, 11.01 Hz, 1H), 3.83 (dd, J=4.14, 11.01 Hz, 1H), 4.53 (d, J=12.03 Hz, 1H),
4.03 (d, J12.03 Hz, 1H), 4.68 (U, J=1.35 Hz, 1H), 4.73 (s, 1H), 4.77 (d, J=6.84 Hz, 1H),
4.87 (d, J=6.84 Hz, 1H), 7.29-7.49 (m, 11H), 7.68-7.74 (m, 4H);
‘3C NMR (100 MHz, CDCÏ3) 12.18, 19.12, 22.66, 26.73, 35.69, 37.13, 44.84, 51.19,
64.11, 69.60, 79.96, 94.31, 111.10, 127.42, 127.58, 127.60, 127.62, 128.23, 129.62,
133.28, 135.54, 135.61, 137.89. 143.59, 175.69;
IR (thin film) vmax 3071, 2932, 2858, 1737, 1428, 1380, 1166, 1112, 1039, 891, 823,
739, 701 cm1;
m/e: 575.3 (M÷1), 543.3, 523.3, 309.2, 197.1, 135.1, 121.1.
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Synthesis of 46
HOMO
O HO
80MO
AgOTf,CH2CI2
To a solution of alcohol 45 (1.37g, 5.16 mmol) in CH2CI2 (35 mL) was added the resin 44
(3.00 g, 0.77 mmol/g, 2.31 mmol) and AgOTf (1.33 g, 5.16 mmol). The reaction mixture
was stirred at r.t for 20 h (The reaction was monitored by infrared spectroscopy). The
resin 46 was then washed with DMF, THF, CH2C12, hexane and dried in vactto. The dried
resin 46 (0.20 g) was suspended in a solution of 3% TFA in CH2CI2 (3 mL) for 1 li. The
resin was then removed by filtration. The fïltrate was washed with NaHCO3 solution and
water, dried over Na2SO4 and concentrated. Column chromatography (E/H=1 :4) afforded
recovered alcohol 45 (0.037 g, 90%, so the loading was 0.69 mmollg).
(4$, 5S)-5-Benzyloxymethoxy-4-methyltetrahydropyran-2-one (49):
1 Me2CuL1, TMSCI
BOMO’SC
46 80% for two steps
Me
To a solution of MeCuLi2 at —78 °C [prepared by the addition of MeLi (complex with
MgBr2, 23.00 mL, 1.50 M in diethyl ether, 34.6 rnmoÏ) to cul (2.88 g, 17.3 mmol) in
THF (60 mL) at —15 °C, and the mixture was warmed to O °C in 0.5 h] was added TMSC1
(72.9 mmol, 7.03 g, 8.03 mL) and resin 46 (2.50 g, 1.73 mmol) in THF (15 mL). The
mixture was stirred at —78 oc for 2 h, -45 oc for 2 h, -25 °c for 2 h before being
neutralized with acetic acid. NH4CYIMI4OH (1:1, 100 mL) solution was added to dissolve
ail the copper saits. The resin was filtered and stirred in a mixture of NH4cI/NH4OH (1:1,
7 mL) in THF (80 mL) for 20 mm, after which, filtration was repeated. This procedure
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was repeated two times. The resin was then washed with water, THF, DMF, CH2CÏ2,
hexane and dried in eacuo for 24 h. This cuprate reaction was repeated exactly as before
to ensure high conversion. The dried resin 47 (0.15 g) was suspended in a solution of 3%
TFA in CH2CI2 (5 mL) for 1 h. The resin was then removed by filtration. The filtrate was
washed with NaHCO3 solution and water, dried over Na2SO4 and concentrated. Column
chromatography of the residue (E/H=1:7) afforded lactone 49 (0.02 1 g, 80%, loading:
0.55 mmollg);
[OEjo 5345 O (c 1.06, CHCI3);
‘H NMR (300 MHz, CDCY3) 1.11 (d, J=6.69 Hz, 3H), 2.17-2.30 (m, 1H), 2.53 (d,
1=4.38 Hz, 1H), 2.56 (d, J=l.80 Hz, 1H), 3.8 1-3.85 (m, 1H), 4.27 (dd, J=2.07, 12.39 Hz,
1H), 4.59 (dd, 1=2.28, 12.39 Hz, 1H), 4.64 (cl, 1=11.01 Hz, 1H), 4.68 (cl, J=11.01 Hz,
1H), 4.82 (d, J=7.32 Hz, 1H), 4.94 (cl, J=7.29 Hz, 1H), 7.32-7.40 (m, 5H);
l3 NMR (100 MHz, CDCI3) 16.83, 3 1.02, 33.65. 69.85, 71.35, 71.73, 93.70, 127.84,
128.45, 137.14, 170.13;
IR (thin film) vmax 2964, 2897, 1738, 1498, 1455, 1402, 1359, 1239, 1202, 1162, 1102,
1042, 913, 853, 802, 740, 699 cm’;
HRMS: C14H1904 (M+1), calcd: 251.12041, found: 251.12102.
(4R, 5S)-5-Benzyloxymethoxy-4-phenyltetrahydropyran-2-one (50):
o o
1. Me2CuLi TMSCI
B0M’
81%fortwosteps I
50
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b a slurry of Cul (3.00 g, 15.57 mmol) in THF (40 mL) was added PhMgBr (3 1.50 mL,
1.00 M in THF, 3 1.50 mmol). The reaction mixture was stirred at —78 oc for 1 h before
TMSCI (5.86 mL, 47.25 mmol) and resin 46 (1.50 g, 1.04 mmol) in 111F (15 mL) were
added. The reaction mixture was stirred at —78 °C for 2 h, -45 oc for 2 h, -25 °C for 2 h
before being quenched with acetic acid. NH4C1/NH4OH (1:1, 150 mL) solution was
added to dissolve ail the copper saits. The resin was filtered and stined in a mixture of
NH4CI/NH4OH (1:1, 10 mL) and THF (100 mL) for 20 mm, after which, filtration was
repeated. This procedure was repeated twice. The resin was then washed with water,
DMF, THF, CH2C12, hexane and dried under vacuum for 24 h. This cuprate reaction was
repeated exactly as before to ensure high conversion. The dried resin (150 mg) was added
to a solution of 3% TFA in CH2CI, (5 mL) and was stined for 1 h. The resin was then
removed by filtration. The filtrate was diluted with ethyl acetate (10 mL), washed with
NaHCO3 solution and water, dried over Na2SO4 and concentrated. CoÏumn
chromatography (E/H=l:2) afforded the lactone 50 (0.026 g, 81%, loading: 0.56
mmollg);
[Œ]D -78.19 ° (c 0.77, CHC13);
‘H NMR (400 MHz, CDC13) 2.82 (dd, J=5.60, 17.20 Hz, 1H), 3.27 (dd, J=13.28, 17.24
Hz, 1H), 3.35-3.45 (m, 1H), 4.10-4.18 (m, 2H), 4.30 (d, J=11.56 Hz, 1H), 4.45 (dd,
J=2.00, 12.48 Hz, 1H), 4.52 (d, J7.32 Hz, 1H), 4.64 (dd, J=1.72, 12.48 Hz, 1H), 4.80 (d,
J=7.36 Hz, 1H), 7.11-7.42 (m, 10H);
‘3C NMR (100 MHz, CDCI3) 30.93, 41.63, 69.49, 71.31, 71.45, 92.99, 127.49, 127.65,
127.77, 127.84, 128.32, 128.58, 136.97, 138.98, 169.90;
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IR (thin film) vmax 3006, 2949, 2895, 1737, 1604, 1498, 1454, 1401, 1201, 1160, 1095,
1036, 990,947, 842, 763, 699 cm’;
HRMS: C19H2104 (M+1), calcd: 313.13611, found: 313.13507.
Solution phase synthesis of lactone 51:
T8DPSO 1. TBAF-AcOH
2.TsOH 80MO
Me 85% Me 51
To a solution of ester 1 (0.30 g, 0.57 mmol) in THF (5 mL) at r. t. was added TBAF
AcOH (1:1, 0.94 M, 3.06 mL, 2.88 mmol). The reaction mixture was stirred and
monitored by TLC. After 1.5 h, the reaction was complete and the reaction mixture was
acidified with TsOHH20 to pH 1. The reaction mixture was then stirred for further 1 h
before being diluted with ethyl acetate (15 mL). The resulting mixture was nutralized
with NaHCO3 solution, washed with saturated NH4CI, brine ami dried over Na2SO4. The
solvent was removed in vacuo. The residue was purified by column chromatography
(E/H=1:7) to give lactone 51(0.12 g, 85%).
Solution phase synthesis of lactone 52:
TBDPSOCO2Me
1. TBAF-AcOH
2. TsOH BOMD :
Ph 86% 52
To a solution of ester 10 (0.25 g, 0.43 mmol) in THF (5 mL) at room temperature was
added TBAF-AcOH (1:1, 0.94 M, 2.28 mL, 2.15 mmol). The reaction mixture was stirred
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and monitored by TLC. After 2 h, the reaction was complete and the reaction mixture
was acidified with TsOHH20 to pH 1. The reaction mixture was then stirred for further 1
h before was diluted with ethyl acetate (15 mL). The resulting mixture was nutralized
with NaHCO3 solution, washed with saturated NH4C1, brine and dried over Na,$Q4. The
solvent was removed in vacuo. The residue was purified by column chromatography
(E/H=1:7) to give lactone 52 (0.12 g, 86%).
(3$, 4$, 5S)-3-Allyl-5-benzyloxymethoxy-4-methyltetrahydropyran-2-one (56):
thenaHyIbomide
Me 56
To a suspension of resin 47 (0.30 g, 0.21 mmol) in THF (5 mL) at —78 °C was added
KHMDS (1.26 mL, 0.50 M in toluene, 0.63 mmol). The mixture was stirred for 1 h
before allyl bromide (91 IIL, 0.13 g, 1.05 mmol) was added via syringe. The reaction
mixture was stirred for further 1.5 h. The resin was then removed by filtration, washed
with DMF, THF, ether, CH2CI2 and dried in vacuo. The dried resin 53 (0.15 g) was
suspended in a solution of 3% TFA in CH2C12 (4 mL) and stined for 1.5 h. The resin was
then removed by filtration. The filtrate was washed with NaHCO3 and water, dried over
Na2SO4 and concentrated. Column chromatography of the residue (E/H=1 :3) afforded the
lactone 56 (0.023 g, 75%, loading: 0.52 mmol/g);
[Œjn 4497 O (c 0.86, CHCÏ3);
‘H NMR (400 MHz, CDCI3) 1.13 (d, J=6.69 Hz, 1H), 1.02-1.13 (m, 1H), 2.34 (ddd,
J=4.59, 9.07, 13.89 Hz, 1H), 2.66 (ddd, J=4.68, 4.71, 11.01 Hz, 1H), 2.84-2.93 (m, 1H),
3.82-3.85 (m, 1H), 4.21 (dd, J=1.71, 12.21Hz, 1H), 4.55 (dd, J=1.1 1, 12.21 Hz, 1H), 4.62
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‘H NMR (300 MHz, CDC13) 1.15 (d, J=6.69 Hz, 1H), 1.89-1.98 (m, 1H), 2.70-2.89 (m,
2H), 3.76 (s, 3H), 3.80-3.84 (m,1H), 4.19 (dd, J=1.74, 12.06 Hz, 1H), 4.51 (dd, J=2.91,
1 2.12 Hz, 1H), 4.61 (d, J=12.01 Hz, 1H), 4.66 (d, .1=12.09 Hz, 1H), 4.79 (d, J=7.29 Hz,
1H), 4.91 (d, J=7.32 Hz, 1H), 5.71 (s, 1H), 6.27 (s, 1H), 7.29-7.40 (m, 5H);
‘3C NMR (100 MHz, CDC13) 15.96, 31.78, 35.17, 43.78, 51.84, 69.82, 72.49, 93.62,
127.80, 127.85, 128.15, 128.41, 137.20, 137.31, 167.49, 172.09;
IR (thin film) vmax 2953, 2897, 1725, 1630, 1497, 144, 1441, 1399, 1302, 1207, 1165,
1142, 1103, 1041,961,906,817,743,699cm’;
HRMS: C19H2506 (M+1), calcd: 349.15729, found: 349.15688.
(3R, 4S, 5S)-5-Benzyloxymethoxy-3-(2-hydroxy-2-methylpropyl)-4-
methyltetrahydropyran-2-one (5$):
BOMO 1. KHMDS, then
Br -
BOMO :
47 Me 2. 3% TFA
To a suspension of resin 47 (0.30 g, 0.21 mmol) in THF (5 mL) at —78 oc was added
KHMDS (1.26 mL, 0.50 M in toluene, 0.63 mmol). The reaction mixture was stirred for
1 h before 3-bromo-2-methylpropene (0.11 mL, 0.14 g, 1.05 mmol) was added via
syringe. The reaction mixture was stirred for further 1.5 h. The resin was removed by
filtration, washed with DMF, THF, ether, CH2C12 and dried in vacuo. The dried resin 55
(0.15 g) was suspended in a solution of 3% TFA in CH2CI2 (4 mL) and was stined for 1.5
h. The resin was then removed by filtration. The filtrate was washed with NaHCO3 and
water, dried over Na2$04 ana concentrated. Column chromatography (E/H=1:3) of the
residue afforded lactone 5$ (0.0 18 g, 56%, loading: 0.39 mmol/g);
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[cL]D -2.12 ° (e 0.80, CHC13);
1H NMR (400 MHz, CDC13) 0.93 (d, J=6.96 Hz, 3H), 1.33 (s, 3H), 1.45 (s, 3H), 1.73
(dd, J=9.03, 9.32 Hz, 1H), 2.00 (dd, J:=9.32, 12.56 Hz. 1H), 2.38-2.44 (m, 1H), 3.19 (ddd,
J=3.52, 8.82, 12.35 Hz, 1H), 3.41-3.48 (m, 1H), 3.59 (dd, J=6.28, 12.20 Hz, 1H), 3.75
(dd, J=2.60, 12.20 Hz, 1H), 4.63 (d, J=11.76 Hz, 1H), 4.73 (d, J=12.00 Hz, 1H), 4.74 (d,
J=6.96 Hz, 1H), 4.93 (d, J7.00 Hz, 1H), 7.30-7.40 (m, 5H);
‘3C NMR (100 MHz, CDC13) 12.71, 27.13, 28.84, 33.71, 36.07, 42.03, 63.60, 70.27,
81.91, 85.03, 95.51, 127.74, 127.87, 127.99, 128.49, 136.84, 178.09;
IR (thin film) vmax 3402, 2974, 2931, 1753, 1659, 1603, 1454, 1387, 1281, 1145, 1115,
1037 cm’;
ITRMS: C17H2505 (M+1), calcd: 309.16233, found: 309.16198.
General procedure for the syntheses of lactones 59, 60, 61 in solution:
TBDPSOL)
1. TBAF-AcOH
._::c )\
BOMO : Re 61R
OH
41 R
42 R= CO2Me
43 R=
To a solution of ester 41, or 42, or 43 (0.30 g) in THF (5 mL) at room temperature was
added TBAF-AcOH (1:1, 0.94 M, 4.00 mL, 3.76 mmol). The reaction mixture was stirred
and monitored by TLC. After 1.5 h, the reactïon was complete and the reaction mixture
was acidified with TsOHH20 to pH 1. The reaction mixture was then stirred for further 1
h before being diluted with ethyl acetate (15 mL). The resulting mixture was nutralized
with NaHCO3 solution, washed with saturated NH4C1 solution, brine and dried over
168
Na2S04. The solvent was removed in vacuo. The residue was purified by column
chromatography (E/H=1 :7) to give lactone 59, or 60, or 61 respectively.
(3$, 4$, 5$)- 5-Benzyloxymethoxy-3-hydroxy-4-methyltetrahydropyran-2-one (63):
-
Ph HOMO - OH
47 Me
2. 3%TFA Me
63
To a suspension of resin 47 (3.00 g, 1.66 mmol) in THF (60 mL) at —7$ OC was slowly
added KHMDS (33.20 mL, 0.50 M in toluene, 16.60 mmol). The reaction mixture was
stirred at —78 oc for 1 h and then slowly warmed to —40 °C in 30 min. The reaction
mixture was then cooled to —78 oc and the Davis reagent (4.33 g, 16.60 mmol) in THF
(25 mL) was added. The reaction mixture was stirred for 2 h and then warmed to —40 °C
over 30 min before being quenched with acetic acid. The resin was then filtered, washed
with DMF, THF, CH2C12, hexane and dried in vacuo. The dried resin 62 (0.15 g) was
added to a solution of 3% TFA in CH2Ci2 (4 mL) and was stirred for 1 h before the resin
was filtered. The filtrate was washed with NaECO3 solution, water, dried over Na2SQ4
and concentrated. Column chromatography (E/H= 1:2) of the residue afforded lactone 63
(0.0 16 g, 70%. Loading: 0.39 mmol/g);
[al0 +3.0 ° (c 0.63 , CHCI3);
‘H NMR (300 MHz, CDCÏ3) 1.29 (d, J=6.63 Hz, 3H), 2.18-2.29 (ni, 1H), 3.95-4.01 (ni,
1H), 4.24 (d, J=11.76 Hz, 1H), 4.33 (dd, J=7.36, 12.48 Hz, 1H), 4.58 (dd, J=2.04, 12.48
Hz, 1H), 4.65 (d, J=11.76 Hz, 1H), 4.68 (d, J=11.76 Hz, 1H), 4.82 (d, J=7.35 Hz, 1H),
4.94 (d, J=7.35 Hz, 1H), 7.32-7.45 (m, 5H);
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‘3C NMR (100 MHz, CDC13) 14.11, 38.18, 68.95, 69.94, 71.78, 73.94, 94.05, 127.78,
127.89, 12844, 136.91, 173.87;
IR(thinfilm)vmax3469,2931, 1735, 1455, 1208, 1160, 1114, 1037cm’;
HR1’IS: C14H1905 (M+1), calcd: 267.11541, found: 267.11498.
(2S, 3S, 4S)-2-Benzyloxymethoxy-4-methoxymethoxy-3-methylpentane-1,5-diol (65):
60MO 0H 1.MOMCI 60Mo OMOM
2. Dibal-H H0..
3. 3% TFA Me
62 65
b a suspension of resin 62 (4.00 g, 0.39 mmol/g, 1.52 mmol) in CH2CI2 (120 mL) was
added 1Pr2NEt (4.05 mL, 3.08 g, 23.28 mmol) and MOMCI (1.52 mL, 1.61 g, 20 mmol).
The reaction mixture was stirred at room temperature for 2 days. The resin was filtered,
washed with water, DMF, THF, diethyl ether, CH2CI2 and dried in vacuo. The dried resin
(0.20 g) was suspended in a solution of 3% TFA in CH2C12 (4 mL) and stirred for 1.5 h.
The resin was then removed by filtration and the filtrate was washed with NaHCO3,
water, dried over Na2SO4 and concentrated. Colurnn chromatography (EIH=1:3) of the
residue afforded the a-MOM ether lactone (0.0 16 g, 67%, loading: 0.26 mmol/g);
[U]D—l$l.97 ° (c 1.16, CHC13);
‘H NMR (400 MHz, CDCP) 1.22 (d, J=6.68 Hz, 3H), 2.20-2.28 (m, 1H), 3.45 (s, 3H),
3.89-3.91 (m, 1H), 4.21 (d, J=11.32 Hz, 1H), 4.22 (dd, J=2.28, 12.40 Hz, 1H), 4.46 (dd,
J=2.36, 12.40 Hz, 1H), 4.59 (d, J11.72 Hz, 1H), 4.63 (d, J=11.72 Hz, 1H), 4.72 (d,
J=6.92 Hz, 1H), 4.77 (d, J=7.28 Hz, 1H), 4.88 (d, J=7.28 Hz, 1H), 5.10 (d, J=6.92 Hz,
1H), 7.26-7.38 (m, 5H);
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‘3C NMR (100 MHz, CDC13) 14.35, 37.87, 56.32, 69.88, 70.78, 73.00, 73.8$, 93.95,
97.30, 127.78, 127.81, 128.40, 137.12, 170.79;
IR (thin film) vmax 2996, 2896, 1747, 1497, 1455, 1402, 1383, 1356, 1251, 1144, 924,
747, 699 cm;
HRMS: C16H2306 (M+1), calcd: 311.14948, found: 311.14850.
To a suspension of the above a-MOM ether lactone resin (3.80 g, 0.26 mmollg, 0.99
mmol) in CH2C12 (120 mL) at —7$ °C was added Dibal-H solution (0.50 M in toluene,
11.85 mL, 5.92 mmol) and the reaction mixture was stirred at this temperature for 2 h.
The mixture was then slowly warmed to —40 °C in 1 .5 h before it was recooled to —78 oc.
A solution of NH4C1 (20 mL) was added and the mixture was warmed to room
temperature. The resin was quickly removed by filtration and then washed with NaOH
solution (0.50 M), NH4cl solution, water, DMF, THF, diethyl ether, cH2cl2 and dried in
vacuo. The dried resin 64 (0.30 g) was suspended in a solution of 3% TFA in CH7C12 (4
mL) and stirred for 1.5 h before the resin was removed by filtration. The filtrate was
washed with NaHCO3, water, dried over Na2SO4 arid concentrated. Column
chromatography of the residue (EIH=1:2) afforded alcohol 65 (0.017 g, 70%, so the
loading was 0.18 mmol/g);
[Œ]D+5O.93 ° (c 1.07, CHC13);
1H NMR (400 MHz, CDCI3) 0.92 (d, .1=7.08 Hz, 3H), 1.82-1.9 1 (m, 1H), 3.42 (s, 3H),
3.50-3.60 (m, 3H), 3.50-3.60 (m, 3H), 3.66-3.73 (m, 1H), 3.78-3.83 (m, 2H), 4.61 (d,
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.1=11.81 Hz, 1H), 4.64 (d, 1=6.80 Hz, 1H), 4.70 (d, J=6.72 Hz, 1H), 4.74 (d, J=6.96 Hz,
1H), 4.75 (d, 1=9.68 Hz, 1H), 4.92 (d, J=6.92 Hz, 1H), 7.28-7.40 (m, 5H);
‘3C NMR (100 MHz, CDCI3) 6 10.97, 37.39, 55.56, 63.27, 65.07, 70.1$, 83.09, 83.95,
95.44, 97.64, 127.83, 127.90, 128.45, 136.8$;
IR (thin film) vmax 3427, 2935, 1455, 1083 cm’;
HRPvIS: C16H9706 (M+1), calcd: 315.18076, found: 315.18090.
(4R, 5S, 6S)-6-Benzyloxymethoxy-7-hydroxy-4-methoxymethoxy-5-methyl-hept-2-
enoic acid methyl ester (67):
BOMO OMOM 1. Swern BOMO OMOM
2. Wiffig
— : 3.3%TFA 2
- 64 Me Me 67
To a suspension of resin 64 (3.50 g, 0.1$ mmol/g, 0.63 mmol) in CH2CÏ2 (120 mL) at
room temperature was added DMSO (2 mL), Et3N (1.52 g, 2.08 mL, 10.00 mmol), and
S03Py (1.5 1 g, 9.52 mmol). The reaction mixture was stirred at this temperature for 14 h
before the resin was quickly removed by filtration, washed with water, DMF, THF,
diethyl ether, CH2C12 and dried in vacuo. This resin was directly used in the next step.
To a suspension of the above resin in CH2C12 (50 mL) at room temperature was added the
methyl (triphenylphosphoranylidene)acetate (2.19 g, 6.34 mmol) and the reaction mixture
was stirred at this temperature for 24 h. The resin was quickly filtered, washed with
DMF, THF, diethyl ether, CH2C12 and dried in vacuo.
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(31?, 4R, 5S, 6S)-6-Benzyloxymethoxy-7-hydroxy-4-methoxymethoxy-3,5-dimethyl-
heptanoic acid methyl ester (69):
BOMO OMOM BOMO OMOM
J. Me2CuLi, TMSCI
2.3%TFA66 Me Me Me
69
To a solution of MeCuLi2 at —78 °C [prepared by the addition of MeLi (complex with
MgBr2, 23 mL, 1.50 M in diethyl ether, 34.6 mmol) to Cul (2.8$ g, 17.3 mmol) in THF
(60 mL) at —15 °C, and the mixture was warmed to O °C in 0.5 h] was added TMSC1
(7.03 g, 8.03 mL, 72.9 mmol) and resin 66 (2.50 g) in TEF (25 mL). The reaction
mixture was stirred at —78 °C for 2 h, -45 °C for 2 h, -25 oc for 2 h before being
neutralized with acetic acid. NH4CÏ/NH4OH (1:1, 100 mL) solution was added to dissolve
ail the copper saits. The resin was filtered and stirred in a mixture of NH4C1INH4OH( 1: 1,
7 mL) in THE (80 mL) for 20 mm, after which, filtration was repeated. This procedure
was repeated twice. The resin was then washed with water, THF, DMF, CH7C12, hexane
and dried in vacuo for 24 h. This cuprate addition reaction was repeated exactly as before
to ensure high conversion. The dried resin 6$ (0.30 g) was suspended in a solution of 3%
TFA in CH2CÏ2 (5 mL) for 1 h. The resin was then removed by filtration. The filtrate was
washed with NaHCO3 solution, water, dried over Na2SO4 and concentrated. Coiurnn
chromatography (E/Hz1:7) of the residue afforded alcohol 69 (0.0 11 g, 50.8% for three
steps, loading: 0.093 mmollg);
{Œ]D +8.07 ° (c 0.83, CHC13);
‘H NMR (400 MHz, CDCI3) 6 0.89 (d, J=7.04 Hz, 3H), 0.92 (d, J=6.68 Hz, 1H), 1.18-
1.19 (m, 1H), 2.11 (dd, J=8.56, 14.84 Hz, 1H), 2.19-2.27 (m, 1H), 2.53 (dd, J=4.$0,
14.92 Hz, 1H), 3.33 (s. 3H), 3.50-3.55 (m, 3H), 3.65 (s, 3H), 3.77-3.82 (m, 1H), 4.57 (d,
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J=6.72 Hz, 1H), 4.58 (d, J=11.$4 Hz, 1H), 4.59 (d, .1=6.64 Hz, 1H), 4.75 (d, J=11.84 Hz,
1H), 4.83 (d, J=7.00 Hz, 1H), 4.92 (d, J=7.04 Hz, 1H), 7.28-7.39 (m, 5H);
‘3C Nl’IR (100 MHz, CDCI3) 10.10, 16.87, 33.70, 36.26, 38.21, 51.24, 55.71, 63.58,
70.12, 83.26, 84.11, 84.53, 95.68, 98.52, 127.77, 127.82, 128.40, 137.05, 173.54;
IR (thin film) vmax 3461, 2949, 1738, 1454, 1437, 1383, 1256, 1150, 1037, 952, 91$,
739, 699 cm’;
HRMS: C20H3307 (M+1), calcd: 385.22263, found: 385.22390.
(2R, 3$, 4$, 5$, 6$)-6-Benzyloxymethoxy-2,7-dihydroxy-4-methoxymethoxy-3,5-
dimetliylheptanoic acid methyl ester (71):
1. KHMDS, then
BOMO OMOM BOMO OMOM OH
PhSO24... HDt1J_
Me Me 2. 3%TFA Me Me
68 71
To a suspension of resin 68 (2.00 g, 0.1$ mmol) in THF (15 mL) at —78 oc was sÏowly
added KHMDS (2.97 mL, 0.50 M in toluene, 1.48 mmol). The reaction mixture was
stirred at —78 °c for 1 h before being slowly warmed to —40 °c in 30 min. The reaction
mixture was then cooled to —7$ °c and the Davis reagent (0.39 g, 1.48 mmol) in THF (4
mL) was added. The reaction mixture was stirred for 2 h and then warmed to —40 °C over
30 min before being quenched with acetic acid. The resin was then filtered, washed with
DMF, THF, CH2C12, hexane and dried in vacuo. The dried resin 70 (1.00 g) was added to
a solution of 3% TFA in CH212 (10 mL) and stined for 1 h before the resin was removed
by filtration. The filtrate was washed with NaHCO3 solution, water, dried over Na2SQ4
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and concentrated. Column chromatography (E/H=1:1) of the residue afforded alcohol 71
(0.023 g, 62%. Loading: 0.057 mmol/g);
[ŒJD +2.67 ° (c 0.98, CHC13);
‘H NMR (400 MHz, CDCI3) 0.75 (d, J=6.88 Hz, 3H), 0.90 (d, J=7.04 Hz, 1H), 1.76-
1.86 (m, 1H), 2.07-2.16 (m, 1H), 3.37 (s, 3H), 3.51-3.58 (m, 2H), 3.80 (s, 3H), 3.82-3.89
(m, 2H), 4.54 (d, J=2.0$ Hz, 1H), 4.61 (d, J=11.$0 Hz, 1H), 4.6$ (d, J=6.4$ Hz, 1H),
4.73 (d, J=6.52 Hz, 1H), 4.77 (d, J=11.76 Hz, 1H), 4.86 (d, J:=7.12 Hz, 1H), 4.96 (d,
J=7.0$ Hz, 1H), 7.28-7.39 (m, 5H);
13C NMR (100 MHz, CDC13) 9.52, 10.33, 35.93, 39.14, 52.35, 55.80, 63.79, 70.22,
70.55, 80.73, 84.29, 95.67, 98.99, 127.82, 128.41, 137.03, 175.67;
IR (thin film) vmax 3457, 2945, 2888, 1737, 1454, 1384, 1216, 1146, 1085, 1037, 955,
916, 740, 699 cm’;
HRMS: C20H3308 (M+1), calcd: 401.21753, found: 401.21670.
(2R, 3S, 4$, 5$, 6S)-6-Benzyloxymetlioxy-7-(tert-butyldiphenylsilanyloxy)-2-
hydroxy-4-methoxymethoxy-3,5-dimethylheptanoic acid methyl ester (72):
80MO OMOM OH 80MO OMOM 0H
Imkiaze,THF
b a solution alcohol 71 (0.020 g, 0.050 mmol) in 111F (3 mL) at O °C were added
imidazole (0.010 g, 0.14 mmol) and TBDP$C1 (0.027 g, 0.10 mmol). The reaction
mixture was stirred at O °C for 1.5 h before being quenched with saturated NH4CI
solution (4 mL). The mixture was extracted with ethyl acetate (15 mL x 2). The
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combined organic layers were washed with brine (15 mL), dried over Na2S04 and
concentrated in vacuo. Column chromatography of the residue afforded TBDPS ether 72
(0.027 g, 92%);
[ŒID—l$.2 ° (c 0.56, CHC13);
1H-NMR (300 MHz, CDCÏ3) 0.84 (d, J=6.$1 Hz, 3H), 0.8$ (d, J=7.12 Hz, 3H), 1.07 (s,
9H), 2.16-2.04 (m, 2H), 3.32 (s, 3H), 3.62-3.59 (m, 1H), 3.73-3.79 (m, 1H), 3.80 (s, 3H),
3.92-3.89 (m, 2H), 4.55 (cl, J=11.2 Hz, 1H), 4.61-4.72 (m, 3H), 4.76 (d, J=6.31 Hz, 1H),
4.81 (d, 1=6.96 Hz, 1H), 4.86 (d, J=6.96 Hz, 1H), 7.29-7.45 (m, 11H), 7.7 1-7.67 (m, 4H);
‘3C-NMR (100 MHz, CDCI3) 9.56, 10.62, 19.16, 26.72, 36.48, 39.38, 52.18, 55.73,
64.32, 69.88, 70.59, 80.63, 80.66, 94.90, 98.88, 127.40, 127.52, 127.57, 127.63, 128.19,
129.54, 133.30, 135.52, 137.78, 175.39;
IR (thin film): vmax 3520, 2950, 1738, 1430, 1384, 1086, 1036, 955, 917, 974, 701 cm’;
HRMS: C36H50O8SiNa (M+Na) calc.: 661.3172, found: 661.3202.
(31?, 4S)-4-Benzyloxymethoxy-5-(tert-butyldïphenylsilanyloxy)-3-p -tolyl-pentanoic
acid methyl ester (73):
OBOM
OBOM TBDPSO
TBDPSO.L..
M
Ar2CuMgBr CO2Me
2 e TMSC, THF,-78 °C
cl tI 1
73
Me
To a suspension of Cul (0.50 g, 2.63 nimol) in THF (20 mL) at —7$ °C was added p-tolyl
magnesium bromide solution (1.00 M in THF, 5.26 mL, 5.26 mmol). The mixture was
stirred for 1 h at —7$ °C before TMSCI (0.88 g, 0.76 mL, 7.00 mmol) and Œ,3-
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unsaturated ester C1 (0.26 g, 0.50 mmol) in TifF (3 mL) were added. The reaction
mixture was stirred for 3 h at —78 °C, 2 h at —50 oc before being quenched witli NH4C1
solution (20 mL). The reaction mixture was warmed to room temperature and extracted
with hexane (100 mL). The extract was washed with NH4OH-NH4cI (1:1, 30 mL x 2),
brine (20 mL), water (20 mL), dried over Na,S04, filtered and concentrated in vacuo. The
residue was purified by column chromatography (E/H=1:20) to give product 73 (0.25 g,
86%);
[Œ]D 13.67 °(c 1.23, CHcl3);
‘H NMR (CDC13, 400 MHz) 1.09 (s, 9H), 2.35 (s, 3H), 2.69 (dd, J=10.08, 15.56 Hz,
1H), 3.03 (dd, J=5.04, 15.56 Hz, 1H), 3.59 (s, 3H), 3.59-3.68 (m, 3H), 3.91-3.95 (m, 1H),
4.48 (U, J=ll.88 Hz, 1H), 4.59 (d, J=11.88 Hz, 1H), 4.72 (cl, J=6.96 Hz, 1H), 4.86 (d,
J=7.0 Hz, 1H), 7.10 (d, J=8.0 Hz, 1H), 7.15 (d, J=8.0 Hz, 1H), 7.26-7.46 (m, 8H), 7.57-
7.68 (m, 3H);
‘3c NMR (CDC13, 100 MHz) 19.21, 21.10, 26.84, 36.77, 42.76, 51.44, 63.71, 69.90,
81.11, 94.40, 127.65, 127.72, 127.78, 128.11, 128.41, 129.16, 129.61, 129.65, 133.19,
133.31, 135.55, 135.67, 136.25, 138.21, 173.07;
IR (thin film) vmax 3021, 3030, 2932, 2858, 1740, 1515, 1472, 1455, 1428, 1362, 1259,
1158, 1113, 1027, 821, 740, 702, 613 cm’;
M/e: 619.5 (M+Na), 539.4, 501.2, 459.4,431.3,411.3,385.2,341.2, 197.1, 135.1.
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(3R, 4S)-4-Benzyloxymethoxy-5-(tert-butyldiphenyÏsilanyloxy)-3-(4-methoxyphenyl)-
pentanoic acid methyl ester (74):
OBOM
OBOM TBDPSO
M
Ar2CuMgBr CO2Me
2 TMSCI, THF,-78 °C
I 74
OMe
To a suspension of Cul (0.50 g, 2.63 mmol) in THF (20 mL) at —78 °C was added 4-
methoxylphenyl magnesium bromide solution (0.50 M in TEF, 10.50 mL, 5.26 mmol).
The reaction mixture was stirred for 1 h at —78 °C before TMSC1 (0.88 g, 0.76 mL, 7
mmol) and Œ,j3-unsaturated ester C1 (0.25 g, 0.5 mmol) in THF (4 mL) were added. The
reaction mixture was stirred for 3 h at —78 °C, 2 h at —50 oc before being quenched with
NH4C1 solution (20 mL). The resulting mixture was warmed to r. t and extracted with
hexane (100 mL). The extract was washed with NH4OH-NH4C1 (1:1, 30 mL x 2), brine
(20 mL), water (20 mL), dried over Na2SO4, filtered and concentrated in vacuo. The
residue was purïfied by column chromatography (E/H=1:20) to give product 74 (0.26 g,
84%);
[a]—42.1 ° (e 1.20, CHCJ3);
‘U NMR (CDCI3, 400 MHz) 6 1.09 (s, 3H), 2.69 (dd, J=10.08, 15.56 Hz, 1H), 3.03 (dd,
J=5.04, 15.56 Hz, 1H), 3.58 (s, 3H), 3.58-3.65 (m, 3H), 3.80 (s, 1H), 3.85-3.89 (m, 1H),
4.49 (d, J=11.88 Hz, 1H), 4.60 (d, J=11.88 Hz, 1H), 4.72 (d, 1=6.90 Hz, 1H), 4.85 (d,
J=6.96 Hz, 1H), 6.82 (d, 1=8.72 Hz, 2H), 7.17 (d, J=$.68 Hz, 2H), 7.35 -7.45 (m, 1H),
7.56-7.66 (m, 4H);
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‘3C NMR (CDC13, 100 MHz) 19.22, 26.84, 36.89, 42.3$, 51.43, 55.17, 63.69, 69.91,
81.15, 94.40, 113.83, 127.64, 127.75, 128.40, 129.19, 129.64, 129.67, 133.29, 135.54,
135.66, 158.37, 173.05;
IR(thin film)vmax 2931, 1738, 1610, 1513, 1428, 1261, 1174, 1113, 1037, 702 cm’;
mIe: 577.4, 565.4, 463.1, 391.1, 345.0, 325.1, 283.0, 197.0, 135.0.
(3R, 4S)-4-Benzyloxymethoxy-5-(tert-butyldiphenylsilanyloxy)-3-(4-fluorophenyl)-
pentanoic acid methyl ester (75):
OOM
OBOM
TBDPSOL-
M
Ar2CuMgBr
TBDPSO
CO2Me
2 e TMSCI,THF,-78°C
11 7
F
To a suspention of Cul (0.50 g, 2.63 mmol) in THF (20 mL) at —7$ °C was added 4-
fluorophenyl magnesium bromide solution (1.00 M in TI-IF, 5.26 mL, 5.26 mmol). The
reaction mixture was stirred for 1 h at —78 °C before TMSCI (0.8$ g, 0.76 mL, 7.00
mmol) and a,f3-unsaturated ester Ci (0.20 g, 0.39 mmol) in THF (3 mL) were added. The
reaction mixture was stirred for 3 h at —7$ °c, 2 h at —50 oc before being quenched with
NH4CI solution (25 mL). The resulting mixture was wanned to room temperature and
extracted with hexane (80 mL). The extract was washed with NH4OH-NH4C1 (1:1, 30 mL
x 2), brine (20 mL), water (20 mL), dried over Na2SO4, filtered and concentrated in
vacuo. The residue was purified by column chromatography (E/H=1:20) to give product
75 (0.20 g, 87%);
[a]—33.O ° (c 1.56, CHC13);
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‘H NMR (CDC13, 400 MHz) 6 1.06 (s, 9H), 2.65 (dd, JzzlO.2$, 15.72 Hz, 1H), 2.99 (dd,
J=4.$$, 15.72 Hz, 1H), 3.56 (s, 3H), 3.56-3.68 (m, 3H), 3.80-3.86 (m, 1H), 4.46 (d,
.1=11.92 Hz, 1H), 4.55 (d, J=11.92 Hz, 1H), 4.67 (d, 1=6.96 Hz, 1H), 4.81 (d, J=6.96 Hz,
1H), 6.95 (t, 1=8.72 Hz, 2H), 7.18-7.45 (m, 15H), 7.45-7.58 (m, 2H), 7.64-7.68 (m, 2H);
‘3c NMR (CDCÏ3, 100 MHz) 6 19.16, 26.79, 36.62, 42.41, 5 1.47, 63.47, 69.93, 80.83,
94.34, 115.13, 115.33, 127.65, 127.70, 128.41, 129.67, 129.72, 133.02, 133.13, 135.47,
135.61, 136.93, 137.67, 160.47, 162.91, 172.81;
IR (thin film) vmax 2931, 1739, 1604, 1510, 1428, 1260, 1232, 1172, 1113, 1037, $24,
740, 701 cm’;
(3R, 4S)-4-Beny1oxymethoxy-5-tert-buty1dipheny]siIany1oxy)-3-(3-methoxypheny1).
pentanoic acid methyl ester (76):
080M
080M
TBDPS0.L
TMSCTHF78
TBDPSO
CO2Me
OMo
76
To a suspension of Cul (7.56 g, 39.60 mmol) in THf (150 mL) at —78 oc was added
meta-methoxy-phenyl magnesium bromide (1.00 M, 39.60 mL, 39.60 mmol). The
reaction mixture was stirred at —78 oc for 1 h before TMSC1 (8.20 mL, 7.16 g, 65.68
mmol) and ester C, (3.0 g, 6.60 mmol) in THF (30 mL) was added dropwise under argon
atmosphere. The reaction mixture was stined at —7$ °C foi- 3 h, at —50 °C for 3 h before
being quenched with a solution of NH4OH and NH4CI (1:1, 150 mL). The resulting
mixture was warmed to room temperature and extracted with hexane (100 mL x 2). The
combined cxtracts were washed with diluted NH4OH solution (50 mL x 2), brine and
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dried over Na2SO4. The solvent was removed in vacuo, and the residue was purified by
column chromatography (E/H=1 :20) to afford product 76 (3.42 g, 84%) as colorless oïl;
[ŒJD—2$.59 ° (c 0.7 1, CHC13)
‘H NMR (CDCI3, 400 MHz) 6 1.0$ (S, 9H), 2.72 (dd, 1=9.80, 15.68 Hz, 1H), 3.02 (dd,
1=5.12, 15.6$ Hz, 1H), 3.59 (s, 3H), 3.59-3.70 (m, 3H), 3.77 (s, 3H), 3.88-3.93 (m, 1H),
4.48 (d, J=1l.88 Hz, 1H), 4.58 (d, J=1l.$$ Hz, 1H), 4.70 (d, J=7.0 Hz, 1H), 4.83 (d,
1=7.0 Hz, 1H), 6.7$-6.$9(m, 3H), 7.20 (t, J=7.4$ Hz, 1H), 7.27-7.48 (m, 1H), 7.57 (d,
J=7.96 Hz, 1H), 7.58 (d, J=$.04 Hz, 1H), 7.64 (d, J=8.04 Hz, 1H), 7.65 (d, 1=7.96 Hz,
1H);
‘3c NMR (CDCI3, 100 MHz) 6 19.20, 26.82, 36.65, 43.15, 51.46, 55.08, 63.65, 69.89,
80.94, 94.36, 112.23, 114.03, 120.57, 127.65, 127.76, 128.39, 129.41, 129.62, 129.6$,
133.13, 133.30, 135.51, 135.64, 137.79, 143.00, 159.58, 172.94;
IR(thinfilm)vmax2934, 1737, 1610,1513,1428,1261,1174, 1113, 1037cm’;
HRMS: C37H44O6SiNa (M+Na), calculated: 635.28052, found: 635.28040.
(3R, 4S)-4-Benyloxymethoxy-5-(tert-butyldiphenylsilanyloxy)-3-(3-methoxyphenyl)-
pentan-1-ol (78):
OBOM OBOM
DibaI-H
CH2CI2 E
80%
IIOMe OMe
76 78
To a stirred solution of ester 76 (3.30 g, 5.37 mmol) in toluene (50 mL) at —78 °C was
added dropwise Dibal-H (1.50 M in toluene, 10.00 mL, 15.00 mmol) under nitrogen. The
resulting mixture was stirred at this temperature for 1 h before being quenched with
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saturated NH4CI solution (50 mL). The reaction mixture was warmed to room
temperature and extracted with ether (100 mL x 2) immediately. The extracts were dried
over Na2SO4, filtered, and concentrated in vacuo. The residue was subjected to colunm
chromatography (E/H=1:6) to afford alcohol 78 (2.50 g, 80%);
[al0 —46.29 ° (c 0.89, CHCI3);
1H NMR (CDC13, 400 MHz) 1.04 (m, 9H), 1.88-1.98 (m, 1H), 2.20-2.30 (m, 1H), 3.10-
3.1$ (m, 1H), 3.44-3.50 (m, 1H), 3.51-3.59 (m, 2H), 3.62 (dd, J=3.96, 11.0$ Hz, 1H),
3.76 (s, 3H), 3.84-3.90 (m, 1H), 4.50 (d, J=1 1.84 Hz, 1H), 4.63 (d, J=1 1.84 Hz, 1H), 4.74
(d, J=6.96 Hz, 1H), 4.87 (d, J=6.96 Hz, 1H), 6.74-6.82 (m, 3H), 7.19 (dt, J=1.16, 7.4$
Hz, 1H), 7.26-7.48 (m, 12 H), 7.52 (d, J=$.0 Hz, 1H), 7.53 (d, J=7.98 Hz, 1H), 7.61 (cl,
J=7.80 Hz, 1H), 7.62 (d, J=7.96 Hz, 1H);
‘3c NMR (CDC13, 100 MHz) 19.17, 26.8 1, 34.24, 43.84, 55.08, 61.44, 63.88, 69.96,
81.62, 94.54, 111.87, 114.17, 120.77, 127.62, 127.76, 128.38, 129.48, 129.56, 129.63,
133.20, 133.34, 135.48, 135.61, 137.81, 143.65, 159.67;
HRIVIS; C36H44O5SiNa (M+Na), calculated: 607.28558, found: 607.28398.
(3R, 4S)-5-Qert-Butyldiphenylsilanyloxy)-3-phenylpentane-1, 4-dïol (79):
OBOM
H2, Pd/C TBDPsO...L__.OH
E CH3OH E
77 79
A mixture of alcohol 77 (2.80 g, 5.0 mmol) in methanol (20 mL) and Pd/C catalyst (0.070
g, 20% Pd, Degussa type) was stined under hydrogen at atmospheric pressure for 20 h.
The reaction mixture was filtered through Celite pad to remove the catalyst and the Celite
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pad was washed with ethyl acetate (20 mL). The combined filtrates were dried over
Na2SO4 and concentrated in vacuo. Purification of the residue by column
chromatography (silica gel, E/H=1:2) afforded product 79 (1.83 g, 84%);
[ŒJD-lO.45 ° (c 1.66, CHCI3);
‘H NMR (CDC13, 400 MHz) 6 1.04 (s, 9H), 1.85-1.94 (m, 1H), 2.23-2.32 (m, 1H), 2.34-
2.55 (broad, 2H), 2.2$ (dt, J=5.66, 7.30 Hz, 1H), 3.37 (dd, J=6.72, 10.36 Hz, 1H), 3.42
(dd, J=3.36, 10.36 Hz, 1H), 3.48-3.55 (m, 1H), 3.58-3.64 (rn, 1H), 3.83-3.88 (m, 1H),
7.02-7.06 (m, 2H), 7.14-7.24 (m, 3H), 7.32-7.46 (m, 6H), 7.52-7.58 (m, 4H);
‘3C NMR (CDC13, 100 MHz) 6 16.63, 24.28, 33.98, 43.84, 58.8 1, 63.66, 72.85, 124.12,
125.16, 125.21, 125.29, 126.06, 127.21, 127.26, 130.27, 130.35, 132, 87, 132.89, 139.25;
IR (thin film) vmax 3370, 2930, 2857, 1493, 1471, 1427, 1073, 1048, 823, 689 cm’;
m/e: 405.2, 377.2, 339.2, 309.2, 199.1, 154.1, 132.9, 91, 77, 57.
(3R, 4S)-5-(tert-Butyldiphenylsflanyloxy)-3-(3-methoxyphenyl)-pentane-1, 4-diol
($0):
OBOM
TBDPSO,L__OH H2, Pd/C TBDPSOJ.%.._._OH
CH3OH E
80%
OMe OMe
78 80
A mixture of alcohol 78 (2.40 g, 5.16 mmol) in methanol (25 mL) and Pd/C catalyst
(10%, 0.080 g) was stirred under hydrogen at atmospheric pressure for 20 h. The reaction
mixture was filtered through Celite pad to remove the catalyst and the pad was washed
with ethyl acetate (50 mL). The combined filtrates were dried over Na2S04 and
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concentrated in vacuo. Purification of the residue by column chromatography (silica gel,
E/H=1:2) afforded product $0 (1.54 g, 80%);
[Œ]D—32.46 ° (c 0.79, CHCJ3);
‘H NMR (CDC13, 400 MHz) 6 1.04 (s, 9H), 1.82-1.92 (m, 1H), 2.24-2.32 (m, 1H), 2.50-
2.56 (broad, 2H), 2.73-2.80 (m, 1H), 3.39 (dd, J=6.68, 10.36 Hz, 1H), 3.45 (dd, J=3.2$,
10.36 Hz, 1H), 3.48-3.53 (m, 1H), 3.59-3.64 (m, 1H), 3.74 (s, 3H), 3.81-3.88 (m, 1H),
6.63-6.67 (m, 2H), 6.71-6.74 (m, 1H), 7.12 (t, .1=8.08 Hz, 1H), 7.3 1-7.48 (m, 6H), 7.53-
7.60 (m, 4H);
‘3c NMR (CDCI3, 100 MHz) 6 19.19, 26.83, 36.42, 46.44, 55.05, 6 1.35, 66.21, 75.34,
111.76, 113.75, 120.19, 127.70, 127.75, 129.60, 129.75, 129.80, 132.81, 132.94, 135.42,
135.44, 143.46, 159.66;
IR (thin film) vmax 3376, 2936, 2857, 1495, 1475, 1111, 1073, 1048, 827, 690 cm’;
m/e: 487.0(M+Na), 445.0, 407.0, 369.0, 299.0, 199.0, 173.0, 135.0.
(1S, 2R)-2,2-Dimethylpropionic acïd 1-(tert-butyldiplienylsilanyloxymethyl)-4-(2,2-
dimethylpropionyloxy)-2-phenylbutyt ester ($1):
PivCI, DMAP
CH2CI2
94%
79 81
To a stirred solution of alcohol 79 (2.20 g, 3.68 mmol) in dry CH2C12 (40 mL) at O °C
was added DMAP (1.34 g, 11.04 mmol) and pivaloyl chloride (0.90 mL, 0.88 g, 7.36
mmol). The reaction mixture was stirred at room temperature for 16 h before being
quenched with saturated NFL4CI solution (50 mL). The resulting mixture was extracted
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with ether (50 mL x 3), and the combined extracts were washed with brine, dried over
Na2SO4 and concentrated in vacuo. The residue was purified by column chromatography
(silica gel, E:H=1:40) to afford product 81(1.03 g, 93%) as a colorless ou;
[ŒJD-45.82 ° (c 1.97, CHCI3);
‘H NMR (CDC13, 400 MHz) 8 1.03 (s, 3H), 1.20 (s, 3H), 1.27 (s, 3H), 1.73-1.86 (m, 1H),
2.09-2.18 (m, 1H), 3.33 (m, 1H), 3.46 (dd, J=4.04, 11.44 Hz, 1H), 3.54 (dd, J=2.46,
11.44 Hz, 1H), 3.69-3.78 (m, 1H), 3.99-4.06 (m, 1H), 5.15-5.20 (m, 1H), 7.18-7.40 (m,
13H), 7.58-7.60 (m, 2H);
‘3C NMR (CDCY3, 100 MHz) 6 16.61, 24.16, 24.66, 24.75, 28.61, 36.16, 36.44, 40.06,
59.47, 60.51, 74.40, 124.49, 124.97, 125.05, 125.93, 126.16, 126.95, 127.11, 130.29,
1330.58, 132.82., 133. 02, 137.45, 175.53, 175.77;
IR (thin film) vmax 2960, 2932, 2858, 1729, 1480, 1462, 1428, 1283, 1154, 1113, 1042,
701cm1;
HRMS: C37H51O5Si (M+1), calc.: 603.35059, found: 603.35340.
(1S, 2R)-2,2-Dimethyl-propionic acid 1-(tert-butyldiphenylsilanyloxymethyl)-4-(2,2-
dimethylpropionyloxy)-2-(3-methoxyphnenylbutyl ester (82):
TBDPSO.J.%_—_OH
PIvCI, DMAP
CH2CI2
95% L%jç
OMe80 82
To a stïrred solution of diol 80 (1.50 g, 3.23 mmol) in dry CH2CI2 (40 mL) at O °C was
added DMAP (1.58 g, 12.92 mmol) and pivaloyl chloride (1.17 g, 1.19 mL, 9.68 mmol).
The reaction mixture was then stirred at room temperature for 16 h before being
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quenched with saturated NH4CI solution (50 mL). The resulting mixture was extracted
with ether (30 mL x 2). The extracts were washed with brine, dried over Na2SQ4 and
concentrated in vacuo. The residue was purifïed by column chromatography (silica gel,
E/H=l:40) to afford product 82(1.94 g, 95%) as a colorless ou;
[]D—S4.7i ° (c 1.38, CHCI3);
‘H NMR (CDCÏ3, 400 MHz) 6 1.04 (s, 9H), 1.21 (s, 9H), 1.27 (s, 9H), 1.74-1.82 (m, 1H),
2.08-2.18 (m, 1H), 3.28-3.38 (m, 1H), 3.48 (dd, 1=3.84, 11.42 Hz, 1 H), 3.56 (dd, J=2.56,
11.42 Hz, 1H), 3.74 (s, 3H), 3.62-3.78 (m, 1H), 4.00-4.07 (m, 1H), 5.15 (dt, J=3.42, 9.76
Hz, 1H), 6.12-6.28 (m, 3H), 7.18-7.42 (m, 9H), 7.57 (d, J=6.4 Hz, 2H);
13C NMR (CDC13, 100 MHz) 6 19.97, 26.70, 27.21, 27.39, 31.17, 38.71, 39.00, 42.66,
55.04, 62.02, 63.07, 76.91, 112.41, 114.24, 120.69, 127.53, 127.59, 129.51, 129.67,
129.73, 132.78, 133.19, 135.37, 135.56, 141.59, 159.77, 178.08, 178.31;
IR (thin film) vmax 2959, 2900, 1727, 1596, 1480, 1463, 1432, 1281, 1255, 1153, 1110,
1038, 702 cm1;
(2S, 3R)-2,5-Bis-(2,2-dimetbylpropionyloxy)-3-phenylpentanoic acid ($3):
OPiv 1 TB OH OPiv
2. SO3y, DMSO
HO2C
E 3. NaCIO, NaH2PO4
t-BuOH, H20
2-Methyl-2-butene
81 71% 83
b a solution of ester 81 (1.30 g, 2.15 mmol) in THF (10 mL) was added TBAF
(complexed with acetic acid, 1:1, 11.46 mL, 10.78 mmol). The reaction mixture was
stirred at room temperature for 16 h before being diluted with ethyl acetate (20 mL) and
hexane (20 mL). The organic layer was washed with saturated NaHCO3 solution (15 mL
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x 3), brine, dried over Na2SO4 and concentrated in vacuo. The residue was purified by
column chromatography (E/H=1:5) to give the alcohol (0.7 1 g, 90%) whicli was used
directly in the next step.
b a solution of the above alcohol (0.69 g, 1.89 mmol), DMSO (1.00 mL) and Et3N (1.49
mL, 1.09 g, 10.75 mmol)) in CH2CÏ2 (15 mL) at O °C was added S03Py (1.36 g, 8.40
mmol). The reaction mixture was stirred 2 h at room temperature before being quenched
with NH4C1 solution (20 mL). Hexane (50 mL) was added to the mixture and the organic
layer was separated, washed with brine, dried over Na2SO4, filtered and concentrated.
The residue was subjected to the column chromatography (E/H=1:7) to afford the
aldehyde (0.62 g, 88%);
[ŒJD 3 1.37 ° (C 0.86, CHC13);
‘H NMR (CDC13, 400 MHz) 6 1.17 (s, 9H), 1.28 (s, 9H), 2.09-2.18 (m, 2H), 3.30-3.39
(m, 1H), 3.72-3.83 (m, 1H), 4.03-4.09 (m, 1H), 5.12 (d, 1=7.88 Hz, 1H), 7.22-7.37 (m,
5H), 9.38 (d, 1=0.64 Hz, 1H);
‘3c NMR (CDC13, 100 MHz) 6 27.07, 29.57, 38.63, 38.78, 42.59, 61.48, 80.63, 127.75,
128.23, 128.91, 138.10, 177.71, 178.18, 197.62;
IR (thin film) vmax 2973, 2934, 1731, 1480, 1283, 1146, 702 cm’;
To a solution of the aldehyde (0.050 g, 0.14 mmol) in t-BuOH (1.5 mL) was added 2-
methyl-butene (0.097 g, 0.15 mL, 1.38 mmol) and a solution of NaClO2 (0.13 g, 1.38
mmol) and KH2PO4 (0.15 g, excess) in water (2 mL). The reaction mixture was stirred at
room temperature for 2 h (the colour of the reaction became yellow). The reacfion
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mixture was then extracted with ethyl acetate (15 mL x 3). The combined organic layers
were dried over Na2SO4 and concentrated in vacuo. Column chromatography of the
residue (silica gel, E/H=1) afforded acid $3 (0.047 g, 90 %);
[Œ]D-l9.O7 ° (c 0.87, CHC13);
‘H NMR (CDC13, 400 MHz) 1.17 (s, 9H), 1.25 (s, 9H), 2.08-2.19 (m, 1H), 2.21-2.3 1
(m, 1H), 3.42 (dt, J=3.76, 11.44 Hz, 1H), 3.75-3.82 (m, 1H), 4.06-4.12 (m, 1H), 5.11 (cl,
J=3.96 Hz, 1H), 7.24-7.35 (m, 5H), 8.8-9.20 (broad, 1H);
‘3C NMR (CDC13, 100 MHz) 24.45, 24.57, 26.01, 36.18, 36.22, 41.03, 59.36, 72.82,
125.11, 125.83, 126.11, 135.98, 171.67, 175.01, 175.90;
IR (thin film) vmax 3227, 2973, 1703, 1480, 1451, 1394, 1363, 1284, 1145 cm’;
mIe: 401.3, 379.3, 361.2, 289.1, 277.2, 249.2, 193.1, 154.1, 137.1, 117.1, 85.0.
(2S, 3R)-2,5-Bis-(2,2-dimethylpropionyloxy)-3-(3-methoxyplienyl)pentanoic acid
($4):
OPiv OPiv
TBDPSO.L-......OPiv
2. S03 y,DMS0
HO2C’
3. NaCI0, NaH2PO4 Z
- t-BuOH, H20 I
- 2-Methyl-2-butene
OMe OMe
82 84
To a solution of ester 82 (2.20 g, 3.47 mmol) in THF (20 mL) was added TBAF (1:1
complexed with acetic acid, 0.94 M, 18.48 mL, 17.38 mmol). The reaction mixture was
stirred at room temperature for 16 h before being diluted with ethyl acetate (20 mL) and
hexane (20 mL). The resulting mixture was washed with saturated NaHCO3 solution (15
mL x 3), brine, dried over Na2SO4 and concentrated in vacuo. The residue was subjected
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to column chromatography (E/H= 1:5) to give the alcohol (1 .21 g, 92%). The product was
used directly in the next step.
To a solution of the above alcohol (1.20 g, 3.19 mmol) in CH7C12 (30 mL) was added
DMSO (1.00 mL, excess), Et3N (3.37 mL, 2.46 g, 24.29 mmol) and S03Py (2.80 g, 17.35
mmol). The mixture was stirred for 2 h at room temperature before being quenched with
NH4C1 solution (20 mL). Hexane (50 mL) was added to the mixture and the organic layer
was separated, washed with brine, dried over Na2SO4 and concentrated in vacuo. The
residue was subjected to the column chromatography (E/H=1:7) to afford the aldehyde
(1.03 g, 86%) which was used directly in the next step.
To a solution of the aldehyde (0.54 g, 1.3$ mmol) in t-BuOH (15 mL) was added 2-
methyl-butene (0.96 g, 1.46 mL, 13.8 mmol) and a solution of NaC1O2 (1.25 g, 13.8
mmol) and KH2PO4 (1.00 g, excess) in water (20 mL). The reaction mixture was stirred
at room temperature for 2 h (the colour of the reaction became yellow). The product was
then extracted with ethyl acetate (15 mL x 3). The combined organic layers were dried
over Na2SO4 and concentrated in vacuo. Purification of the residue by column
chromatography (silica gel, E/H=1:1) afforded acid 84 (0.49 g, 92 %);
(c 1.24, CHC13);
‘H NMR (CDCI3, 400 MHz) 1.14 (s, 9H), 1.25 (s, 9H), 2.04-2.13 (m, 1H), 2. 14-2.27
(m, 1H), 3.40 (dt, J=3.26, 10.86 Hz, 1H), 3.79 (s, 3H), 3.74-3.88 (m, 1H), 4.02-4.12 (m,
1H), 5.11 (d, J=3.86 Hz, 1H), 6.78-6.88 (m, 3H), 7.20-7.26 (m, 1H);
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‘3C NMR (CDC13, 100 MHz) 27.22, 27.23, 28.56, 39.11, 44.00, 55.01, 60.20, 75.08,
113.21, 114.37, 120.98, 129.89, 140.46, 174.48, 178.11, 179.01;
IR (thin film) vmax 3410, 2935, 1727, 1595, 1483, 1466, 1436, 1282, 1257, 1155, 1111,
702 cm’;
(1R, 2S)-2,2-Dimetliylpropionic acid 1-[2-(2,2-dimetliylpropionyloxy)ethylJ-3-oxo-
indan-2-yl ester (85):
OPiv
HO2C I. fCOCI)2 OPiv
2.AIccH2cI2
To a solution of acid 83 (0.040 g, 0.11 mmol) at O °C was added oxalyl chloride (0.14 g,
0.095 mL, 1.06 mmol). DMF (20 iL) was added dropwise to the reaction (the gas was
evolved). The mixture was stirred for 30 min and the solvent was then removed in vacuo.
The residue was dissolved in anhydrous CH2C12 (15 mL) and cooled to O °C before A1C13
(0.14 g, 1.06 mmol) was added in one potion. The mixture was then stirred at room
temperature for 40 min before being quenched with HCI (1 M, 10 mL) solution at O °C.
The product was extracted with ethyl acetate (20 mL x 3). The combined extracts were
washed with NaHCO3 solution, water, dried over Na2SO4, fiÏtered and concentrated in
vacuo. Column chromatography of the residue (silica gel, EIH=1 :5) afforded product 85
(0.03 1 g, 82%);
[Œ]-3.65 ° (c 0.57, CHC13);
‘H NMR (CDCI3, 400 MHz) 1.19 (s, 9H), 1.27 (s, 9H), 1.99-2.09 (m, 1H), 2.48-2.56
(m, 1H), 3.45-3.50 (m, 1H), 4.12-4.20 (m, 1H), 4.30-4.38 (m, 1H), 5.17 (d, J=4.92 Hz,
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the residue by column chromatography (silica gel, E/H=1:5) afforded product $6 (0.072
g, 84%);
[Œ]D—29.59 ° (c 1.5$, CHC13);
‘H NMR (CDC13, 300 MHz) 1.17 (s, 9H), 1.24 (s, 9H), 1.90-2.04 (m, 1H), 2.39-2.52
(m, 1H), 3.32-3.42 (m, 1H), 3.88 (s, 3H), 4.10-4.19 (m, 1H), 4.30-4.37 (m, 1H), 5.16 (d,
J=4.6$ Hz, 1H), 6.89-6.96 (m, 2H), 7.6$ (d, J=8.46 Hz, 1H);
13C NMR (CDC13, 100 MHz) 24.5 1, 24.60, 29.35, 36.1$, 38.80, 53.25, 59.43, 77.07,
106.19, 113.34, 123.64, 124.87, 152.98, 163.60, 175.23, 175.81, 194.70;
IR(thinfilm)vmax 2971, 1723, 1600, 1480, 1432, 1281, 1147, 1037cm’;
HRMS; C22H3106 (M+1), calcd: 391.21207, found: 391.213 16.
tiR, 2R)-i-(2-Hydroxyethyl)-ïndan-2-ol ($7):
OPiv
OPiv
___
OH
1. H2, Pd/C, AcOH
2. DibaI-H, ToIueie
A mixture of ketone 85 (0.020 g, 0.056 mmol) in acetic acid (1.50 mL) and Pd/C catalyst
(10%, 10 mg) was stirred under hydrogen at atmospheric pressure for 2 h. The reaction
mixture was filtered through a Celite pad to remove the catalyst and the pad was washed
wïth ethyl acetate (20 mL). The combined filtrates were concentrated in vacuo. Column
chromatography of the residue (silica gel, E/H=1 :2) afforded the product (0.016 g, 85%);
° (c 1.19, CHCI3);
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‘H NMR (CDCI3, 400 MHz) 1.17 (s, 9H), 1.21 (s, 9H), 1.88-1.98 (m, 1H), 2.04-2.13
(m, 1H), 2.83 (dd, J=4.20, 16.84 Hz, 1H), 3.30-3.36 (m, 1H), 3.44 (dd, J=6.$4, 16.84 Hz,
1H), 4.12-4.28 (m, 2H), 5.20-5.26 (m, 1H), 7.21 (s, 4H);
‘3C NMR (CDCÏ3, 100 MHz) 24.48, 24.64, 29.55, 35.57, 36.01, 36.17, 44.95, 59.59,
77.38, 121.44, 122.23, 124.34, 124.69, 137.37, 140.53, 175.85, 175.90;
IR (thin film) vmax 2971, 1728, 1480, 1459, 1283, 1153 cm’;
HRMS: C21H3104 (M+1), caic.: 347.22223, found: 347.22290.
To a solution of the above product (0.017 g, 0.049 mmol) in toluene (5 mL) at —78 °C
was added Dibal-H (0.50 M, 0.39 mL, 0.20 mmoÏ). The reaction mixture was stirred at —
78 °c for 1.5 h before being quenched with NH4C1 solution. The resulting mixture was
warmed to room temperature and extracted with diethyl ether (20 mL x 2). The combined
extracts were dried over Na2S04, filtered and concentrated in vacuo. The residue was
purified by column chromatography (silica gel, EIH=1:2) to afford product 87 (0.009 g,
93%);
[Œ]u—19.25 ° (c 0.8 1, cHcl3);
‘H NMR (D13, 400 MHz) 1.70-1.81 (m, 1H), 2.26-2.37 (m, 1H), 2.91 (dd, J=8.32,
15.24 Hz, 1H), 3.03-3.09 (m, 1H), 3.22 (dd, J=7.28, 15.32 Hz, 1H), 3.40-3.50 (broad,
2H), 3.87 (dt, J=3.08, 10.2 Hz, 1H), 4.04-4.09 (m, 1H), 4.31 (dd, J=7.44, 15.92 Hz, 1H),
7.12-7.26 (m, 4H);
‘3c NMR (CDC13, 100 MHz) 32.54, 37.24, 49.31, 59.95, 77.59, 120.67, 122.09,
124.16, 124.46, 137.62, 141.11;
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IR (thin film) vax 3337, 2934, 1610, 1586, 1490, 1432, 1328, 1284, 1175, 1151, 1069,
1036 cm’;
HRMS: C11H1502 (M÷l), caic.: 179.10721, found: 179.10810.
(1R, 2R)-1 -(2-Hydroxyethyl)-6-methoxyindan-2-ol ($8):
OPiv OH
)Piv
1 H2, Pd/C, AcOH
2. Dibat-H, Toluene
76%
A mixture of ketone $6 (0.05 g, 0.13 mmol) in acetic acid (5 mL) and PdJC catalyst
(10%, 20 mg) was stirred under hydrogen at atmospheric pressure for 2 h. The reaction
mixture was then filtered through a Celite pad which was then washed with ethyl acetate
(20 mL). The combined filtrates were concentrated in vacuo. Purification of the residue
by column chromatography (silica gel, E/H=1:2) afforded the indane (0.039 g, 81%);
[ŒJD—l3.9O ° (c 1.28, CHC13);
‘H NMR (CDC13, 300 MHz) 1.16 (s, 9H), 1.21 (s, 9H), 1.83-1.92 (m, 1H), 2.01-2.11
(m, 1H), 2.75 (dd, 1=4.08, 16.5 Hz, 1H), 3.22-3.32 (m, 1H), 3.36 (dd, 1=6.75, 16.5 Hz,
1H), 3.78 (s, 3H), 4.12-4.29 (m, 2H), 5.19-5.25 (m, 1H), 6.72-6.78 (m, 2H), 7.08-7.13
(m, 1H);
‘3c NMR (CDCI3, 100 MHz) 26.96, 27.12, 31.98, 37.24, 38.46, 38.63, 47.65, 55.28,
62.03, 80.23, 109.52, 112.95, 125.25, 131.66, 144.45, 159.05, 178.20, 178.26;
IR (thin film) vax 2970, 1728, 1611, 1596, 1480, 1462, 1433, 1480, 1462, 1397, 1366,
1284, 1157, 1034cm’;
86 88
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HRMS: C22H3106 (M+1), calculated: 391.21207, found: 391.21316.
b a solution of the above indane (0.070 g, 0.19 mmol) in toluene (10 mL) at —78 °C was
added Dibal-H (1.50 M, 0.37 mL, 0.56 mmol). The reaction mixture was stirred at—78 °C
for 1.5 h before being quenched with saturated NH4C1 solution (10 mL). The resulting
mixture was warmed to room temperature and extracted with ether (15 mL x 3). The
combined extracts were dried over Na2SO4 and concentrated in vacuo. The residue was
subjected to column chromatography (E/H=1:2) to afford product 8$ (0.033 g, 86%) as a
solid which was recrystallized from a mixture of hexane and CH2C12;
mp: 97 °C;
[a]—3O.8O ° (c 1.18, CHC13);
‘II NMR (CDC13, 400 MHz) 1.66-1.76 (m, 1H), 2.2 1-2.28 (rn. 1H), 2.82 (dd, J=8.44,
14.92 Hz, 1H), 2.99-3.04 (m, 1H), 3.15 (dd, J=7.2$, 14.95 Hz, 1H), 3.70 (broad, 2H),
3.79 (s, 3H), 3.85 (dt, J=3.12, 10.68 Hz, 1H), 6.68 (s, 1H), 6.17-6.74 (in, 1H), 7.09 (d,
J=8.l6Hz, 1H);
‘3c NMR (CDC13, 100 MHz) 32.50, 36.41, 49.42, 52.87, 59.78, 77.74, 106.8 1, 109.79,
122.68, 129.46, 142.57, 156.42;
IR (thin film) vmax 3340, 2934, 1611, 1587, 1491, 1431, 1284, 1175, 1151, 1069, 1036
cm1;
HRMS: C12H1703 (M+1), calculated: 209.10956, found: 209.10911.
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2,2-Dfmethylpropionic acid (3R, 4S)-4-benzyloxymethoxy-5-(tert-
butyldiphenylsilany])-3-phenylpentyl ester (89):
080M 080M
PivC, Pyr. TBDPS0.J%_..,0Piv
CH2CI2, 92%
ri
77 89
To a stirred solution of alcohol 77 (3.00 g, 5.35 mmol) in dry CH2CI2 (40 mL) at O °C
was added 2,6-lutidine (2.50 mL, 2.33 g, 16.2 mmol) and pivaloyl chloride (1.33 mL,
1.30 g, 10.8 1 mmol). The reaction mixture was stirred at room temperature for 16 h. The
reaction was quenched with saturated NH4C1 solution (50 mL) and extracted with ether
(50 mL x 3). The combined extracts were washed with brine, dried over Na7SO4 and
concentrated in vacua. The residue was purified by coÏumn chromatography (silica gel,
E/H=1:30) to afford 89(3.22 g, 92%) as acolorless oil;
[Œ]D -39.73 ° (c 2.23, CHC13)
‘H NMR (CDCI3, 400 MHz) 1.07 (s, 9H), 1.19 (s, 9H), 1.90-2.10 (m, 1H), 2.39-2.50
(m, 1H), 3.19-3.26 (m 1H), 3.52 (dd, J=4.44, 11.12 Hz, 1H), 3.63 (dd, J=4.00, 11.16 Hz,
1H), 3.78-3.83 (m, 1H), 3.84-3.89 (m, 1H), 3.99-4.05 (m, 1H), 4.49 (d, J=11.80 Hz, 1H),
4.62 (d, J=11.84 Hz, 1H), 4.72 (d, J=7.04 Hz, 1H), 4.84 (d, J=7.04 Hz, 1H), 7.20-7.47
(m, 8H), 7.50-7.52 (m, 1H), 7.62-7.67 (m, 1H);
‘3C NMR (CDC13, 100 MHz) 19.09, 26.73, 27.11, 29.97, 38.58, 43.42, 62.76, 63.46,
69.81, 81.51, 94.29, 126.65, 127.52, 127.54, 127.67, 128.30, 128.36, 128.44, 129.48,
129.55, 133.11, 133.19, 135.39, 135.52, 137.71, 141.16, 178.36;
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IR (thin film) vmax 3069, 2968, 2932, 2868, 1727, 1495, 1479, 1454, 1428, 1284, 1156,
11134, 1026, 823, 740, 701, 611 cm’;
m/e: 655.5 (M+1), 651.3, 603.5, 577.5, 551.5, 501.3, 453.2, 339.1, 263.1, 197.0, 135.0,
117.0.;
2, 2-Dimethylpropionic acid (3R, 4S)-4-benzyloxymethoxy-5-hydroxy-3-
phenylpentyl ester (90):
OBOM OBOM
TBDPSO).—_.,OPiv TBAF
THF, 86% -
ç)
89 90
To a solution of 89 (3.00 g, 4.62 mmol) in THF (40 mL) was added TBAF solution (1:1
complexed with AcOH, 0.94 M, 24.59 mL, 23.11 mmol). The resulting mixture was
stirred for 6 h at ambient temperature and then diluted with hexane-ethyl acetate (1:1, 200
mL). The organic layer was separated, washed with saturated NaHCO3 solution (50 mL x
2), brine (50 mL x 2), dried over anhydrous Na2SO4 and concentrated in vacuo.
Purification of the crude product by column chromatography (E/H=1 :6) provided alcohol
90 (1.59 g, 86%) as a clear, colorless ou;
(e 0.55, CHC13);
‘H NMR (CDC13, 300 MHz) 1.17 (s, 9H), 1.88-1.99 (m, 1H), 2.3 1-2.43 (m, 1H), 2.89-
2.97 (m, 1H), 3.36 (dd, J=6.1$, 12.0 Hz, 1H), 3.49 (dcl, J=2.07, 12.00 Hz, 1H), 3.69-3.82
(m, 2H), 3.92-4.00 (m, 1H), 4.65 (d, J=11.73 Hz, 1H), 4.77 (d, J=7.05 Hz, 1H), 4.7$ (d,
J=11.73 Hz, 1H), 4.99 (cl, J=7.05 Hz, 1H), 7.12-7.43 (m, 10H);
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‘3C NMR (CDC13, 100 MHz) 27.08, 30.66, 38.56, 44.50, 62.57, 63.61, 70.24, 85.92,
95.56, 126.96, 127.83, 127.92, 128.08, 128.40, 128.4$, 128.70, 136.99, 140.57, 178.32;
IR (thin film) vmax 3468, 2960, 1726, 1480, 1455, 1285, 1162, 1037, 701 cm’.
mIe: 401.1 (M+1), 369.2, 293.1, 191.0, 154.0, 137.0, 91.0.
(4R, 5R)-4-Benzyloxymethoxy-7-(2,2-dimetbylpropionyloxy)-5-phenylhept-2-enoic
acid methyl ester (91):
030M 030M
1. Swern MeO2CN0
2. Wittig
84%
90 gi
To a solution of oxalyl chloride (1.27 g, 0.87 mL, 9.9$ mmol) in CH2C12 (30 mL) at —7$
°C was added DMSO (1.06 mL, 1.17 g, 14.97 mmol). The mixture was stirred for 15 min
before alcohol 90 (2.00 g, 4.99 mmol) in CH2C12 (10 mL) was slowly added. The mixture
was stirred and slowly warmed to —30 oc in about 30 min before triethylamine (2.78 mL,
2.02 g, 19.96 mmol) was added. The white precipitate was formed and the mixture was
stirred at this temperature for 15 min before being quenched by saturated NH4cÏ solution
(30 mL). The organic layer was separated, dried and concentrated in vacito. The crude
aldehyde was dissolved in dry CH2cl2 (30 mL) and Ph3P=cHCO2CH3 (3.34 g, 9.9$
mmol) was added. The mixture was stirred at r.t. for 12 h ami then the solvent was
removed in vacuo. The residue was purified by column chromatography (EIH=1: 10) to
give 91 (1.90 g, 84%) as a colorless ou;
[ŒJD-65.42 ° (c 2.3, CHC13);
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‘H NMR (CDCI3, 400 MHz) 1.17 (s, 9H), 1.96-2.07 (m, 1H), 2,29-2.39 (m, 1H), 2.90-
2.9$ (m, 1H), 3.69 (s, 3H), 3.77-3.83 (m, 1H), 4.00-4.06 (m, 1H), 4.41 (dt, J=1.10, 6.72
Hz, 1H), 4.47 (d, J=11.68 Hz, 1H), 4.69 (d, J=7.12 Hz, 1H), 4.72 (d, J=7.12 Hz, 1H),
5.86 (dd, J=1.10, 15.80 Hz, 1H), 6.73 (dd, J6.60, 15.80 Hz, 1H), 7.17-7.39 (m, 10H);
‘3c NMR (CDCI3, 100 MHz) 27.05, 29.48, 38.56, 47.29, 51.51, 62.33, 69.91, 79.07,
92.79, 122.71, 127.11, 127.69, 127.78, 128.32, 128.46, 128.51, 137.35, 139.53, 146.19,
166.11, 178.24;
IR (thin film) vmax 3030, 2957, 2898, 1727, 1496, 1480, 1454, 1436, 1283, 1164, 1277,
1165, 1101, 1026, 700 cm’.
HRMS; C27H3506 (M+1), calcd: 455.24338, found: 455.24240.
3-[(1R, 2R)-1-Benzyloxymethoxy-4-(2,2-dimethylpropionyloxy)-2-phenylbutyl] -pent
4-enoic acid methyl ester (92):
080M 080M
fCH=CH)CuMgCI MeO2C.0
TMSCTHF E
r)
91 92
To a slurry of Cul (1.90 g, 10.00 mmol) in THF (50 mL) at —78 oc was added vinyl
magnesium bromide solution (1.00 M in THF, 20.00 mL, 20.00 mmol). The resulting
mixture was stirred at —78 °C for 1 h before TMSC1 (3.79 mL, 3.26 g, 15 mmol) and ester
91 (1.10 g, 2.42 mmol) in TUF (15 mL) were added. The reaction mixture was stined at
—78 °C for 6 h before being quenched with NFLOH-NH4C1 solution (1:1, 30 mL). The
resulting mixture was warmed to room temperature and extracted with hexane (100 mL x
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3). The combined extracts were washed with a dilute NH4OH solution, brine, dried over
Na2SO4 and concentrated in vacuo. Purification of the residue by column
chromatography (E/H=1: 14) afforded 92 (0.99 g, 85%) as a colorless oïl;
(c 1.78, CHCÏ3);
‘H Ms’ffl (CDCI3, 400 MHz) 6 1.16 (s, 9H), 1.98-2.90 (m, 1H), 2.29 (dd, J=10.00, 15.44
Hz, 1H), 2.31-2.38 (m, 1H), 2.55 (dd, J=4.04, 15.40 1H), 2.72-2.80 (m, 1H), 2.92-3.00
(m, 1H), 3.59 (s, 3H), 3.68 -3.77 (m, 2H), 3.95-4.04 (m, 1H), 4.45 (d, J=7.0 Hz, 1H),
5.04 (dd, J=1.32, 17.24, 1H), 5.09 (dd, J=1.32, 10.40 Hz, 1H), 5.77-5.87 (m, 1H), 7.17 -
7.38 (m, 10H);
‘3C NMR (CDCI3, 100 MHz) 6 27.06, 28.66, 34.82, 38.55, 43.13, 44.85, 51.31, 62.52,
70.32, 85.85, 96.39, 116.67, 126.89, 127.62, 128.22, 128.32, 128.65, 137.51, 138.14,
140.97, 172.91, 178.26;
IR (thin film) vmax 3030, 2958, 2900, 1727, 1660, 1496, 1480, 1454, 1365, 1283, 1163,
1037, 737, 700 cm’;
mIe: 512.2,495.2,451.2,421.2,375.1,273.1,243.1,211.1, 169.1, 117.
2,2-Dimethylpropionïc acid (3R)-3-[(2R, 3S)-5-oxo-3-vinyltetrahydrofuran-2y1j -3-
phenylpropyl ester (93):
MeO2C CH2C,79%
92 93
200
To a solution of ester 92 (2.00 g, 4.13 mmol) in CH2CI2 (40 mL) at —30 °C was added
TMSBr (2.18 mL, 2.53 g, 16.52 mmol). The reaction mixture was stirred at —30 oc for
2.5 h before being quenched with saturated NaHCO3 solution (15 mL). The resulting
mixture was extracted with hexane (25 mL x 2). The combined extracts were washed
with brine, dried over Na2SO4 and concentrated in vacuo. The residue was purified by
column chromatography (E/H=1:10) to give 93 (1.08 g, 79%) as a colorless ou;
[Œ1D -49.34 ° (c 0.89, cDcl3);
‘H NMR (cDcl3, 400 MHz) 1.15 (s, 9H), 1.97-2.08 (m, 1H), 2.28-2.37 (m, 1H), 2.38
(dd, J=9.16, 17.76 Hz, 1H), 2.59 (dd, J=8.80, 17.76 Hz, 1H), 2,82-2.97 (m, 2H), 3.77-
3.84 (m, 1H), 3.97-4.05 (m, 1H), 4.34 (t, J=7.00 Hz, 1H), 4.78 (dd, 1=0.88, 17.00 Hz,
1H), 4.83 (dd, J=0.76, 10.24 Hz, 1H), 5.32-5.43 (m, 1H), 7.15-7.35 (m, 5 H);
‘3c NMR (CDCI3, 100 MHz) 27.06, 30.27, 34.08, 38.57, 43.46, 46.57, 61.86, 87.46,
116.79, 127.55, 128.41, 128.77, 135.84, 138.67, 175.26, 178.18;
IR(thinfilm)vmax 2957, 1728, 1480, 1454, 1365, 1285, 1159, 1026cm’;
HRMS; C20H2704 (M+1), calcd: 331.19095, found: 331.19000.
2-[3-(2,2-Dïmethylpropionyloxy)-1-phenylpropylJ-5-oxo-tetrahydrofuran-3-
carboxylic acid (94):
OPiv RuCI3 n H20 0Piv
‘
NalO,, 86% HODa
93 94
201
To a solution of ester 93 (0.40 g, 0.83 mmol) in a mixture of CC14 (10 mL), CH3CN (5
mL) and H20 (2 mL) at room temperature was added Na104 (1.50 g, excess) and then
RuCI3nH2O (8.0 mg, 0.038 mmol). The reaction mixture was stirred for 1.5 h at room
temperature before being diluted with NH4CI solution. The mixture was extracted with
ethyl acetate (30 mL x 2). The combined extracts were washed with brine, dried over
Na2SO4 and concentrated in vacuo. The residue was purified by column chromatography
(EIH=1:1) to give 94(0.25 g, 86%);
[a]0 34•790 (c 1.9, CHCI3);
‘H NMR (CDCI3, 400 MHz) 6 1.14 (s, 9H), 2.00-2.12 (m, 1H), 2.29-2.39 (m, 1H), 2.55
(dd, J9.$4, 17.95 Hz, 1H), 2.76 (dd, J=7.2, 17.95 Hz, 1H), 2.92-3.04 (m, 2H), 3.80-3.87
(m, 1H), 3.99-4.07 (m, 1H), 4.87 (dd, J=5.92, 7.8 Hz, 1H), 7.19-7.40 (m, 5H), 9.20-9.50
(broad, 1H) ppm;
‘3C NMR (CDCI3, 400 MHz) 626.99,30.33,31.72,38.59,43.34,47.30,61.78, 84.37,
127.94, 128.48, 128.95, 137.01, 174.05, 176.05, 178.46ppm;
IR(thinfilm)vmax3600,2963, 1728, 1480, 1454, 1365, 1285, 1159, 1026cm’;
HRMS; C19H2506 (M+1), calcd: 349.165 10, found: 349.16600.
2.2-Dimethylpropionic acid 2-(2, 4-dioxo-2, 3, 3a, 4, 9, 9a -hexahydronaphtho [2, 3-
bJ-furan-9-yl)ethyl ester (96):
OPiv I. (COCI)2
2. AICI3, CH2C
94 96
202
To a solution of acid 94 (0.12 g, 0.34 mmol) in CH2C12 (6 mL) at O °C was added oxalyl
chloride (0.2$ g, 0.19 mL, 2.12 mmol). DMF (30 jiL) was added dropwise to the reaction
(the gas was evolved). The reaction mixture was stined for 30 min and then the solvent
was removed in vactto. The residue was dissolved in anhydrous CH2C12 (8 mL) and the
resulting solution was cooled to O °C before A1CI3 (0.23 g, 1.72 mmol) was added in one
potion. The reaction mixture was then stirred at room temperature for 40 min before
being slowly quenched with HC1 (1 M, 10 mL) solution at O °C. The product was
extracted with ethyl acetate (10 mL x 3). The combined organic layers were washed with
dilute NaHCO3 solution, water, dried over Na2SO4 and concentrated in vacito.
Purification of the residue by column chromatography (silica gel, E/H=Ï :5) afforded 96
(0.093 g, 82%);
ta]0 —75.02 ° (c 0.85, CHCI3);
‘U NMR (CDC13, 400 MHz) 1.25 (s, 9H), 1.68-1.80 (m, 1H), 2.04-2.16 (m, 1H), 3.03
(dd, 1=2.20, 24 Hz, 1H), 3.06 (dd, J=13.16, 24.12 Hz, 1H), 3.47-3.51(m, 1H), 3.55-3.61
(m, 1H), 3.97 -4.06 (m, 1H), 4.11-4.21 (m, 1H), 5.07 (dd, J=3.64, 7.04 Hz, 1H), 7.27 (dd,
J=1.60, 10.2$ Hz, 1H), 7.43 (ddd, 1=1.60, 10.2$, 10.2$ Hz, 1H), 7.62 (ddd, J=Ï .92, 9.96,
10.7$ Hz, 1H), 7.96 (dd, 1=1.92, 9.96 Hz, 1H);
‘3c NMR (CDC13, 100 MHz) 27.08, 33.56, 34.76, 37.66, 38.67, 43.45, 60.77, 80.50,
127.97, 128.10, 129.71, 130.30, 134.94, 141.91, 174.11, 178.14, 195.57;
IR (thin film) vmax 2972, 1785, 1727, 1683, 1601, 1480, 1457, 1420, 1398, 1344, 1283,
1210, 1152, 1034, 9$8, 937, 770.cm’;
HRM$; C19H2305 (M+1), calcd: 331.15454, found: 331.15360.
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2.2-Dimethylpropïonic acid 2-(-oxo-2, 3, 3a, 4, 9, 9a -hexahydronaphtho [2, 3b]-
furan-9-y])-ethyl ester (9$):
2iv H2, Pd/C
AcOH, 82%
A mixture of ketone 96 (0.050 g, 0.15 mmol) in acetic acid (3 mL) and PdJC (10%, 30
mg) was stirred under hydrogen at atmospheric pressure for 2 h. The reaction mixture
was filtered through a Celite pad which was then washed with ethyl acetate (20 mL). The
combined filtrates were concentrated in vacuo. Purification of the residue by column
chromatography (E/H=1:2) afforded 9$ (0.039 g, 82%);
(c 1.34, CHC13);
‘II NMR (CDC13, 300 MHz) 6 1.21 (s, 9H), 1.9$ -2.06 (m, 1H), 2.09-2.18 (m, 1H), 2.26
(dd, J=4.84, 18.40 Hz, 1H), 2.61 (dd, J=7.72, 17.12 Hz, 1H), 2.82 (dd, J= 0.16, 18.4 Hz,
1H), 2.92-3.19 (m, 3H), 4.00-4.09 (m, 1H), 4.18-4.27 (m, 1H), 4.75 (dd, J=4.44, 8.29 Hz,
1H), 7.15-7.26 (m, 4H);
‘3C NMR (CDCI3, 100 MHz) 6 24.65, 27.13, 30.14, 30.16, 32.21, 36.20, 38.54, 59.51,
80.75, 124.78, 124.83, 125.56, 125.98, 132.82, 135.53, 173.76, 175.92;
IR (thin film) vmax 2973, 2873, 1775, 1725, 1483, 1461, 1341, 1368, 1287, 1160, 1012,
941, 756 cm’;
HRMS; C19H2504 (M+1), calcd: 3 17.17529, found: 3 17.17300.
96 98
204
9-(2-Uydroxyethyl)-3a, 4, 9, 9a-tetrahydro-3H-naphtho [2, 3-b]furan-2-one (99):
1. NaOMe, CR3OH
2. TsOH, THF, 80%
To a solution of lactone 98 (0.03 g, 0.095 mmol) in MeOH (3 mL) was added sodium
methoxide solution (1 M, 0.10 mL, 0.10 mmol). The reaction mixture was stined at room
temperature for 18 h before being quenched with TsOH (neutralized to PH=7). The
solvent was removed in vacuo and the residue was dissolved in THF (5 mL). TsOHH7Q
(0.040 g, 0.21 mmol) was added and the mixture was stirred at room temperature for 1 h
before being quenched with saturated NaHCO3 solution (8 mL). The resulting mixture
was extracted with ethyl acetate (20 mL x 2), and the combined extracts were washed
with brine, dried over Na2SO4, and concentrated in vacuo. The residue was purified by
column chromatography (silica gel, EIH=1:2) to give 99 (0.01$ g, 80%) as a solid which
was recrystallized from a mixture of hexane and CH2CI2;
mp: 104-105 °C;
[Œ]D—3 1.87 O (c 0.64, CHC13)
‘H NMR (CDC13, 400 MHz) 1.60-1.74 (Broad, 2H), 1.99-2.22 (m, 2H), 2.29 (dd,
Jt4.00, 17.72 Hz, 1H), 2.61 (dd, J=5.80, 14.08 Hz, 1H), 2.84 (dd, J=10.14, 17.84, 1H),
2.88-3.20 (m, 3H), 3.08-3.14 (m, 1H), 3.74-3.84 (m, 2H), 4.75 (dd, J=4.96, 8.12 Hz, 1H),
7.13-7.28 (m, 4H);
l3 NMR (CDC13, 100 MHz) 30.4 1, 30.61, 30.95, 32.22, 38.06, 57.99, 8 1.29, 124.56,
124.68, 124.99, 125.68, 133.36, 134.18, 173.93;
98 99
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W (thin film) vmax 3457, 2993, 2883, 1726, 1448, 1412, 1367, 1314, 1223, 1052, 997,
975 cmi;
HRMS; C14H1703 (M+1), calcd: 233.11777, found: 233.11870.
9-(2-Azidoethyl)-3a,4,9,9a-tetrahydro-3H-naplitho[2,3-bJfuran-2-one (100):
N3.
100
To a solution of alcohol 99 (0.050 g, 0.22 mmol) and Ph3P (0.22 g, .0.86 mmol) in TEF
(5 mL) was added DEAD (0.15 mL, 0.86 mmol) and then (PhO)2P0N3 (0.19 mL, 0.86
mmol) at O °C. The resulting mixture was stirred at O °C for 30 min and then at room
temperature for 6 h before being diluted with hexane-ethyl acetate (1:1, 30 mL). The
mixture was washed with a saturated NH4C1 solution (15 mL), dried over Na,S04 and
concentrated in vacuo. The cmde product was purified by column chromatography
(E/H=1:8) to afford 100 (0.045 g, 81%) as a colorless oil;
° (e 0.53, CH3CÏ);
‘H NMR (CDCÏ3, 300 MHz) 6 1.47 (d, J=7.20 Hz, 1H), 1.52 (d, J=7.20 Hz, 1H), 1.74
(dd, J=4.35, 17.79 Hz, 1H), 2.08-2.23 (m, 2H), 2.58 (dd, J=7.29, 12.72 Hz, 1H), 2.85 (t,
J=7.47 Hz, 2H), 3.86 (dd, J=5.22, 7.77 Hz, 1H), 6.83 (dd, 1=5.16, 8.94 Hz, 2H), 7.03-
7.06 (m, 2H);
‘3c NMR (CDC13, 100 MHz) 6 29.91, 32.8 1, 32.89, 34.64, 41.38, 49.35, 83.42, 127.36,
127.43, 127.75, 128.52, 135.64, 135.71, 177.21;
99
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IR (thin film) vmax 2928, 2854, 2093, 1774, 148$, 1458, 1416, 1346, 1259, 1181, 1012,
755 cm’;
2.2-Dimethylpropionic acid 2-(-oxo-2, 3, 3a, 4, 9, 9a -hexahydronaphtho [2, 3b1-
furan-9-yl)ethyl ester (101):
OPiv H2, Pd/C OPiv
AcOH ::
ioi
A mixture of the crude Friedel-Crafts product (95 and 96) (0.040 g, 0.13 mmoÏ) in acetic
acid (2 mL) and PdJC (10%, 0.025 g) was stirred under hydrogen at atmospheric pressure
for 2 h. The reaction mixture was filtered through a Celite pad which was then washed
with ethyl acetate (20 mL). The combined filtrates were concentrated in vacuo.
Purification of the residue by column chromatography (silica gel, E/H=1 :2) afforded cis
product 101 (0.025 g, 65%) and its trans isomer 98 (0.006 g, 14%);
[ŒJD+47.47 ° (c 1.2$, CHC13);
1H NMR (CDCI3, 400 MHz) 1.16 (s, 9H), 2.20-2.28 (m, 1H), 2.38-2.50 (m, 33H), 2.73
(dd, J=12.8, 22.5 Hz, 1H), 2.78-2.88 (m, 1H), 3.08-3.13 (dcl, J=3.80, 15.92 Hz, 1H),
3.22-3.30 (m, 1H), 4.10-4.18 (m, 2H), 4.26-4.32 (m, 1H), 7.12 (cl, J=7.40 Hz, 1H), 7.19
(t, J=6.58, 1H), 7.25 (t, J=6.68 Hz, 1H), 7.38 (d, J=7.84 Hz, 1H);
‘3C NMR (CDCI3, 100 MHz) 24.58, 28.63, 3 1.33, 33.04, 36.10, 37.57, 38.44, 59.28,
83.12, 124.23, 124.5 1, 125.32, 127.68, 132.48, 133.44, 173.42, 175.89;
IR (thin film) vmax 2971, 2873, 1776, 1726, 1481, 1459, 1416, 1399, 1366, 1285, 1159,
1011, 940, 755 cm’;
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HRMS; C19H2504 (M+1), calcd: 3 17.17529, found: 317.17300.
9-(2-llydroxyethyl)-3a, 4, 9, 9a-tetrahydro-311-naphtho [2, 3-b]furan-2-one (102):
1. CH3ONa, CHOH
2. TsOH, THF NN
74% for two steps
101 102
To a solution of lactone 101 (0.020 g, 0.063 mmol) in MeOH (5 mL) was added sodium
methoxide solution (1 M in methanol, 30 tL, 0.030 mmol). The reaction mixture was
stirred at room temperature for 18 h before being quenched with p-TsOH (neutralized to
pH=7). The solvent was removed in vacuo and the residue was dissolved in THF (5 mL).
p-TsOHH20 (0.030 g, 0.15$ mmol) was added and the mixture was stined at room
temperature for 1 h before being quenched with saturated NaHCO3 solution. The
resulting mixture was extracted with ethyl acetate (20 mL x 2), and the combined extracts
were washed with brine, dried over Na2SO4, and concentrated in vacuo. The residue was
purified by column chromatography (silica gel, E/H=Ï:2) to give alcohol 102 (0.011 g,
74%);
(c 0.76, CHCI3);
1 NMR (CDC13, 400 MHz) 1.58-2.72 (broad, 2H), 1.82-1.98 (m, 1H), 2.40-2.58 (m,
3H), 2.74 (dd, J=12.80, 22.44 Hz, 1H), 2.84 (dU, J=10.76, 14.84 Hz, 1H), 3.10 (dd,
J=3.76, 15.88 Hz, 1H), 3.2$ (t, J=9.l6Hz, 1H), 3.85-3.95 (m, 2H), 4.15 (t, J=Ï0.52 Hz,
1H), 7.13 (d, J=7.38 Hz, 1H), 7.19 (t, .1=7.10 Hz, 1H), 7.25 (t, J=7.28 Hz, 1H), 7.40 (d,
J=7.88 Hz, 1H);
20$
‘3c NMR (CDC13, 100 MHz) 3 1.27, 32.24, 34.00, 37.62, 38.3 1, 57.87, 84.56, 124.07,
124.45, 125.48, 126.98, 132.35, 134.27, 173.56;
W (thin film) vmax 3458, 2995, 2880, 1724, 1448, 1411, 1368, 1313, 1221, 1053, 998,
977 cm’;
HRMS; C14H1703 (M+1), calcd: 233.11777, found: 233.11870.
(2R)-2-Hydroxy-3-methylbutyric acid methyl ester (103)168:
NH2 OH
1.NaN02,H I
T CO2H 2. CH2N2
53% for two steps
D-valine 103
A three-neck flask, equipped with a thermometer, magnetic stirring bar, and dropping
funnel, was charged with D-valine (12.00 g, 102.00 mmol) and iN sulfuric acid (154
mL). A solution of sodium nitrite (10.50 g, 153.00 mmol) in water (40 mL) was added
dropwise over 2 h while keeping the internai temperature below O °C with ice-sait bath.
The resuiting solution was stirred at room temperature for 20 h. The reaction solution was
adjusted to pH 7 with solid NaHCO3, and then the volume of the solution was reduced to
50-60 mL. The concentrated solution was adjusted to PH 2 with concentrated H3P04, and
then extracted with THF (200 mL x 3). The combined organic layers were washed with
brine, and then dried over Na2SO4. The crude product was recrystaliization from ether
hexane in a refrigerator to afford a-hydroxy acid 103 (6.50 g, 53%);
The Œ-hydroxy acid was esterified in ether by diazomethane generated from the diazald
kit (from Aidrich) to give Œ-hydroxy methyl ester.
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(2R)-2-Benzyloxymethoxy-3-methylbutan-1-oI (104):
OH BOMO
1. 0MCI, base
COMe 2. DaH
103 104
To a solution of 103 (14.7$ g, 112 mmol) in CH2CI, (22 mL) was added
diisopropylethylamine (95.60 mL, 550 mmol) and BOMC1 (65%, 76.00 mL, 550.00
mmol) at O °C. The resulting solution was stirred at room temperature for 52 h. The
reaction mixture was diluted with EtOAc, washed with water, saturated NH4CI, and
brine, then dried over Na2SO4. The crude product was purified by chromatography
(EIH=1:$) to afford the BOM-methyl ester as a syrup (24.00 g, 85%);
TLC: E/H = 1:5, Rf = 0.4$;
[a]0-58.40°(c 1.38, CHC13);.
‘H-NMR (400 MHz, CDC13) 0.99 (d, J = 4.3 Hz, 3H), 1.01 (d, J = 5.6 Hz, 1H), 2.20-
2.10 (m, 1H), 3.70 (s, 3H), 3.98 (d, J= 5.6 Hz, 1H), 4.64 (s, 2H), 4.81 (s, 2H), 7.37-7.26
(m, 5H);
13C..NMR (100 MHz, CDC13) 17.60, 18.68, 31.35, 51.58, 69.89, 80.96, 94.50, 127.62,
127.72, 128.31, 137.50,172.70;
IR (neat) vmax 2960, 1750, 1270, 1170, 1050, 740, 700, cm’;
mIe: 253 (M+Ï), 223, 181, 145, 117;
IIRMS: C14H21O4(M+1),calcd: 253.14403: found: 253.14680.
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To a solution of the above product (12.32 g, 48.00 mmol) in THF (150 mL) at —78 °C
was added DIBAL-H (1.0 M in 111F, 165.00 mL, 165.00 mmol). The resulting solution
was stirred at O °C for 3 h, and then recooled to —78 °C. The reaction was quenched by
adding methanol (25 mL), water (12 mL), EtOAc, Celite and Na2SO4. The mixture was
ffltered and washed with EtOAc. The crude product vas purified by chromatography
(E/H=1:3) to afford alcohol 104 (9.52 g, 87%);
TLC: EIH = 1:4, Rf = 0.40;
(c 1.4, CHC13);
‘H-NMR (400 MHz, CDC13) 0.94 (d, J 5.1 Hz, 3H), 0.96 (d, J= 5.1 Hz, 3H), 1.89-
1.84 (m, 1H), 3.05-3.02 (m, 1H), 3.38-3.34 (m, 1H), 3.67-3.57 (m, 2H), 4.63 (d, J= 11.7
Hz, 1H), 4.75 (d, J 11.7 Hz, 1H), 4.76 (d, J = 6.9 Hz, 1H), 4.94 (d, J = 6.9 Hz, 1H),
7.36-7.26 (m, 5H) ppm;
‘3C-N1\’IR (400 MHz, CDCI3) 18.15, 18.72, 30.09, 63.56, 70.02, 87.62, 95.64, 127.85,
128.45, 137.11 ppm;
IR (thin film) vmax 3440, 2980, 1080, 760, 700 cnï’;
mIe: 225 (M+1), 214, 207, 197, 181, 169, 149:
HRMS: C13H2103 (M+1), calcd: 225.14913: found: 225.14667.
(4R)-4-Benzyloxymethoxy-5-methylhex-2-enoic acid methy] ester (G15):
BOMO BOMO
CO2Me
104 15
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To a solution of oxalyl chloride (3.80 mL, 43.8 mmol) in CH2C12 (200 mL) at —70 oc was
added DMSO (6.20 mL, 87.60 mmol). The resulting mixture was stirred for 15 min
during which time the temperature was allowed to rise to —55 °C, then a solution cf
alcohol 104 (6.5 g, 29 mmcl) in cH2cl2 (40 mL) was added. The reaction mixture was
warmed to —40 °c over 20 min and diisopropylethylamine (20.30 mL, 117.00 mmol) was
added, then temperature was allowed to rise further to —30 oc over 30 min. The reaction
mixture was quenched with saturated NH4c1 solution, diluted with H2Cl2, washed with
2.5% HC1, saturated NaHcO3 and brine, then dried over Na2SO4 for 2 h. After removing
solvent, the residue was dried on an oil pump for 2 h. Te a solution cf the above crude
aldehyde in CH2C12 (100 mL) was added methyl (triphenylphosphoranylidene) acetate
(14.6 g, 44 mmcl, solid). The resulting mixture was stirred for 14 h at room temperature.
The reaction mixture after removing solvent was purified by chromatography (E/H=1:2)
te afford G15 as colorless ou (7.00 g, 86% overail);
TLC: E/H = 1:4, Rf = 0.60;
[Œ]D+l06.00 ° (c 1.1, cHcl3);
‘H-NMR (300 MHz, cDcl3) 6 0.94 (d, J = 6.8 Hz, 3H), 0.99 (d, J = 6.8 Hz, 3H), 1.95-
1.80 (m, 1H), 3.75 (s, 3H), 4.05 (t, J = 6.0 Hz, 1H), 4.55 (d, J = 11.7 Hz, 1H), 4.80-4.65
(m, 3H), 6.00 (dd, J = 1.2, 15.8 Hz, 1H), 6.85 (dd, J = 6.7, 15.8 Hz, 1H), 7.40-7.30 (m,
5H);
13C..NMR (100 MHz, cDcl3) 6 18.27, 32.59, 51.58, 69.79, 80.53, 92.87, 122.6$, 127.74,
127.89, 128.44, 137.72, 146.76, 166.52;
IR (cDcl3) vmax 3020, 1725, 1230 cm’;
212
mIe: 279 (M+1), 237, 213, 181, 141, 109;
HRMS: C16H23O4(M+1), calcd: 279.15969: found: 279.16292.
(3$, 4R)-4-Benzyloxymethoxy-3,5-dimethylhexanoic acid methyl ester (105):
BOMO BOMO
Me2CuLI
CO2Me
TMSCI
- CO2Me
G15 90% e
To a suspension of Cul (9.60 g, 50.3 mmol) in THF (250 mL) was added MeLj•LiBr (1.5
M in ether, 67.00 mL, 101.00 mmol) at —15 °C. The reaction mixture was allowed to
warm up to O °C over 30 mm, then cooled to —7$ °C. To the resulting mixture was added
Me3SiCÏ (25.40 mL, 201.00 mmol), and then a solution of G15 (7.00 g, 25.00 mmol) in
THF (50 mL). Stirring was continued for 3.5 h at —7$ °C, then the mixture was qucnched
with saturated NH4C1, diluted with EtOAc and washed with concentrated NH4QH. The
aqueous layer was extracted with EtOAc, and the combined organic extracts were washed
with saturated NH4C1-NH4OH (1:1), saturated NRC1 and brine, then dried over Na2SO4.
The crude product was purified by chromatography (EIH= 1:16) to afford 105 as a
colorless ou (7.00 g, 90%);
TLC: EIH = 1:5, Rf =0.57;
[Œ]D-17.9O ° (c 1.1, CHC13);
‘H-NMR (400 MHz, CDC13) 0.96 (d, J= 3.4 Hz, 3H), 0.97 (d, J= 3.4 Hz, 3H), 1.00 (d,
J = 6.8 Hz, 3H), 1.90-1.80 (m, 1H), 2.16 (dd, J = 9.6, 15.0 Hz, 1H), 2.30-2.20 (m, 1H),
2.63 (dd, J= 3.6, 15.0 Hz, 1H), 3.11 (t, J= 5.4 Hz, 1H), 3.66 (s, 3H), 4.66 (dd, J= 11.8,
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17.1 Hz, 2H), 4.79 (dd, 1=6.8, 12.3 Hz, 2H), 7.37-7.26 (m, 5H);
13C..NMR (100 MHz, CDC13) 6 17.52, 17.73, 20.03, 30.38, 32.76, 37.06, 51.33, 79.06,
88.83, 96.62, 127.51, 127.64, 128.29, 137.76, 173.98;
IR (CDCI3): vmax 2960, 1760, 1215, 1060 cm’;
m/e: 295 (M+1), 217, 187, 157, 149, 109, 92;
HRMS: C16H3O4 (M+Na), calcd: 295.19101, found: 295.19447.
(2S, 3S, 4R)-4-Benzyloxymethoxy-2-hydroxy-3,5-dimethylhexanoic acid methyl ester
(106):
BOMO BOMO OH* KHMDS E
- CO2Me : CO2Me -
E Davis oxaziridine
Me
105 80% 706
To a solution of 105 (7.00 g, 25.00 mmol) in TifF (220 mL) was added KHMDS (0.50 M
in toluene, 60.00 mL, 30.00 mmol) at —78 °C. The resulting mixture was stirred for 30
min and then a solution of Davis oxaziridine (9.80 g, 38.00 mmol) in THF (30 mL) was
added. Stirring was continued for 3 h at —78 °C, and the mixture was quenched with
saturated NH4CI. The reaction mixture was extracted with EtOAc and the combjned
organic extracts were washed wïth saturated NILC1 and brine, then dried over Na2SO4.
The crude product was purified by chromatography (E/H=1 :6) to give 106 as colorless oïl
(6.50 g, 80%);
TLc: E/H = 1:4, Rf =0.37;
{ŒJD -9.58 ° (c 2.4, cHcl3);
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1H-NMR (400 MHz, CDC13) 60.82 (d, J 6.9 Hz, 3H), 0.92 (d, Jz 6.8 Hz, 3H), 1.01 (d,
J = 6.9 Hz, 3H), 1.90-1.80 (m, 1H), 2.20-2.10 (m, 1H), 3.3$ (dd, J = 3.0, 9.1 Hz, 1H),
4.66 (d, J= 2.1 Hz, 1H), 3.79 (s, 3H), 4.67 (s, 2H), 4.80 (d, J= 6.5 Hz, 1H), 4.88 (cl, J=
6.5 Hz, 1H), 7.37-7.26 (m, 5H);
‘3C-NMR (100 MHz, CDCI3) 6 10.62, 15.42, 20.40, 29.59, 39.04, 52.14, 70.26, 70.64,
85.86, 97.02, 127.60, 128.30, 137.54, 175.26;
IR (neat): vmax 3525, 2970, 1740, 1250, 1150, 1040 cm’;
mIe: 311,279,257,216,203, 131, 108,91,73,57;
HRMS: (M+1),cafcd: 311.18591,found: 311.18957.
(2S, 3R, 4R)-4-Benzyloxymethoxy-2-(tert-butyldimethylsilanyloxy)-3,5-
dimethylliexanoic acid methyl ester (107):
80MO OH 80MO OTBS
CO2Me
26utne YeC02Me
706 107
To a solution of 106 (9.20 g, 30.00 mmol) in CH2CI2 (200 mL) at O °C were added 2,6-
lutidine (10.30 mL, 89.00 mmol) and TBSOTf (10.21 mL, 44.52 mmol). The resulting
solution was stirred for 1 h at O °C. The reaction mixture was diluted with CH2C12,
washed with saturated NH4C1 and brine, then dried over Na2SO4. The crude product was
purified by chromatography (EIH= 1:20) to give the TBS ether as a colorless ou (1 2.40 g,
94%);
TLC:E/H= 1:5,Rf =0.80;
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[Œ]D-l2.48 ° (c 1.5, CHC13);
‘H-NMR (400 MHz, CDC13) 0.00 (s, 3H), 0.01 (s, 3H), 0.85 (d, J=7.0, 3H), 0.92 (s,
9H), 0.93 (d, J6.9, 1H), 1.01 (d, J=6.92, 3H), 1.90 (m, 1H), 2.10 (m, 1H), 3.30 (dd,
J=2.40, 8.79 Hz, 1H), 3.72 (s, 3H), 4.65 (d, J=11.9 Hz, 1H), 4.68 (d, J=11.9 Hz, 1H),
4.78 (d, J=6.72 Hz, 1H), 4.84 (d, J=6.72 Hz, 1H), 7.23 (m, 5H);
‘3C-NMR (100 MHz, CDC13) -4.99, -4.83, 10.84, 15.35, 18.32, 20.52, 25.83, 29.64,
41.24, 5 1.44, 69.87, 72.26, 86.74, 97.04, 127.46, 127.73, 129.22, 137.88, 174.6 1;
IR (neat): vmax 2940, 2850, 2710, 1406, 1250, 1150, 1040, 860, 780 cm’;
mIe: 424, 317, 237, 216, 196, 149, 131, 108, 93;
HRMS: C23H41O5Si (M+1), calcd: 425.27243, found: 425.26974.
(2S, 3R, 4R)-4-Benzyloxymethoxy-2-(tert-butyldimethylsilanyloxy)-3,5-
dimethylhexan-1-ol (108):
BOMO OTBS 80MO OTBS
CO2Me
DaH OH
107 108
To a solution of 107 (12.40 g, 29.00 mmol) in THF (150 mL) at —78 oc was added
DIBAL-H (1.50 M in toluene, 43.00 mL, 64.50 mmol) dropwise over 30 min and the
reaction mixture was stined at O °c for 1 h. The mixture was cooled to —78 °c and
quenched with saturated NH4C1, then diluted with EtOAc. HC1 solution (2%, 100 mL)
was added to dissolve inorganic gel. The aqueous layer was extracted with EtOAc, the
combined organic layers were washed with saturated NaHCO3, saturated NH4C1 and
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brine, then dried over Na2SO4. The crude product was purified by chromatography
(E/H=1:6) to afford 108 as colorless ou (9.0 1 g, 86%);
TLC: E/H = 1:3, Rf = 0.30;
[ŒÏD 16.300 (e 2.5, CHC13);
‘H-NMR (300 MHz, CDCÏ3) 0.06 (s, 3H), 0.08 (s, 3H), 0.95-0.90 (m, 15H), 0.99 (d, J
= 6.8 Hz, 3H), 1.94-1.82 (m, 3H), 2.28 (dd, J= 4.0, 7.1 Hz, 1H), 3.63-3.54 (m, 2H), 3.9$
(dd, J = 4.9, 8.7 Hz, 1H), 4.66 (s, 2H), 4.79 (cl, J = 6.7 Hz, 1H), 4.84 (d, J = 6.7 Hz, 1H),
7.37-7.26 (m, 5H);
‘3C-NMR (00 MHz, CDC13) -4.54, -4.18, 12.09, 16.52, 18.15, 20.74, 25.84, 29.93,
38.70, 65.82, 69.94, 73.11, 87.16, 95.59, 127.49, 127.69, 128.26, 137.86;
IR (neat): vmax 3450, 2950, 2880, 1460, 1380, 1250, 1140, 1090, 1080, 830, 770 cm’;
m/e: 397 (M+1), 289, 237, 216, 196, 149, 131, 108, 93;
HRMS: C72H41O4Si (M+1), calcd: 397.27753, found: 397.27607.
(2R, 3R, 4R, 5S, 6S)-6-Benzyloxymethoxy-2,7-dihydroxy-4-metlioxymethoxy-3,5-
dimethylheptanoic acid methyl ester (109):
OBOM OMOM OH OBOM OMOM OH
TBDPSO....___L.:_L. TBAF-HOAcÎtHF
109
To a solution of the common chiron (3.40 g, 5.40 mmol) in THF (27 mL) was added a
solution of TBAF-AcOH (8.5 1 mL, 0.95 M in THE, 8.00 mmol) at room temperature.
The resulting mixture was stirred for 21 h at room temperature. The reaction mixture was
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diluted with EtOAc and washed with saturated NH4CI, brine, and then dried over
Na2SO4. The crude product was purified by chromatography (EfH=1 :2) to afford diol 109
as a colorless ou (2.00 g, 95%);
TLC:E/H= l:l,Rf =0.45;
[ŒID +1.70 O (c 0.9, CHC13);
‘H-NMR (300 MHz, CDC13) 0.75 (d, J = 6.9 Hz, 3H), 0.89 (d, J = 7.0 Hz, 3H), 1.84-
1.79 (m, 1H), 2.15-2.09 (m, 1H), 3.17 (broad, 2H), 3.35 (s, 3H), 3.58-3.52 (m, 2H), 3.77
(s, 3H), 3.90-3.78 (m, 2H), 4.52 (d, J= 2.1 Hz, 1H), 4.60 (d, J= 11.7 Hz, 1H), 4.67 (d, J
= 6.5 Hz, 1H), 4.73 (d, J= 6.5 Hz, 1H), 4.76 (d, J= 11.7 Hz, 1H), 4.86 (d, J= 7.1 Hz,
1H), 4.95 (d, J 7.1 Hz, 1H), 7.35-7.27 (m, 5H);
‘3C-NMR (100 MHz, CDC13) 9.60, 10.40, 35.97, 39.19, 52.43, 55.87, 63.87, 70.28,
70.60, 80.80, 84.39, 95.97, 99.06, 127.91, 128.46, 128.4$, 128.49, 137.07, 175.74;
IR (neat) vmax 3490, 2980, 2950, 1745, 1460, 1390, 1250, 1220, 1150, 1050 cm’;
mIe: 423 (M+Na), 418, 383, 369, 339, 313, 261, 181, 165, 149, 133 ppm;
HRMS: C20H3208 (M+Na), calcd: 423.19949, found: 423.20130.
(2R, 3R, 4R, 5R, 6S)-2,6,7-Trihydroxy-4-methoxymethoxy-3,5-dimethylheptanoic
acid methyl ester (110):
080M OMOM 0H 0H OMOM 0H
109 110
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A mixture of 109 (2.00 g, 5.21 mmol) and Pd(OH)2/C (0.20 g, 20% Pd, Degussa type) in
MeOH (26 mL) under 1 atm hydrogen was stirred at room temperature for 3 h. The
resulting mixture was filtered through a pad of Celite to remove the catalyst. The crude
triol 110 was directly used for next step without purification. TLC: B/H = 1:0, Rf = 0.25.
6-Hydroxy-4-methoxymethoxy-3,5-dimethyltetrahydro-pyran-2-carboxylic acid
methyl ester (111):
OH
OH OMOM OH Me,, I
I I Na104 “[ O
HO
CO2Me MeOH-H20
MOMO CO,Me
Me Me
Me
110 111
To a solution of crude triol 110 (5.20 mmol) in a mixture of MeOH (34 mL) and H20 (17
mL) was added sodium periodate (1.60 g, 7.80 mmol, as solid) at room temperature. The
resulting mixture was stirred for 2 h, then evaporated to remove MeOH. The reaction
mixture was diluted with EtOAc, washed with saturated NH4CÏ and brine, and dried over
Na2SO4. The crude 111 after drying on ou pump was used for next step directly without
purification. TLC: E/H = 1:0, Rf = 0.80.
(3R, 4R, 5R)-5-[(1S)-1-[1,3]Dithian-2-yl-ethyl)-3-hydroxy-4-methyldihydrofuran-2-
one (112):
OH
Me,, HS(CH2)3SH
j j BF3-Et20
MOMO CO2Me CH2CI2, O C
Me
111
Me
“OH
112
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To a solution of cmde 111 (5.20 mmol) in CH2CI2 (40 mL) at O °C were added 1,3-
propanedithiol (1.56 mL, 15.60 mmol) and boron trifluoride diethyl etherate (1.2$ mL,
10.40 mmol). The resuÏting mixture was stirred for 3.5 h at O °C, diluted with CH2C12,
washed with saturated NaHCO3, saturated NH4CJ, brine, and then dried over Na7SQ4.
The crude product was purified by chromatography (EIH=l:2) to afford 112 as a
colorless oïl (0.88 g, 65% for three steps);
TLC: E/H= 1:1, Rf = 0.40;
{Œ]D -27.50 ° (e 0.4, CHC13);
‘H-NMR (300 MHz, CDC13) 1.14 (d, J = 7.0 Hz, 3H), 1.21 (d, J = 6.5 Hz, 3H), 1.90-
1.80 (m, 1H), 2.09-2.02 (m, 2H), 2.27-2.11 (m, 1H), 2.87-2.83 (m, 4H), 3.50 (broad, 1H),
4.13-4.07 (m, 2H), 4.40 (dd, J= 1.4, 10.0 Hz, 1H);
‘3C-NMR (100 MHz, CDC13) 10.89, 14.21, 25.73, 30.29, 30.35, 39.32, 41.61, 51.39,
8 1.74 176.23;
IR (neat) vmax 3390, 2982, 2947, 1765, 1462, 1393, 1220, 1150, 1050 cm1;
HRMS: C11H19O3S2(M+1), calcd: 263.07758, found: 263.07730.
(2R, 3$, 4R, 5S)-5-[1 ,3]Dithian-2-yl-3-methylhexane-1,2,4-triol (113):
OH OH
THFH2O
96% Me Me
113
Me
112
220
To a solution of 112 (0.24 g, 0.9 mmol) in a mixture of THF (8 mL) and 11,0 (2 mL) was
added sodium borohydride (0.17 g, 4.50 mmol, as solid) at room temperature. The
resulting mixture was stirred for 2 h, then quenched with 2% aqueous HC1 carefully. The
reaction mixture was diluted with EtOAc, washed with saturated NaHCO3, saturated
NH4C1 and brine. The aqueous phase was re-extracted with EtOAc four times. The
combined organic phase was dried over Na2SO4. The crude product was purified by
column chromatography (E/H=2:1) to give alcohol 113 (0.23 g, 95%);
TLC: E/H = 1:0, = 0.40;
[ŒJD -17.2 ° (c 2.5, CHC13);
1U-NMR (300 MHz, CDC13) 0.81 (d, J= 7.0 Hz, 3H), 1.08 (d, J= 6.9 Hz, 3H), 2.14-
1.77 (m, 4H), 2.93-2.81 (m, 4H), 3.60 (dd, J= 3.40, 11.2 Hz, 1H), 3.67 (d, J= 8.4 Hz,
1H), 3.98 (d, J= 9.6 Hz, 2H), 3.73 (s, 3H), 4.14 (d, J= 7.1 Hz, 1H);
‘3C-NMR (100 MHz, CDC13) 10.08, 11.52, 226.02, 30.50, 30.75, 37.68, 39.87, 52.89,
64.85, 73.5 1, 73.62;
IR (neat) vmax 3490, 2990, 2970, 1790, 1470, 1440, 1205, 1140, 990, 940, 750 cm’;
mIe: 262, 217, 181, 126, 109, 91.
(2R, 3S, 4R, 5S)-1 -(tert-Butyldiphenylsilanyloxy)-5-[1 ,3]dithian-2-yI-3-
methylhexane-2,4-diol (114):
S S OH OH TBDPSCI imidazole S s OH OH
113 114
221
b a solution of alcohol 113 (0.23 g, 0.85 mmol) and imidazole (0.24 g, 3.59 mmol) in
THE (7 mL) was added TBDPSC1 (0.25 mL, 0.94 mmol) at room temperature. The
resulting mixture was stirred for 2 h, and then diluted with EtOAc, washed with
saturated. NH4CI and brine. The aqueous phase was re-extracted with EtOAc. The
combined organic phase was dried over Na2SO4. The crude product was purified by
chromatography (E/H=1:3) to afford dithiane-diol 114 as an ou (0.34 g, 88%);
TLC: E[H = 1:3, Rf = 0.30;
{Œ]D -4.0 O (c 4.8, CHC13);
1H-NMR (300 MHz, CDCI3) 0.81 (d, J= 7.1 Hz, 3H), 1.09 (s, 9H), 1.14 (d, 1=6.9Hz,
3H), 2.12-1.79 (m, 4H), 2.92-2.83 (broad, 6H), 3.67 (dd, 1=5.00, 10.1 Hz, 1H), 3.74 (dcl,
J = 7.5, 10.2 Hz, 1H), 3.98 (dd, J = 3.6, 8.0 Hz, 1H), 4.14-4.07 (rn, 1H), 4.18 (d, J = 6.6
Hz, 1H), 7.47-7.27 (m, 6H), 7.71-7.67 (m, 4H);
‘3C-NMR (100 MHz, CDC13) 10.55, 11.27, 19.11, 26.02, 26.79, 30.50, 30.87, 36.55,
40.43, 52.92, 65.45, 72.79, 74.54, 127.69, 129.71, 129.74, 132.99, 133.03, 135.43,
135.46;
IR (neat) vmax 3400, 2900, 1440, 1410, 1260, 1090, 800, 740, 680 crn;
HRMS: C27RO3SiS2(M+1), calcd: 423.19949, found: 423.20130.
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tert-Butyl-[(4R, 5$, 6R)-6-(1-[1,3]dithian-(2S)-yl-ethyl)-2,2,5-trimethyl-[1,3]dioxan-4-
yl-methoxy]diphenylsilane (G16):
OH OH
Me><MePpTS
114
b a solution of dithane-diol 114 (0.34 g, 0.68 mmol) in dichioromethane (10 mL) were
added 2,2-dimethoxypropane (1.00 mL, 8.20 mmol) and PPTS (0.033 g, 0.14 mmoÏ, as
solid) subsequently at room temperature. The resulting mixture was stirred for 2 h and
then directly purified by chromatography to afford G16 as a colorless ou (0.35 g, 96%);
TLC: E/H = 1:5, Rf = 0.75;
[Œ]D +19.740 (c 1.17, CHCI3);
‘H-NMR (300 MHz, CDC13) 0.83 (d, J= 6.8 Hz, 3H), 1.07 (s, 9H), 1.45 (d, J= 6.9 Hz,
3H), 1.29 (s, 3H), 1.36 (s, 3H), 1.92-1.82 (m, 3H), 2.18-2.05 (m, 1H), 2.87-2.79 (m, 4H),
3.72-3.63 (m, 3H), 3.89 (dd, J= 6.50, 11.5 Hz, 1H), 4.08 (d, J= 8.0 Hz, 1H), 7.45-7.26
(m, 6H), 7.72-7.68 (m, 4H);
‘3C-NMR (100 MHz, CDCI3) 11.45, 11.78, 20.00, 23.79, 26.69, 30.14, 30.29, 35.26,
40.62, 51,62, 63.28, 69.76, 73.51, 100.54, 127.47, 127.53, 129.53, 133.68, 135.45,
135.53;
IR (neat) vmax 2900, 1440, 1360, 1090, 1000 cm’;
mIe: 545 (M+1), 487, 429, 397, 339, 281, 241, 217, 181, 147;
HR1’vIS: C30H45O3Si$2 (M+1), calcd: 545.25792, found: 545.255600.
Me
G16
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[(2S, 3S)-2-Benzyloxymethoxy-5-iodo-3-methylpentyloxy]-tert-butyldiphenylsilane
(115):
080M 080M
PPh3, 2, imidazole TBDPSO.J..._._I
CH2CI2, 87%
Me
1 115
To a solution of 1 (1.50 g, 3.01 mmol) in CH2CI2 (30 mL) at O °C were added PPh3 (1.58
g, 6.02 mmol), imidazole (0.41 g, 6.02 mmol) and ‘2 (1.53 g, 6.02 mmol). The reaction
mixture was stirred for 1.5 h before being quenched by an aqueous NH4C1 solution (30
mL) and then diluted with hexane (60 mL). The organic layer was separated, dried over
Na2SO4, and concentrated in vacuo. The residue was purified by column chromatography
(BIH=1:50) to afford iodide 115 (1.57 g, 87%) as a colorless ou;
‘H-NMR (300 MHz, CDC13) 0.94 (d, J=6.$7 Hz, 3H), 1.07 (s, 9H), 1.64-1.78 (m, 1H),
1.98-2.17 (m, 2H), 3.08-3.18 (m, 1H), 3.58-3.80 (m, 3H), 4.54 (d, J=11.85 Hz, 1H), 4.67
(d, J=11.85 Hz, 1H), 4.78 (d, J=6.96 Hz, 1H), 4.88 (d, J=6.96 Hz, 1H), 7.28-7.49 (m,
10H), 7.65-7.75 (m, 5H);
‘3C-NMR (100 MHz, CDC13) 15.07, 19.0$, 26.76, 35.65, 35.96, 63.90, 69.68, $1.50,
94.61, 127.53, 127.65, 127.72, 128.31, 129.4$, 129.63, 129.63, 129.68, 133.22, 135.49,
135.54, 137.78;
[(2S, 3S)-5-Benzenesulfonyl-2-benzyloxymethoxy-3-methylpentyloxy]-tert-
butyldiphenylsilane (116):
080M 080M
I NaSO2Ph I
TBDPS0....k....S02Ph
E DMF, O C, 83% E
Me Me
715 116
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To a solution of 115 (1.50 g, 2.49 mmol) in DMF (40 mL) at room temperature was
added NaSO2Ph (0.8 1 g, 4.98 mmol). The mixture was stirred for 24 h before being
quenched with an aqueous NH4CI solution (30 mL). The mixture was extracted with
diethyl ether (30 mL x 2). The combined organic layers were washed with brine (30 mL),
dried over Na2SO4 and concentrated in vacuo. The residue was purified by column
chromatography (E/H=1:15) to give 116 (1.27 g, 83%) as acolorless ou;
[Œ]D —25.7 O (c 1.2, CHC13).
‘H-NMR (400 MHz, CDC13) 0.94 (d, J=6.84 Hz, 3H), 1.05 (s, 9H), 1.62-1.72 (m, 1H),
1.91-2.10 (m, 2H), 3.09-3.14 (m, 1H), 3.18-3.28 (m, 1H), 3.49-3.54 (m, 1H), 3.66 (dd,
1=4.22, 11.04 Hz, 1H), 3.72 (dd, J=5.56, 11.04 Hz, 1H), 4.48 (d, J=11.92 Hz, 1H), 4.58
(d, J=11.92 Hz, 1H), 4.69 (d, J=6.96 Hz, 1H), 4.80 (d, J=6.96 Hz, 1H), 7.28-7.54 (rn, 12
H), 7.60-7.68 (m, 4H), 7.88-7.90 (m, 2H);
‘3C-NMR (100 MHz, CDC13) 15.08, 19.09, 20.97, 24.89, 26.75, 33.29, 54.49, 63.72,
69.71, 81.43, 94.42, 127.57, 127.62, 127.68, 127.97, 128.33, 129.13, 129.70, 129.73,
133.12, 133.47, 135.46, 135.56, 137.69, 139.05;
[(2S, 3S)-5-Benzenesulfonyl-2-benzyloxymethoxy-3-methylhexyloxyJ-tert-
butyldiphenylsilane (117):
OBOM OBOM
1, KHMDS, THF
Me 82% Me Me
116 117
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To a solution of 116 (1.20 g, 1.95 mmol) in THF (10 mL) at —78 oc was added LDA (2
M in THF, 1.95 mL, 2.53 mmol). The reaction mixture was stirred for 30 min before
CH3i (0.55 g, 0.24 mL, 3.89 mmol) was added. The resulting mixture was sti;Ted at —78
°c for another 30 min before being quenched with NH4CI solution (20 mL) and diluted
with diethyl ether (50 mL). The organic layer was washed with brine (30 mL), dried over
Na2SO4 ami concentrated in vacuo. The residue was purified by column chromatography
(H/E=1:10) to provide 117 (0.99 g, 82%).
For synthetic procedures of compounds 118 to G25, please see the corresponding
procedures of compounds 143 to G29.
(5S, 4S)-5-Benzyloxymethoxy-6-(tert-butyldiphenylsilanyloxy)-4-methylhexan-2-ol
(132):
OBOM 2 2 0BOM
T8DPSO0H 90%
• TBDPSO
2. CH3U, THF
- 0H
132
To a solution of alcohol 1 (1.00 g, 2.40 mmol) in CH2C12 (20 mL) was added pyridium
chlorochromate (0.73 g, 3.36 mmol). The reaction mixture was stirred for 1.5 h and more
pyrïdium chlorochromate (0.48 g, 2.24 mmol) was added. The mixture was stirred for 1 h
before being diluted wïth diethyl ether (40 mL). The resulting mixture was filtered
through a silica pad to remove the inorganic saits and the pad was washed with ether (20
mL x 2). The combined extracts were dried over Na2SO4 and concentrated in vacuo. The
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residue was purified by column chromatography (BfH=1 :15) to give aldehyde (0.89 g,
90%) which was used directly in the next step.
To the above aldehyde (0.89 g, 2.16 mmol) in THF (15 mL) in —78 oc was added MeLi
(1.5 M in ether, 2.88 mL, 4.32 mmol). The mixture was stirred for 30 min before being
quenched with NH4C1 solution (20 mL) and diluted with ether (40 mL). The organic layer
was washed with brine (20 mL), dried over Na2SO4 and concentrated in vacuo. The
residue was purified with column chromatography (EIH=1 :8) to afford alcohol 132 (0.8 8
g, 92%) as a colorless ou.
(3$, 4S)-5-Benzyloxymethoxy-6-(tert-butyldiphenylsïlanyloxy)-4-methylhexan-2-one
(133)
OBOM OBOM
PDCCH2CI2
132 133
To a solution of alcohol 132 (0.88 g, 1.98 mmol) in H2C12 (15 mL) was added pyridium
chlorochromate (0.86 g, 3.96 mmol). The reaction mixture was stirred for 1 h and more
pyridium chlorochromate (0.32 g, 1.49 mmol) was added. The mixture was stirred for 1 h
before being diluted with diethyl ether (30 mL). The mixture was filtered through a silica
pad to remove the inorganic saits and the pad was washed with ether (15 mL x 2). The
combined extracts were dried over Na2SO4 and concentrated in vacuo. The residue was
purified by column chromatography (E/H=1:16) to give ketone 133 (0.78 g, 89%) as a
colorless ou;
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‘H NMR (CDC13, 400 MHz) 0.93 (d, J=6.76 Hz, 3H), 1.06 (s, 9H), 2.09 (s, 3H), 2.25
(dd, J=8.96 Hz, 16.28 Hz, 1H), 2.40-2.49 (m, 1H), 2.58 (dd, 1=3.09, 16.6$ Hz, 1H), 3.55-
3.59 (m, 1H), 3.67 (dd, J=4.$0, 10.88 Hz, 1H), 3.73 (dd, J=5.76, 10.88 Hz, 1H), 4.52 (d,
J=11.92 Hz, 1H), 4.63 (d, 1=11.92 Hz, 1H), 4.76 (d, 1=6.92 Hz, 1H), 4.85 (d, 1=6.92 Hz,
1H), 7.26-7.46 (m, 11H), 7.65-7.69 (m, 4H).
(5S, 6S)-6-Benzyloxymethoxy-7-(tert-butyldiphenylsilanyloxy)-3,5-dimethylhept-2-
enoic acid ethyl ester (134):
T6DPSO( TBDPSO
Me 0 86% Me Me
133 134
To a solution of triethyl phosphonateacetate (1.97 g, 8.81 mmol) in THF (30 mL) at —30
was added NaH (0.32 g, 60% in minerai ou, 8.00 mmol). The reaction mixture was
stirred for 30 min before ketone 133 (0.77 g, 1.52 mmol) in THF (4 mL) was added. The
reaction mixture was heated at reflux for 4$ h before being cooled to room temperature
and quenched with NH4C1 solution (20 mL). The resulting mixture was extracted with
ether (30 mL x 2). The combined extracts were washed with brine, dried over Na2SO4
and concentrated in vacuo. The residue was purified by coiumn chromatography
(E/H=1:8) to afford 134 (0.75 g, 86%);
‘H NMR (CDCI3, 300 MHz) 0.88 (d, 1=6.78 Hz, 3H), 1.07 (s, 9H), 1.30 (t, 1=6.8 1 Hz,
3H), 1.88 (dd, J=l0.05, 13.56 Hz, 1H), 2.16 (s, 3H), 2.16-2.27 (m, 1H), 2.43 (dd, 1=3.85,
13.56 Hz, 1H), 3.58-3.62 (m, 1H), 3.74-3.85 (m, 2H), 4.17 (q, 1=6.8 1 Hz, 2H), 4.54 (cl,
J=11.79 Hz, 1H), 4.66 (d, J=11.79 Hz, 1H), 4.79 (cl, J=6.76 Hz, 1H), 4.89 (d, J=6.$9 Hz,
1H), 5.68 (s, 1H), 7.26-7.48 (m, 11H), 7.68-7.74 (m, 4H).
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(5$, 6S)-6-Benzyloxymetlioxy-7-(tert-butyldiphenylsilanyloxy)-3,5-dimethylhept-2-
enal (135):
OOM OOM
2. Mn02,86%
134 135
To a solution of ester 134 (0.70 g, 1.31 mmol) in toluene (20 mL) at —78 oc was added
Dibal-H (0.5 M, 7.17 mL, 3.58 mmol). The reaction mixture was stirred at —78 °C for 1 h
before a solution of HC1 (Ï M, 20 mL) was added. The resulting mixture was warrned to
room temperature and then extracted with hexane-ethyl acetate (1:1, 20 mL x 2). The
cornbined organic layers were washed with NaHCO3 solution, dried over Na2SO4 and
concentrated in vacuo. The residue was purified by column chromatography (E/H=1:5) to
give the alcohol (0.6 1 g, 87%);
To the above alcohol (0.60 g, 1.10 mmol) in CH2C12 (15 mL) was added Mn02 (0.48 g,
5.5 mmol). The reaction mixture was stirred for 4 h before the mixture was filtered
through a Celite pad to remove the inorganic salts. The pad was washed with CH2C12 (10
mL x 2) and the combined filtrates were concentrated in vacuo. The residue was purified
by coïumn chromatography (E/H= 1:12) to afford aldehyde 135 (0.51 g, 86%);
‘H NMR (CDC13, 300 MHz) 0.8$ (d, J=6.84 Hz, 3H), 1.06 (s, 9H), 1.95 (dd, 1=10.24,
13.59 Hz, 1H), 2.13 (s, 3H), 2.13-2.27 (m, 1H), 2.4$ (dd, 1=4.57, 13.59 Hz, 1H), 3.53-
3.61 (m, 1H), 3.62-3.83 (m, 2H), 4.53 (d, J=11.97 Hz, 1H), 4.63 (d, J=11.97 Hz, 1H),
4.76 (d, J=7.02 Hz, 1H), 4.86 (d, J=7.02 Hz, 1H), 5.87 (d, J=7.92 Hz, 1H), 7.26-7.48 (m,
12 H), 7.62-7.73 (m, 3H), 9.99 (d, J=7.92 Hz, 1H) ppm.
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[(2$, 3S)-2-Benzyloxymethoxy-3,5-dimethyloct-5-en-7-ynyloxyl-tert-
butyldfphenylsilane (136):
2.LDA,THF
135 88% 136
To a solution of CBr4 (1.56 g, 4.73 mmol) in THF (40 mL) at —30 oc was slowly added
HMPT (0.77 g, 0.86 mL, 4.73 mmol). The color of the reaction changed from red to
beige. The reaction mixture was stirred for further 15 min after addition, and then
aldehyde 135 (0.50 g, 0.94 mmol) was added. Stirring continued for 1 h at —30 °c before
NaHcO3 solution was added to the mixture. The resulting mixture was extracted with
hexane (30 mL x 2). The combined extracts were washed with brine, dried over Na2SO4
and concentrated in vacuo. The residue was purified by column chromatography
(E/H=l :70) to afford the dibromide compound (0.58 g, 90%) as a colorless oil;
‘H NMR (cDcl3, 300 MHz) 6 0.89 (d, J=6.82 Hz, 3H), 1.09 (s, 9H), 1.74 (s, 3H), 1.87
(dd, J=J0.50, 13.5$ Hz, 1H), 2. 10-2.22 (m, 1H), 2.35 (dd, J=3.74, 13.58 Hz, 1H), 3.61-
3.6$ (m, 1H), 3.72-3.87 (m, 2H), 4.57 (d, J=11.76 Hz, 1H), 4.68 (d, J=11.76 Hz, 1H),
4.82 (d, J=6.93 Hz, 1H), 4.92 (d, J=6.93 Hz,.1H), 5.88 (d, J=10.50 Hz, 1H), 7.14 (d,
J=10.5 Hz, 1H), 7.27-7.51 (m, 11H), 7.69-7.74 (m, 4H).
To a solution of the above dibromide compound (0.5$ g, 0.84 mmol) in THF (15 mL) at —
7$ °c was added LDA (2.0 M in ether, 1.26 mL, 2.52 mmol). The reaction mixture was
stirred for 15 min before being quenched with aqueous NH4C1 solution. The resulting
mixture was extracted with hexane (20 mL x 2). The combined extracts were washed
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with brine, dried over Na2SO4 and concentrated in vacuo. The residue was purified by
column chromatography (E/H=1:80) to afford enyne 136 (0.39 g, 88%) as a colorless oll;
‘H NMR (CDCI3, 300 MHz) 6 0.87 (U, J=6.81 Hz, 3H), 1.08 (s, 9H), 1.76 (s, 3H), 1.89
(dU, J=10.53, 13.6$ Hz, 1H), 2. 14-2.26 (m, 1H), 2.37 (dd, J=3.81, 13.68 Hz, 1H), 3.01 (s,
1H), 3.62-3.68 (m, 1H), 3.73-3.89 (m, 2H), 4.58 (d, J=l1.29 Hz, 1H), 4.69 (U, J=11.29
Hz, 1H), 4.83 (d, J6.93 Hz, 1H), 4.93 (U, J=6.93 Hz, 1H), 5.26 (s, 1H), 7.27-7.51 (m,
11H), 7.69-7.24 (m, 4H).
General procedure for stannyl cuprate additions to the enyne 136:
To a slurry of dried CuCN (0.090 g, 1.00 mmol) in THF (5 mL) at —35 oc was slowly
added the organometallic reagents (2.00 mmol). The resultant clear, yellow solution was
stirred for 30 min at —35 °C, cooled to —78 °c, treated dropwise with tributyltin hydride
(0.50 mL, 2.00 mmol), and stirred 30 min further. A solution of enyne 136 (0.063 g, 0.12
mmol) in THF (2 mL) was added. The reaction mixture was warmed to one specific
temperature and stirred for 12 h before being carefully quenched with methanol and
saturated aqueous NH4C1 (10 mL). The dark brown solution was warmed to room
temperature, stirred for an additional 1 h and then extracted with hexane (40 mL). The
organic phase was washed with brine, dried over Na2SO4, concentrated in vacuo. The
residue was purified by column chromatography (E/H=1:100, with 1% Et3N as a
stabilizer).
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2,2-Dimethylpropionic acid 4-benzyloxymethoxy-2-(tert-butyldimethylsilanloxy)-3,5-
dimethylhexyl ester (13$):
BOMO OTBS BOMO OTBS
PivCPyr.
108 138
To a solution of 108 (8.00 g, 20.00 mmol) and DMAP (4.87 g, 40.00 mmol) in CH2Cb
(40 mL) at O °C was added pivaloyl chloride (3.66 mL, 30.00 mmol). The resulting
solution was stirred for 12 h at O °C. The reaction mixture was directly purified by
chromatography (E/H=1:25) to give 138 as colorless oil (8.50 g, 88%);
TLC: E/H = 1:10, Rf = 0.70;
[Œ]D —9.96 O (c 1.2, CHC13)
‘H NMR (CDCI3, 400 MHz) 0.058 (s, 3H), 0.074 (s, 3H), 0.089 (s, 3H), 0.092 (s 3H),
0.84 (d, J=6.76 Hz, 3H), 0.86-0.93 (m, 24H), 1.19 (s, 9H), 1.75-1.85 (m, 2H), 3.46 (dd,
J=3.04, 6.44 Hz, 1H), 3.98-4.20 (m, 2H), 4.01 (dd, 1=6.88, 12.4 Hz, 1H);
‘3C NMR (CDCÏ3, 100 MHz) -4.35, -4.12, -3.92, -3.57, 11.70, 16.39, 18.03, 18.38,
20.82, 25.69, 26.05, 27.10, 30.94, 38.59, 40.69, 66.68, 70.85, 78.57, 178.16;
IR (thin film) vmax 2958, 2858, 1732, 1472, 1389, 1367, 1282, 1254, 1147, 1094, 1052,
1006, 985, 836 cm’;
HR1’IS: C23H53O6Si2(M+1), calcd: 48 1.33807, found: 48 1.33590.
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2,2-Dimethylpropionic acid 2-(tert-butyldimethylsilanyloxy)-4-hydroxy-3,5-dimethyl
liexyl ester (139):
BOMO OTBS OH OTBS
H2,Pd(OH)21C
738 139
A mixture of 138 (3.00 g, 6.32 mmol) and 20% Pd(OH)2/C (0.40 g, Degussa type) in
methanol (40 mL) under 1 atm of hydrogen was stined at room temperature for 6 h. The
reaction mixture was filtered through a pad of Celite to remove the catalyst and then
washed with EtOAc. The crude alcohol 139 was subjected to next step without ftirther
purification.
2,2-Dimethyl-propionic acid 2,4-bis-(tert-butyldimethylsilanyloxy)-3,5-
dimethylhexyl ester (140):
OH OTBS so o-rss
e0P
2uUne
OPiv
139 95/ for two steps 740
To a solution of above alcohol 139 in CH2C12 (30 mL) at O °C were added 2,6-lutidine
(1.66 mL, 14.23 mmol), then TBSOTf (2.19 mL, 9.49 mmol). The resulting solution was
stirred for 1 h at this temperature. The reaction mixture was directly purified by
chromatography (E/H=1:35) to afford 140 as colorless oïl (2.86 g, 95%);
TLC:E/H= 1:10,Rf =0.90;
[Œ]D +2.82 O (c 1.35, CHC13);
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‘H NMR (CDCI3, 400 MHz) 0.05 (s, 3H), 0.07 (s, 3H), 0.09 (s, 3H), 0.$4 (d, J=6.76
Hz, 3H), 0.86-0.93 (m, 24H), 1.19 (s, 9H), 1.75-1.85 (m, 2H), 3.46 (dd, J=3.04, 6.44 Hz,
1H), 3.98-4.20 (m, 2H), 4.01 (dd, J=6.$8, 12.40 Hz, 1H);
‘3C NMR (CDC13, 100 MHz) —4.35, -4.12, -3.92, -3.57, 11.70, 16.39, 18.03, 18.38,
20.82, 25.69, 26.05, 27.10, 30.94, 38.59, 40.69, 66.68, 70.85, 78.57, 178.16;
IR(thinfilm)vmax2958,2858, 1732, 1472, 1389, 1362, 1282, 1254, 1147, 1094, 1052,
1006, 985, 836 cm1;
HRMS: C25H55O4Si2 (M+1), calcd: 475.36389, found: 475.36560.
2,4-Bis-(tert-butyldimethylsilanyloxy)-3.5-dimethylhexan-1-oI (141):
TBSO OTBS TBSO OTBS
Dibal-H
140 141
To a solution of 140 (2.80 g, 5.86 mmol) in TFW (20 mL) at —78 °C was added DffiAL-H
(1.5 M in toluene, 10.00 mL, 15.00 mmol) dropwise. The resulting mixture was stirred
for 1 h at —78 oc before being quenched with saturated NH4CI (25 mL). The reaction
mixture was diluted with EtOAc (50 mL) and 2% HC1 (20 mL) was added to dissolve
inorganic sait. The aqueous layer was extracted wïth EtOAc, the combined organic layers
were washed with saturated NaHCO3, saturated NRZl and brine, then dried over
Na2SO4. The cmde product was purified by chromatography (E/H= 1:10) to afford alcohol
141 as acolorless ou (2.08 g, 91%);
TLC:E/H= 1:10,Rf =0.47;
234
[Œ]D +2.23 O (c 0.8 1, CHCI3).
‘H NMR (CDCI3, 400 MHz) 0.063 (s, 3H), 0.083 (s, 3H), 0.094 (s, 6H), 0.88-0.98 (m,
27H), 1.76-1.83 (m, 1H), 1.89-1.96 (m, 1H), 2.00-2.05 (m, 1H), 3.41 (t, J=4.64 Hz, 1H),
3.55-3.64 (m, 2H), 3.68 (dd, J=3.64, 7.22 Hz, 1H);
‘3c NMR (CDC13, 100 MHz) -4.44, -4.38, -4.26, -3.77, 14.38, 19.95, 18.04, 18.23,
20.87, 25.79, 25.96, 3 1.53, 40.03, 65.19, 74.47, 79.24;
IR (thin film) vmax 3400, 2961, 2856, 1476, 1368, 1280, 1256, 1173, 1088, 1053, 989,
841cm’;
URMS: C20H47O3Si2(M+1), calcd: 391.30637, found: 391.30580.
(2S, 3R, 4R)-2,4-Bis-(tert-butyldimethylsîlanyloxy)-1-iodo-3,5-dimethylhexane (G38):
TBSO OTES TBSO OTBS
‘2 H11IdaZO,PPh3
141 G35
To a solution of alcohol 141 (2.00 g, 5.00 mmol), dry imidazole (0.73 g, 10.0 mmol) and
triphenylphosphine (2.69 g, 10.00 mmol) in toluene (20 mL) at O °C was added iodine
(2.6 1g, 10.00 mmoO. The resulting mixture was stirred for 1.5 h at this temperature. The
reaction mixture was directly purified by chromatography (E[H=1 :50) to afford G38 as a
colorless ou (2.15 g, 84%);
TLC: EJH = 1:10, Rf = 0.95;
[Œ]D —1.32 O (c 1.21, CHC13);
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‘H NMR (CDC13, 400 MHz) 6 0.097 (s, 6H), 0.12 (s, 3H), 0.14 (s, 3H), 0.88-0.95 (m,
27H), 1.72-1.82 (m, 1H), 1.98-2.20 (m, 1H), 3.2$ (dd, J=5.92, 10.22 Hz, 1H), 3.35 (dd,
J=2.60, 10.2 Hz, 1H), 3.42 (m, 2H);
l3 NMR (CDC13, 100 MHz) 6 -4.32, -3.96, -3.39, 12.13, 14.04, 17.20, 18.04, 18.31,
21.31, 25.80, 26.05, 31.19, 42.73, 7l.50, 78.25;
IR (thin film) vmax 2971, 2863, 1465, 1287, 1261, 1179, 1078, 1053, 990, $51 cm’;
(2S, 3S)-(2-Benzyloxymethoxy-5-methoxymethoxy-3-methylpentyloxy)-tert-butyl-
diphenyl-silane (142):
OBOM OBOM
DPSOOH_MOMCI, DIPEA TPSOOMoM
CH2CI2 92% E
Me rle
1 142
To a solution of 1 (18.00 g, 36 mmol) in dichloromethane (200 mL) at O °C under
nitrogen atmosphere was added diisopropylethylamine (18.81 mL, 13.96 g, 10$ mmol)
and methyl chloromethyl ether (5.47 mL, 5.79 g, 72.00 mmol). The resultant mixture was
stirred ovemight at ambient temperature and then quenched by addition of saturated
NH4C1 (200 mL). The organic layer was separated, washed with brine (50 mL), dried
over anhydrous sodium sulfate and concentrated in vacuo. Purification of the crude
product by column chromatography (E/H=20:1) afforded MOM ether 142 (17.78 g, 92%)
as a colorless oil;
TLC: Rff 0.4 (EIH=1:10);
[ŒJD-l7.6O ° (c 0.7 1, CH2C12);
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‘H NMR (CDC13, 400 MHz) 0.95 (d, J= 6.92 Hz, 3H), 1.04 (s, 9H), 1.30-1.45 (m, 1H),
1.78-1.87 (m, 1H), 1.98-2.50 (m, 1H), 3.34 (s, 3H), 3.50-3.61 (m, 2H), 3.61-3.66 (m,
1H), 3.69-3.79 (m, 2H), 4.55 (d, J =11.84 Hz, 1H), 4.59 (d, J =1.44 Hz, 1H), 4.60 (d, J
=1.44 Hz, 1H), 4.67 (d, J =11.84 Hz, 1H), 4.81 (d, J =6.92 Hz, 1H), 4.91 (d, J =6.92 Hz,
1H), 7.26-7.46 (m, 10H), 7.65-7.62 (m, 5H);
‘3c NMR (CDCÏ3, 100 MHz) 15.65, 19.06, 26.68, 3 1.65, 3 1.69, 55.01, 64.16, 65.93,
69.49, 82.09, 94.62, 96.23, 127.45, 127.57, 127.68, 128.25, 129.54, 129.56, 133.31,
134.68, 135.47, 135.5 1, 137.87;
IR (thin film) vmax 2931, 2884, 1472, 1428, 1388, 1112, 1041, 918, 740, 702 cm’;
HRMS: C32H45O5Si (M+1), calcd: 537.30365, found: 537.30490.
(2S, 3S)-2-Benzyloxymethoxy-5-methoxymethoxy-3-methylpentan-1-ol (143):
OBOM OBOM
TH92
142 143
To a solution of 142 (15.00 g, 27.94 mmol) in THF (250 mL) was added TBAF solution
(83.8 mL, 1 M, 83.83 mmol). The resulting mixture was stirred for 7 h at ambient
temperature and then diluted with a mixture of hexane-ethyl acetate (1:1, 200 mL). The
organic layer was washed with saturated NaHCO3 (50 mL x 2) and brine (50 mL x 2),
dried over anhydrous Na2SO4 and concentrated in vacuo. Purification of the crude
product by column chromatography (EIH=1 :3) provided 143 (7.65 g, 92%) as a clear,
colorless ou;
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TLC: Rf= 0.4 (EIH=2: 1);
tŒJD +24.20 O (c 0.69, CH2C12);
‘H NMR (CDC13, 400 MHz) 0.97 (d, J = 6.8$ Hz, 3H), 1.39-1.45 (m, 1H), 1.80-1.90
(m, 1H), 1.90-1.97 (m, 1H), 3.36 (s, 3H), 3.43-3.48 (m, 1H), 3.50-3.69 (m, 4H), 4.62 (d, J
= 6.56 Hz, 2H), 4.68 (d, J= 11.72 Hz, 2H), 4.77 (d, J=6.96 Hz, 1H), 4.93 (d, J =6.96,
2H), 7.28-7.38 (m, 5H);
l3 NMR (CDCI3, 100 MHz) 15.46, 32.01, 32.06, 55.02, 63.03, 65.69, 69.92, 86.08,
95.35, 96.26,127.80, 128.38, 137.1;
IR (thin film) vmax 3466, 2934, 2883, 1725, 1454, 1382, 1271, 1151, 1107, 1039, 918,
739, 699 cm1;
HRMS: C16H2705 (M+1), calcd: 299.18585, found: 299.18490.
(4S, 5S)-4-Benzyloxymethoxy-7-methoxymethoxy-5-methylhept-2-trans-enoic acid
methyl ester (144):
OBOM OBOM
1. Swem
2. Wittig
Me le
143 144
To oxalyl chloride (2 1.00 g, 14.50 mL, 167.00 mmol) in CH2C12 (200 mL) at —78 oc was
added DMSO (16.38 g, 14.90 mL, 209.70 mmol). The reaction mixture was stirred for 15
mm, before 143 (25.00 g, 83.89 mmol) in CH2C12 (100 mL) was added slowly at —78 °C.
The reaction mixture was stirred and slowly warmed to —30 oc in about 30 min before
triethylamine (25.46 g, 25 1.67 mmol, 35 mL) was added. A white precipitate was formed
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and the mixture was stirred at this temperature for 15 min before being quenched with
saturated NRC1 (150 mL). The organic layer was separated, dried, filtrated and
concentrated in vacuo. The crude aldehyde was dissolved in dry CH2C12 (270 mL) and
Ph3P=CHCO2CH3 (36.0 g, 334.36 mmol) was added to the solution. The resulting
mixture was stirred at r.t. for 12 h. The solvent was removed and the residue was purified
by column chromatography (E/H=1:10) to give 144 (26.85 g, 87%) as a colorless ou;
TLC: Rff 0.4 (E/H=1:8);
{Œ]D —53.8 ° (c 0.7 1, CHC13).
‘H NMR (CDC13, 400 MHz) 0.95 (d, J = 6.84 Hz, 3H), 1.37-1.47 (m, 1H), 1.80-1.90
(m, 1H), 1.91-1.99 (m, 1H), 3.33 (s, 3H), 3.53-3.61 (m, 2H), 3.72 (s, 3H), 4.17 (t, J= 6.6
Hz, 1H), 4.54 (d, J= 11.72 Hz, 1H), 4.58 (d, J=6.6 Hz, 1H), 4.59 (d, J=6.6 Hz, 1H), 4.67
(d, J = 11.72 Hz, 1H), 4.71(d, J =7.08 Hz, 1H), 4.74 (d, J =7.08 Hz, 1H), 6.01 (dd, J=
1.04, 15.76 Hz, 1H), 6.84 (dd, J=6.6, 15.76 Hz, 1H), 7.22-7.35 (m, 5H);
13 NMR (CDCI3, 100 MHz) 15.03, 32.07, 34.39, 51.45, 55.01, 65.46, 69.66, 79.25,
92.67, 96.26, 122.78, 127.60, 127.7 1, 128.28, 137.52, 146.12, 166.25;
IR(thinfilm)vmax29l7, 1726, 1456, 1436, 1212, 1169, 1108, lO38cm’;
HRMS: C19H2906 (M+1), calcd: 353.19642, found: 353.19547.
(3R, 4S, 5S)-4-Benzyloxymethoxy-7-methoxymethoxy-3, 5-methyl-heptanoic acïd
methyl ester (145):
OBOM OBOM
Me2CuL1, TMSCI MeO2CIM0M
le THF, 90°’ Me Me
144 145
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To a stined solution of the lithio dimethyl cuprate reagent (1 30.40 mmol) [prepared by
treating a suspension of Cul (24.83 g, 130.40 mmol) in dry THF (250 mL) with MeLi
LiBr (1.5 M in ether, 173.00 mL, 260.00 mmol) at—5 °CJ at—78 °C were added dropwise
TMSC1 (49.00 mL, 42.49 g, 391.00 mmol) and 144 (24.00 g, 65.20 mmol) in THF (150
mL). The reation mixture was stïrred at —78 °C for 3 h before being quenched with a
solution of NH4OHINH4C1 (1:1, 300 mL). The resulting mixture was warmed to room
temperature and extracted with hexane (200 mL x 2). The combined extracts were
washed with diluted NH4OH (100 mL x 2), brine and dried over sodium sulfate. The
solvent was removed in vacuo, and the residue was purified by flashed chromatography
(EIH=1:20) to afford 145 (22.50 g, 90%) as acolorless ou;
{Œ]D +2.37 O (c 0.76, CHC13);
‘H NMR (CDC13, 400 MHz) 0.99 (d, J =6.76 Hz, 3H), 1.01 (d, J=6.76 Hz, 3H), 1.38-
1.46 (m, 1H), 1.84-1.96 (m, 2H), 2.16 (dd, J = 9.68, 14.98 Hz, 1H), 2.23-2.32 (m, 1H),
2.62 (dd, J= 3.76, 14.9$ Hz, 1H), 3.20 (t, J= 5.12 Hz, 1H), 3.35 (s, 3H), 3.57-3.65 (m,
2H), 3.66 (s, 3H), 4.61 (dd, J= 0.64, 6.52 Hz, 1H), 4.62 (dd, J=0.64, 6.52 Hz, 1H), 4.64
(s, 2H), 4.78 (s, 2H), 7.26-7.36 (m, 5H);
‘3C NMR (CDCÏ3, 100 MHz) 16.70, 17.82, 31.35, 32.43, 32.60, 37.25, 51.27, 55.02,
65.89, 70.03, 88.33, 96.2$, 96.46, 127.5 1, 127,63, 128.27, 137.72, 173.83;
IR (thin film) vmax 2950, 2881, 1737, 1455, 1439, 1383, 1276, 1194, 1108, 1037cm’;
HRMS: C20H3206 (M+1), calcd: 369.22772, found: 369.22690.
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(2S, R, 3R, 4$, 5S)-4-Benzyloxymethoxy-2-hydroxy-7-methoxymethoxy-3, 5-
dimethyllieptanoic acid methyl ester (146):
080M 0H 080M
1. KHMDS
E E 2. Daviss reagent E
Me Me 84% tle 1e
145 146
b a stirred solution of 145 (25.00 g, 65.00 mmol) in THF (250 mL) at —78 °C was added
KHMDS solution (0.50 M in toluene, 260.00 mL) under argon. After 30 mm, a solution
of trans-2-phenyl-sulfonyl-3-phenyloxaziridine (Davis’ reagent, 38.6 1 g, 143 mmol) in
THf (250 mL) was then added dropwise at —78 oc under argon. The reaction mixture
was stirred at this temperature for 2.5 h. The reaction was quenched with saturate NH4C1
solution (200 mL) and extracted with ether (200 mL x 3). The organic extracts were dried
over sodium sulfate, filtered and concentrated in vacuo. The cnide product was purified
by column chromatography (E/H=1:3) to afford -hydroxy ester 146 (21.89 g, 84%) as a
colorless ou which was directly used in the next step.
(2$, R, 3R, 4$, 5S)-4-Benzyloxymethoxy-2-hydroxy-7-methoxymethoxy-3,S-
dimethylheptane-1,2-dïol (147):
0H 080M OH 080M
M
0M0M UBH4 H0OM0M
e 2 MeOH88% E E
Me Me le g
146 147
To a solution of 146 (7.00 g, 17.50 mmol) in THF (150 mL) at O °c was added LiBH4
solution (2.0 M, 26.00 mL, 52.50 mmol). MeOH (4.00 mL) was added dropwise. The
reaction mixture was then warmed to room temperature and allowed to stir for 2 h. The
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reaction was then quenched with samrated ammonium chloride solution (100 mL) and
extracted with ether (200 mL x 2). The organic extracts were dried over NaSO4, filtered
and concentrated in vacuo. The cmde product was purified by column chromatography
(E/H=1:1) to afford 147 (5.98 g, 92%) as a colorless oïl which was directly used in the
next step.
(2S,R, 3S, 4S, 5S)-7-methoxymetlioxy-3, 5-dimethylheptane-1, 2, 4-triol (14$):
OH OBOM OH OH
H2, Pd(OH)2/C HONJ,._l....._oMOM
MeOH, 90% E E
e e Me Me
147 148
A mixture of 147 (2.00 g, 7.93 mmol), 10% Pd(OH)2 on active carbon (0.20 g, 20% Pd,
Degussa type) in methanol (30 mL) was stirred under hydrogenation for 8 h, then filtered
through Celite, washed completely with ether. The combined filtrates were dried over
Na2SO4 and concentrated in vacuo. The residue was purified by column chromatography
(E/H=l:2) to give 148 (1.68 g, 90%) which was used directly in the next step.
(4R, 5$, 6S)-5-Hydroxy-8-methoxymethoxy-2, 4, 6-trïmethyloct-2-traits-enoic acid
ethyl ester (149):
OH 0H 1 NalO CH Cl 0H
(2%H20)
2
E 2. Wittig , benzene E
Me Me
reflux Me Me Me
148
85%
149
To a solution of 148 (1.68 g, 7.23 mmol) in CH2CI2 (40 mL) were added Na104 (6.79 g,
3 1.74 mmol) and H20 (1.0 mL). The reaction mixture was stirred at room temperature for
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1.5 h. The precipitate was filtered and washed with CH2CI2 (20 mL x 2). The organic
layer was dried over Na2SO4 and solvent was removed in vacuo. The crude aldehyle was
used directly in the next step with out further purification.
To a solution of the above aldehyde from the previous reaction in benzene (40 mL) was
added Ph3P=CHCO2Et (5.60 g, 15.45 mmol). The mixture was heated at reflux for 2
days. The solvent was removed and the residue subjected to column chromatography
(EIH=1:4) to afford 149 (1.94 g, 85%);
[al0 +12.3 1 O (0.58, CHC13);
‘H NMR (CDC13, 400 MHz) 0.87 (d, J = 6.84 Hz, 3H), 0.99 (d, J = 6.84 Hz, 3H), 1.23
(t, J= 6.84 Hz, 3H), 1.48-1.54 (m, 1H), 1.60-1.68 (m, 1H), 1.72-1.82 (m, 1H), 1.81 (d, J
= 0.8 Hz, 3H), 2.60-2.70 (broad, 2 H), 3.23 (dd, J =5.08, 6.66 Hz, 1H), 3.31 (d, J= 0.64
Hz, 3H), 3.57-3.63 (m, 1H), 4.09-4.17 (m, 2H), 4.56 (s, 2H), 6.74 (dd, J=10.08, 0.96 Hz,
1H) ppm;
‘3c NMR (CDC13, 400 MHz) 12.42, 14.06, 16.22, 16.68, 31.50, 33.91, 36.23, 55.03,
60.23, 65.47, 79.01, 96.19, 127.78, 143.20, 167.99 ppm;
W (thin film) vmax 3502, 3061, 2991, 2879, 1708, 1461, 1388, 1270, 1236, 1138, 1108,
1037, 99, 918, 752 cm’;
HRMS: C15H28O5Na(M+Na), calcd: 3 11.18344, found: 3 11.18440.
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(4R, 5S, 6S)--8-methoxymethoxy-2, 4, 6-trimethyl-5-(triethylsilanyloxy)-oct-2-trans-
enoic acid ethyl ester (150):
TESCIDMAP
149
150
To a solution of 149 (2.20 g, 7.23 inmol) in CH2CI2 (40 mL) at O °C was added imidazole
(1.47 g. 21.69 mmol) and triethylsilyl chloride (2.43 mL, 2.18 g, 14.47 mmol). The
resulting mixture was stirred for 24 h at ambient temperature and then diluted with hexane
(100 mL) and ethyl acetate (20 mL). The organic layer was washed with saturated NH4C1
(50 mL x 2) and brine (50 mL x 2), drïed over anhydrous Na2SO4 and concentrated in
vacuo. Purification of the residue by column chromatography (EIH=1 :9) on silica gel
provided 150 (2.84 g, 95%) as a clear, colorless ou;
[ŒJD +11.980 (c 1.11, CHCI3).
‘H NMR (CDCI3, 400 MHz) 6 0.59 (q, J =7.92 Hz, 6H), 0.88 (d, J=6.$ Hz, 3H), 0.94 (t,
J=7.92 Hz, 9H), 0.96 (d, .1=6.88 Hz, 3H), 1.27 (t, J=7.12 Hz, 3H), 1.28-1.40 (m, 1H),
1.72-1.81 (m, 2H), 1.82 (d, J=1.36 Hz, 3H), 2.60-2.73 (m, 1H), 3.35 (s. 1H), 3.48-3.63
(m, 3H), 4.10-4.23 (m, 2H), 4.60 (d, J=6.52 Hz, 1H), 4.61 (d, J=6.52 Hz, 1H), 6.23 (dd,
J=10.2, 1.40 Hz, 1H);
‘3c NMR (CDC13, 100 MHz) 6 5.28, 6.90, 12.34, 14.11, 16.25, 17.56, 31.47, 34.89,
36.51, 54.99, 60.15, 66.11, 80.61, 96.27, 126.28, 145.36, 168.22;
IR (thin film) vmax 2957, 2877, 1711, 1650, 1459, 1414, 1384, 1356, 1292, 1238, 1037,
738 cm*
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2,2-Dimethylpropionic acid-(4R, 5S, 6S)--8-methoxymethoxy-2, 4, 6-trimethyl-5-
(triethylsilanyloxy)-oct-2-trans-enyl ester (151):
OTES OTES
1 DibaI-H
Me Me Me 84% Me Me Me
750 751
To a stirred solution of 150 (5.60 g, 13.26 mmol) in toluene (150 mL) at —78 °C was
added dropwise Dibal-H (1 M in toluene, 40.10 mL, 40.09 mmol)) under nitrogen. The
reaction mixture was stirred at this temperature for 1 h before being quenched with
saturated NH4C1 solution (50 mL). The resulting mixture was warmed to room
temperature and extracted with ether (75 mL x 3) immediately. The extracts were dried
Na2SO4, and then filtered. The solvent was removed in vacuo and the residue
subjected to the column chromatography (E/H=6: 1) to afford the alcohol (4.2$ g, 89%) as
a colorless ou;
[Œ]D -2.28 O (c 1.32, CHC13).
‘H NMR (CDC13, 400 MHz) 0.57 (q, J =7.94 Hz, 6H), 0.86 (d, J=6.84 Hz, 3H), 0.9 1-
0.95 (m, 12H), 1.22-1.33 (m, 1H), 1.63 (s, 3H), 1.79-1.86 (m, 1H), 2.1 (broad, 1H), 2.52-
2.57 (m, 1H), 3.32 (s. 3H), 3.38 (t, J=4.4$ Hz, 1H), 3.44-3.57 (m, 2H), 3.94 (s, 2H), 4.56
(d, J= 6.6 Hz, 1H), 4.57 (d, J=6.6 Hz, 1H), 5.43 (d, J=9.64 Hz, 1H);
l3 NMR (CDC13, 100 MHz) 5.33, 6.96, 13.65, 16.59, 18.65, 31.73, 34.47, 35.59,
54.90, 66.28, 68.99, 80.89, 96.13, 129.13, 133.27;
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IR (thin film) vmax 3426, 2929, 1473, 1463, 1387, 1361, 1253, 1149, 1106, 1037, 836,
773, 676 cm1;
HRMS: C19H41O4Si (M+1), calcd: 361.27742, found: 361.27677.
To a stirred solution of the above alcohol (4.8 1 g, 13.35 mmol) in dry CH2C12 (100 mL)
at O °C was added pyridine (3.42 mL, 3.34 g, 39.75 mmol) and pivaloyl chloride (3.2$
mL, 3.20 g, 26.70 mnoO. The reaction mixture was then stined at room temperature for
16 h. The reaction mixture was quenclied with saturated NH4Q solution (50 mL) and
extracted with ether (50 mL x 3). The extracts were washed with brine, dried over
Na2SO4 and concentrated in vacuo. The residue was purified by column chromatography
(E/H=1 :40) afford 151 (5.64 g, 95%) as a colorless oil;
[Œ] -4.32° (c 1.23, CH2CI2);
‘H NMR (CDC13, 400 MHz) 0.59 (q, J =7.88 Hz, 6H), 0.86 (d, 1=6.84 Hz, 3H), 0.92
(d, 1=6.96 Hz, 3H), 0.94 (t, J=7.$$ Hz, 9H), 1.20 (s, 9H), 1.28-1.38 (m, 1H), 1.62 (s, 3H),
1.65-1.73 (m, 1H), 1.77-1.85 (m, 1H), 2.52-2.61 (m, 1H), 3.35 (s, 3H), 3.40 (t, J=4.64
Hz, 1H), 3.48-3.61 (m, 2H), 4.42 (d, J=12.52 Hz, 2H), 4.44 (d, J=12.52 Hz, 2H), 4.60 (d,
J=5.84 Hz, 1H), 4.62 (d, J=5.$4 Hz, 1H), 5.49 (d, J=9.64 Hz, 1H);
‘3C NMR (CDC13, 100 MHz) 5.34, 6.97, 13.85, 16.30, 18.50, 27.06, 31.69, 34.43,
35.42, 38.70, 54.94, 66.23, 69.67, 20.74, 96.24, 128.55, 131.61, 178.14;
IR (thin film) vmax 2958, 2877, 1732, 1481, 1460, 1283, 1238, 1153, 1107, 1035, 73$
cm1;
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HfflvIS: C24H49O5Si (M+1), calcd: 445.33493, found: 455.33350.
2,2-Dimethylpropionic acid-(4R, 5S, 6S)--5, $-dihydroxy-2, 4, 6-trimethyl-oct-2-
trans-eny] ester (152):
OIES OH
JOMOM B-brornocatecholborane
152
To a solution of 151 (0.70 g, 1.67 mmol) in CHCl2 (20 mL) at —78 °C was added a
solution of catecheolborane bromide (0.29 g, 1.67 mmol) in cH2ci2 (5 mL). The reaction
mixture was stirred and warmed to —30 0C in 30 min. F120 (10 mL) was added and the
mixture was stirred for 30 min before NaOH solution (1.0 M, 15 mL) was added at O °C.
The mixture was diluted with CH2cl2 (20 mL). The organic layer was washed with 1 M
NaOH solution (15 mL x 2) and brine (15 mL x 2), dried over anhydrous sodium sulfate
and concentrated in vactto. Purification of the residue by column chromatography on
sifica-gel provided 153 (0.20 g, 30%, E/H=1:8), and 152 (0.21 g, 60%, B/H=1:2) as
colorless oils;
[OEju +14.70 O (c 0.38, CH2C12).
‘H NMR (CDC13, 400 MHz) 6 0.97 (d, J = 6.84 Hz, 6H), 1.19 (s, 9 H), 1.60-1.72 (m,
1H), 1.67 (d, J=1.24 Hz, 3H), 1.73-1.86 (m, 1H), 2.60-2.70 (m, 1H), 2.62-2.67 (broad,
2H), 3.20 (t, J=5.88 Hz, 1H), 3.56-3.62 (m, 1H), 4.42 (d, J= 12.28 Hz, 1H), 4.52 (d,
J=12.28 Hz, 1H), 5.39 (dd,J=9.72, 1.21 Hz, 1H) ppm;
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‘3C NMR (CD3C1, 400 MHz) 14.06, 17.10, 17.29, 27.05, 33.18, 34.06, 35.53, 38.76,
59.8 1, 69.87, 79.27, 130.57, 13 1.57, 178.4 ppm;
IR (thin film) vmax 3370, 2961, 2931, 1728, 1480, 1459, 1397, 1284, 1156, 1060, 991
cm
HRMS: C16H3104 (M+1), calcd: 287.22223, found: 287.22160.
2, 2-Dimethylpropîonic acid-(4R, 5S, 6S)-8-hydroxy-2, 4, 6-trimethyl-5-
(triethylsilanyloxy)-oct-2-traizs-enyl ester (153):
OH OTES
1 TESOTf,26-Lutidine
Me
152
Me
CH3OH,93% Me Me Me
To a solution of 152 (0.080 g, 0.28 mmol) in CH2C12 (3 mL) at O °C was added 2,6-
lutidine (0.089 mg, 0.83 mmdl, 97 i.tL) and TESOTf (0.18 g, 0.70 mmol, 0.16 mL). The
reaction mixture was stirred for 0.5 h at O °C before being quenched with saturated
NH4CI (10 mL). The resulting mixture was extracted with hexane (10 mL x 2). The
combined extracts were washed with brine (10 mL x 2), dried over anhydrous sodium
sulfate and concentrated in vacuo. Purification of the crude product by column
chromatography (E/H=50: 1) on silica-gel provided the di-TES ether (0.14 g, 95%) as a
colorless ou;
[Œ] 3.45 ° (C 0.52, CHC13);
‘H NMR (CDC13, 400 MHz) 6 0.54-0.61 (m, 12H), 0.85 (d, J=6.68 Hz, 3H), 0.90-0.96
(m, 21H), 1.21 (s, 9H), 1.23-1.36 (m, 1H), 1.62 (s, 3H), 1.64-1.74 (m, 1H), 2.54-2.59 (m,
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1H), 3.40 (t, J = 4.2$ Hz, 1H), 3.53-3.59 (m, 1H), 3.65-3.70, (m, 1H), 4.41 (d, J=12.6
Hz, 1H), 4.44 (d, J=12.6 Hz, 1 H), 5.50 (d, J=9.64 Hz, 1 H);
‘3C NMR (CDC13, 100 MHz) 6 4.28, 5.30,6.62, 6.93, 13.81, 16.17, 18.50, 27.04, 34.07,
34.98, 35.32, 38.69, 61.14, 68.75, 80.79, 128.24, 132.70, 178.16;
IR (thim film) vmax 2994, 2931, 1732, 1480, 1459, 1414, 1380, 1282, 1239, 1123, 1095,
1006, 972, 740 cm’;
To a solution of the above di-TES ether (2.00 g, 3.89 mmol) in MeOH-CH2CI, solution
(made from 15 mL of CH2C12 and 5 mL of MeOH) at —10 °C was added PPTS (0.20 g,
0.79 mmol). The reaction mixture was stirred for 1 h at —io oc before being quenched
with saturated NH4c1 solution (50 mL), and then was extracted with ether (50 mL x 3).
The extracts were washed with brine, dried over Na2SO4 and concentrated in vacuo. The
residue was purified by column chromatography (E/H=40: 1) to afford 153 (1.46 g, 93%)
as a colorless ou;
[Œ]0 -16.10° (c 1.93, CHC13).
‘H NMR (cDcl3, 400 MHz) 60.56 (q, J=7.92 Hz, 6H), 0.86-0.94 (m, 15H), 1.16 (s, 9H),
1.47-1.54 (m, 1H), 1.60 (d, J=1.12 Hz, 3H), 1.60-1.66 (m, 1H), 1.74-1.79 (m, 1H), 2.60-
2.65 (m, 1H), 2.66-2.72 (broad, 1H), 3.38 (dd, J = 5.96, 5.92 Hz, 1H), 3.47-3.53 (m, 1H),
3.63-3.68 (m, 1H), 4.37 (d, J=12.4$ Hz, 1H), 4.42 (d, J=12.48 Hz, 1H), 5.39 (dd, J=9.$2,
1.04 Hz, 1H);
‘3c NMR (CDcl3, 100 MHz) 6 5.26, 6.87, 13.79, 16.75, 18.07, 27.00, 33.71, 34.01,
35.98, 38.68, 59.79, 69.61, 80.96, 128.98, 131.76, 178.26;
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IR (thinfiim) vmax 3401, 2962, 2931, 1728, 1480, 1458, 1397, 1284, 1156 cm1;
HRMS: C22H45O4Si (M+1), calcd: 401.30872, found: 401.30872.
2, 2-Dimethylpropionic acid-(4R, 5$, 6S)-8-oxo-2, 4, 6-trimethyl-5-
(triethylsilanyloxy)-oct-2-trans-enyl ester (154):
OTES OTS
Dess-Martin
Me Me Me Me Me Me
153 154
To a solution of 153 (1.35 g, 3.25 mmol) in dry CH2C12 (20 mL) at room temperature was
added Dess-Martin reagent (2.37 g, 6.50 mmol). The mixture was stirred for 30 mm, and
then was diluted with hexane (20 mL) and ethyl acetate (5 mL). The mixture was filtered
through a silica pad and the pad was washed with hexane-ethyl acetate solution (5:1, 50
mL). The filtrates were combined and concentrated in vacuo. The residue was purified by
column chromatography (EIH=1:10) to give 154 (1.20 g, 93%).
2, 2-Dimethylpropionic acid-(4R, 5$, 6S)-2, 4, 6-trimethyl-5-(triethylsilanyloxy)-non-
2-trans-en-$ynyl ester (155):
o o
OTES 1.-OMe OrES
N2
Me Me Me 2C03, MeOH, 91 Me Me Me
154 155
To a solution of 155 (0.24 g, 0.60 mmol) in MeOH (8 mL) was added dimethyl(1-diazo-
2-oxopropyl)phosphonate (0.35 g, 1.80 mmol) and K2C03 (0.25 g, 1.8 mmol). The
resulting mixture was stirred for 4 h at ambient temperature and then diluted with hexane
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(20 mL) and ethyl acetate (8 mL). The organic layer was washed with saturated
ammonium chloride (15 mL x 2) solution and brine (15 mL x 2), dried over anhydrous
sodium sulfate and concentrated in vacuo. Purification of the residue by column
chromatography (E/H=60: 1) on silica-gel provided 156 (0.22 g, 91%) as a clear, colorless
ou.
{Œ]D -4.36 ° (c 1.33, CH2CI2);
‘H NMR (C6D6, 400 MHz) 6 0.68 (q, J = 7.84 Hz, 6H), 0.97 (d, J=6.96 Hz, 3H), 0.9$-
1.06 (m, 12H), 1.23 (s, 9H), 1.56 (d, 1=1.28 Hz, 3H), 1.82-1.85 (m, 1H), 1.85 (t, J=2.6$
Hz, 1H), 2.21 (ddd, 1=7.68, 2.68 Hz, 18.86 Hz, 1H), 2.31 (ddd, J=7.6$, 2.68, 18.86 Hz,
1H), 2.52-2.56 (m, 1H), 3.52 (dU, J= 6.44, 6.44 Hz, 1H), 4.48 (d, J =17.3 Hz, 1H), 4.51
(d, 1=17.3 Hz, 1H), 5.64 (dd, J=9.72, 1.16 Hz, 1H);
‘3c NMR (C6D6, 100 MHz) 65.47, 6.99, 13.58, 16.17, 18.36, 21.78, 26.94, 35.39, 36.96,
38.45, 69.04, 69.66, 79.30, 82.96, 129.60, 129.85, 176.86;
IR (thin film) vmax 3312, 2959, 2876, 1731, 1480, 1459, 1379, 1283, 1152, 1102, 1034,
1009, 729 cm’;
HRMS: C23H43O3Si (M+1), calcd: 395.29816, found: 395.29740.
2, 2-Dimethylpropionic acid-(4R, 5S, 6S)-9-iodo-2, 4, 6, $-tetramethyl-5-
(triethylsllanyloxy)-nona-2, $-frans-dienyl ester (156):
OTES OTES
1. CpZrCI, Me3AI
PivO
Me e Me
H20(cat.), -30 C PivO
Me Me Me
15
2. 12 78% 756
251
To a solution of Cp2ZrC12 (0.22 g, 0.73 mmol) in CH2CI, (15 mL) at —20 oc was added a
solution of trimethylalane (2 M in hexane, 1.60 mL, 3.20 mmol). The reaction mixture
was stirred for another 30 min at —20 °C before water (13.00 mg, 0.73 mmol) was added.
After 30 mm, a solution of 155 (0.45 g, 1.42 mmol) in CH2CY2 (4 mL) was added. The
reaction mixture was stirred for another 3 h at —20 °c before a solution of iodine (0.76 g,
3.00 mmoÏ) in THF (3 mL) was added dropwise. After 10 mm, the mixture was warmed
to room temperature, and a saturated solution of NaHCO3 (10 mL) was added slowly
with vigorous stinÏng. The mixture was extracted with diethyl ether (30 mL x 3). The
combined ether extract was dried over Na2SO4, concentrated in vacuo. The residue was
purified by column chromatography (E/H=1:50) to afford 156 (0.59 g, 78%);
[ŒJD -7.8 1 ° (e 0.84, cH2cl2),
1H NMR (C6D6, 400 MHz) 6 0.65 (q, J 7.96 Hz, 6H), 0.76 (d, 1=6.80 Hz, 3H), 0.95 (d,
J=6.96 Hz, 3H), 1.06 (t, J=7.96 Hz, 9H), 1.26 (s, 9H), 1.59 (d, J=1.21 Hz. 3H), 1.68-1.78
(m, 1H), 1.79 (s, 3H), 1.89 (dd, J=l0.84, 12.90 Hz, 1H), 2.40 (dd, 1= 12.9, 3.52 Hz, 1H),
2.50-2.57 (m, 1 H), 3.31 (t, J =4.76 Hz, 1H), 4.53 (d, J =12.56 Hz, 1H), 4.58 (d, J=12.52
Hz, 1H), 5.67 (d, J=9.48 Hz, 1H), 5.84 (s, 1H);
‘3c NMR (c6D6, 100 MHz) 65.50,7.00, 13.66, 15.81, 18.42, 23.01, 26.96, 35.44, 35.63,
38.43, 42.42, 69.06, 75.40, 80.63, 129.8, 130.2, 147.6, 178.9;
IR (thin film) vmax 2958, 2875, 1731, 1457, 1377, 1281, 1149, 1097, 1281, 1149, 1097,
1035, 735, 668 cm1;
HRMS: C24HO3Si1 (M+1), calcd: 535.21045, found: 535.21230.
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(4R, 5S, 6S)-9-Iodo-2, 4, 6, 8-tetramethyl-5-(triethylsilanyloxy)-nona-2, 8-trans-dien-
1-ol (157):
OTES OTES
Ioluetie -78
156 92, 157
To a stirred solution of 156 (0.12 g, 0.22 mmol) in toluene (6 mL) at —78 oc was added
dropwise Dibal-H (0.50 M in toluene, 1.10 mL, 0.56 mmol) under nitrogen. The reaction
mixture was stirred at this temperature for f h before being quenched with saturated
NH4C1 solution (15 mL). The resulting mixture was warrned to room temperature and
extracted with ether (25 mL x 3) immediately. The extracts were dried over Na2SO4, and
then filtered. The solvent was removed in vacuo and the residue was subjected to the
column chromatography (E/H=1:6) to afford 157 (0.10 g, 92%) as a colorless ou;
[Œ] .15.020 (c 1.0, hexane)
‘H NMR (C6D6, 300 MHz) 0.67 (q, 1=7.89 Hz, 6H), 0.78 (d, 1=6.69 Hz, 3H), 0.99 (d,
Jtz6.93 Hz, 3H), 1.06 (t, J7.89 Hz, 9H), 1.65 (d, J=1.32 Hz, 3H), 1.77 (d, 1=0.42 Hz,
3H), 1.72-1.79 (m, 1H), 1.91 (dd, J=10.71, 10.74 Hz, 1H), 2.43 (dd, 1=12.99, 3.09 Hz,
1H), 2.56-2.60 (m, 1H), 3.34 (t, J=4.41 Hz, 1H), 3.87 (d, J 0.87 Hz, 1H), 5.62 (dd, J
=9.78, 0.84 Hz, 1H), 5.83 (s, 1H);
‘3c NMR (C6D6, 100 MHz) 5.53, 7.03, 13.53, 15.97, 18.63, 23.25, 35.38, 35.62, 42.43,
68.34, 75.40, 80.89, 127.77, 134.07, 146.74;
IR (thin film) vmax 3326, 2957, 1480, 1457, 1414, 1377, 1272, 1238, 1142, 1096, 1038,
1000, 968, 851, 784, 737 cm1;
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HRMS: C19H36O2Si1 (M-1), calcd: 451.15292, found: 451.15210.
(4R, 5S, 6S)-9-Iodo-2, 4, 6, 8-tetramethyl-5-(trfethylsilanyloxy)-nona-2, 8-trans-
dienal (158):
OTES O OTES
HOÇi
Me Me Me Me Me Me Me Me
157 158
To a stirred solution of 157 (0.50 g, 1.10 mmol) in CH2C12 (1$ mL) at room temperature
was added Mn02 (0.4$ g, 5.50 mmol) in one portion. The mixture was stirred at room
temperature for 2 h and then filtered tlirough Celite. The Celite pad was washed with
CH2CI2 (40 mL) and the filtrate was concentrated in vactto. The residue was purified by
column chromatography (F/H=9:1) to give 158 (0.45 g, 90%);
[Œ]D -0.96 O (c 1.67, hexane).
‘H NMR (C6D6, 300 MHz) 0.59 (q, J = 8.04 Hz, 6H), 0.64 (d, J=6.88 Hz, 3H), 0.85 (d,
J=6.93 Hz, 3H), 1.00 (t, J=8.04 Hz, 9H), 1.56-1.64 (m, 1H), 1.71 (d, J=0.56 Hz, 3H),
1.75 (d, J=1.32 Hz, 3H), 1.75-1.85 (m, 1H), 2.23 (dd, J=13.08 Hz, 3.09 Hz, 1H), 2.61-
2.66 (m, 1H), 3.31 (dd, J=3.56, 5.16 Hz, 1H), 5.80 (s, 1H), 6.4$ (dd, J=9.4$, 1.32 Hz,
1H), 9.40 (s, 1H);
‘3c NMR (C6D6, 100 MHz) 5.39, 6.89, 9.17, 15.23, 17.62, 23.17, 36.08, 36.19, 42.62,
75.84, 79.87, 138.18, 146.06, 154.59, 193.68;
IR (thin film) vmax 2958, 2876, 1691, 1643, 1456, 1414, 1379, 1272, 1239, 1144, 1096,
1034, 1010, 968, 852, 739 cm’;
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HRMS: C19H34O2Si1 (M-1), calcd: 449.13730, found: 449.13800.
(6R, 7S, 8S)-1 1-Iodo-2-methyl-4, 6, 8, 10-tetramethyl-7-(triethylsilanyloxy)-undeca-
2, 4, 10 -trans-trïenoic acid methyl ester (G29):
OTES OTES
1. LiHMDSMeQ2COMe
158 80% G29
To a stirred solution of methyl methoxy acetate (0.10 g, 0.10 mL, 1.00 mmol) in THF (3
mL) at —78 °C was added LiHMDS (1 M in THF, 0.60 mL, 0.60 mmol). The reaction
mixture was stirred at —78 °C for 0.5 h before a solution of 158 (0.090 g, 0.20 mmol) in
THF (1 mL) was added. The mixture was then stirred at —7$ °C for 2 h, after which TLC
indicated no aldehyde remained. The reaction mixture vas quenchcd with dilute aqueous
NH4CI and extracted with diethyl ether (15 mL x 3). The combined ether extracts were
dried over sodium sulfate and concentrated in vacuo. Column chromatography
(E/H=1 :70) of the residue afforded the ‘y-hydroxy ester (0.096 g, 86%). The mixttire was
used for the next step directly.
To a solution of the above y-hydroxy ester (0.10 g, 0.18 mmol) in CH2CÏ2 (2 mL) was
added MsC1 (0.041 g, 27 fiL, 0.36 mmol) and Et3N (0.055 g, 75 !IL, 0.54 mmol). The
reaction mixture was stirred at room temperature for 3 h before DBU (0.054 g, 55 iL,
0.36 mmol) was added. The reaction mixture was stirred for another 2 h and then
quenched with aqueous NH4CI. The resulting mixture was extracted with diethyl ether (5
mL x 3). The combined ether extracts were dried over Na2SO4 ami then concentrated
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under reduced pressure. Chromatography (E/H=1 :4) of the residue afforded 4 (0.077 g,
80%);
[ŒID —1.24 ° (c 1,23, hexane);
‘H NMR (C6D6, 400 MHz) 0.63 (q, J = 7.96 Hz, 6H), 0.74 (d, J=6.76 Hz, 3H), 0.96 (d,
J=6.88 Hz, 3H), 1.02 (t, J=7.96 Hz, 9H), 1.62-1.68 (m, 1H), 1.72 (s. 3 H), 1.85 (dcl,
J1=10.32, 13.34 Hz, 1H), 2.10 (cl, J=1.24 Hz, 3H), 2.3$ (dd, J=9.76, 3.98 Hz, 1H), 2.63-
2.71 (m, 1H), 3.33 (dd, J 5.02, 3.96 Hz, 1H), 3.40 (s, 3H), 3.60 (s, 3H), 5.81 (s, 1H),
6.05 (cl, J=9.22 Hz, 1H), 6.91 (d, J=0.96 Hz, 1H);
‘3C NMR (C6D6, 100 MHz) 5.48, 6.98, 14.83, 15.67, 18.19, 23.19, 35.76, 36.01, 42.57,
50.95, 59.43, 75.53, 80.56, 128.75, 130.69, 140.53, 143.45, 146.53, 164.45;
IR (thin film) vmax 2956, 2874, 1749, 1457, 1378, 1272, 1237, 1147, 1102, 1041, 1011
cm’;
HRMS: C13H42IO4Si (M+1), calcd: 537.18972, found: 537.18877.
4-(1 -{2-[2,4-Bis-(tert-butyldimethylsilanyloxy)-3,5-dimethylhexyl]
-[1 ,3]-dithian-2-
y l}-ethyl)-6-(tert-butyldiphenylsilanyloxymethyl)-2,2,5-trimethyl-[1 ,3] -dioxane
(159):
t-BuLi, HMPA
THF, -78CC, 8
TflSO OTBS
then
81%
Me
G16
Me tle
159
256
To a solution of G,6 (0.5$ g, 1.06 mmol) in THF (5 mL) at —7$ °C were added HMPA
(0.74 mL, 4.26 mmol) and tert-butyl lithium (1.70 M in pentane) until yellow color
remained, and then more tert-butyl lithium (1.70 M in pentane, 0.75 mL, 1.27 mmol) was
added. The resulting orange mixture was stirred for one hour at —78 °C before a solution
of G38 (0.7 1 g, 1.41 mmol) in THF (3 mL) was added. The reaction was continued for 2 h
at —78 °C, and then quenched with saturated NH4C1. The reaction mixture was extracted
with EtOAc (15 mL x 3) and dried over Na2SO4. The residue was purified by column
chromatography (E/H=1:30) to give 159 (0.79 g, 81%) as a foam;
[Œ]D +8.83 O (c 1.18, CHCI3);
‘H NMR (CDC13, 400 MHz) 0.105 (s, 3H), 0.173 (s, 3H), 0.21 (s, 3H), 0.23 (s, 3H),
0.84-1.0 (m, 30H), 1.09 (s, 9H), 1.117 (d, J=6.$$ Hz, 3H), 1.29 (s, 3H), 1.30-1.37 (m,
2H), 1.38 (s, 3H), 1.75-2.0 (m, 4H), 2.1-2.18 (m, 1H), 2.23 (d, J=6.92 Hz, 1H), 2.52-2.62
(m, 2H), 2.90 (d, J=12.08 Hz, 2H), 3.64-3.74 (m, 3H), 3.88-3.91 (m. 1H), 4.06 (d, J=7.84
Hz, 1H), 4.41 (d, J=7.2$ Hz, 1H), 7.4-7.5 (m, 6H), 7.11-7.76 (m, 4H);
‘3C NMR (CDCÏ3, 100 MHz) 6-4.41,-3.34, -2.92, -2.46, 9.23, 9.39, 11.92, 15.92, 18.34,
18.62, 19.11, 21.84, 23.13, 26.25, 26.73, 30.32, 37.12, 41.00, 41.41, 45.36, 57.49, 63.36,
69.65, 70.17, 73.50, 77.88, 100.30, 127.52, 127.56, 129.53, 129.56, 133.54, 133.68,
135.48, 135.56;
IR (thin film) vmax 2930, 2856, 1471, 1428, 1380, 1362, 1251, 1224, 1177, 1112, 1056,
1022, 835, 773, 736, 702 cm1.
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[6-(1-{2-[2,4-Bis-(tert-butyldimethylsilanyloxy)-3,5-dimethylhexylJ
-[1,3]-dithian-2-
yl}ethyl)-2,2,5-trimethyl-[1,3J-dioxan-4-ylJ-methanol (160):
TBSO TSO O0 TBSO TBSO 0<0
TBAF-HOAc
159 160
To a solution of 159 (0.33 g, 0.35 mmol) in 111F (3 mL) at room temperature was added
TBAF-AcOH (0.95 M in THF, 0.75 mL, 0.71 mmol). The resulting mixture was stirred
for 9 h before being diluted with EtOAc (15 mL), washed with saturated NaHCO3 (10
mL x 3) and then dried over Na2SO4. The residue was purified by chrornatography
(E/H=Ï:4) to give the alcohol (0.22 g, 91%) as a colorless ou;
[ŒJn +1.49 O (c 0.87, CHCÏ3);
‘H NMR (CDCI3, 400 MHz) 6 0.069 (s, 3H), 0.15 (s, 3H), 0.7$ (s, 3H), 0.19 (s, 3H),
0.86-0.97 (m, 30H), 1.15 (d, J=9.36 Hz, 3H), 1.34 (s, 3H), 2.21 (d, J=9.41 Hz, 1H), 2.5-
2.62 (m, 2H), 2.85 (d, J=2.6 Hz, 18.2 4Hz, 2H), 3.55 (dd, Jtt4.72, 15.22 Hz, 1H), 3.62-
3.89 (m, 2H), 3.87-3.97 (m, 1H), 4.08 (d, J=10.6 Hz, 1H), 4.38 (dt, J=9.24, 2.2$ Hz, 1H);
‘3C NMR (CDC13, 100 MHz) 6 -4.46, -3.3$, -3.0 1, -2.53, 9.20, 9.33, 12.09, 14.04, 15.87,
18.27, 18.54, 2 1.75, 23.89, 24.17, 25.05, 25.77, 25.88, 25.99, 26.17, 30.28, 37.04, 40.74,
41.35, 45.32, 57.34, 62.36, 70.12, 70.43, 73.33, 77.80, 100.4$;
IR (thin film) vmax 3436, 2931, 2856, 1472, 1382, 1251, 1226, 1171, 1142, 1113, 1056,
1022, 835, 773 cm;
HRMS: C34H69O5Si2S2 (M-1), calcd: 677.41248, found: 677.40990.
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6-(1 -{2-[2,4-Bis-(tert-butyldimethylsilanyloxy)-3,5-dimethylhexylj-[1,3Jdithian-2-
yl}ethyl)-2,2,5-trimetbyl-[1,3Jdioxane-4-carbaldehyde (161):
TBSO TS0 OO TSO SO O<O
DMSOEt3N
LJLCHO
160 161
To a solution of 160 (0.24 g, 0.36 mmol) in CH2CI2 (4 mL) at room temperature were
added dimethylsulfoxide (1.00 mL, excess), triethylamine (0.18 g, 0.25 mL, 1.80 mrnoÏ),
S03Py (0.23 g, 1.44 mmcl) in that order. The reaction mixture was stirred for 2 h at room
temperature before was quenched with saturated NH4C1 (6 mL). The resulting mixture
was extracted with ethyl acetate (15 mL x 2). The combined extracts were dried over
Na2S04 and then concentrated in vacuo. The residue was purified by column
chromatography (EfH1:7) to give the aldehyde (0.23 g, 91%) as a colorless ou which
was used in the next step right away. TLC: EIH = 1:5, Rf = 0.35.
1 -[6-(1 -{2-[2,4-Bis-(tert-buty)dimethylsilanyloxy)-3,5-dimethylhexylj-[1,3]
-dithian-2-
yI}-ethyl)-2,2,5-trimethyl[1,3J-dioxan-4-ylJ-prop-2-yn-1-ol (162):
TO TflSO O><O TBsO TBSO OO
Me Feeue
161 162
To a solution of 161 (1.00 g, 1.47 mmcl) in THF (15 mL) at —20 oc was added the
ethynyl magnesium bromide (5.95 mL, 0.5 M, 2.95 mmcl). The reaction mixture was
stirred at —20 °c for 1 h before being quenched with saturated aqueous NH4CI (20 mL).
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The mixture was extracted with EtOAc (30 mL x 3) and dried over Na2SO4. The solvent
was removed in vacuo and the resulting residue was purified by column chromatography
(E/H=1:15-1:10) to afford 162-R-isomer (0.40 g, 38.6%) and 162-S-isomer (0.52 g,
50.3%) as colorless oils;
For 161-R-isomer
[a]0 +9.86 ° (c 1.73, CHC13);
‘H NMR (CDCÏ3, 400 MHz) 0.062 (s, 3H), 0.13 (s, 3H), 0.17 (s, 3H), 0.19 (s, 3H),
0.81-0.95 (m, 27H), 1.99 (d, J=6.76 Hz, 3H), 1.16 (d, J=6.64 Hz, 3H), 1.34 (s, 3H), 1.39
(s, 3H), 1.70 (dd, J=2.44, 15.88 Hz, 1H), 1.78-1.90 (m, 2H), 1.93-2.15 (m, 4H), 2.23 (q,
J=7.00 Hz, 1H), 2.47 (d, J2.16 Hz, 1H), 2.50-2.62 (m, 2H), 2.78-2.92 (m, 2H), 3.68 (dd,
J=1.04, 7.04 Hz, 1H), 3.81 (dd, J=4.64, 9.32 Hz, 1H), 4.09 (d, J=7.68 Hz, 1H), 4.31 (d,
J=9.32 Hz, 1H), 4.37 (d, J=7.04 Hz, 1H);
‘3c NMR (CDC13, 100 MHz) -4.45, -3.37, -2.99, -2.53, 9.21, 9.31, 12.05, 13.97, 15.88,
18.2$, 18.56, 21.73, 22.51, 22.55, 23.69, 24.15, 25.06, 25.74, 25.91, 25.99, 26.18, 30.32,
36.83, 41.02, 41.42, 45.43, 57.30, 62.03, 70.11, 73.19, 73.60, 74.14, 77.83, 80.48, 80.48,
101.10;
IR (thin film) vmax 3500, 2954, 2930, 1471, 1383, 1250, 1223, 1056, 1024, 835, 722
cm1.
For 162-S-fsomer:
{Œ] +8.53 O (c 0.9 1, CHC13);
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‘H NMR (CDC13, 300 MHz) 6 0.007 (s, 3H), 0.14 (S, 3H), 0.18 (s, 3H), 0.19 (s, 3H),
0.80-0.92 (m, 27H), 1.05 (d, J=6.81 Hz, 3H), 1.17 (d, J=6.96 Hz, 3H), 1.33 (s, 3H), 1.41
(s, 3H), 1.7-1.95 (m, 4H), 1.95-2.18 (m, 4H), 2.25 (q, J=7.02 Hz, 1H), 2.50 (d, J=2.07
Hz, 1H), 2.50-2.62 (m, 2H), 2.78-2.96 (m, 2H), 3.6$ (dU, J=1.20, 7.11 Hz, 1H), 3.85 (du,
J=4.71, 8.28 Hz, 1H), 4.11 (U, J=7.74 Hz, 1H), 4.3$ (dd,J=2.04, 8.23 Hz, 1H);
‘3C NMR (CDC13, 100 MHz) 6 -4.45, -3.39, -2.99, -2.50, 9.17, 12.36, 15.89, 18.29,
18.57, 21.77, 23.68, 24.19, 24.90, 25.79, 25.91, 26.00, 26.19, 30.29, 36.97, 41.40, 45.39,
57.37, 61.91, 70.12, 71.51, 73.55, 76.57, 83.09, 100.90;
IR (thin film) vmax 3426, 3311, 2955, 2930, 2856, 1471, 1462. 1251, 1222, 1172, 1143,
1112, 1055, 1026, 836, 773 cm1;
HRMS: C36H71O5S12S2 (M+ 1), calcd: 703.42815, found: 703.42728.
Conversion of 162-R-isomer to 162-S-isomer:
TBSQ TBSO OO
rH
162-R 93%
To a solution of the 162-R-isomer (0.50 g, 0.71 mmol) in CH2C12 (15 mL) at room
temperature was added Dess-Martin reagent (0.77 g, 2.13 mmol) in one portion. The
reaction mixture was stirred for 1.5 h and TLC showed the reaction completed. The
reaction mixture was concentrated in vacuo and the residue was subjected directly to
column chromatography (H/E=30: 1) to afford the ketone (0.46 g, 92%);
162-S
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1fl NMR (CDC13, 300 MHz) 0.068 (s, 3H), 0.14 (s, 3H), 0.17 (s, 3H), 0.19 (s, 3H),
0.84-0.95 (m, 27H), 0.99 (d, J=6.76 Hz, 3H), 1.21 (d, 1=6.99 Hz, 3H), 1.34 (s, 3H), 1.4$
(s, 3H), 1.71 (dd, J=2.22, 15.72 Hz, 1H), 1.80-1.95 (m, 2H), 1.96-2.18 (m, 3H), 2.27 (q,
1=7.05 Hz, 1H), 2.35-2.45 (m, 1H), 2.52-2.64 (m, 2H), 2.80-2.95 (m, 2H), 3.33 (s, 1H),
3.67 (d, J=7.17 Hz, 1H), 4.16 (d, J=7.68 Hz, 1H), 4.36-4.42 (m, 1H), 4.53 (d, J=4.89 Hz,
1H);
‘3C NMR (CDCI3, 100 MHz) -4.44, -3.35, -2.96, -2.54, 9.26, 9.30, 12.58, 14.00, 15.86,
18.29, 18.58, 21.71, 22.57, 23.56, 24.10, 25.03, 25.79, 25.8$, 25.98, 26.19, 29.24, 29.54,
30.34, 31.80, 38.56, 40.96, 42.33, 45.35, 57.14, 70.06, 73.51, 76.37, 80.54, 101.65,
184.84;
To a solution of the above ketone (0.42 g, 0.68 mmol) in CH2C12 (19 mL) at —78 °C was
added Super-hydride solution (1 M in THF, 2.65 mL, 2.65 mmol). The reaction mixture
was stirred at —78 oc for 2 h before was quenched with saturated aqueous ammonium
chloride solution (20 mL). The resultïng mixture was warmed to room temperature,
extracted with ethyl acetate (30 mL x 3). The combined organic extracts were dried over
Na2SO4, filtered and concentrated. column chromatography (H/E=20:1) of the residue
afforded 162-S-isomer (0.44 g, 93%).
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4-(1-{2-[2,4-Bis-(tert-butyldimethylsilanyloxy)-3,5-dimetliylhexylJ-[1,3J-dithian-2-
yI}ethyl)-(1-methyoxyprop-2-ynyl)-2,2,5-trimethyl-[1,3]-dioxane (163):
SO IBSO s O<O so so
162-S 163
To a solution of 162-S isomer (0.4 1 g, 0.58 mmol) in THF (10 mL) at —20 oc was added
t-BuOK (0.70 mL, 1 M, 0.70 mmol). The mixture was stirred 0.3 h before methyl iodide
(0.099 g, 0.044 mL, 0.70 mmol) was added dropwise. The reaction mixture was stirred at
—20 °c for 1 h. The reaction mixture was quenched with saturated aqueous ammonium
chloride and extracted with ethyl acetate (30 mL x 3). The combined organic extracts
were dried over Na2SO4 and concentrated in vacuo. The residue was purified by column
chromatography (HIE=15:1) to give 163 (0.36 g, 86%) as a colorless ou;
[Œ]D +12.24 O (c 0.2.96, cHcl3);
‘H NMR (cDcl3, 400 MHz) 0.063 (s, 3H), 0.14 (s, 3H), 0.17 (s, 3H), 0.19 (s, 3H),
0.82-0.96 (m, 30H), 1.15 (d, J=6.96 Hz, 3H), 1.33 (s, 3H), 1.39 (s, 3H), 1.72 (dd, J=2.04,
15.72 Hz, 1H), 1.1.82-2.04 (m, 4H), 2.05-2.16 (m, 2H), 2.23 (q, J=7.00 Hz, 1H), 2.44 (s,
1H), 2.50-2.62 (m, 2H), 2.80-2.96 (m, 2H), 3.44 (s, 3H), 3.67 (d, J=7.08 Hz, 1H), 3.88 (d,
J=1.92 Hz, 1H), 4.07 (d, J=7.22 Hz, 1H), 4.37 (d, J=7.20 Hz, 1H);
‘3c NMR (cDcl3, 100 MHz) -4.46, -3.41, -3.00, -2.50, 9.12, 9.23, 11.85, 15.90, 18.29,
18.57, 21.78, 23.66, 24.20, 24.71, 25.76, 25.93, 26.00, 26.19, 30.28, 37.07, 41.15, 41.42,
45.46, 56.40, 57.42, 70.11,70.32,70.53,73.41,73.90,77.87, 81.1 1, 100.83;
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IR (thin film) vmax 2955, 2938, 1472, 1470, 1382, 1252, 1225, 1147, 1095, 1057, 1024,
836, 773, 668 cm1;
HRMS: C7H73O5Si2S2 (M+1), calcd: 717.44379, found: 717.44170.
2-{2- [2,4-Bis-(tert-butyldimethylsilanyloxy)-3,5-dimethylhexyl] -[1,3] -dithian-2-yI}-6-
methoxy-4-methyl-oct-7-yn-3,5-diol (164):
TBSO TBSO 00 TBSO TSO OH OH
MeOHCSA
163 164
To a solution of 163 (0.25 g, 0.35 mmol) in MeOH (10 mL) at O °C was added CSA
(0.081 g, 0.35 mmol) and the reaction mixture was stirred for 2 h, after which TLC
indicated that a by-product began to form. The reaction mixture was quenched with
saturated aqueous sodium bicarbonate solution (15 mL), extracted with ethyl acetate (15
mL x 3). The combined organic extracts were dried over Na2SO4, and concentrated in
vacuo. The residue was purified by column chromatography (E/H=1:15) to give
recovered 164 (0.10 g, 40%) and the diol (0.12 g, 86% based on recovered starting
material) (H!E= 4:1);
[Œ]D +5.20 O (c 01.7 1, CHCÎ3);
1H NMR (C6D6, 400 MHz) 0.31 (s, 3H), 0.42 (s, 3H), 0.44 (s, 3H), 0.51 (s, 3H), 1.08
(d, J=7.0 Hz, 3H), 1.12-1.20 (m, 27H), 1.27 (d, J=7.0 Hz, 3H), 2.07 (d, J=2.00 Hz, 1H),
2.08-2.30 (m, 3H), 2.30-2.61 (m, 8H), 3.25 (s, 3H), 3.94 (d, J=7.48 Hz, 1H), 4.02 (dd,
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1=1.88, 7.6$ Hz, 1H), 4.25 (d, J=7.0 Hz, 1H), 4.67 (t, J=6.52 Hz, 1H), 4.78 (d, 1=8.52
Hz, 1H);
‘3c NI’W (CDC13, 100 MHz) -4.36, -3.27, -3.00, -2.33, 7.99, 9.01, 11.45, 15.65, 18.40,
18.54, 21.04, 24.39, 26.01, 26.12, 26.18, 26.27, 30.53, 38.75, 40.84, 41.13, 43.67, 56.66,
57.56, 770.53, 73.79, 73.41, 75.45, 78.11, 80.95;
IR (thin film) vmax 3469, 3309, 2955, 2929, 2856, 1471, 1387, 1360, 1252, 1112, 108$,
1055, 835, 772 cm1;
HRMS: C34H68O5Si2S2 (Mj, calcd: 676.40466, found: 676.40790
2-{2-[2,4-Bis-(tert-butyldimethylsilanyloxy)-3,5-dfmethylhexyl]- [1 ,3]-dithian-2-yI}-6-
methoxy-4-methyl-5-triethylsilanyloxy-oct-7-yn-3-oI (165):
THSO TBSO OH OH TOSO TBSO OH OTES
TESnDMAP
164 165
To a solution of 164 (0.089 g, 0.13 mmol) in THF-DMF (3:1, 3 mL) at room temperature
was added DMAP (0.36 g, 0.30 mmol) and TESCI (0.034 mL, 0.030 g, 0.20 mmol). The
reaction mixture was stirred at room temperature for 18 h before being quenched with
saturated aqueous ammonium solution (8 mL). The resulting mixture was extracted with
EtOAc (14 mL x 3) and dried over Na2SO4, The solvent was removed under reduced
pressure and the residue was purified by column chromatography (E/H=1 :8) to give 165
(0.36 g, 87%);
[Œ] +3.89 O (c 0.54, CH2CI2);
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‘H NMR (C6D6, 300 MHz) 0.33 (s, 3H), 0.438 (S, 3H), 0.439 (s, 3H), 0.53 (s, 3H), 0.95
(t, J=7.55 Hz, 6H), 1.11 (d, J:=6.93 Hz, 3H), 1.10-1.25 (m, 39H), 1.60-1.72 (m, 1H), 2.01-
2.12 (m, 2H), 2.13 (d, J=2.04 Hz, 1H), 2.29-2.49 (m, 6H), 2.49-2.68 (m, 3H), 3.35 (s,
3H), 3.95 (dd, J=1.29, 7.72 Hz, 1H), 4.02 (dd, 1=2.04, 6.81 Hz, 1H), 4.57 (dd, J=1.74,
6.81 Hz, 1H), 4.67 (cld, J=6.52, 12.3 Hz, 1H), 4.80 (dd, 1=1.26, 9.09 Hz, 1H);
‘3C NMR (CDCI3, 100 MHz) -4.28, -3.34, -2.75, -2.36, 5.40, 6.40, 7.06, 7.31, 8.93,
11.20, 15.60, 18.43, 18.66, 21.51, 24.24, 25.78, 26.02, 26.12, 26.40, 30.56, 39.12, 40.08,
41.17, 44.25, 55.89, 57.88, 70.68, 72.01, 75.05, 74.04, 75.09, 78.50, 8 1.98;
IR (thin film) vmax 3436, 1472, 1470, 1382, 1253, 1056, 1027, 836, 773 crn’;
HRMS; C40H83O5Si3S2 (M+1), calcd: 791.49898, found: 791.49803.
2-{2-[2,4-Bis-Qert-butyldimethylsilanyloxy)-3,5-dimethyl-hexyll-[1,3J-dithian-2-yl}-
6-methoxy-4-methyl-8-tributylstannanyl-5-triethylsilanyloxy-oct-7-en-3-oI (G28):
TBSO TBSO S OH OTES 1H50 TBSO S s OH OIES
Pd(PPhCI2(cat)
165 G28
To a solution of 165 (0.30 g, 0.38 mmol) in TNF (10 mL) at O °C was added
Pd(PPh3)2C12 (0.013 g, 0.019 mmol). Bu3SnH (0.17 g, 0.57 mmol) was then added
dropwise and the reaction mixture was stirred at O °C for 1 h. TLC ïndicated that ail the
starting material reacted. The mixture was concentrated in vacuo and the residue was
subjected to column chromatography (E/H=1: 100, with 1% Et3N as a stabilizer) to give
G23 (0.36 g, 87%);
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[Œ]D -2.79 0 (c 0.43, CHC13);
‘H NMR (C6D6, 400 MHz) 0.23 (s, 3H), 0.35 (s, 3H), 0.37 (s, 3H). 0.70-0.83 (rn, 6H),
0.94 (t, J=7.32 Hz, 9H), 0.97-1.16 (m, 45 H), 1.18 (d, J=6.96 Hz, 1H), 1.25-1.30 (m, 1H),
1.30-1.38 (m, 1H), 1.38 (q, .1=7.28 Hz, 6H), 1.50-1.66 (m, 7H), 1.98-1.21 (m, 1H), 2.20-
2.36 (m, 3H), 2.38-2.46 (m, 2H), 2.48-2.62 (m, 4H), 3.25 (s, 3H), 3.72 (t, J=7.0 Hz, 1H),
3.8$ (d, J=7.62 Hz, 1H), 4.33 (d, J=7.0 Hz, 1H), 4.61 (dd, J=5.24, 10.44 Hz, 1H), 4.73
(d, J=8.32 Hz, 1H), 6.15 (dd, J7.04, 19.08 Hz, 1H), 6.3$ (d, 1=19.08 Hz, 1H);
‘3C NMR (C6D6, 100 MHz) -6.7 1, -5.77, -5.17, -4.78, 3.10, 4.63, 5.13, 6.43, 6.94, 9.94,
11.12, 13.29, 16.07, 16.24, 19.19, 21.83, 23.37, 23.63, 23.71, 23.97, 24.95, 26.82, 28.13,
36.77, 38.48, 38.83, 41.98, 53.20, 55.84, 68.27, 70.02, 73.52, 76.22, $5.28, 130.55,
140.74;
R (thin film) vmax 2956, 2928, 2856, 1463, 1380, 1250, 1112, 1082, 1047. 835 cm’;
1$-{2-[2,4-Bis-(tert-butyldimethylsilanyloxy)-3,5-dimethylhexylJ
-[1,3]dithian-2-yl}-
17-hydroxy-2,14-dimethoxy-4,6,8,1O,16-pentamethyl-7,15-bis-
triethylsilanyloxynonadeca-2,4,1O,12-tetraenoic acid methyl ester (166):
OTES
+
G28 G29
0Mo Me Me
A
Mo0C
OTES
EIPEPh35OC
166
267
To a solution of G29 (0.050 g, 0.092 mmol) in THF-DMF (1:1, 3 mL) at 50 oc was added
diisopropylethylamine (0.12 mL, 0.93 mmol), triphenylarsine (0.14 g, 0.46 mmol) and
Pd(dppOCl2 catalyst (0.022 g, 0.027 mmol). After 10 mm, G28 (0.10 g, 0.092 mmol) in
THF (1 mL) was added. The reaction mixture was stined at 50 oc for 9 h (the color of
the reaction changed from red to black), at which point, TLC indicated that no starting
material remained. The reaction mixture was quenched with icy water (5 mL) and
extracted with ethyl acetate (15 mL x 3). The combined extracts were dried over Na2SO4,
concentrated in vacuo. Chromatography of the cmde product (E/H=1: 15) to afford 166
(0.066 g, 60 %) as a colorless oil;
[Œ] +20.33 O (cl.50, cH2cl2);
‘H NMR (c6D6, 400 MHz) 0.33 (s, 3H), 0.45 (s, 3H), 0.47 (s, 3H), 0.54 (s, 3H), 0.71
(q, J=7.96 Hz, 6H), 0.81 (q, J=7.98 Hz, 6H), 0.9$ (d, J=5.92 Hz, 3H), 1.04-1.22 (m,
51H), 1.27 (d, J=6.92 Hz, 3H), 1.30-1.5 1 (m, 2H), 1.61-1.72 (m, 1H), 1.26 (s, 3H), 1.8$-
1.9$ (m, 1H), 2.12-2.26 (m, 2H), 2.16 (s, 3H), 2.30-2.38 (m, 3H), 2.42-2.52 (m, 2H),
2.53-2.74 (m, 3H), 2.80-2.90 (m, 1H), 3.30 (s, 3H), 3.19 (s, 3H), 3.49 (t, 1=4.02 Hz, 1H),
3.61 (s, 3H), 3.8$ (t, J=7.96 Hz, 1H), 3.97 (d, J=6.56 Hz, 1H), 4.34 (d, J=7.OHz, 1H),
4.70 (dd, J=5.36, 10.04 Hz, 1H), 6.15 (dd, J=9.68, 15.72 Hz, 1H), 6.66 (dd, 1=10.92,
15.22 Hz, 1H), 6.96 (s, 1H);
‘3c NMR (c6D6, 100 MHz) -4.29, -3.34, -2.74, -2.37, 5.37, 5.57, 6.99, 7.01, 7.58, 8.85,
12.26, 14.85, 15.69, 15.73, 16.03, 18.33, 18.52, 18.67, 21.65, 24.26, 25.77, 26.05, 26.12,
26.41, 30.56, 36.06, 36.13, 39.23, 40.72, 41.26, 43.33, 44.51, 50.91, 55.49, 58.14, 59.42,
70.70, 72.37, 76.07, 78.68, 80.07, 84.25, 126.34, 128.88, 130.39, 130.63, 130.94, 137.8 1,
140.79, 143.44, 164.50;
26$
W vmax (thin film) 3468, 2955, 2875, 1722, 1617, 1459, 1382, 1343, 1249, 1105, 1047,
1018, 825, 773 cm’.
18-{2-[2,4-Bis-(tert-butyldimethylsilanyloxy)-3,5-dimethylhexylj
-[1,3jdithian-2-yI}-
7,15,17-trihydroxy-2,14-dimethoxy-4,6,8,1O,16-pentamethylnonadeca-2,4,1O,12-
tetraenoic acid methyl ester (167):
OMe Me Me 0M M M
BeH0T:e0TEsT=H) SOSOH0H
Me Me Me OMe Me166
767
To a solution of 166 (0.035 g, 0.029 mmol) in THF (3 mL) at room temperature was
added TBAF (complexed with AcOH, 1:1, 0.94 M, 0.45 mL, 0.44 mrnol). The reaction
mixture was stirred at room temperature for 1.5 h before was quenched with NaHCO3
solution (5 mL). The resulting mixture was extracted with ethyl acetate (15 mL x 3) and
the combined extracts were dried over Na2$04. The solvent was removed in vacuo and
the resulting residue was purified by column chromatography (E/H=1:6) to afford 167
(0.025 g, 88%) as a colorless oil;
[Œ]D +12.640 (c 1.21, hexane);
‘H NMR (C6D6, 400 MHz) 0.33 (s, 3H), 0.46 (s, 3H), 0.50 (s, 3H), 0.54 (s, 3H), 0.89
(d, J=6.72 Hz, 3H), 0.93 (d, 1=7.04 Hz, 3H), 1.14 (s, 9H), 1.14-1.24 (m, 21H), 1.36 (d,
J=6.96 Hz, 3H), 1.67 (s, 3H), 1.75-1.85 (m, 1H), 1.91 (dd, J=10.16, 13.44 Hz, 1H), 2.09
(d, J=1.24 Hz, 3H), 2.12-2.32 (m, 4H), 2.39-2.60 (m, 6H), 2.60-2.80 (m, 3H), 3.01 (t,
J=4.72 Hz, 1H), 3.19 (s, 3H), 3.44 (s, 3H), 3.55 (s, 3H), 3.73 (t, J=7.96 Hz, 1H), 3.98 (dd,
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were dried over Na2SO4, and concentrated in vacuo. Column chromatography (E/H=1:1)
of the residue afforded 167 (0.026 g, 88%);
[Œ]D +1 8.30 O (c 3.75, CH2C12);
1H NMR (400 MHz, C6D6) 0.33 (s, 3H), 0.46 (s, 3H), 0.50 (s, 3H), 0.54 (s, 3H), 0.89
(d, J=6.64 Hz, 3H), 0.95 (d, J=6.68 Hz, 3 H), 1.12-1.22 (m, 30H), 1.36 (d, J=7.04 Hz,
1H), 1.38-1.48 (m, 1H), 1.60-1.67 (m, 1H), 1.68 (s, 3H), 1.72-1.82 (m, 1H), 1.85-1.95
(m, 1H), 2.08 (s, 3H), 2.12-2.20 (m, 1H), 2.22-2.38 (m, 2H), 2.40-2.60 (m, 5H), 2.62-
2.72 (m, 2H), 3.06 (t, J=6.16 Hz, 1H), 3.21 (s, 3H), 3.57 (s, 3H), 3.75 (t, J=8.00 Hz, 1H),
3.98 (d, J=7.12 Hz, 1H), 4.11 (dd, J=2.20, 7.84 Hz, 1H), 4.74 (d, J=7.60 Hz, 1H), 4.84
(d, J=7.04 Hz, 1H), 5.54 (dd, J=$.36, 15.26 Hz, 1H), 5.89 (d, J=z9.56 Hz, 1H), 6.08 (d,
J=11.OHz, 1H), 6.64(dd,J=11.08, 15.24Hz, 1 H),7.04(s 1H);
‘3C NMR (100 MHz, C6D6) -4.40, -3.39, -2.76, -2.37, 8.77, 9.04, 11.70, 14.61, 15.84,
16.29, 16.38, 17.21, 18.51, 18.67, 21.81, 24.17, 25.78, 26.15, 26.40, 30.51, 34.49, 35.66,
39.25, 40.47, 41.02, 42.43, 44.75, 55.77, 58.16, 59.57, 70.61, 73.14, 73.81, 78.79, 79.89,
83.76, 125.82, 129.30, 130.63, 131.88, 132.19, 139.01, 10.43, 140.43, 142.94, 142,94,
168.43;
IR (thin film) vmax 3440, 2828, 1696, 1151, 1100, 1047, 976, 835, 773 cm’;
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16-(3-{2-[2,4-Bis-(tert-butyldimethylsilanyloxy)-3,5-dimethylhexyl]-[1,3ldithian-2-
yl}-2-hydroxy-1-methylbutyl)-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-
oxacyclohexadeca-3,5,1 1,13-tetraen-2-one (169):
EDO, DMAP
168 169
To a solution of EDCHC1 (0.040 g, 0.02 1 mmol) and DMAP (0.030 g, 0.025 mmol) in
CH2C12 (5 mL) at reflux was slowly added 168 (0.020 g, 0.02 1 mmol) in CH2C12 (3 mL)
through syringe pump over 2.5 h. After the addition was completed, the mixture was
heated at reflux for another 30 min. The solvent was then removed in vacuo ami
chromatography of the residue afforded 169 (0.0 13 g, 65%);
[Œ] +4.00 ‘ (c 0.33, CH2C12);
‘H NMR (400 MHz, C6D6) 6 0.34 (s, 3H), 0.50 (s, 3H), 0.54 (s, 3H), 0.58 (s, 3H), 0.79
(d, J=5.$1 Hz, 3H), 0.93 (d, J=7.0 Hz, 3H), 1.10-1.22 (m, 30H), 1.51 (d, J=6.8$ Hz, 3H),
1.64-1.84 (m, 4H), 1.94 (s, 3H), 2.06 (s, 3H), 2.12-2.32 (m, 4H), 2.48-2.74 (m, 6H), 2.83-
2.93 (m, 2H), 3.18 (s, 3H), 3.73 (s, 3H), 4.01-4.06 (m, 2H), 4.51 (dd, J=5.12, 9.9$ Hz,
1H), 4.73 (d, J=4.80 Hz, 1H), 4.89 (d, J=8.8 Hz, 1H), 5.22 (dcl, J=9.2$, 14.90 Hz, 1H),
5.63 (cl, J=$.$ Hz, 1H), 5.6$ (U, J=10.72 Hz, 1H), 5.8$ (d, J=8.56 Hz, 1H), 6.60 (dU,
J=10.84, 15.0$ Hz, 1H), 6.88 (s, 1H);
‘3C NMR (100 MHz, C6D6) 6 -4.31, -3.34, -2.26, -2.26, 8.57, 8.77, 10.90, 13.94, 15.69,
16.91, 18.53, 18.71, 19.89, 21.56, 21.93, 24.13, 25.65, 25.84, 26.18, 26.44, 30.43, 36.65,
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39.19, 39.57, 40.18, 40.97, 41.23, 44.85, 54.86, 58.48, 59.07, 70.51, 71.22, 76.93, 78.86,
80.35, 82.48, 125.18, 127.47, 13 1.83, 132.79, 133.06, 141.90, 142. 14, 142.59, 166.60;
IR (thin film) vmax 3494, 2927, 2863, 1691, 1462, 1360, 1248, 1098, 1054, 965, 835,
772 cm’;
16-(3- [2-(2,4-Dihydroxy-3,5-dimethylhexyl]-[1,3jdithian-2-yl}-2-liydroxy-1-methyl-
butyl)-$-hydroxy-3,15-dimethoxy-5,7,9,1 1-tetramethyl-oxacyclohexadeca-3,5,11,13-
tetraen-2-one (171):
OMe Me Me OMe Me Me
BSOOHOMh1
MeOH,86
MeMMMe Me Me OMe Me e e
- 169 171
To a solution of 169 (10 mg, 0.011 mmol) in MeOH (0.5 mL) was added TsOH .H20 (6
mg, 0.32 mmol). The reaction mixture was stirred 4 h at room temperature and then was
quenched with triethylamine. The solvent was removed in vacuo. The residue was
purified by column chromatography (E/H=1 :4) to afford 171 (6.5 mg, 86%);
[Œ]D +2.82 O (c 0.50, CH2C12);
‘H NMR (400 MHz, C6D6) 0.79 (d, J=5.88 Hz, 3H), 0.93 (d, J=7.04 Hz, 3H), 1.09 (d,
J=6.76 Hz, 3H), 1.13 (d, J=7.08 Hz, 3H), 1.14 (d, J=6.92 Hz, 3H), 1.21 (d, J=6.56 Hz,
3H), 1.46 (d, J7.08 Hz, 3H), 1.78-1.83 (m, 2H), 1.88-1.93 (m, 2H), 1.94 (s, 3H), 2.00-
2.04 (m, 1H), 2.04 (d, Jt1.16 Hz, 3H), 2.26-2.48 (m, 7H), 2.53-2.62 (m, 2H), 2.81 (dd,
J=9.56, 15.64 Hz, 1H), 2.90-2.94 (m, 1H), 3.17 (s, 3H), 3.44-3.50 (m, 1H), 3.65 (s, 3H),
3.99 (t, J—8.8 Hz, 1H), 4.48 4.56 (m, 1H), 4.78 4.82 (m, 1H), 5.22 (dd, J—9.32, 15.66 Hz,
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[Œ]D —3.27 O (c 0.26, CH2C12) [reported117 for natural bafilomycin A1, [Œ]30D —3.07 O (c
0.26, CH2C12)];
mp 96-97 oc [reported”7 for natural bafilomycin A1, mp: 98.0-99.0 °c];
‘H NMR (600 MHz, c6D6) 0.84 (d, J=6.12 Hz, 3H), 0.96 (d, J=6.90 Hz, 3H), 0.99 (d,
J=7.02 Hz, 3H), 1.02 (d, J=6.78 Hz, 3H), 1.04 (d, J=6.48 Hz, 3H), 1.19 (d, J=6.78 Hz,
3H), 1.28 (d, J=7.2 Hz, 3H), 1.46-1.54 (m, 1H), 1.80-1.28 (m, 2H), 1.94-1.99 (m, 2H),
1.97 (s, 3H), 2.07 (d, J=11.16 Hz, 1H), 2.11 (d, J=1.02 Hz, 3H), 2.37-2.42 (m, 1H), 2.46
(dd, J=4.68, 11.79 Hz, 1H), 2.51-2.58 (m, 1H), 2.96-3.00 (m, 1H), 3.17 (s, 3H), 3.74 (s,
3H), 3.86 (dd, J2.72, 10.32 Hz, 1H), 3.92-3.95 (m, 1H), 4.00 (t, J=9.00 Hz, 1H), 4.60-
4.63 (m, 1H), 5.17 (dd, J=9.42, 15.12 Hz, 1H), 5.26 (d, J=3.3 Hz, 1H), 5.47 (dd, J=L21,
8.76 Hz, 1H), 5.72 (d, J=10.68 Hz, 1H), 5.89 (d, J=1 .36 Hz, 1H), 5.92 (d, J=9.00 Hz, 1H)
6.57 (dd, J=10.74, 15.03 Hz, 1H), 6.92 (s, 1H);
‘3c NMR (100 MHz, C6D6) 7.07, 9.72, 12.00, 13.91, 14.34, 16.91, 19.91, 21.27, 21.48,
28.05, 36.71, 37.16, 40.16, 41.17, 41.23, 42.37, 44.07, 54.83, 58.29, 70.41, 70.80, 75.86,
76.96, 80.35, 82.13, 99.01, 125.12, 127.35, 132.67, 132.79, 133.07, 141.66, 142.59,
167.19;
W (thïn film) vmax 3440, 2965, 2928, 2875, 1689, 1630, 1469, 1382, 1112, 967 cm’;
HRPvIS: C35H5909 (M+1), calcd: 623.4158, found: 623.4258.
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Appendix
nCRYSTAL AND MOLECULAR STRUCTURE 0F
C12 H16 03 COMPOUND fHAN278)
Equioe HANESSIAN
Déartement de chimie, Université de Montréal,
C.P. 612$, Succ. Centre-Ville, Montréal, Québec, H3C 3J7 (Canada)
(1R, 2R)-1 -(2-Hydroxy-ethyl)-6-methoxy-indan-2-ol (8$):
Structure résolue au laboratoire de diftraction des rayons X de l’Université deMontréal par Dr. Michel Simard.
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Table 1. Crystal data and structure refinement for C12 HiC 03.
Identification code
Empirical formula
formula weight
Temperature
Wavelength
Crystal system
Space group
Unit ceil dimensions
Volume
z
Density (calculated)
Absorption coefficient
F (000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
IndeDendent reflections
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-ïit on F2
Final R indices [I>2sigma(I))
R indices (ail data)
Absolute structure parameter
Extinction coefficient
Largest diff. peak and hole
HAN2 78
Cl2 Hl6 03
208.248
293 (2)K
1. 54178À
Monoclinic
P2
a = 5.0988(ll)Â
b = 8.594(3)A
c = l2.516(6)À
546.5(3 )Â3
2
1.2655 Mg/m3
0.732 nrn1
224.0
0.67 x 0.25 x 0.19 mm
3.54 to 69.89°
-6<=h<=6, -lO<=k<=l0, -l5<=1<=lS
8611
2058 [R(int) = 0.032]
Integration
0.8932 and 0.7560
Fuli-matrix least-squares on F2
2058 / 1 / 140
0.974
Rl = 0.0418, wR2 = 0.1109
Ri = 0.0448, wR2 = 0.1139
—0.1(3)
0.061(5)
0.172 and
—0.144 e.À3
a = 90°
F3 = 94.82(3)°
y = 90°
111
Table 2. Atomic coordinates (X 10g’) and equivalent isotropic
dispiacement pararneters (À2 x i03) for C12 8116 03.
U(eq) is defined as one third of the trace of the orthogonalized
lJij tensor.
x y z U(eq)
0(2) 8997(4) 8844(2) 5376(2) 109(1)
0(6) 1452(3) 10327(2) 9916(1) 94(1)
0(11) 8424(5) 5876(2) 5702(1) 112(1)
0(1) 7144(4) 8537(2) 7143(1) 67(1)
C(2) 6930(5) 9247(2) 6016(1) 77(1)
C(3) 6800(5) 11003(2) 6189(2) 83(1)
0(4) 3743(5) 12252(2) 7526(2) 87(1)
0(5) 2411(5) 12041(2) 8455(2) 83(1)
0(6) 2658(4) 10647(2) 9000(2) 75(1)
C(7) 4187(4) 9441(2) 8636(1) 71(1)
Ct8) 5467(4) 9666(2) 7714(1) 66(1)
0(9) 5249(4) 11074(2) 7158(2) 74(1)
0(10) 6360(4) 6823(2) 7214(2) 73(1)
0(11) 8315(5) 5682(2) 6821(2) 83(1)
C(12) —474(5) 11414(3) 10202(2) 95(1)
iv
Table 3. Hydrogen coordinaes (X 10) and isotropic dispiacement
parameters (Â2 x l0) for C12 H16 03.
x y z Ufeq)
H(2) 9196 7897 5383 164
H(1l) 9559 5303 5492 168
H(1) 8969 8644 7447 80
Hf2A) 5262 8910 5641 93
H(3A) 8540 11451 6334 99
H(3B) 5891 11525 5579 99
Hf4) 3603 13194 7159 104
H(5) 1374 12834 8700 100
H(7) 4344 8503 9006 85
H(1OA) 6109 6582 7956 88
H(1OB) 4683 6675 6801 88
H(11A) 10040 5863 7188 100
H(11B) 7783 4627 6974 100
H(12A) 365 12323 10403 143
H(123) —1346 11014 10795 143
H(12C) —1742 11578 9602 143
V
Table 4 Anisotropic parameters (Â2 x 10) for C12 H16 03.
The anisotropic dispiacement factor exponent takes the form:
-2 r2 h2 a*2 Uli + - + 2 h k a* b* U12
Uli 022 U33 U23 U13 U12
0(2) 167(2) 74(1) 98(1) 5(1) 73(1)
—1(1)
0(6) 128(1) 75(1) 82(1) —6(1) 38(1) 18(1)
0(11) 177(2) 80(1) 86(1) —8(1) 49(1) 24(1)
C(1) 88(1) 51(1) 63(1)
—3(1) 18(1)
—4(1)
C(2) 110(1) 61(1) 65(1) 2(1) 22(1)
—4(1)
c(3) 117(2) 56(1) 77(1) 8(1) 22(1)
—5(1)
C(4) 112(2) 53(1) 96(1) 5(1) 14(1) 4(1)
c(5) 106(2) 54(1) 93(1)
—7(1) 19(1) 7(1)
C(6) 98(1) 60(1) 69(1) —7(1) 15(1) 3(1)
C(7) 97(1) 52(1) 65(1) —3(1) 15(1) 4(1)
C(8) 86(1) 48(1) 63(1) —3(1) 8(1)
—1(1)
C(9) 98(1) 50(1) 74(1) 1(1) 13(1)
—4(1)
C(l0) 96(1) 53(1) 75(1) —1(1) 23(1)
—7(1)
C(11) 116(2) 55(1) 83(1) —1(1) 31(1) 3(1)
C(12) 111(2) 87(2) 91(1) —21(1) 26(1) 10(1)
vi
Table 5. Bond lengths [À) and angles [°) for C12 H16 03
0(2)—c (2)
0(6)—C(12)
C(1) —C(8)
C(1)—Ct2)
C(3)-C(9)
C(4) —c(5)
C (6)—c (7)
c(8)—c(9)
1.419(3)
1.423 (3)
1.512(2)
1.532 f2)
1 . 504 (3)
1.407(3)
1.396(2)
1.396(2)
0(6)—c (6)
0(11)—C(11)
C(1)—c(10)
c (2) —c (3)
c(4)—c(9)
c(5)—cf6)
c(7)—c(8)
C(10) —c (11)
1.375(2)
1.417(3)
1.531(2)
1 .527 (3)
1.373(3)
1.379(3)
1.385(3)
1.509(3)
c(6)—of6)—c(12)
ct8) —ctl) —c (2)
o(2)-C(2) -c(3)
c (3)-c (2)-c (1)
C (9) —c (4) —c (5)
o(6)—ct6) —c(5)
C(5)-C(6)
-C(7)
C(7)—c(8)—C(9)
ct9)—C(8)—C(1)
c(4)—ct9) —C (3)
C (11)-c (10)-c (1)
116.45 (18)
100.40(14)
111 . 40 (17)
105.27 (14)
120.28 (18)
123.89(18)
120.95 (18)
120.81(17)
110.19 (16)
130.30 (19)
115.02(16)
c (8) —c (1) —C (10)
c(10)—C(1)—c(2)
0(2) -C (2) -c(1)
c(9)-C(3)-ct2)
C (6) —c f5) —c (4)
0(6) —Cf6) —c(7)
c (8)—c (7)—c (6)
c (7)—c (8)—c (1)
c (4)—c (9)—c (8)
c(8) —c(9)—c(3)
0(11) -C(11) —c (10)
115.39)15)
116.01(15)
115.05(19)
100.77(15)
119.33(19)
115 . 17 (17)
118.90(17)
128.98(16)
119.73 (18)
109.97 (17)
109.15(19)
vii
Table 6. Torsion angles [0] for C12 H16 03.
C (8)—C (1)—c (2)—0 (2)
C(10)—C(1)—C(2)—0(2)
C(8) —cfl)—c(2)
—cf3)
cflO)—C(1)—c(2)—c(3)
0(2)—C(2)—cf3)—Cf9)
c (1)—c (2)—c (3)—c (9)
(9) —cC4)—Ct5) —ct6)
c (12)—0 (6)—cf 6)—c (5)
c(12)—o(6)—c(6)—cf7)
cf4) -c(5)-c(6) -0(6)
C (4) -cf5)-c(6) -Cf7)
0f6)--c(6)—c(7)—C(8)
c(5) —c(6)—c(7) —c (8)
c (6)—c (7)—cf 8)—c (9)
c (6)—c (7)—C (8)—c (1)
ctlO)—Cfl)—cf8)—Cf7)
cf2) —cfl)—c(8) —cf7)
c (10) —Cf 1) —c f 8) —c (9)
Cf2)—c(1)—cf8) —c(9)
C(5) -cf4)-c(9) -c (8)
C(5) —c(4)—cf9) —c(3)
c(7) —cf8)—c(9) —c(4)
C(1) -Cf8)-C(9) -C(4)
C (7) -c (8) -c (9) -c f3)
C(1) -c(8)-Ct9) -Ct3)
c(2) -Cf3)-c(9) -cf4)
Cf 2) -cf 3)-cf 9) -Cf 8)
C(8)—C(1)-CflO)—C(11)
C (2) —cfl)—cflO) —cfll)
Ct1) -C(10) -C fil) -0(11)
157.53(16)
—77.4(2)
34.5 f2)
159.57(17)
—160.58 f18)
—35.2(2)
0.7(3)
10.4(3)
—169.31(18)
179.7(2)
-0.6(3)
179 .83 (18)
0.1(3)
0.3 (3)
—177.76(18)
31.9 (3)
157.45(18)
—146.31(17)
—20.8(2)
-0.3 (3)
178.8(2)
-0.2 f3)
178 .22 (17)
-179 .43(17)
-1.1(2)
—156.6(2)
22.5(2)
—169.34(17)
73.7(2)
—66.5(3)
viii
Table 7. Bond lengths [Â] and angles t°] related to the hydrogen
bonding for C12 H16 03.
D-H d(D-H) d(H. .A) <DHA d(D. .A) .
0(2)—H(2) 0.82 1.83 156.1 2.603(3) 0(l1)*1
0(ll)—H(ll) 0.82 1.85 157.0 2.626(2) 0(2)#2
Symmetry transformations used to generate equivalent atoms:
*1 x,y,z #2 -x+2,y—l/2,—z+l
ix
ORTE? VÎW 0f the C12 H16 03
comoound with the numbering scheme adooted. Ellipsoids drawn at
30% probality level. Hydrogens represented by sphere cf arbitrary size.
C(4)
Ct9)
3)
0(2)
C(8)
C(7)
Ctll)
X
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CRYSTAL A.ND MOLECULAR STRUCTURE 0F
C14 H16 03 C0MPOUND fHAN273)
Equipe HANESSIAN
Département de chimie, Université de Montréal,
C.P. 6128, Succ. Centre-Ville, Montréal, Québec, H3C 3J7 (Canada)
9-(2-Hydroxy-ethyl)-3a, 4, 9, 9a-tetrahydro-3H-naphtho [2, 3-bjfuran-2-one (99):
Structure résolue au laboratoire de diffraction des rayons X de l’Université de
Montréal par Dr. Michel Simard.
xii
Table 1. Crystai dat.a and structure refinement for C14 H16 03.
Identification code
Empirical formula
Formula weight
Temperature
Wavelength
Crystal system
Space group
Unit ceil dimensions
Volume
z
Density (calculated)
Absorption coefficient
F(000)
Crystal size -
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (ail data)
Absolute structure parameter
Extinction coefficient
Largest dif f. peak and hole
HAN273
C14 H16 03
232.268
293 (2)K
1. 54056Â
Orthorhombic
P212121
5.68630(l0)Â
b = 9.6974f2)Â
= 2l.9238(5)À
1208.93 (4)Â3
4
1.2761 Mg/m3
0.722 mm1
496.0
0.76 x 0.34 x 0.33 mm
4.03 to 72.64°
-6c=h<=5, —ll<=k<=ll, -24<=l<=27
6036
2292 [R(int) = 0.0249]
Mul t i - scan
0.8488 and 0.5954
Full—matrix least-sguares on F2
2292 / O / 156
0.980
Ri = 0.0356, wR2 = 0.0926
Rl = 0.0389, wR2 0.0952
—0.1(2)
0.0195 (13)
0.110 and —0.124 e.Â3
= 90°
f3 = 90°
y = 90°
xiii
Table 3. Hydrogen coordinates (x 10g) and isotropic dispiacement
parameters (Â2 x i03) for C14 H16 03.
x y z U(eq)
Hf14) 689 —5031 9224 145
H(2A) 4462 2897 9438 71
1-1(23) 3987 2655 8738 71
Hf3) 6109 876 9494 57
H(4A) 6661 1089 8386 74
3(43) 7015 —378 8671 74
H(6) 5119 636 7385 100
H(7) 2379 —386 6756 119
3(8) —381 —1857 7145 111
3(9) —487 —2311 8187 79
3(11) 711 —1671 9205 55
Hf12) 3170 —290 9865 53
H(13A) 5565 —2308 9129 80
H(13B) 4118 —2522 9730 80
H(14A) 3274 —3954 8631 89
3(143) 4407 —4611 9217 89
xiv
Table 4. Anisotropic parameters (Â2 x l0) for C14 H16 03.
The anisotropic dispiacement factor exponent takes the form:
—2 2 [ h2 a2 Uli ÷ - - . + 2 h k a* b* U12
Uli U22 U33 U23 U13 U12
0(1) 54(1) 44(1) 108(1) —6(1)
—4(1) 6(1)
0(12) 42(1) 39(1) 75(1) —3(1) 7(1)
—3(1)
0(14) 134(1) 43(1) 112(1) —7(1) 62(1)
—11(1)
C(l) 50(1) 39(1) 54(1)
—6(1)
—5(1) —2(1)
C(2) 50(1) 45(1) 83(1) 6(1) 2(1)
—6(1)
C(3) 38(1) 47(1) 59(1)
—2(1)
—5(1) —3(1)
Cf4) 49(1) 65(1) 72(1) —5(1) 13(1)
—12(1)
C(5) 59(1) 59(1) 51(1)
—5(1) 10(1) 3(1)
C(6) 96(2) 98(2) 55(1) 1(1) 16(1) 1(2)
CC7) 113(2) 138(2) 47(1)
—8(1) 2(1) 19(2)
CtB) 79(2) 132(2) 68(1)
—43(1)
—19(1) 14(1)
C(9) 56(1) 75(1) 67(1) —24(1)
—6(1) 2(1)
CflO) 46 (1) 44(1) 52 (1) —9(1)
—1(1) 6(1)
Ctll) 46(1) 37(1) 55(1) 0(1)
—1(1)
—1(1)
0(12) 44(1) 41(1) 47(1) 2(1)
—3(1) 1(1)
0(13) 75(1) 47(1) 77(1) 5(1)
—6(1) 13(1)
0(14) 101(2) 43(1) 78(1) 5(1) 26(1) 14(1)
xv
Table 2. Atomic coordinates f’ 10) and equivalent isotropic
dispiacement parameters (À2 x l0) for C14 H16 03.
U(eq) is defined as one third of the trace of the orthogonalized
U±j tensor.
X y z U(ea)
0(1) —309(2) 2981(1) 9258(1) 68(1)
0(12) 724(2) 808(1) 9422(1) 52(1)
0(14) 1023(4) —4227(1) 9302(1) 97(1)
Cfl) 1211(3) 2110(2) 9271(1) 48(1)
C(2) 3752(3) 2278(2) 9144(1) 59(1)
Cf3) 4845(3) 848(2) 9191(1) 48(1)
C(4) 5860(3) 334(2) 8588(1) 62(1)
Cf5) 4004(3) —240(2) 8165(1) 56(1)
Cf6) 4007(5) 37(3) 7548(1) 83(1)
C(7) 2360(5) —573(3) 7172(1) 100(1)
C(8) 709(5)
—1445(3) 7403(1) 93(1)
C(9) 650(4) —1722(2) 8029(1) 66(1)
C(10) 2290(3) —1117(2) 8412(1) 48(1)
C(l1) 2297(3) —1374(1) 9090(1) 46(1)
C(12) 2828(3) —54(2) 9440(1) 44(1)
C(13) 4014(4)
—2516(2) 9288(1) 67(1)
cf14) 3291(4) —3927(2) 9073(1) 74(1)
n
xvi
Table 5. Bond lengths [À] and angles [O] for C14 H16 03
0(1)—C fi)
0(12)—C(12)
C(1)—C(2)
C(3)—Ct4)
C(4) —C(5)
C(5) —C(10)
C(7) —C(8)
C(9)—C(10)
C(li) —C(12)
C(13)—C(14)
1.208 (2)
1.4598 (18)
1.481(3)
1.526 (2)
1.511(3)
1.402 f2)
1.361(4)
1.386(2)
1.523 (2)
1.505(3)
0(12)—C(1)
0(14)—C(14)
C (2)—c (3)
C(3)—C(12)
C(5)—c(6)
cf6)—cf7)
C(8)—C(9)
C(10)
—C(11)
cfll)—c(13)
1.334(2)
1.414(3)
1.523 (2)
1.542(2)
1.380(2)
1.381(4)
1.398 f3)
1.506 (2)
1.539 (2)
c(l)—0f12)—C(12)
0 (1)
—c t 1) —c t 2)
c(1)—c(2)—c(3)
cf2)—Cf3)—C(12)
C(5)—C(4)—Cf3)
c(6)—C(5)—cf4)
C (5) —c (6) —c t 7)
C(7)—C(8)—C(9)
C(9)—Ctl0)—C(5)
C (5) —c (10) —C (ii)
C (10)-C (11)—C (13)
0(12) —c(12)—C(l1)
C (11)—c (12)—c(3)
0(14) —C (14) —C (13)
112.24(11)
128.07 (16)
106.59 (13)
103.68 (12)
112.80(14)
121.94(19)
120.1(2)
120.1(2)
119.33 (17)
118. 67(14)
113 .55 (14)
107 .77 (12)
116.45(13)
108.94(17)
0(1)—C (1) —0(12)
0(12)—C(1)—C(2)
cf2)—C(3)—C(4)
C(4) —C(3)—C(12)
C(6)—C(5)—C(10)
C (10) —C (5) —C (4)
C (8) —C (7) —C (6)
C(10) —C(9)—C(8)
C(9)—C(10)—C(11)
C (10) —C (11)—C (12)
C (12) —C (11)—C (13)
0f12)—C(12)—C(3)
C(14) —C(13)—C(11)
121.25(15)
110.67(14)
113.17(15)
113 .75 (13)
119.89(19)
118.13 (15)
120.8(2)
119.8(2)
122.01 (16)
111.00(12)
109.70(13)
106.00(11)
113 .13 (17)
xvii
Table 6. Torsion angles [0) for C14 H16 03.
c(12)—0(12)—C(1)-0(1)
C(12)
—0(12) —Cf1)—C(2)
0(l)—C (1)—c (2) —C(3)
0(12)—Cfl)
—c(2) —C(3)
c(1)—c(2)—c(3)—c(4)
C(1)—c(2)—cf3)—c(12)
c(2)—c(3) —C(4) —c(5)
C(12)—C(3)
—c(4) —Cf5)
Cf3) —c(4) —C(5)—C(6)
C(3) —C(4) —C(5) —C(l0)
C(l0)—C(5) —C(6) —C(7)
Cf4)—C(5)—C(6)—C(7)
C(5) —C(6) —C(7) —C(8)
C (6) —c (7) —C (8) —c (9)
C(7)—C(8)—C(9) —C(l0)
C(8) —C(9) —C(l0) —C(5)
C(8)—C (9)—C (10) —C(ll)
Cf6)—Cf5)—C(lO)—Cf9)
C(4) —C(5) —C(l0) —C(9)
C(6)—C(5) —C(l0) —C(ll)
C(4)—Cf5)—C(l0)—C(ll)
C(9)—C(10)—C(ll)—C(12)
C(5)—C(l0)—C(11)-C(12)
Cf9) -Cfl0) —C(ll)-C(13)
C(5)—C(l0)—C(ll)—C(13)
C(l) —0(12) —C(12)—Cfll)
Cfl) —0(12) —C(12)—C(3)
C(l0)—C(ll)—C(12)—0f12)
Cf13)—C(ll)—C(12)—0(12)
C (10) —C(ll) —C(12)—C(3)
C(13) —C(ll) —C(12)—C(3)
C(2) —C(3) —C (12)—0 (12)
C(4) —C(3)—Cfl2) —0(12)
C(2) —C(3)—C(12) —C(ll)
c (4)—c (3)—C (12) —C (11)
C(l0)—C(1l)—C(13)—C(14)
C(12)—C(1l)—C(13)—Cf14)
C (11)-C (13) —C (14) —0(14)
—176.93 (15)
2.14(19)
—177.05(17)
4.0 (2)
115.85(16)
—7.87(18)
—80.23 (19)
37.8(2)
138.0(2)
—44.3 (2)
—1.5 (3)
176.2 (2)
0.4 (4)
0.6(4)
—0.6(4)
—0.5 (3)
179.64(18)
1.6(3)
—176.25(16)
—178.57(18)
3.6 (2)
—139.83(16)
40.30 (19)
96.04(19)
—83.84(19)
—132.58(13)
—7.24(16)
74.81(16)
—158.89(14)
—44.04 (18)
82.25(16)
8.99 (16)
—114.34(15)
128.81(15)
5.47 (19)
—67.9 (2)
167.22 (16)
—58.3 (2)
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Table 7. Bond lengths [Â] and angles [0] related to the hydrogen
bonding for C14 H16 03.
D-H d(D-H) d(H. .A) <DHA dfD. .A)
0f14)—Hf14) 0.82 2.01 165.7 2.813(2) 0(1)#1
Syrnmetry transformations used to generate equivalent atoms:
*1 x.y—l,z
xix
o (‘4)
compound w±h the nurnber±ng scheme adopted. E11±pso±ds drawn a
40% probality level. Hydrogens represented by sphere cf arbitrary size.
ORTEP view cf the C14 H16 03
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